1	Articles	NNPS	O	Articles	_	0	SENT_1	[p1l1833t151r2057b205],

1	Point-of-care	JJ	O	point-of-care	amod	3	SENT_2	[p1l9t362r403b417],
2	genetic	JJ	O	genetic	amod	3	SENT_2	[p1l421t364r642b434],
3	testing	NN	O	testing	_	0	SENT_2	[p1l656t364r869b434],
4	for	IN	O	for	_	0	SENT_2	[p1l887t362r976b417],
5	personalisation	NN	O	personalisation	prep_for	3	SENT_2	[p1l991t362r1454b433],
6	of	IN	O	of	_	0	SENT_2	[p1l1473t362r1537b417],
7	@	IN	O	@	dep	8	SENT_2	[p1l1870t359r1934b433],
8	antiplatelet	JJ	O	antiplatelet	amod	9	SENT_2	[p1l6t454r359b525],
9	treatment	NN	O	treatment	prep_of	5	SENT_2	[p1l372t463r685b509],
10	(	CD	NUMBER	(	num	13	SENT_2	[p1l704t457r911b523],
11	RAPID	JJ	O	rapid	amod	13	SENT_2	[p1l704t457r911b523],
12	GENE	NN	O	gene	nn	13	SENT_2	[p1l929t457r1132b523],
13	)	NN	O	)	dep	3	SENT_2	[p1l929t457r1132b523],
14	:	:	O	:	_	0	SENT_2	[p1l929t457r1132b523],
15	a	DT	O	a	det	23	SENT_2	[p1l1151t472r1183b509],
16	prospective	JJ	O	prospective	amod	23	SENT_2	[p1l1199t456r1567b525],
17	,	,	O	,	_	0	SENT_2	[p1l1199t456r1567b525],
18	randomised	JJ	O	randomised	amod	23	SENT_2	[p1l9t545r381b609],
19	,	,	O	,	_	0	SENT_2	[p1l9t545r381b609],
20	proof-of-concept	JJ	O	proof-of-concept	amod	23	SENT_2	[p1l400t545r920b616],
21	trial	NN	O	trial	nn	23	SENT_2	[p1l933t545r1053b600],
22	jason	NN	PERSON	jason	nn	23	SENT_2	[p1l6t668r77b697],
23	D	NN	PERSON	d	dep	3	SENT_2	[p1l86t668r103b691],
24	Roberts	NNP	PERSON	Roberts	dep	23	SENT_2	[p1l112t665r211b696],
25	,	,	O	,	_	0	SENT_2	[p1l112t665r211b696],
26	George	NNP	PERSON	George	nn	28	SENT_2	[p1l221t667r307b699],
27	A	NNP	PERSON	A	nn	28	SENT_2	[p1l313t668r331b691],
28	Wells	NNP	PERSON	Wells	appos	24	SENT_2	[p1l339t665r410b696],
29	,	,	O	,	_	0	SENT_2	[p1l339t665r410b696],
30	Michel	NNP	PERSON	Michel	nn	33	SENT_2	[p1l419t665r503b691],
31	R	NNP	PERSON	R	nn	33	SENT_2	[p1l510t668r525b691],
32	Le	NNP	PERSON	Le	nn	33	SENT_2	[p1l533t667r560b691],
33	May	NNP	PERSON	May	appos	24	SENT_2	[p1l567t667r628b699],
34	,	,	O	,	_	0	SENT_2	[p1l567t667r628b699],
35	Marina	NNP	PERSON	Marina	nn	36	SENT_2	[p1l637t667r728b691],
36	Labinaz	NNP	PERSON	Labinaz	appos	24	SENT_2	[p1l736t665r839b696],
37	,	,	O	,	_	0	SENT_2	[p1l736t665r839b696],
38	Chris	NNP	PERSON	Chris	nn	39	SENT_2	[p1l848t665r910b691],
39	Glover	NNP	PERSON	Glover	appos	24	SENT_2	[p1l918t665r1001b696],
40	,	,	O	,	_	0	SENT_2	[p1l918t665r1001b696],
41	Michael	NNP	PERSON	Michael	nn	42	SENT_2	[p1l1011t665r1110b691],
42	Froeschl	NNP	PERSON	Froeschl	appos	24	SENT_2	[p1l1117t665r1224b696],
43	,	,	O	,	_	0	SENT_2	[p1l1117t665r1224b696],
44	Alexander	NNP	PERSON	Alexander	nn	45	SENT_2	[p1l1232t665r1361b691],
45	Dick	NNP	PERSON	Dick	appos	24	SENT_2	[p1l1368t665r1426b696],
46	,	,	O	,	_	0	SENT_2	[p1l1368t665r1426b696],
47	jean	NN	O	jean	appos	24	SENT_2	[p1l1430t667r1604b697],
48	.	.	O	.	_	0	SENT_2	[p1l1430t667r1604b697],

1	—	NN	O	—	_	0	SENT_3	[p1l1430t667r1604b697],
2	.	.	O	.	_	0	SENT_3	[p1l1430t667r1604b697],

1	Francois	NNP	PERSON	Francois	nn	2	SENT_4	[p1l1430t667r1604b697],
2	Marquis	NNP	PERSON	Marquis	_	0	SENT_4	[p1l1612t667r1721b699],
3	,	,	O	,	_	0	SENT_4	[p1l1612t667r1721b699],
4	Edward	NNP	PERSON	Edward	nn	5	SENT_4	[p1l11t710r105b736],
5	O'Brien	NNP	PERSON	O'Brien	appos	2	SENT_4	[p1l112t711r210b740],
6	,	,	O	,	_	0	SENT_4	[p1l112t711r210b740],
7	Sandro	NNP	PERSON	Sandro	nn	8	SENT_4	[p1l218t710r307b736],
8	Goncalves	NNP	PERSON	Goncalves	appos	2	SENT_4	[p1l315t710r448b740],
9	,	,	O	,	_	0	SENT_4	[p1l315t710r448b740],
10	Irena	NNP	PERSON	Irena	nn	11	SENT_4	[p1l457t712r519b736],
11	Druce	NNP	PERSON	Druce	appos	2	SENT_4	[p1l527t713r604b740],
12	,	,	O	,	_	0	SENT_4	[p1l527t713r604b740],
13	Alexandre	NNP	PERSON	Alexandre	nn	14	SENT_4	[p1l612t710r740b736],
14	Stewart	NNP	PERSON	Stewart	appos	2	SENT_4	[p1l746t712r852b740],
15	,	,	O	,	_	0	SENT_4	[p1l746t712r852b740],
16	Michael	NNP	PERSON	Michael	nn	18	SENT_4	[p1l861t710r960b736],
17	H	NNP	PERSON	H	nn	18	SENT_4	[p1l967t712r986b736],
18	Gollob	NNP	PERSON	Gollob	appos	2	SENT_4	[p1l994t710r1079b740],
19	,	,	O	,	_	0	SENT_4	[p1l994t710r1079b740],
20	Derek	NNP	PERSON	Derek	nn	21	SENT_4	[p1l1089t710r1159b736],
21	Y	NN	PERSON	y	appos	2	SENT_4	[p1l1166t712r1182b736],
22	F50	CD	NUMBER	f50	num	21	SENT_4	[p1l1189t712r1238b736],

1	Summary	NNP	O	Summary	nn	4	SENT_5	[p1l6t797r184b838],
2	Background	NNP	O	Background	nn	4	SENT_5	[p1l6t845r187b881],
3	Prospective	JJ	O	prospective	amod	4	SENT_5	[p1l205t845r383b882],
4	assessment	NN	O	assessment	nsubjpass	10	SENT_5	[p1l399t850r580b873],
5	of	IN	O	of	_	0	SENT_5	[p1l596t844r631b873],
6	pharmacogenetic	JJ	O	pharmacogenetic	amod	7	SENT_5	[p1l642t844r912b882],
7	strategies	NNS	O	strategy	prep_of	4	SENT_5	[p1l929t845r1076b882],
8	has	VBZ	O	have	aux	10	SENT_5	[p1l1093t844r1145b873],
9	been	VBN	O	be	auxpass	10	SENT_5	[p1l1162t844r1238b873],
10	limited	VBN	O	limit	_	0	SENT_5	[p1l1253t844r1366b873],
11	by	IN	O	by	_	0	SENT_5	[p1l1381t844r1418b882],
12	an	DT	O	a	det	13	SENT_5	[p1l1433t854r1471b873],
13	inability	NN	O	inability	agent	10	SENT_5	[p1l1487t844r1615b882],
14	to	TO	O	to	aux	15	SENT_5	[p1l1630t850r1660b873],
15	undertake	VB	O	undertake	xcomp	10	SENT_5	[p1l1676t844r1834b873],
16	Lancet	NNP	O	Lancet	dobj	15	SENT_5	[p1l6t899r75b917],
17	2012	CD	DATE	2012	num	16	SENT_5	[p1l81t900r140b921],
18	;	:	O	;	_	0	SENT_5	[p1l81t900r140b921],
19	379	CD	NUMBER	379	num	21	SENT_5	[p1l147t900r194b920],
20	:	:	O	:	_	0	SENT_5	[p1l147t900r194b920],
21	1705-11	CD	DATE	1705-11	dep	16	SENT_5	[p1l201t900r290b920],
22	bedside	NN	O	bedside	nn	24	SENT_5	[p1l303t890r423b919],
23	genetic	JJ	O	genetic	amod	24	SENT_5	[p1l435t891r547b928],
24	testing	NN	O	testing	dep	21	SENT_5	[p1l558t891r672b928],
25	.	.	O	.	_	0	SENT_5	[p1l558t891r672b928],

1	The	DT	O	the	det	5	SENT_6	[p1l684t890r745b919],
2	CYP2C19	NN	O	cyp2c19	nn	5	SENT_6	[p1l759t892r942b919],
3	*	NN	O	*	nn	5	SENT_6	[p1l759t892r942b919],
4	2	CD	NUMBER	2	num	5	SENT_6	[p1l759t892r942b919],
5	allele	NN	O	allele	nsubj	10	SENT_6	[p1l952t890r1032b919],
6	is	VBZ	O	be	cop	10	SENT_6	[p1l1044t891r1068b919],
7	a	DT	O	a	det	10	SENT_6	[p1l1080t900r1097b919],
8	common	JJ	O	common	amod	10	SENT_6	[p1l1108t900r1249b919],
9	genetic	JJ	O	genetic	amod	10	SENT_6	[p1l1260t891r1372b928],
10	variant	NN	O	variant	_	0	SENT_6	[p1l1383t891r1492b919],
11	associated	VBN	O	associate	partmod	10	SENT_6	[p1l1503t890r1662b919],
12	with	IN	O	with	_	0	SENT_6	[p1l1672t890r1741b919],
13	increased	VBN	O	increase	amod	14	SENT_6	[p1l1753t890r1902b919],
14	rates	NNS	O	rate	prep_with	11	SENT_6	[p1l1913t895r1987b919],
15	of	IN	O	of	_	0	SENT_6	[p1l1999t890r2035b919],
16	major	JJ	O	major	prep_of	14	SENT_6	[p1l2041t891r2134b928],
17	Published	VBN	O	publish	partmod	16	SENT_6	[p1l6t945r105b965],
18	Online	NN	O	online	nn	20	SENT_6	[p1l111t945r182b965],
19	adverse	JJ	O	adverse	amod	20	SENT_6	[p1l6t973r123b1002],
20	events	NNS	O	event	dobj	17	SENT_6	[p1l132t979r230b1002],
21	in	IN	O	in	_	0	SENT_6	[p1l240t974r271b1001],
22	individuals	NNS	O	individual	prep_in	17	SENT_6	[p1l280t973r452b1002],
23	given	VBN	O	give	partmod	22	SENT_6	[p1l462t974r546b1011],
24	clopidogrel	NN	O	clopidogrel	iobj	23	SENT_6	[p1l555t973r729b1011],
25	after	IN	O	after	dep	26	SENT_6	[p1l738t973r809b1002],
26	percutaneous	JJ	O	percutaneous	amod	31	SENT_6	[p1l817t979r1028b1010],
27	coronary	JJ	O	coronary	amod	31	SENT_6	[p1l1038t983r1175b1010],
28	intervention	NN	O	intervention	nn	31	SENT_6	[p1l1183t974r1375b1002],
29	(	CD	NUMBER	(	num	31	SENT_6	[p1l1386t975r1476b1011],
30	PCI	NN	O	pcus	nn	31	SENT_6	[p1l1386t975r1476b1011],
31	)	NN	O	)	dobj	23	SENT_6	[p1l1386t975r1476b1011],
32	.	.	O	.	_	0	SENT_6	[p1l1386t975r1476b1011],

1	We	PRP	O	we	nsubj	22	SENT_7	[p1l1485t976r1535b1002],
2	used	VBD	O	use	_	0	SENT_7	[p1l1544t973r1618b1002],
3	a	DT	O	a	det	5	SENT_7	[p1l1626t983r1643b1002],
4	novel	JJ	O	novel	amod	5	SENT_7	[p1l1651t973r1735b1002],
5	point	NN	O	point	dobj	2	SENT_7	[p1l1744t974r1835b1010],
6	-	:	O	-	_	0	SENT_7	[p1l1744t974r1835b1010],
7	March	NNP	DATE	March	dep	5	SENT_7	[p1l1873t973r1935b993],
8	292012	CD	NUMBER	292012	num	7	SENT_7	[p1l1943t976r2032b997],
9	of-care	JJ	O	of-care	amod	11	SENT_7	[p1l6t1019r110b1048],
10	genetic	JJ	O	genetic	amod	11	SENT_7	[p1l123t1020r235b1057],
11	test	NN	O	test	dep	7	SENT_7	[p1l246t1025r302b1048],
12	to	TO	O	to	aux	13	SENT_7	[p1l313t1025r343b1048],
13	identify	VB	O	identify	xcomp	2	SENT_7	[p1l355t1019r475b1057],
14	carriers	NNS	O	carrier	dobj	13	SENT_7	[p1l487t1020r604b1048],
15	of	IN	O	of	_	0	SENT_7	[p1l617t1019r652b1048],
16	the	DT	O	the	det	20	SENT_7	[p1l659t1019r708b1048],
17	CYP2C19	NN	O	cyp2c19	nn	20	SENT_7	[p1l723t1021r906b1048],
18	*	NN	O	*	nn	20	SENT_7	[p1l723t1021r906b1048],
19	2	CD	NUMBER	2	num	20	SENT_7	[p1l723t1021r906b1048],
20	allele	NN	O	allele	prep_of	14	SENT_7	[p1l917t1019r998b1048],
21	and	CC	O	and	_	0	SENT_7	[p1l1010t1019r1068b1048],
22	aimed	VBN	O	aim	conj_and	2	SENT_7	[p1l1080t1019r1177b1048],
23	to	TO	O	to	aux	24	SENT_7	[p1l1189t1025r1218b1048],
24	assess	VB	O	assess	xcomp	22	SENT_7	[p1l1230t1029r1326b1048],
25	a	DT	O	a	det	27	SENT_7	[p1l1339t1029r1355b1048],
26	pharmacogenetic	JJ	O	pharmacogenetic	amod	27	SENT_7	[p1l1368t1019r1638b1057],
27	approach	NN	O	approach	nsubj	30	SENT_7	[p1l1650t1019r1794b1056],
28	to	TO	O	to	aux	30	SENT_7	[p1l1806t1025r1836b1048],
29	'	''	O	'	_	0	SENT_7	[p1l1873t1010r2086b1072],
30	(	CD	NUMBER	(	xcomp	24	SENT_7	[p1l1873t1010r2086b1072],
31	?	.	O	?	_	0	SENT_7	[p1l1873t1010r2086b1072],

1	g	NN	O	g	_	0	SENT_8	[p1l1873t1010r2086b1072],
2	:61	CD	NUMBER	:61	num	1	SENT_8	[p1l1873t1010r2086b1072],
3	(	CD	NUMBER	(	num	4	SENT_8	[p1l1873t1010r2086b1072],
4	°	NN	O	°	dep	1	SENT_8	[p1l1873t1010r2086b1072],
5	1	CD	NUMBER	1	dep	4	SENT_8	[p1l1873t1010r2086b1072],
6	;	:	O	;	_	0	SENT_8	[p1l1873t1010r2086b1072],
7	)	CD	NUMBER	)	number	8	SENT_8	[p1l1873t1010r2086b1072],
8	(	CD	NUMBER	(	dep	5	SENT_8	[p1l1873t1010r2086b1072],
9	’	NN	O	’	dep	8	SENT_8	[p1l1873t1010r2086b1072],
10	61	CD	NUMBER	61	num	9	SENT_8	[p1l1873t1010r2086b1072],
11	(	CD	NUMBER	(	num	12	SENT_8	[p1l1873t1010r2086b1072],
12	:31	CD	NUMBER	:31	dep	8	SENT_8	[p1l1873t1010r2086b1072],
13	/	:	O	/	punct	8	SENT_8	[p1l1873t1010r2086b1072],
14	:	:	O	:	_	0	SENT_8	[p1l1873t1010r2086b1072],
15	(	CD	NUMBER	(	number	16	SENT_8	[p1l1873t1010r2086b1072],
16	1	CD	NUMBER	1	dep	4	SENT_8	[p1l1873t1010r2086b1072],
17	’	CD	NUMBER	’	num	18	SENT_8	[p1l1873t1010r2086b1072],
18	_	NN	O	_	dep	16	SENT_8	[p1l1873t1010r2086b1072],
19	1	CD	NUMBER	1	dep	16	SENT_8	[p1l1873t1010r2086b1072],
20	;	:	O	;	_	0	SENT_8	[p1l1873t1010r2086b1072],
21	l	NN	O	l	dep	4	SENT_8	[p1l1873t1010r2086b1072],
22	°	NN	O	°	dep	21	SENT_8	[p1l1873t1010r2086b1072],
23	'	''	O	'	_	0	SENT_8	[p1l1873t1010r2086b1072],
24	dual	JJ	O	dual	amod	26	SENT_8	[p1l6t1065r74b1094],
25	antiplatelet	JJ	O	antiplatelet	amod	26	SENT_8	[p1l84t1065r258b1102],
26	treatment	NN	O	treatment	dep	1	SENT_8	[p1l268t1071r422b1094],
27	after	IN	O	after	_	0	SENT_8	[p1l432t1065r503b1094],
28	PCI	NNP	O	PCI	prep_after	26	SENT_8	[p1l514t1067r581b1094],
29	.	.	O	.	_	0	SENT_8	[p1l514t1067r581b1094],

1	See	VB	O	see	_	0	SENT_9	[p1l1872t1097r1907b1115],
2	Comment	NN	O	comment	nn	3	SENT_9	[p1l1913t1097r2021b1115],
3	page	NN	O	page	dobj	1	SENT_9	[p1l2027t1102r2076b1121],
4	1680	CD	DATE	1680	num	3	SENT_9	[p1l2083t1095r2137b1115],

1	Methods	NNS	O	method	nsubjpass	17	SENT_10	[p1l7t1122r141b1149],
2	Between	IN	O	between	_	0	SENT_10	[p1l153t1124r286b1150],
3	Aug	NN	DATE	aug	prep_between	17	SENT_10	[p1l296t1123r360b1159],
4	26	CD	DATE	26	num	3	SENT_10	[p1l371t1124r414b1154],
5	,	,	DATE	,	_	0	SENT_10	[p1l371t1124r414b1154],
6	2010	CD	DATE	2010	conj_and	3	SENT_10	[p1l427t1124r505b1154],
7	,	,	O	,	_	0	SENT_10	[p1l427t1124r505b1154],
8	and	CC	O	and	_	0	SENT_10	[p1l517t1121r575b1150],
9	Iuly	NN	O	iuly	conj_and	3	SENT_10	[p1l586t1121r645b1158],
10	7	CD	NUMBER	7	num	9	SENT_10	[p1l656t1123r680b1154],
11	,	,	O	,	_	0	SENT_10	[p1l656t1123r680b1154],
12	2011	CD	DATE	2011	appos	9	SENT_10	[p1l693t1124r769b1154],
13	,	,	O	,	_	0	SENT_10	[p1l693t1124r769b1154],
14	200	CD	NUMBER	200	num	15	SENT_10	[p1l781t1124r835b1150],
15	patients	NNS	O	patient	appos	9	SENT_10	[p1l846t1122r969b1158],
16	were	VBD	O	be	auxpass	17	SENT_10	[p1l980t1131r1055b1150],
17	enrolled	VBN	O	enrol	_	0	SENT_10	[p1l1065t1121r1194b1150],
18	into	IN	O	into	_	0	SENT_10	[p1l1204t1122r1265b1150],
19	our	PRP$	O	we	poss	25	SENT_10	[p1l1275t1131r1330b1150],
20	prospective	JJ	O	prospective	amod	25	SENT_10	[p1l1339t1122r1525b1158],
21	,	,	O	,	_	0	SENT_10	[p1l1339t1122r1525b1158],
22	randomised	JJ	O	randomised	amod	25	SENT_10	[p1l1536t1121r1732b1154],
23	,	,	O	,	_	0	SENT_10	[p1l1536t1121r1732b1154],
24	proofof-concept	JJ	O	proofof-concept	amod	25	SENT_10	[p1l1743t1121r1836b1158, p1l6t1167r168b1204],
25	study	NN	O	study	prep_into	17	SENT_10	[p1l179t1167r267b1204],
26	.	.	O	.	_	0	SENT_10	[p1l179t1167r267b1204],

1	Patients	NNS	O	patient	nsubjpass	13	SENT_11	[p1l281t1168r405b1196],
2	undergoing	VBG	O	undergo	partmod	1	SENT_11	[p1l417t1167r601b1205],
3	PCI	NNP	O	PCI	dobj	2	SENT_11	[p1l612t1169r671b1196],
4	for	IN	O	for	_	0	SENT_11	[p1l683t1167r728b1196],
5	acute	JJ	O	acute	amod	7	SENT_11	[p1l739t1173r821b1196],
6	coronary	JJ	O	coronary	amod	7	SENT_11	[p1l833t1177r970b1205],
7	syndrome	NN	O	syndrome	prep_for	3	SENT_11	[p1l981t1167r1137b1205],
8	or	CC	O	or	_	0	SENT_11	[p1l1149t1177r1181b1196],
9	stable	JJ	O	stable	amod	10	SENT_11	[p1l1193t1167r1282b1196],
10	angina	NN	O	angina	conj_or	7	SENT_11	[p1l1294t1168r1400b1205],
11	were	VBD	O	be	auxpass	13	SENT_11	[p1l1411t1177r1486b1196],
12	randomly	RB	O	randomly	advmod	13	SENT_11	[p1l1497t1167r1649b1205],
13	assigned	VBN	O	assign	_	0	SENT_11	[p1l1659t1167r1796b1205],
14	to	TO	O	to	xcomp	13	SENT_11	[p1l1807t1173r1836b1196],

1	Division	NN	O	division	_	0	SENT_12	[p1l6t1244r93b1263],
2	of	IN	O	of	_	0	SENT_12	[p1l99t1243r123b1263],
3	Cardiology	NNP	O	Cardiology	prep_of	1	SENT_12	[p1l127t1243r245b1269],
4	(	CD	NUMBER	(	num	3	SENT_12	[p1l6t1281r19b1305],
5	J	NN	PERSON	j	nn	8	SENT_12	[p1l6t1281r19b1305],
6	D	NN	PERSON	d	nn	8	SENT_12	[p1l28t1281r41b1299],
7	Roberts	NNP	PERSON	Roberts	nn	8	SENT_12	[p1l49t1280r126b1300],
8	MD	NNP	O	MD	dep	3	SENT_12	[p1l134t1281r173b1303],
9	,	,	O	,	_	0	SENT_12	[p1l134t1281r173b1303],
10	Prof	NNP	PERSON	Prof	nn	15	SENT_12	[p1l6t1316r49b1336],
11	M	NNP	PERSON	M	nn	15	SENT_12	[p1l55t1318r73b1336],
12	R	NN	PERSON	r	nn	15	SENT_12	[p1l81t1318r93b1336],
13	Le	NNP	PERSON	Le	nn	15	SENT_12	[p1l100t1318r121b1336],
14	May	NNP	PERSON	May	nn	15	SENT_12	[p1l128t1318r171b1342],
15	MD	NNP	O	MD	appos	8	SENT_12	[p1l178t1318r218b1340],
16	,	,	O	,	_	0	SENT_12	[p1l178t1318r218b1340],
17	rapid	JJ	O	rapid	amod	19	SENT_12	[p1l6t1348r87b1386],
18	point-of-care	JJ	O	point-of-care	amod	19	SENT_12	[p1l97t1348r294b1386],
19	genotyping	NN	O	genotyping	appos	8	SENT_12	[p1l305t1349r480b1386],
20	or	CC	O	or	_	0	SENT_12	[p1l490t1358r523b1377],
21	to	TO	O	to	conj_or	8	SENT_12	[p1l532t1354r562b1377],
22	standard	JJ	O	standard	amod	23	SENT_12	[p1l573t1348r708b1377],
23	treatment	NN	O	treatment	pobj	21	SENT_12	[p1l718t1354r879b1377],
24	.	.	O	.	_	0	SENT_12	[p1l718t1354r879b1377],

1	Individuals	NNS	O	individual	nsubjpass	8	SENT_13	[p1l892t1348r1067b1377],
2	in	IN	O	in	_	0	SENT_13	[p1l1078t1349r1109b1377],
3	the	DT	O	the	det	6	SENT_13	[p1l1119t1348r1168b1377],
4	rapid	JJ	O	rapid	amod	6	SENT_13	[p1l1179t1348r1260b1386],
5	genotyping	NN	O	genotyping	nn	6	SENT_13	[p1l1270t1349r1446b1386],
6	group	NN	O	group	prep_in	1	SENT_13	[p1l1455t1358r1548b1386],
7	were	VBD	O	be	auxpass	8	SENT_13	[p1l1557t1358r1632b1377],
8	screened	VBN	O	screen	_	0	SENT_13	[p1l1643t1348r1782b1377],
9	for	IN	O	for	_	0	SENT_13	[p1l1791t1348r1836b1377],
10	Prof	NNP	O	Prof	nn	13	SENT_13	[p1l1873t1352r1916b1373],
11	M	NNP	O	M	nn	13	SENT_13	[p1l1922t1354r1940b1372],
12	Labinaz	NNP	O	Labinaz	nn	13	SENT_13	[p1l1948t1352r2025b1373],
13	MD.	NNP	O	MD.	prep_for	8	SENT_13	[p1l2032t1354r2071b1376],
14	.	.	O	.	_	0	SENT_13	[p1l2032t1354r2071b1376],

1	C	NN	O	c	nn	4	SENT_14	[p1l2078t1354r2090b1373],
2	G	NN	O	g	nn	4	SENT_14	[p1l6t1398r118b1422],
3	|	NNS	O	|	nn	4	SENT_14	[p1l6t1398r118b1422],
4	overMD	NN	O	overmd	_	0	SENT_14	[p1l6t1398r118b1422],
5	,	,	O	,	_	0	SENT_14	[p1l6t1398r118b1422],
6	the	DT	O	the	det	8	SENT_14	[p1l131t1394r180b1423],
7	CYP2C19	NN	O	cyp2c19	nn	8	SENT_14	[p1l199t1396r382b1423],
8	*	NN	O	*	appos	4	SENT_14	[p1l199t1396r382b1423],
9	2	CD	NUMBER	2	num	10	SENT_14	[p1l199t1396r382b1423],
10	allele	NN	O	allele	dep	8	SENT_14	[p1l397t1394r485b1423],
11	.	.	O	.	_	0	SENT_14	[p1l397t1394r485b1423],

1	Carriers	NNS	O	carrier	nsubjpass	3	SENT_15	[p1l504t1395r629b1423],
2	were	VBD	O	be	auxpass	3	SENT_15	[p1l645t1404r720b1423],
3	given	VBN	O	give	_	0	SENT_15	[p1l736t1395r821b1426],
4	10	CD	NUMBER	10	num	6	SENT_15	[p1l838t1397r870b1423],
5	mg	NN	O	mg	nn	6	SENT_15	[p1l887t1404r939b1426],
6	prasugrel	NN	O	prasugrel	dobj	3	SENT_15	[p1l955t1394r1103b1426],
7	daily	RB	SET	daily	advmod	3	SENT_15	[p1l1119t1394r1197b1426],
8	,	,	O	,	_	0	SENT_15	[p1l1119t1394r1197b1426],
9	and	CC	O	and	_	0	SENT_15	[p1l1215t1394r1273b1430],
10	non-carriers	NNS	O	non-carrier	dep	25	SENT_15	[p1l1289t1395r1480b1423],
11	and	CC	O	and	_	0	SENT_15	[p1l1497t1394r1555b1423],
12	patients	NNS	O	patient	dep	25	SENT_15	[p1l1571t1395r1694b1426],
13	in	IN	O	in	_	0	SENT_15	[p1l1712t1395r1743b1423],
14	the	DT	O	the	det	15	SENT_15	[p1l1759t1394r1808b1423],
15	standard	JJ	O	standard	prep_in	10	SENT_15	[p1l1825t1394r1961b1423],
16	"	``	O	"	punct	15	SENT_15	[p1l1998t1389r2106b1409],
17	"	``	O	"	punct	18	SENT_15	[p1l1998t1389r2106b1409],
18	F	NN	O	f	dep	15	SENT_15	[p1l1998t1389r2106b1409],
19	'	''	O	'	_	0	SENT_15	[p1l1998t1389r2106b1409],
20	°	CD	NUMBER	°	dep	25	SENT_15	[p1l1998t1389r2106b1409],
21	e5	NN	O	e5	nn	25	SENT_15	[p1l1998t1389r2106b1409],
22	‘	NN	O	‘	nn	25	SENT_15	[p1l1998t1389r2106b1409],
23	l	NN	O	l	nn	25	SENT_15	[p1l1998t1389r2106b1409],
24	"	''	O	"	punct	25	SENT_15	[p1l1998t1389r2106b1409],
25	MD	NN	O	md	dep	35	SENT_15	[p1l6t1440r45b1461],
26	’	NN	O	’	nn	31	SENT_15	[p1l6t1440r45b1461],
27	A	NN	O	a	nn	31	SENT_15	[p1l52t1439r66b1457],
28	W	NN	O	w	nn	31	SENT_15	[p1l74t1438r116b1458],
29	‘	CD	NUMBER	‘	num	31	SENT_15	[p1l74t1438r116b1458],
30	MD	NN	O	md	nn	31	SENT_15	[p1l123t1440r163b1461],
31	’	NN	O	’	dep	25	SENT_15	[p1l123t1440r163b1461],
32	treatment	NN	O	treatment	nn	33	SENT_15	[p1l182t1449r336b1472],
33	group	NN	O	group	nsubjpass	35	SENT_15	[p1l345t1453r438b1481],
34	were	VBD	O	be	auxpass	35	SENT_15	[p1l446t1453r521b1472],
35	given	VBN	O	give	conj_and	3	SENT_15	[p1l531t1444r615b1481],
36	75	CD	NUMBER	75	num	38	SENT_15	[p1l625t1445r659b1472],
37	mg	NN	O	mg	nn	38	SENT_15	[p1l670t1453r722b1481],
38	clopidogrel	NN	O	clopidogrel	dobj	35	SENT_15	[p1l731t1443r905b1481],
39	daily	RB	SET	daily	advmod	35	SENT_15	[p1l914t1443r992b1480],
40	.	.	O	.	_	0	SENT_15	[p1l914t1443r992b1480],

1	The	DT	O	the	det	3	SENT_16	[p1l1003t1443r1063b1472],
2	primary	JJ	O	primary	amod	3	SENT_16	[p1l1072t1444r1198b1481],
3	endpoint	NN	O	endpoint	_	0	SENT_16	[p1l1207t1443r1348b1480],
4	was	VBD	O	be	cop	6	SENT_16	[p1l1356t1453r1415b1472],
5	the	DT	O	the	det	6	SENT_16	[p1l1424t1443r1474b1472],
6	proportion	NN	O	proportion	rcmod	3	SENT_16	[p1l1483t1444r1651b1480],
7	of	IN	O	of	_	0	SENT_16	[p1l1660t1443r1696b1472],
8	C	NN	O	c	nn	10	SENT_16	[p1l1703t1445r1726b1472],
9	YP2C19	NN	O	yp2c19	nn	10	SENT_16	[p1l1728t1445r1886b1472],
10	*	NN	O	*	prep_of	6	SENT_16	[p1l1728t1445r1886b1472],
11	2	CD	NUMBER	2	num	12	SENT_16	[p1l1728t1445r1886b1472],
12	carriers	NNS	O	carrier	dep	6	SENT_16	[p1l1894t1444r2011b1472],
13	:	:	O	:	_	0	SENT_16	[p1l6t1485r215b1542],
14	:	:	O	:	_	0	SENT_16	[p1l6t1485r215b1542],
15	:	:	O	:	_	0	SENT_16	[p1l6t1485r215b1542],
16	lE	NN	O	le	dep	3	SENT_16	[p1l6t1485r215b1542],
17	'	''	O	'	_	0	SENT_16	[p1l6t1485r215b1542],
18	:	:	O	:	_	0	SENT_16	[p1l6t1485r215b1542],
19	l	NN	O	l	dep	16	SENT_16	[p1l6t1485r215b1542],
20	;	:	O	;	_	0	SENT_16	[p1l6t1485r215b1542],
21	:	:	O	:	_	0	SENT_16	[p1l6t1485r215b1542],
22	i	FW	O	i	dep	3	SENT_16	[p1l6t1485r215b1542],
23	:	:	O	:	_	0	SENT_16	[p1l6t1485r215b1542],
24	lnU	NN	O	lnu	dep	22	SENT_16	[p1l6t1485r215b1542],
25	,	,	O	,	_	0	SENT_16	[p1l6t1485r215b1542],
26	l	NN	O	l	appos	22	SENT_16	[p1l6t1485r215b1542],
27	\	CD	NUMBER	\	num	28	SENT_16	[p1l6t1485r215b1542],
28	SMl	NN	O	sml	rcmod	26	SENT_16	[p1l6t1485r215b1542],
29	)	CD	NUMBER	)	num	30	SENT_16	[p1l6t1485r215b1542],
30	lD	NN	O	ld	dobj	28	SENT_16	[p1l6t1485r215b1542],
31	'	''	O	'	_	0	SENT_16	[p1l6t1485r215b1542],
32	with	IN	O	with	_	0	SENT_16	[p1l227t1499r297b1528],
33	high	JJ	O	high	amod	35	SENT_16	[p1l309t1499r381b1537],
34	on-treatment	JJ	O	on-treatment	amod	35	SENT_16	[p1l393t1505r598b1528],
35	platelet	NN	O	platelet	prep_with	30	SENT_16	[p1l611t1499r725b1537],
36	reactivity	NN	O	reactivity	dep	44	SENT_16	[p1l737t1500r878b1537],
37	(	CD	NUMBER	(	num	39	SENT_16	[p1l892t1502r999b1537],
38	P2Y12	NN	O	p2y12	nn	39	SENT_16	[p1l892t1502r999b1537],
39	reactivity	NN	O	reactivity	dep	36	SENT_16	[p1l1013t1500r1154b1537],
40	unit	NN	O	unit	dep	44	SENT_16	[p1l1165t1500r1230b1528],
41	[	CD	NUMBER	[	num	40	SENT_16	[p1l1244t1502r1335b1537],
42	PRU	NNP	O	PRU	nn	44	SENT_16	[p1l1244t1502r1335b1537],
43	]	CD	NUMBER	]	num	44	SENT_16	[p1l1244t1502r1335b1537],
44	value	NN	O	value	dep	28	SENT_16	[p1l1349t1499r1431b1528],
45	of	IN	O	of	_	0	SENT_16	[p1l1444t1499r1479b1528],
46	more	JJR	O	more	mwe	47	SENT_16	[p1l1487t1509r1569b1528],
47	than	IN	O	than	quantmod	48	SENT_16	[p1l1581t1499r1652b1528],
48	234	CD	NUMBER	234	num	49	SENT_16	[p1l1666t1502r1730b1537],
49	)	NN	O	)	prep_of	44	SENT_16	[p1l1666t1502r1730b1537],
50	after	IN	O	after	_	0	SENT_16	[p1l1745t1499r1816b1528],
51	1	CD	DURATION	1	num	52	SENT_16	[p1l1829t1502r1843b1527],
52	week	NN	NUMBER	week	prep_after	28	SENT_16	[p1l1855t1499r1936b1528],
53	of	IN	O	of	_	0	SENT_16	[p1l1948t1499r1983b1528],
54	dual	JJ	O	dual	amod	55	SENT_16	[p1l1991t1499r2058b1528],
55	560	CD	NUMBER	560	prep_of	52	SENT_16	[p1l6t1558r250b1581],
56	.	.	O	.	_	0	SENT_16	[p1l6t1558r250b1581],

1	-	:	O	-	_	0	SENT_17	[p1l6t1558r250b1581],
2	.	.	O	.	_	0	SENT_17	[p1l6t1558r250b1581],

1	.	.	O	.	_	0	SENT_18	[p1l6t1558r250b1581],

1	;	:	O	;	_	0	SENT_19	[p1l6t1558r250b1581],
2	a	DT	O	a	det	4	SENT_19	[p1l6t1558r250b1581],
3	|	NN	O	|	nn	4	SENT_19	[p1l6t1558r250b1581],
4	\	NN	O	\	_	0	SENT_19	[p1l6t1558r250b1581],
5	,	,	O	,	_	0	SENT_19	[p1l6t1558r250b1581],
6	e5MD	NN	O	e5md	dep	4	SENT_19	[p1l6t1558r250b1581],
7	,	,	O	,	_	0	SENT_19	[p1l6t1558r250b1581],
8	|	CD	NUMBER	|	num	10	SENT_19	[p1l6t1558r250b1581],
9	D.-Uce	NN	O	d.-uce	nn	10	SENT_19	[p1l6t1558r250b1581],
10	M5	NN	O	m5	appos	6	SENT_19	[p1l257t1559r304b1581],
11	,	,	O	,	_	0	SENT_19	[p1l257t1559r304b1581],
12	;	:	O	;	_	0	SENT_19	[p1l257t1559r304b1581],
13	antiplatelet	JJ	O	antiplatelet	amod	14	SENT_19	[p1l317t1545r492b1582],
14	treatment	NN	O	treatment	dep	4	SENT_19	[p1l507t1551r669b1578],
15	,	,	O	,	_	0	SENT_19	[p1l507t1551r669b1578],
16	which	WDT	O	which	nsubj	19	SENT_19	[p1l685t1545r781b1573],
17	is	VBZ	O	be	cop	19	SENT_19	[p1l797t1546r822b1573],
18	a	DT	O	a	det	19	SENT_19	[p1l839t1555r855b1573],
19	marker	NN	O	marker	rcmod	14	SENT_19	[p1l871t1545r986b1573],
20	associated	VBN	O	associate	partmod	19	SENT_19	[p1l1001t1545r1160b1573],
21	with	IN	O	with	_	0	SENT_19	[p1l1175t1545r1245b1573],
22	increased	VBN	O	increase	prepc_with	20	SENT_19	[p1l1261t1545r1410b1573],
23	adverse	JJ	O	adverse	amod	25	SENT_19	[p1l1426t1545r1544b1573],
24	cardiovascular	JJ	O	cardiovascular	amod	25	SENT_19	[p1l1560t1545r1785b1573],
25	events	NNS	O	event	dobj	22	SENT_19	[p1l1800t1551r1907b1573],
26	.	.	O	.	_	0	SENT_19	[p1l1800t1551r1907b1573],

1	Interventional	JJ	O	interventional	amod	5	SENT_20	[p1l1925t1545r2147b1573],
2	M	NN	O	m	nn	5	SENT_20	[p1l6t1595r24b1613],
3	H	NN	O	h	nn	5	SENT_20	[p1l33t1595r46b1613],
4	Gollob	NNP	ORGANIZATION	Gollob	nn	5	SENT_20	[p1l53t1593r119b1613],
5	MD	NNP	ORGANIZATION	MD	nsubjpass	18	SENT_20	[p1l126t1595r166b1616],
6	,	,	O	,	_	0	SENT_20	[p1l126t1595r166b1616],
7	DY	NNP	O	DY	appos	5	SENT_20	[p1l174t1595r206b1613],
8	F	NN	O	f	nn	11	SENT_20	[p1l213t1595r222b1613],
9	50	CD	NUMBER	50	num	11	SENT_20	[p1l229t1595r253b1613],
10	MD	NN	O	md	nn	11	SENT_20	[p1l261t1594r310b1618],
11	)	NN	O	)	dep	7	SENT_20	[p1l261t1594r310b1618],
12	,	,	O	,	_	0	SENT_20	[p1l261t1594r310b1618],
13	cardiologists	NNS	O	cardiologist	conj_and	11	SENT_20	[p1l6t1620r202b1657],
14	and	CC	O	and	_	0	SENT_20	[p1l215t1620r273b1648],
15	data	NNS	O	datum	nn	16	SENT_20	[p1l284t1620r348b1648],
16	analysts	NNS	O	analyst	conj_and	11	SENT_20	[p1l360t1620r483b1657],
17	were	VBD	O	be	auxpass	18	SENT_20	[p1l495t1630r570b1648],
18	masked	VBN	O	mask	_	0	SENT_20	[p1l581t1620r703b1648],
19	to	TO	O	to	_	0	SENT_20	[p1l713t1625r743b1648],
20	genetic	JJ	O	genetic	amod	21	SENT_20	[p1l754t1621r867b1657],
21	status	NN	O	status	prep_to	18	SENT_20	[p1l879t1625r969b1648],
22	and	CC	O	and	_	0	SENT_20	[p1l981t1620r1039b1648],
23	treatment	NN	O	treatment	conj_and	21	SENT_20	[p1l1050t1625r1211b1648],
24	.	.	O	.	_	0	SENT_20	[p1l1050t1625r1211b1648],

1	Patients	NNS	O	patient	nsubjpass	4	SENT_21	[p1l1225t1621r1349b1648],
2	were	VBD	O	be	auxpass	4	SENT_21	[p1l1360t1630r1435b1648],
3	not	RB	O	not	neg	4	SENT_21	[p1l1447t1625r1498b1648],
4	masked	VBN	O	mask	_	0	SENT_21	[p1l1509t1620r1631b1648],
5	to	TO	O	to	_	0	SENT_21	[p1l1641t1625r1671b1648],
6	treatment	NN	O	treatment	nn	7	SENT_21	[p1l1682t1625r1836b1648],
7	allocation	NN	O	allocation	prep_to	4	SENT_21	[p1l6t1666r165b1694],
8	.	.	O	.	_	0	SENT_21	[p1l6t1666r165b1694],

1	All	DT	O	all	det	2	SENT_22	[p1l176t1666r221b1694],
2	analyses	NNS	O	analysis	nsubj	3	SENT_22	[p1l231t1665r361b1703],
3	were	VBD	O	be	_	0	SENT_22	[p1l371t1676r446b1694],
4	by	IN	O	by	_	0	SENT_22	[p1l456t1666r493b1703],
5	intention	NN	O	intention	prep_by	3	SENT_22	[p1l503t1667r647b1694],
6	to	TO	O	to	aux	7	SENT_22	[p1l657t1671r686b1694],
7	treat	VB	O	treat	xcomp	3	SENT_22	[p1l696t1671r774b1694],
8	.	.	O	.	_	0	SENT_22	[p1l696t1671r774b1694],

1	This	DT	O	this	det	2	SENT_23	[p1l786t1666r855b1694],
2	study	NN	O	study	nsubjpass	4	SENT_23	[p1l867t1666r950b1703],
3	is	VBZ	O	be	auxpass	4	SENT_23	[p1l960t1667r985b1694],
4	registered	VBN	O	register	_	0	SENT_23	[p1l996t1665r1152b1703],
5	with	IN	O	with	_	0	SENT_23	[p1l1161t1666r1230b1694],
6	ClinicalTrials	NNS	O	clinicaltrial	prep_with	4	SENT_23	[p1l1242t1666r1516b1703],
7	.	.	O	.	_	0	SENT_23	[p1l1242t1666r1516b1703],

1	gov	NN	O	gov	_	0	SENT_24	[p1l1242t1666r1516b1703],
2	,	,	O	,	_	0	SENT_24	[p1l1242t1666r1516b1703],
3	NCT01184300	NN	O	nct01184300	appos	1	SENT_24	[p1l1529t1667r1755b1694],
4	.	.	O	.	_	0	SENT_24	[p1l1529t1667r1755b1694],

1	Cardiovascular	NNP	O	Cardiovascular	nn	2	SENT_25	[p1l6t1737r165b1757],
2	Methods	NNS	O	method	_	0	SENT_25	[p1l171t1737r267b1757],
3	Centre	NNP	O	Centre	dep	2	SENT_25	[p1l273t1739r343b1757],
4	(	CD	NUMBER	(	num	3	SENT_25	[p1l7t1773r76b1799],
5	ProfG	NNP	O	ProfG	nn	9	SENT_25	[p1l7t1773r76b1799],
6	A	NNP	O	A	nn	9	SENT_25	[p1l82t1775r97b1793],
7	Wells	NNP	O	Wells	nn	9	SENT_25	[p1l102t1773r155b1793],
8	PhD	NN	O	phd	nn	9	SENT_25	[p1l163t1773r218b1798],
9	)	NN	O	)	dep	3	SENT_25	[p1l163t1773r218b1798],
10	,	,	O	,	_	0	SENT_25	[p1l163t1773r218b1798],
11	and	CC	O	and	_	0	SENT_25	[p1l225t1773r265b1793],
12	Canadian	JJ	MISC	canadian	amod	13	SENT_25	[p1l6t1810r106b1830],
13	Cardiovascular	NNP	MISC	Cardiovascular	conj_and	3	SENT_25	[p1l112t1810r271b1830],

1	Genetics	NNP	O	Genetics	nn	3	SENT_26	[p1l1985t1847r2077b1866],
2	Centre	NNP	O	Centre	nn	3	SENT_26	[p1l2083t1847r2154b1866],
3	Findings	NNS	O	finding	nsubj	9	SENT_26	[p1l8t1882r136b1917],
4	After	IN	O	after	_	0	SENT_26	[p1l147t1881r226b1909],
5	randomisation	NN	O	randomisation	prep_after	9	SENT_26	[p1l236t1881r473b1914],
6	,	,	O	,	_	0	SENT_26	[p1l236t1881r473b1914],
7	187	CD	NUMBER	187	num	8	SENT_26	[p1l486t1882r537b1909],
8	patients	NNS	O	patient	appos	5	SENT_26	[p1l548t1882r670b1918],
9	completed	VBD	O	complete	_	0	SENT_26	[p1l682t1881r844b1918],
10	follow-up	JJ	O	follow-up	acomp	9	SENT_26	[p1l855t1881r1001b1918],
11	(	CD	NUMBER	(	tmod	10	SENT_26	[p1l1014t1883r1057b1918],
12	91	CD	NUMBER	91	num	15	SENT_26	[p1l1014t1883r1057b1918],
13	rapid	JJ	O	rapid	amod	15	SENT_26	[p1l1068t1881r1149b1918],
14	genotyping	NN	O	genotyping	nn	15	SENT_26	[p1l1160t1882r1334b1918],
15	group	NN	O	group	dep	10	SENT_26	[p1l1345t1891r1445b1918],
16	,	,	O	,	_	0	SENT_26	[p1l1345t1891r1445b1918],
17	96	CD	NUMBER	96	num	20	SENT_26	[p1l1458t1883r1493b1909],
18	standard	JJ	O	standard	amod	20	SENT_26	[p1l1505t1881r1639b1909],
19	treatment	NN	O	treatment	nn	20	SENT_26	[p1l1650t1884r1822b1918],
20	)	NN	O	)	appos	15	SENT_26	[p1l1650t1884r1822b1918],
21	.	.	O	.	_	0	SENT_26	[p1l1650t1884r1822b1918],

1	(	NN	O	(	nn	4	SENT_27	[p1l1860t1884r1882b1908],
2	A	NN	O	a	nn	4	SENT_27	[p1l1860t1884r1882b1908],
3	Stewart	NNP	O	Stewart	nn	4	SENT_27	[p1l1889t1884r1968b1903],
4	PHD	NNP	O	PHD	_	0	SENT_27	[p1l1975t1883r2030b1908],
5	)	NN	O	)	dep	4	SENT_27	[p1l1975t1883r2030b1908],
6	.	.	O	.	_	0	SENT_27	[p1l1975t1883r2030b1908],

1	University	NNP	O	University	dep	3	SENT_28	[p1l2037t1884r2148b1909],
2	23	CD	NUMBER	23	dep	1	SENT_28	[p1l7t1929r41b1955],
3	individuals	NNS	O	individual	nsubj	7	SENT_28	[p1l55t1926r226b1955],
4	in	IN	O	in	_	0	SENT_28	[p1l239t1927r270b1954],
5	each	DT	O	each	det	6	SENT_28	[p1l283t1926r353b1955],
6	group	NN	O	group	prep_in	3	SENT_28	[p1l365t1936r457b1964],
7	carried	VBD	O	carry	_	0	SENT_28	[p1l469t1926r577b1955],
8	at	IN	O	at	quantmod	10	SENT_28	[p1l589t1932r617b1955],
9	least	JJS	O	least	mwe	8	SENT_28	[p1l628t1926r699b1954],
10	one	CD	NUMBER	one	nn	15	SENT_28	[p1l711t1936r767b1955],
11	CYP2C19	NN	O	cyp2c19	nn	13	SENT_28	[p1l782t1928r964b1955],
12	"	''	O	"	punct	13	SENT_28	[p1l782t1928r964b1955],
13	‘	NN	O	‘	dep	10	SENT_28	[p1l782t1928r964b1955],
14	2	CD	NUMBER	2	amod	15	SENT_28	[p1l782t1928r964b1955],
15	allele	NN	O	allele	dobj	7	SENT_28	[p1l974t1926r1062b1955],
16	.	.	O	.	_	0	SENT_28	[p1l974t1926r1062b1955],

1	None	NN	O	none	_	0	SENT_29	[p1l1077t1929r1159b1955],
2	of	IN	O	of	dep	1	SENT_29	[p1l1172t1926r1207b1954],
3	the	DT	O	the	det	5	SENT_29	[p1l1213t1926r1262b1955],
4	23	CD	NUMBER	23	num	5	SENT_29	[p1l1275t1929r1309b1955],
5	carriers	NNS	O	carrier	pobj	2	SENT_29	[p1l1323t1927r1439b1955],
6	in	IN	O	in	_	0	SENT_29	[p1l1452t1927r1484b1954],
7	the	DT	O	the	det	10	SENT_29	[p1l1495t1926r1544b1955],
8	rapid	JJ	O	rapid	amod	10	SENT_29	[p1l1556t1926r1637b1963],
9	genotyping	NN	O	genotyping	nn	10	SENT_29	[p1l1649t1927r1824b1964],
10	(	NN	O	(	prep_in	5	SENT_29	[p1l1859t1919r2139b1975],
11	'	''	O	'	_	0	SENT_29	[p1l1859t1919r2139b1975],
12	;	:	O	;	_	0	SENT_29	[p1l1859t1919r2139b1975],
13	ft	NN	O	ft	dep	10	SENT_29	[p1l1859t1919r2139b1975],
14	:	:	O	:	_	0	SENT_29	[p1l1859t1919r2139b1975],
15	)	CD	NUMBER	)	num	16	SENT_29	[p1l1859t1919r2139b1975],
16	E1t	NN	O	e1t	dep	13	SENT_29	[p1l1859t1919r2139b1975],
17	:	:	O	:	_	0	SENT_29	[p1l1859t1919r2139b1975],
18	v	LS	O	v	dep	16	SENT_29	[p1l1859t1919r2139b1975],
19	:	:	O	:	_	0	SENT_29	[p1l1859t1919r2139b1975],
20	w	VB	O	w	parataxis	18	SENT_29	[p1l1859t1919r2139b1975],
21	‘	CD	NUMBER	‘	dobj	20	SENT_29	[p1l1859t1919r2139b1975],
22	:	:	O	:	_	0	SENT_29	[p1l1859t1919r2139b1975],
23	'	''	O	'	_	0	SENT_29	[p1l1859t1919r2139b1975],
24	:	:	O	:	_	0	SENT_29	[p1l1859t1919r2139b1975],
25	'	''	O	'	_	0	SENT_29	[p1l1859t1919r2139b1975],
26	°	CD	NUMBER	°	nsubj	62	SENT_29	[p1l1859t1919r2139b1975],
27	:	:	O	:	_	0	SENT_29	[p1l1859t1919r2139b1975],
28	;	:	O	;	_	0	SENT_29	[p1l1859t1919r2139b1975],
29	T1	NN	O	t1	dep	26	SENT_29	[p1l1859t1919r2139b1975],
30	'	''	O	'	_	0	SENT_29	[p1l1859t1919r2139b1975],
31	a	DT	O	a	npadvmod	29	SENT_29	[p1l1859t1919r2139b1975],
32	'	''	O	'	_	0	SENT_29	[p1l1859t1919r2139b1975],
33	:	:	O	:	_	0	SENT_29	[p1l1859t1919r2139b1975],
34	:	:	O	:	_	0	SENT_29	[p1l1859t1919r2139b1975],
35	;	:	O	;	_	0	SENT_29	[p1l1859t1919r2139b1975],
36	‘	CD	NUMBER	‘	dep	37	SENT_29	[p1l1859t1919r2139b1975],
37	lt	NN	O	lt	dep	38	SENT_29	[p1l1859t1919r2139b1975],
38	”	NN	O	”	prep	43	SENT_29	[p1l1859t1919r2139b1975],
39	t	NN	O	t	dep	38	SENT_29	[p1l1859t1919r2139b1975],
40	°	NN	O	°	dep	38	SENT_29	[p1l1859t1919r2139b1975],
41	'	''	O	'	_	0	SENT_29	[p1l1859t1919r2139b1975],
42	group	NN	O	group	nsubj	43	SENT_29	[p1l7t1982r98b2009],
43	had	VBD	O	have	dep	31	SENT_29	[p1l109t1972r166b2000],
44	a	DT	O	a	det	46	SENT_29	[p1l176t1982r192b2000],
45	PRU	NNP	ORGANIZATION	PRU	nn	46	SENT_29	[p1l204t1975r277b2000],
46	value	NN	O	value	dobj	43	SENT_29	[p1l287t1972r369b2000],
47	of	IN	O	of	_	0	SENT_29	[p1l379t1972r415b2000],
48	more	JJR	O	more	mwe	49	SENT_29	[p1l420t1982r502b2000],
49	than	IN	O	than	quantmod	50	SENT_29	[p1l512t1972r582b2000],
50	234	CD	NUMBER	234	prep_of	46	SENT_29	[p1l593t1974r648b2000],
51	at	IN	O	at	mark	52	SENT_29	[p1l658t1977r685b2000],
52	day	NN	DURATION	day	dep	43	SENT_29	[p1l695t1972r748b2009],
53	7	CD	NUMBER	7	num	52	SENT_29	[p1l759t1973r784b2005],
54	,	,	O	,	_	0	SENT_29	[p1l759t1973r784b2005],
55	compared	VBN	O	compare	partmod	52	SENT_29	[p1l796t1972r951b2009],
56	with	IN	O	with	_	0	SENT_29	[p1l960t1972r1029b2000],
57	seven	CD	PERCENT	seven	prep_with	29	SENT_29	[p1l1040t1982r1126b2000],
58	(	CD	PERCENT	(	prep	29	SENT_29	[p1l1139t1974r1226b2009],
59	30	CD	PERCENT	30	advmod	58	SENT_29	[p1l1139t1974r1226b2009],
60	%	NN	PERCENT	%	dep	58	SENT_29	[p1l1139t1974r1226b2009],
61	)	CD	NUMBER	)	dep	26	SENT_29	[p1l1139t1974r1226b2009],
62	given	VBN	O	give	dep	1	SENT_29	[p1l1238t1973r1322b2009],
63	standard	JJ	O	standard	amod	66	SENT_29	[p1l1333t1972r1468b2000],
64	treatment	NN	O	treatment	nn	66	SENT_29	[p1l1477t1977r1631b2000],
65	(	NN	O	(	nn	66	SENT_29	[p1l1642t1974r1710b2009],
66	p	NN	O	p	dobj	62	SENT_29	[p1l1642t1974r1710b2009],
67	=	JJ	O	=	amod	68	SENT_29	[p1l1642t1974r1710b2009],
68	o	NN	O	o	dep	66	SENT_29	[p1l1642t1974r1710b2009],
69	-	:	O	-	_	0	SENT_29	[p1l1717t1988r1722b1993],
70	0092	CD	DATE	0092	number	71	SENT_29	[p1l1729t1974r1822b2009],
71	)	CD	NUMBER	)	dep	68	SENT_29	[p1l1729t1974r1822b2009],
72	.	.	O	.	_	0	SENT_29	[p1l1729t1974r1822b2009],
73	'	''	O	'	_	0	SENT_29	[p1l1941t1971r1946b1978],
74	'	''	O	'	_	0	SENT_29	[p1l1987t1971r1992b1978],

1	The	DT	O	the	det	4	SENT_30	[p1l6t2017r66b2045],
2	point-of-care	JJ	O	point-of-care	amod	4	SENT_30	[p1l76t2017r272b2054],
3	genetic	JJ	O	genetic	amod	4	SENT_30	[p1l283t2018r394b2054],
4	test	NN	O	test	nsubj	5	SENT_30	[p1l404t2023r459b2045],
5	had	VBD	O	have	_	0	SENT_30	[p1l468t2017r526b2045],
6	a	DT	O	a	det	7	SENT_30	[p1l536t2027r552b2045],
7	sensitivity	NN	O	sensitivity	dobj	5	SENT_30	[p1l563t2018r719b2054],
8	of	IN	O	of	_	0	SENT_30	[p1l729t2017r764b2045],
9	100	CD	PERCENT	100	number	10	SENT_30	[p1l770t2019r852b2047],
10	%	NN	PERCENT	%	amod	13	SENT_30	[p1l770t2019r852b2047],
11	(	CD	PERCENT	(	number	12	SENT_30	[p1l865t2019r942b2055],
12	95	CD	PERCENT	95	num	13	SENT_30	[p1l865t2019r942b2055],
13	%	NN	PERCENT	%	prep_of	7	SENT_30	[p1l865t2019r942b2055],
14	CI	NN	O	ci	dep	13	SENT_30	[p1l953t2019r989b2045],
15	92	CD	NUMBER	92	num	14	SENT_30	[p1l1001t2020r1036b2045],
16	-	:	O	-	_	0	SENT_30	[p1l1043t2033r1049b2038],
17	3-100	CD	NUMBER	3-100	num	18	SENT_30	[p1l1056t2020r1154b2055],
18	)	NN	O	)	dep	13	SENT_30	[p1l1056t2020r1154b2055],
19	and	CC	O	and	_	0	SENT_30	[p1l1166t2017r1224b2045],
20	a	DT	O	a	det	21	SENT_30	[p1l1234t2027r1250b2045],
21	speciﬁcity	NN	O	speciﬁcity	dep	13	SENT_30	[p1l1261t2017r1415b2054],
22	of	IN	O	of	_	0	SENT_30	[p1l1425t2017r1460b2045],
23	99	CD	NUMBER	99	prep_of	21	SENT_30	[p1l1466t2020r1501b2045],
24	-	:	O	-	_	0	SENT_30	[p1l1508t2033r1513b2038],
25	3	CD	PERCENT	3	num	26	SENT_30	[p1l1521t2019r1569b2047],
26	%	NN	PERCENT	%	dep	13	SENT_30	[p1l1521t2019r1569b2047],
27	(	CD	NUMBER	(	number	28	SENT_30	[p1l1581t2020r1627b2055],
28	96	CD	NUMBER	96	dep	26	SENT_30	[p1l1581t2020r1627b2055],
29	-	:	O	-	_	0	SENT_30	[p1l1634t2033r1639b2038],
30	3-100	CD	NUMBER	3-100	dep	13	SENT_30	[p1l1647t2020r1755b2055],
31	)	NN	O	)	dep	30	SENT_30	[p1l1647t2020r1755b2055],
32	.	.	O	.	_	0	SENT_30	[p1l1647t2020r1755b2055],

1	Correspondence	NN	O	correspondence	_	0	SENT_31	[p1l1860t2003r2025b2029],
2	to	TO	O	to	dep	1	SENT_31	[p1l2030t2007r2057b2023],
3	:	:	O	:	_	0	SENT_31	[p1l2030t2007r2057b2023],
4	Dr	NN	O	dr	nn	6	SENT_31	[p1l1860t2041r1883b2059],
5	DerekY	NN	O	dereky	nn	6	SENT_31	[p1l1890t2039r1964b2059],
6	F	NN	O	f	dep	1	SENT_31	[p1l1972t2041r1981b2059],
7	So	RB	O	so	advmod	6	SENT_31	[p1l1987t2041r2017b2062],
8	,	,	O	,	_	0	SENT_31	[p1l1987t2041r2017b2062],
9	University	NNP	ORGANIZATION	University	appos	6	SENT_31	[p1l2024t2041r2127b2065],
10	of	IN	ORGANIZATION	of	_	0	SENT_31	[p1l2132t2039r2154b2059],
11	Ottawa	NNP	ORGANIZATION	Ottawa	nn	13	SENT_31	[p1l1830t2077r1905b2096],
12	Heart	NNP	ORGANIZATION	Heart	nn	13	SENT_31	[p1l1913t2077r1968b2096],
13	Institute	NNP	ORGANIZATION	Institute	prep_of	9	SENT_31	[p1l1975t2077r2067b2099],
14	,	,	O	,	_	0	SENT_31	[p1l1975t2077r2067b2099],
15	Ottawa	NNP	LOCATION	Ottawa	appos	13	SENT_31	[p1l2073t2077r2154b2099],
16	,	,	O	,	_	0	SENT_31	[p1l2073t2077r2154b2099],

1	Interpretation	NN	O	interpretation	nn	4	SENT_32	[p1l6t2111r221b2146],
2	Point-of-care	JJ	O	point-of-care	amod	4	SENT_32	[p1l234t2109r431b2138],
3	genetic	JJ	O	genetic	amod	4	SENT_32	[p1l441t2110r553b2147],
4	testing	NN	O	testing	nsubjpass	9	SENT_32	[p1l562t2110r669b2147],
5	after	IN	O	after	_	0	SENT_32	[p1l678t2109r749b2138],
6	PCI	NNP	O	PCI	prep_after	4	SENT_32	[p1l759t2111r818b2138],
7	can	MD	O	can	aux	9	SENT_32	[p1l829t2119r883b2138],
8	be	VB	O	be	auxpass	9	SENT_32	[p1l892t2109r928b2138],
9	done	VBN	O	do	_	0	SENT_32	[p1l938t2109r1015b2138],
10	effectively	RB	O	effectively	advmod	9	SENT_32	[p1l1025t2109r1181b2147],
11	at	IN	O	at	_	0	SENT_32	[p1l1190t2115r1217b2138],
12	the	DT	O	the	det	13	SENT_32	[p1l1226t2109r1275b2138],
13	bedside	NN	O	bedside	prep_at	9	SENT_32	[p1l1284t2109r1405b2138],
14	and	CC	O	and	_	0	SENT_32	[p1l1414t2109r1473b2138],
15	treatment	NN	O	treatment	conj_and	13	SENT_32	[p1l1481t2115r1636b2138],
16	of	IN	O	of	_	0	SENT_32	[p1l1645t2109r1681b2138],
17	identiﬁed	JJ	O	identiﬁed	prep_of	13	SENT_32	[p1l1685t2109r1835b2138],
18	ON	IN	O	on	_	0	SENT_32	[p1l1871t2114r1903b2133],
19	K1Y	NN	O	k1y	nn	20	SENT_32	[p1l1911t2114r1949b2132],
20	4W7	NN	O	4w7	prep_on	17	SENT_32	[p1l1955t2114r2005b2136],
21	,	,	O	,	_	0	SENT_32	[p1l1955t2114r2005b2136],
22	Canada	NNP	LOCATION	Canada	nn	25	SENT_32	[p1l2012t2112r2087b2133],
23	C	NNP	O	C	nn	25	SENT_32	[p1l6t2157r29b2184],
24	YP2C19	NN	O	yp2c19	nn	25	SENT_32	[p1l32t2157r194b2184],
25	*	NN	O	*	appos	20	SENT_32	[p1l32t2157r194b2184],
26	2	CD	NUMBER	2	num	27	SENT_32	[p1l32t2157r194b2184],
27	carriers	NNS	O	carrier	nsubj	31	SENT_32	[p1l203t2156r324b2184],
28	with	IN	O	with	_	0	SENT_32	[p1l334t2155r405b2184],
29	prasugrel	NN	O	prasugrel	prep_with	27	SENT_32	[p1l416t2155r568b2194],
30	can	MD	O	can	aux	31	SENT_32	[p1l579t2165r634b2184],
31	reduce	VB	O	reduce	rcmod	25	SENT_32	[p1l645t2155r753b2184],
32	high	JJ	O	high	amod	35	SENT_32	[p1l763t2155r837b2194],
33	on-treatment	JJ	O	on-treatment	amod	35	SENT_32	[p1l847t2161r1058b2184],
34	platelet	NN	O	platelet	nn	35	SENT_32	[p1l1068t2155r1185b2193],
35	reactivity	NN	O	reactivity	dobj	31	SENT_32	[p1l1195t2156r1344b2194],
36	.	.	O	.	_	0	SENT_32	[p1l1195t2156r1344b2194],

1	‘	NN	O	‘	_	0	SENT_33	[p1l1919t2149r2154b2173],
2	l‘°@°“aW“‘l‘°“’t	NN	O	l‘°@°“aw“‘l‘°“’t	dep	1	SENT_33	[p1l1919t2149r2154b2173],
3	"	''	O	"	punct	2	SENT_33	[p1l1919t2149r2154b2173],
4	“	SYM	O	“	dep	1	SENT_33	[p1l1919t2149r2154b2173],

1	Funding	NNP	O	Funding	nn	3	SENT_34	[p1l13t2325r306b2411],
2	Spartan	NNP	O	Spartan	nn	3	SENT_34	[p1l342t2327r627b2411],
3	Biosciences	NNP	O	Biosciences	_	0	SENT_34	[p1l654t2325r1107b2391],
4	.	.	O	.	_	0	SENT_34	[p1l654t2325r1107b2391],

1	Introduction	NN	O	introduction	_	0	SENT_35	[p1l14t2530r554b2609],

1	The	DT	O	the	det	3	SENT_36	[p1l7t2650r148b2718],
2	clinical	JJ	O	clinical	amod	3	SENT_36	[p1l195t2650r452b2718],
3	potential	NN	O	potential	nsubj	9	SENT_36	[p1l496t2650r816b2739],
4	of	IN	O	of	_	0	SENT_36	[p1l861t2650r943b2718],
5	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	3	SENT_36	[p1l974t2650r1640b2740],
6	has	VBZ	O	have	aux	9	SENT_36	[p1l1685t2650r1808b2718],
7	become	VBN	O	become	cop	9	SENT_36	[p1l1854t2650r2139b2718],
8	increasingly	RB	O	increasingly	advmod	9	SENT_36	[p1l8t2760r452b2850],
9	apparent	JJ	O	apparent	_	0	SENT_36	[p1l488t2773r811b2849],
10	in	IN	O	in	_	0	SENT_36	[p1l846t2764r920b2826],
11	several	JJ	O	several	amod	12	SENT_36	[p1l959t2760r1206b2828],
12	areas	NNS	O	area	prep_in	9	SENT_36	[p1l1244t2784r1428b2828],
13	of	IN	O	of	_	0	SENT_36	[p1l1469t2760r1551b2827],
14	medicine	NN	O	medicine	prep_of	12	SENT_36	[p1l1575t2760r1914b2828],
15	since	IN	O	since	_	0	SENT_36	[p1l1955t2764r2139b2828],
16	the	DT	O	the	det	17	SENT_36	[p1l7t2868r122b2937],
17	identiﬁcation	NN	O	identiﬁcation	prep_since	9	SENT_36	[p1l158t2868r642b2937],
18	of	IN	O	of	_	0	SENT_36	[p1l678t2868r760b2937],
19	common	JJ	O	common	amod	21	SENT_36	[p1l784t2893r1114b2937],
20	genetic	JJ	O	genetic	amod	21	SENT_36	[p1l1151t2873r1411b2958],
21	Variants	NNS	O	variant	prep_of	17	SENT_36	[p1l1444t2873r1731b2937],
22	that	WDT	O	that	nsubj	23	SENT_36	[p1l1767t2868r1909b2937],
23	affect	VBP	O	affect	rcmod	21	SENT_36	[p1l1944t2869r2141b2937],
24	treatment	NN	O	treatment	nn	25	SENT_36	[p1l7t2991r368b3045],
25	effectiveness	NN	O	effectiveness	dobj	23	SENT_36	[p1l387t2977r935b3045],
26	.	.	O	.	_	0	SENT_36	[p1l387t2977r935b3045],

1	“	NN	O	“	npadvmod	24	SENT_37	[p1l387t2977r935b3045],
2	Despite	IN	O	despite	_	0	SENT_37	[p1l956t2982r1229b3066],
3	compelling	JJ	O	compelling	amod	4	SENT_37	[p1l1251t2977r1661b3067],
4	ﬁndings	NNS	O	ﬁndings	prep_despite	24	SENT_37	[p1l1681t2977r1982b3067],
5	and	CC	O	and	_	0	SENT_37	[p1l2006t2977r2141b3045],
6	their	PRP$	O	they	poss	9	SENT_37	[p1l7t3087r181b3155],
7	proposed	VBN	O	propose	amod	9	SENT_37	[p1l207t3087r546b3176],
8	clinical	JJ	O	clinical	amod	9	SENT_37	[p1l574t3087r831b3155],
9	effects	NNS	O	effect	conj_and	4	SENT_37	[p1l860t3087r1111b3165],
10	,	,	O	,	_	0	SENT_37	[p1l860t3087r1111b3165],
11	integration	NN	O	integration	nsubjpass	24	SENT_37	[p1l1143t3091r1545b3177],
12	of	IN	O	of	_	0	SENT_37	[p1l1574t3087r1655b3155],
13	genetics	NNS	O	genetics	prep_of	11	SENT_37	[p1l1672t3091r1966b3177],
14	into	IN	O	into	_	0	SENT_37	[p1l1997t3091r2139b3154],
15	clinical	JJ	O	clinical	amod	16	SENT_37	[p1l9t3195r267b3264],
16	practice	NN	O	practice	prep_into	13	SENT_37	[p1l296t3200r579b3284],
17	as	IN	O	as	_	0	SENT_37	[p1l610t3220r681b3264],
18	a	DT	O	a	det	19	SENT_37	[p1l714t3220r752b3264],
19	way	NN	O	way	prep_as	16	SENT_37	[p1l779t3220r922b3285],
20	to	TO	O	to	_	0	SENT_37	[p1l949t3209r1016b3264],
21	guide	NN	O	guide	nn	22	SENT_37	[p1l1048t3195r1250b3285],
22	treatment	NN	O	treatment	prep_to	19	SENT_37	[p1l1279t3209r1640b3264],
23	is	VBZ	O	be	auxpass	24	SENT_37	[p1l1668t3200r1725b3264],
24	restricted	VBN	O	restrict	_	0	SENT_37	[p1l1757t3195r2139b3264],
25	?	.	O	?	_	0	SENT_37	[p1l1757t3195r2139b3264],

1	Major	JJ	O	major	amod	2	SENT_38	[p1l12t3309r226b3394],
2	obstacles	NNS	O	obstacle	nsubj	11	SENT_38	[p1l266t3304r590b3372],
3	to	TO	O	to	_	0	SENT_38	[p1l632t3318r700b3372],
4	genetic	JJ	O	genetic	amod	5	SENT_38	[p1l742t3309r1003b3394],
5	testing	NN	O	testing	prep_to	2	SENT_38	[p1l1041t3309r1289b3394],
6	in	IN	O	in	_	0	SENT_38	[p1l1328t3309r1402b3371],
7	the	DT	O	the	det	9	SENT_38	[p1l1441t3304r1555b3372],
8	clinical	JJ	O	clinical	amod	9	SENT_38	[p1l1596t3304r1854b3372],
9	setting	NN	O	setting	prep_in	5	SENT_38	[p1l1896t3309r2140b3394],
10	are	VBP	O	be	cop	11	SENT_38	[p1l9t3438r119b3482],
11	accessibility	NN	O	accessibility	_	0	SENT_38	[p1l167t3414r601b3503],
12	and	CC	O	and	_	0	SENT_38	[p1l647t3414r783b3482],
13	its	PRP$	O	its	poss	15	SENT_38	[p1l829t3418r911b3481],
14	time-consuming	JJ	O	time-consuming	amod	15	SENT_38	[p1l960t3418r1569b3504],
15	nature	NN	O	nature	conj_and	11	SENT_38	[p1l1616t3427r1871b3482],
16	.	.	O	.	_	0	SENT_38	[p1l1616t3427r1871b3482],

1	These	DT	O	these	det	2	SENT_39	[p1l1921t3414r2139b3482],
2	diﬁiculties	NNS	O	diﬁiculties	nsubj	5	SENT_39	[p1l9t3522r391b3591],
3	are	VBP	O	be	cop	5	SENT_39	[p1l443t3547r552b3591],
4	particularly	RB	O	particularly	advmod	5	SENT_39	[p1l601t3522r1016b3612],
5	important	JJ	O	important	_	0	SENT_39	[p1l1062t3527r1430b3611],
6	in	IN	O	in	_	0	SENT_39	[p1l1477t3527r1551b3589],
7	the	DT	O	the	det	8	SENT_39	[p1l1597t3522r1712b3591],
8	context	NN	O	context	prep_in	5	SENT_39	[p1l1762t3536r2023b3591],
9	of	IN	O	of	_	0	SENT_39	[p1l2071t3522r2153b3591],
10	percutaneous	JJ	O	percutaneous	amod	12	SENT_39	[p1l8t3645r500b3720],
11	coronary	JJ	O	coronary	amod	12	SENT_39	[p1l545t3656r866b3721],
12	intervention	NN	O	intervention	prep_of	8	SENT_39	[p1l906t3636r1354b3699],
13	(	CD	NUMBER	(	num	15	SENT_39	[p1l1401t3636r1608b3721],
14	PCI	NN	O	pcus	nn	15	SENT_39	[p1l1401t3636r1608b3721],
15	)	NN	O	)	tmod	12	SENT_39	[p1l1401t3636r1608b3721],
16	,	,	O	,	_	0	SENT_39	[p1l1401t3636r1608b3721],
17	when	WRB	O	when	advmod	22	SENT_39	[p1l1652t3631r1855b3700],
18	immediate	JJ	O	immediate	amod	20	SENT_39	[p1l1898t3636r2138b3699, p1l9t3741r183b3808],
19	treatment	NN	O	treatment	nn	20	SENT_39	[p1l206t3754r566b3808],
20	decisions	NNS	O	decision	nsubjpass	22	SENT_39	[p1l589t3741r925b3808],
21	are	VBP	O	be	auxpass	22	SENT_39	[p1l952t3765r1061b3808],
22	made	VBN	O	make	dep	15	SENT_39	[p1l1085t3741r1306b3808],
23	.	.	O	.	_	0	SENT_39	[p1l1085t3741r1306b3808],

1	Treatment	NN	O	treatment	nsubj	8	SENT_40	[p2l78t40r456b104],
2	with	IN	O	with	_	0	SENT_40	[p2l482t35r645b103],
3	aspirin	NN	O	aspirin	prep_with	1	SENT_40	[p2l675t40r928b124],
4	and	CC	O	and	_	0	SENT_40	[p2l958t35r1094b104],
5	clopidogrel	NN	O	clopidogrel	prep_with	1	SENT_40	[p2l1123t35r1527b125],
6	is	VBZ	O	be	cop	8	SENT_40	[p2l1557t40r1613b104],
7	standard	JJ	O	standard	amod	8	SENT_40	[p2l1648t35r1963b104],
8	care	NN	O	care	_	0	SENT_40	[p2l1992t60r2139b104],
9	for	IN	O	for	_	0	SENT_40	[p2l8t144r113b212],
10	patients	NNS	O	patient	prep_for	8	SENT_40	[p2l162t149r449b233],
11	after	IN	O	after	_	0	SENT_40	[p2l504t144r667b212],
12	PCI	NN	O	pcus	prep_after	10	SENT_40	[p2l720t149r901b212],
13	.	.	O	.	_	0	SENT_40	[p2l720t149r901b212],

1	“	NN	O	“	nn	3	SENT_41	[p2l720t149r901b212],
2	Many	JJ	O	many	amod	3	SENT_41	[p2l956t151r1160b234],
3	patients	NNS	O	patient	nsubj	10	SENT_41	[p2l1209t149r1496b233],
4	given	VBN	O	give	partmod	3	SENT_41	[p2l1551t149r1746b234],
5	this	DT	O	this	det	8	SENT_41	[p2l1796t144r1929b212],
6	dual	JJ	O	dual	amod	8	SENT_41	[p2l1983t144r2140b212],
7	antiplatelet	JJ	O	antiplatelet	amod	8	SENT_41	[p2l9t254r414b343],
8	regimen	NN	O	regimen	dobj	4	SENT_41	[p2l448t258r758b344],
9	remain	VBP	O	remain	cop	10	SENT_41	[p2l793t258r1057b322],
10	vulnerable	JJ	O	vulnerable	_	0	SENT_41	[p2l1091t254r1475b322],
11	to	TO	O	to	_	0	SENT_41	[p2l1510t267r1578b321],
12	major	JJ	O	major	amod	15	SENT_41	[p2l1615t258r1833b343],
13	adverse	JJ	O	adverse	amod	15	SENT_41	[p2l1868t254r2139b322],
14	cardiovascular	JJ	O	cardiovascular	amod	15	SENT_41	[p2l9t362r532b431],
15	events	NNS	O	event	prep_to	10	SENT_41	[p2l586t366r888b431],
16	.	.	O	.	_	0	SENT_41	[p2l586t366r888b431],

1	”	NN	O	”	nsubjpass	6	SENT_42	[p2l586t366r888b431],
2	This	DT	O	this	det	4	SENT_42	[p2l941t363r1101b431],
3	persistent	JJ	O	persistent	amod	4	SENT_42	[p2l1158t367r1519b451],
4	vulnerability	NN	O	vulnerability	dep	1	SENT_42	[p2l1569t362r2029b452],
5	is	VBZ	O	be	auxpass	6	SENT_42	[p2l2081t367r2137b431],
6	associated	VBN	O	associate	_	0	SENT_42	[p2l9t471r379b539],
7	with	IN	O	with	_	0	SENT_42	[p2l399t471r561b539],
8	high	JJ	O	high	amod	11	SENT_42	[p2l582t471r750b561],
9	on-treatment	JJ	O	on-treatment	amod	11	SENT_42	[p2l773t485r1250b539],
10	platelet	NN	O	platelet	nn	11	SENT_42	[p2l1271t471r1535b560],
11	reactivity	NN	O	reactivity	prep_with	6	SENT_42	[p2l1556t476r1892b560],
12	,	,	O	,	_	0	SENT_42	[p2l1556t476r1892b560],
13	which	WDT	O	which	nsubjpass	15	SENT_42	[p2l1916t471r2140b539],
14	is	VBZ	O	be	auxpass	15	SENT_42	[p2l8t586r65b650],
15	characterised	VBN	O	characterise	rcmod	11	SENT_42	[p2l111t582r593b650],
16	by	IN	O	by	_	0	SENT_42	[p2l633t582r719b671],
17	inadequate	JJ	O	inadequate	amod	18	SENT_42	[p2l759t582r1160b671],
18	inhibition	NN	O	inhibition	agent	15	SENT_42	[p2l1204t582r1567b650],
19	of	IN	O	of	_	0	SENT_42	[p2l1610t582r1691b650],
20	the	DT	O	the	det	23	SENT_42	[p2l1720t582r1834b650],
21	platelet	NN	O	platelet	nn	23	SENT_42	[p2l1877t582r2141b671],
22	P2Y12	NN	O	p2y12	nn	23	SENT_42	[p2l13t696r233b757],
23	receptor	NN	O	receptor	prep_of	18	SENT_42	[p2l320t704r620b779],
24	after	IN	O	after	_	0	SENT_42	[p2l703t690r867b759],
25	treatment	NN	O	treatment	prep_after	15	SENT_42	[p2l948t704r1308b759],
26	with	IN	O	with	_	0	SENT_42	[p2l1389t690r1551b759],
27	clopidogrel	NN	O	clopidogrel	prep_with	25	SENT_42	[p2l1636t690r2141b780],
28	.9	CD	NUMBER	.9	number	29	SENT_42	[p2l1636t690r2141b780],
29	‘“	CD	NUMBER	‘“	num	27	SENT_42	[p2l1636t690r2141b780],
30	Although	IN	O	although	mark	36	SENT_42	[p2l7t799r353b889],
31	several	JJ	O	several	amod	33	SENT_42	[p2l391t799r638b867],
32	clinical	JJ	O	clinical	amod	33	SENT_42	[p2l674t799r931b867],
33	variables	NNS	O	variable	nsubjpass	36	SENT_42	[p2l964t799r1283b868],
34	have	VBP	O	have	aux	36	SENT_42	[p2l1320t799r1487b867],
35	been	VBN	O	be	auxpass	36	SENT_42	[p2l1521t799r1698b867],
36	implicated	VBN	O	implicate	advcl	45	SENT_42	[p2l1734t799r2136b888],
37	,	,	O	,	_	0	SENT_42	[p2l1734t799r2136b888],
38	the	DT	O	the	det	40	SENT_42	[p2l7t909r122b977],
39	strongest	JJS	O	strongest	amod	40	SENT_42	[p2l155t922r490b999],
40	predictor	NN	O	predictor	nsubj	45	SENT_42	[p2l518t909r849b998],
41	is	VBZ	O	be	cop	45	SENT_42	[p2l878t913r934b977],
42	the	DT	O	the	det	45	SENT_42	[p2l966t909r1080b977],
43	loss-of-function	NN	O	loss-of-function	nn	45	SENT_42	[p2l1109t909r1678b977],
44	C	NN	O	c	nn	45	SENT_42	[p2l1715t914r1769b976],
45	YPZCI9	NN	O	ypzci9	ccomp	15	SENT_42	[p2l1775t914r2056b977],

1	vwvw	NN	O	vwvw	_	0	SENT_43	[p2l7t1179r540b1230],
2	.	.	O	.	_	0	SENT_43	[p2l7t1179r540b1230],

1	the	DT	O	the	det	2	SENT_44	[p2l7t1179r540b1230],
2	|	NN	O	|	_	0	SENT_44	[p2l7t1179r540b1230],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_44	[p2l7t1179r540b1230],
4	Vol	NNP	O	Vol	dep	2	SENT_44	[p2l585t1179r672b1230],
5	379	CD	NUMBER	379	num	6	SENT_44	[p2l691t1185r795b1237],
6	May	NNP	DATE	May	dep	2	SENT_44	[p2l844t1183r962b1244],
7	5,2012	CD	DATE	5,2012	num	6	SENT_44	[p2l979t1185r1181b1239],

1	allele	NN	O	allele	_	0	SENT_45	[p2l10t1372r142b1421],
2	(	CD	NUMBER	(	num	4	SENT_45	[p2l162t1375r496b1436],
3	rs4244285	NN	O	rs4244285	nn	4	SENT_45	[p2l162t1375r496b1436],
4	)	NN	O	)	dep	1	SENT_45	[p2l162t1375r496b1436],
5	.	.	O	.	_	0	SENT_45	[p2l162t1375r496b1436],

1	”	NN	O	”	nsubjpass	7	SENT_46	[p2l162t1375r496b1436],
2	This	DT	O	this	det	5	SENT_46	[p2l511t1372r625b1421],
3	common	JJ	O	common	amod	5	SENT_46	[p2l643t1390r879b1421],
4	genetic	JJ	O	genetic	amod	5	SENT_46	[p2l896t1376r1082b1436],
5	variant	NN	O	variant	dep	1	SENT_46	[p2l1096t1376r1276b1421],
6	is	VBZ	O	be	auxpass	7	SENT_46	[p2l1291t1376r1331b1421],
7	carried	VBN	O	carry	conj_and	7	SENT_46	[p2l1349t1372r1529b1421],
8	by	IN	O	by	_	0	SENT_46	[p2l8t1450r70b1514],
9	nearly	RB	O	nearly	quantmod	10	SENT_46	[p2l80t1450r241b1514],
10	30	CD	PERCENT	30	num	11	SENT_46	[p2l255t1453r366b1501],
11	%	NN	PERCENT	%	agent	7	SENT_46	[p2l255t1453r366b1501],
12	of	IN	O	of	_	0	SENT_46	[p2l380t1450r438b1499],
13	individuals	NNS	O	individual	prep_of	11	SENT_46	[p2l442t1450r727b1499],
14	of	IN	O	of	_	0	SENT_46	[p2l742t1450r801b1499],
15	western	JJ	O	western	amod	18	SENT_46	[p2l802t1460r1009b1499],
16	European	JJ	MISC	european	amod	18	SENT_46	[p2l1024t1453r1274b1513],
17	ancestry	NN	O	ancestry	nn	18	SENT_46	[p2l1287t1453r1528b1514],
18	“	NN	O	“	prep_of	13	SENT_46	[p2l1287t1453r1528b1514],
19	and	CC	O	and	_	0	SENT_46	[p2l10t1529r107b1577],
20	as	IN	O	as	_	0	SENT_46	[p2l124t1546r175b1577],
21	many	JJ	O	many	advmod	22	SENT_46	[p2l194t1546r343b1592],
22	as	IN	O	as	quantmod	23	SENT_46	[p2l359t1546r410b1577],
23	50	CD	PERCENT	50	num	24	SENT_46	[p2l432t1532r543b1579],
24	%	NN	PERCENT	%	prep_as	7	SENT_46	[p2l432t1532r543b1579],
25	of	IN	O	of	_	0	SENT_46	[p2l562t1529r621b1577],
26	those	DT	O	those	prep_of	24	SENT_46	[p2l629t1529r768b1577],
27	of	IN	O	of	_	0	SENT_46	[p2l787t1529r845b1577],
28	Asian	JJ	MISC	asian	amod	29	SENT_46	[p2l853t1532r1003b1577],
29	descent	NN	O	descent	prep_of	26	SENT_46	[p2l1021t1529r1261b1577],
30	.	.	O	.	_	0	SENT_46	[p2l1021t1529r1261b1577],

1	“	NN	O	“	_	0	SENT_47	[p2l1021t1529r1261b1577],
2	Two	CD	NUMBER	two	num	5	SENT_47	[p2l1276t1532r1383b1577],
3	large	JJ	O	large	amod	5	SENT_47	[p2l1400t1529r1528b1593],
4	meta-analyses	NNS	O	meta-analysis	nn	5	SENT_47	[p2l9t1606r438b1670],
5	”	NN	O	”	nsubj	6	SENT_47	[p2l9t1606r438b1670],
6	showed	VBD	O	show	rcmod	1	SENT_47	[p2l460t1606r657b1655],
7	that	IN	O	that	complm	21	SENT_47	[p2l676t1606r777b1655],
8	one	CD	NUMBER	one	num	9	SENT_47	[p2l797t1624r890b1655],
9	copy	NN	O	copy	nsubjpass	21	SENT_47	[p2l912t1624r1031b1670],
10	of	IN	O	of	_	0	SENT_47	[p2l1050t1606r1108b1655],
11	the	DT	O	the	det	13	SENT_47	[p2l1118t1606r1200b1655],
12	C	NN	O	c	nn	13	SENT_47	[p2l1225t1610r1264b1655],
13	YP2C19	NN	O	yp2c19	prep_of	9	SENT_47	[p2l1268t1610r1531b1655],
14	"	''	O	"	punct	13	SENT_47	[p2l1268t1610r1531b1655],
15	'	''	O	'	_	0	SENT_47	[p2l1268t1610r1531b1655],
16	~	FW	O	~	nn	17	SENT_47	[p2l1268t1610r1531b1655],
17	‘	FW	O	‘	amod	9	SENT_47	[p2l1268t1610r1531b1655],
18	2	CD	NUMBER	2	num	19	SENT_47	[p2l1268t1610r1531b1655],
19	allele	NN	O	allele	dep	9	SENT_47	[p2l10t1684r142b1733],
20	is	VBZ	O	be	auxpass	21	SENT_47	[p2l171t1687r211b1733],
21	associated	VBN	O	associate	ccomp	6	SENT_47	[p2l242t1684r506b1733],
22	with	IN	O	with	_	0	SENT_47	[p2l532t1684r647b1733],
23	a	DT	O	a	det	26	SENT_47	[p2l676t1701r703b1733],
24	signiﬁcantly	RB	O	signiﬁcantly	amod	26	SENT_47	[p2l733t1684r1050b1748],
25	increased	VBN	O	increase	dep	24	SENT_47	[p2l1077t1684r1326b1733],
26	risk	NN	O	risk	prep_with	21	SENT_47	[p2l1353t1684r1452b1733],
27	of	IN	O	of	_	0	SENT_47	[p2l1479t1684r1538b1733],
28	major	JJ	O	major	amod	31	SENT_47	[p2l9t1766r164b1826],
29	adverse	JJ	O	adverse	amod	31	SENT_47	[p2l190t1763r384b1811],
30	cardiovascular	JJ	O	cardiovascular	amod	31	SENT_47	[p2l411t1763r784b1811],
31	events	NNS	O	event	prep_of	26	SENT_47	[p2l810t1772r972b1811],
32	(	JJ	O	(	amod	34	SENT_47	[p2l1004t1763r1197b1827],
33	hazard	NN	O	hazard	nn	34	SENT_47	[p2l1004t1763r1197b1827],
34	ratio	NN	O	ratio	dep	1	SENT_47	[p2l1222t1766r1339b1811],
35	1	CD	NUMBER	1	dep	34	SENT_47	[p2l1368t1767r1409b1810],
36	-	:	O	-	_	0	SENT_47	[p2l1368t1767r1409b1810],
37	55	CD	DATE	55	number	38	SENT_47	[p2l1423t1765r1528b1827],
38	)	CD	NUMBER	)	num	39	SENT_47	[p2l1423t1765r1528b1827],
39	“	NN	O	“	dep	1	SENT_47	[p2l1423t1765r1528b1827],
40	and	CC	O	and	_	0	SENT_47	[p2l10t1840r107b1889],
41	stent	NN	O	stent	nn	42	SENT_47	[p2l131t1850r257b1889],
42	thrombosis	NN	O	thrombosis	dep	1	SENT_47	[p2l278t1840r575b1889],
43	(	CD	NUMBER	(	num	45	SENT_47	[p2l604t1843r797b1904],
44	2-67	CD	NUMBER	2-67	num	45	SENT_47	[p2l604t1843r797b1904],
45	)	NN	O	)	dep	42	SENT_47	[p2l604t1843r797b1904],
46	.	.	O	.	_	0	SENT_47	[p2l604t1843r797b1904],

1	“	NN	O	“	nsubj	4	SENT_48	[p2l604t1843r797b1904],
2	These	DT	O	these	det	3	SENT_48	[p2l821t1840r977b1889],
3	ﬁndings	NNS	O	ﬁndings	dep	1	SENT_48	[p2l1001t1840r1215b1904],
4	led	VBD	O	lead	_	0	SENT_48	[p2l1240t1840r1318b1889],
5	the	DT	O	the	det	7	SENT_48	[p2l1340t1840r1422b1889],
6	US	NNP	ORGANIZATION	US	nn	7	SENT_48	[p2l1448t1844r1525b1889],
7	Food	NNP	ORGANIZATION	Food	nsubj	12	SENT_48	[p2l12t1918r138b1967],
8	and	CC	ORGANIZATION	and	_	0	SENT_48	[p2l154t1918r251b1967],
9	Drug	NNP	ORGANIZATION	Drug	nn	10	SENT_48	[p2l269t1923r403b1982],
10	Administration	NNP	ORGANIZATION	Administration	nsubj	12	SENT_48	[p2l418t1918r818b1967],
11	to	TO	O	to	aux	12	SENT_48	[p2l834t1928r882b1967],
12	issue	VB	O	issue	xcomp	4	SENT_48	[p2l899t1921r1031b1967],
13	a	DT	O	a	det	15	SENT_48	[p2l1049t1935r1075b1967],
14	warning	NN	O	warning	nn	15	SENT_48	[p2l1090t1921r1308b1982],
15	label	NN	O	label	dobj	12	SENT_48	[p2l1323t1918r1446b1967],
16	on	IN	O	on	_	0	SENT_48	[p2l1463t1935r1529b1967],
17	packaging	NN	O	packaging	prep_on	12	SENT_48	[p2l9t1997r274b2061],
18	for	IN	O	for	_	0	SENT_48	[p2l290t1997r365b2045],
19	clopidogrel	NN	O	clopidogrel	prep_for	17	SENT_48	[p2l381t1997r711b2061],
20	.	.	O	.	_	0	SENT_48	[p2l381t1997r711b2061],

1	”	NN	O	”	_	0	SENT_49	[p2l381t1997r711b2061],

1	Prasugrel	NNP	O	Prasugrel	nsubj	7	SENT_50	[p2l62t2074r309b2138],
2	and	CC	O	and	_	0	SENT_50	[p2l331t2074r427b2123],
3	ticagrelor	NN	O	ticagrelor	conj_and	1	SENT_50	[p2l446t2074r693b2138],
4	are	VBP	O	be	cop	7	SENT_50	[p2l713t2092r791b2123],
5	novel	JJ	O	novel	amod	7	SENT_50	[p2l812t2074r951b2123],
6	P2Y12	NN	O	p2y12	nn	7	SENT_50	[p2l974t2079r1132b2122],
7	inhibitors	NNS	O	inhibitor	_	0	SENT_50	[p2l1154t2074r1407b2123],
8	that	WDT	O	that	nsubj	9	SENT_50	[p2l1428t2074r1530b2123],
9	provide	VBP	O	provide	rcmod	7	SENT_50	[p2l9t2151r202b2214],
10	more	JJR	O	more	amod	13	SENT_50	[p2l260t2168r397b2199],
11	potent	JJ	O	potent	amod	13	SENT_50	[p2l454t2161r621b2214],
12	platelet	NN	O	platelet	nn	13	SENT_50	[p2l676t2151r865b2214],
13	inhibition	NN	O	inhibition	nsubj	15	SENT_50	[p2l921t2151r1180b2199],
14	than	IN	O	than	advmod	15	SENT_50	[p2l1235t2151r1354b2199],
15	does	VBZ	O	do	ccomp	9	SENT_50	[p2l1411t2151r1527b2199],
16	clopidogrel	NN	O	clopidogrel	dobj	15	SENT_50	[p2l10t2230r310b2294],
17	.	.	O	.	_	0	SENT_50	[p2l10t2230r310b2294],

1	Both	DT	O	both	det	2	SENT_51	[p2l353t2230r474b2278],
2	agents	NNS	O	agent	nsubj	3	SENT_51	[p2l512t2239r678b2294],
3	reduce	VB	O	reduce	_	0	SENT_51	[p2l717t2230r891b2278],
4	major	JJ	O	major	amod	7	SENT_51	[p2l929t2233r1085b2293],
5	adverse	JJ	O	adverse	amod	7	SENT_51	[p2l1121t2230r1315b2278],
6	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_51	[p2l1353t2230r1527b2278, p2l8t2307r221b2356],
7	events	NNS	O	event	dobj	3	SENT_51	[p2l265t2317r426b2356],
8	after	IN	O	after	_	0	SENT_51	[p2l472t2307r589b2356],
9	acute	JJ	O	acute	amod	11	SENT_51	[p2l632t2317r767b2356],
10	coronary	JJ	O	coronary	amod	11	SENT_51	[p2l812t2325r1040b2371],
11	syndrome	NN	O	syndrome	prep_after	3	SENT_51	[p2l1084t2307r1355b2371],
12	;	:	O	;	_	0	SENT_51	[p2l1084t2307r1355b2371],
13	however	RB	O	however	advmod	18	SENT_51	[p2l1401t2307r1527b2356, p2l10t2402r124b2441],
14	,	,	O	,	_	0	SENT_51	[p2l1401t2307r1527b2356, p2l10t2402r124b2441],
15	they	PRP	O	they	nsubjpass	18	SENT_51	[p2l163t2385r274b2449],
16	are	VBP	O	be	auxpass	18	SENT_51	[p2l311t2403r389b2434],
17	also	RB	O	also	advmod	18	SENT_51	[p2l428t2385r527b2434],
18	associated	VBN	O	associate	parataxis	3	SENT_51	[p2l567t2385r830b2434],
19	with	IN	O	with	_	0	SENT_51	[p2l866t2385r982b2434],
20	increased	VBN	O	increase	amod	22	SENT_51	[p2l1019t2385r1268b2434],
21	bleeding	NN	O	bleeding	nn	22	SENT_51	[p2l1304t2385r1529b2449],
22	complications	NNS	O	complication	prep_with	18	SENT_51	[p2l10t2464r453b2527],
23	.	.	O	.	_	0	SENT_51	[p2l10t2464r453b2527],

1	”	NN	O	”	nsubj	34	SENT_52	[p2l10t2464r453b2527],
2	Notably	RB	O	notably	advmod	34	SENT_52	[p2l496t2464r700b2527],
3	,	,	O	,	_	0	SENT_52	[p2l496t2464r700b2527],
4	retrospective	JJ	O	retrospective	amod	6	SENT_52	[p2l744t2467r1075b2527],
5	genetic	JJ	O	genetic	amod	6	SENT_52	[p2l1118t2467r1303b2528],
6	studies	NNS	O	study	nsubj	7	SENT_52	[p2l1346t2464r1527b2512],
7	showed	VBD	O	show	parataxis	34	SENT_52	[p2l11t2541r208b2590],
8	that	IN	O	that	complm	13	SENT_52	[p2l232t2541r333b2590],
9	prasugrel	NN	O	prasugrel	nsubj	13	SENT_52	[p2l357t2541r603b2605],
10	and	CC	O	and	_	0	SENT_52	[p2l629t2541r726b2590],
11	ticagrelor	NN	O	ticagrelor	conj_and	9	SENT_52	[p2l750t2541r996b2605],
12	were	VBD	O	be	cop	13	SENT_52	[p2l1019t2559r1144b2590],
13	unaffected	JJ	O	unaffected	ccomp	7	SENT_52	[p2l1169t2541r1445b2590],
14	by	IN	O	by	_	0	SENT_52	[p2l1468t2541r1530b2605],
15	the	DT	O	the	det	16	SENT_52	[p2l8t2618r90b2666],
16	CYP2C19	NN	O	cyp2c19	prep_by	13	SENT_52	[p2l139t2621r445b2667],
17	"	''	O	"	punct	16	SENT_52	[p2l139t2621r445b2667],
18	"	``	O	"	punct	34	SENT_52	[p2l139t2621r445b2667],
19	2	CD	NUMBER	2	num	21	SENT_52	[p2l139t2621r445b2667],
20	allele	NN	O	allele	nn	21	SENT_52	[p2l487t2618r703b2667],
21	.2	NN	NUMBER	.2	nsubj	34	SENT_52	[p2l487t2618r703b2667],
22	°	CD	NUMBER	°	number	23	SENT_52	[p2l487t2618r703b2667],
23	’21	CD	NUMBER	’21	num	25	SENT_52	[p2l487t2618r703b2667],
24	Prospective	JJ	O	prospective	amod	25	SENT_52	[p2l749t2621r1044b2681],
25	identiﬁcation	NN	O	identiﬁcation	dep	21	SENT_52	[p2l1089t2618r1434b2666],
26	of	IN	O	of	_	0	SENT_52	[p2l1479t2618r1538b2666],
27	CYP2C19	NN	O	cyp2c19	prep_of	21	SENT_52	[p2l14t2700r320b2745],
28	"	''	O	"	punct	34	SENT_52	[p2l14t2700r320b2745],
29	"	``	O	"	punct	34	SENT_52	[p2l14t2700r320b2745],
30	2	CD	NUMBER	2	num	32	SENT_52	[p2l14t2700r320b2745],
31	carrier	NN	O	carrier	nn	32	SENT_52	[p2l357t2700r527b2745],
32	status	NN	O	status	nsubj	34	SENT_52	[p2l568t2706r716b2745],
33	might	MD	O	might	aux	34	SENT_52	[p2l758t2697r916b2761],
34	allow	VB	O	allow	_	0	SENT_52	[p2l955t2697r1092b2745],
35	personalisation	NN	O	personalisation	dobj	34	SENT_52	[p2l1129t2697r1529b2760],
36	of	IN	O	of	_	0	SENT_52	[p2l10t2774r68b2823],
37	dual	JJ	O	dual	amod	39	SENT_52	[p2l86t2774r198b2823],
38	antiplatelet	JJ	O	antiplatelet	amod	39	SENT_52	[p2l225t2774r514b2837],
39	treatment	NN	O	treatment	prep_of	35	SENT_52	[p2l538t2784r796b2823],
40	after	IN	O	after	_	0	SENT_52	[p2l822t2774r938b2823],
41	PCI	NN	O	pcus	prep_after	34	SENT_52	[p2l967t2778r1062b2823],
42	that	WDT	O	that	nsubj	44	SENT_52	[p2l1091t2774r1192b2823],
43	successfully	RB	O	successfully	advmod	44	SENT_52	[p2l1219t2774r1530b2838],
44	minimises	VBZ	O	minimise	rcmod	41	SENT_52	[p2l9t2855r287b2901],
45	major	JJ	O	major	amod	48	SENT_52	[p2l340t2855r495b2916],
46	adverse	JJ	O	adverse	amod	48	SENT_52	[p2l547t2852r740b2901],
47	cardiovascular	JJ	O	cardiovascular	amod	48	SENT_52	[p2l793t2852r1165b2901],
48	events	NNS	O	event	dobj	44	SENT_52	[p2l1216t2862r1378b2901],
49	and	CC	O	and	_	0	SENT_52	[p2l1433t2852r1529b2901],
50	adverse	JJ	O	adverse	amod	52	SENT_52	[p2l10t2931r203b2979],
51	bleeding	NN	O	bleeding	nn	52	SENT_52	[p2l219t2931r445b2995],
52	events	NNS	O	event	dobj	44	SENT_52	[p2l462t2940r638b2979],
53	.	.	O	.	_	0	SENT_52	[p2l462t2940r638b2979],

1	|	NN	O	|	dep	3	SENT_53	[p2l6t3235r54b3434],
2	|	SYM	O	|	dep	3	SENT_53	[p2l6t3235r54b3434],
3	Arﬂdes	FW	O	arﬂdes	_	0	SENT_53	[p2l101t3398r251b3434],

1	§	NN	O	§	nsubj	5	SENT_54	[p2l2057t913r2098b934],
2	'	''	O	'	_	0	SENT_54	[p2l2057t913r2098b934],
3	4	CD	NUMBER	4	dep	1	SENT_54	[p2l2057t913r2098b934],
4	I	PRP	O	I	dep	1	SENT_54	[p2l2063t936r2092b952],
5	\	VBP	O	\	_	0	SENT_54	[p2l2063t936r2092b952],

1	A	DT	O	a	det	4	SENT_55	[p3l77t103r137b164],
2	point-of-care	JJ	O	point-of-care	amod	4	SENT_55	[p3l156t97r616b186],
3	genetic	JJ	O	genetic	amod	4	SENT_55	[p3l639t102r901b187],
4	test	NN	O	test	nsubjpass	17	SENT_55	[p3l919t111r1049b166],
5	for	IN	O	for	_	0	SENT_55	[p3l1068t97r1173b166],
6	the	DT	O	the	det	10	SENT_55	[p3l1190t97r1306b166],
7	CYP2C19	NN	O	cyp2c19	nn	10	SENT_55	[p3l1333t102r1765b166],
8	*	NN	O	*	nn	10	SENT_55	[p3l1333t102r1765b166],
9	2	CD	NUMBER	2	num	10	SENT_55	[p3l1333t102r1765b166],
10	allele	NN	O	allele	prep_for	4	SENT_55	[p3l1782t97r1969b166],
11	with	IN	O	with	_	0	SENT_55	[p3l1988t98r2151b166],
12	a	DT	O	a	det	14	SENT_55	[p3l8t231r46b274],
13	buccal	JJ	O	buccal	amod	14	SENT_55	[p3l72t206r307b274],
14	swab	NN	O	swab	prep_with	10	SENT_55	[p3l338t206r518b274],
15	has	VBZ	O	have	aux	17	SENT_55	[p3l545t206r669b274],
16	been	VBN	O	be	auxpass	17	SENT_55	[p3l698t206r877b274],
17	developed	VBN	O	develop	_	0	SENT_55	[p3l906t206r1273b295],
18	(	CD	NUMBER	(	dobj	17	SENT_55	[p3l1306t211r1612b296],
19	Spartan	NNP	O	Spartan	nn	21	SENT_55	[p3l1306t211r1612b296],
20	RX	NNP	O	RX	nn	21	SENT_55	[p3l1644t213r1756b273],
21	CYPZC19	NNP	O	CYPZC19	tmod	17	SENT_55	[p3l1785t211r2147b284],
22	,	,	O	,	_	0	SENT_55	[p3l1785t211r2147b284],
23	Spartan	NNP	O	Spartan	nn	30	SENT_55	[p3l13t321r294b405],
24	Biosciences	NNP	O	Biosciences	nn	30	SENT_55	[p3l333t320r774b394],
25	,	,	O	,	_	0	SENT_55	[p3l333t320r774b394],
26	Ottawa	NNP	LOCATION	Ottawa	appos	30	SENT_55	[p3l816t322r1089b394],
27	,	,	O	,	_	0	SENT_55	[p3l816t322r1089b394],
28	ON	NNP	O	ON	appos	30	SENT_55	[p3l1131t322r1276b394],
29	,	,	O	,	_	0	SENT_55	[p3l1131t322r1276b394],
30	Canada	NNP	LOCATION	Canada	appos	21	SENT_55	[p3l1318t316r1632b406],
31	)	CD	NUMBER	)	num	30	SENT_55	[p3l1318t316r1632b406],
32	.	.	O	.	_	0	SENT_55	[p3l1318t316r1632b406],

1	This	DT	O	this	det	3	SENT_56	[p3l1671t316r1832b383],
2	bedside	NN	O	bedside	nn	3	SENT_56	[p3l1869t316r2150b384],
3	technology	NN	O	technology	nsubj	4	SENT_56	[p3l6t424r408b514],
4	enables	VBZ	O	enable	_	0	SENT_56	[p3l429t424r703b493],
5	health-care	NN	O	health-care	nn	6	SENT_56	[p3l725t424r1129b493],
6	personnel	NNS	O	personnel	dobj	4	SENT_56	[p3l1151t424r1518b513],
7	with	IN	O	with	_	0	SENT_56	[p3l1537t424r1700b493],
8	no	DT	O	no	det	10	SENT_56	[p3l1722t449r1814b493],
9	previous	JJ	O	previous	amod	10	SENT_56	[p3l1836t429r2148b513],
10	training	NN	O	training	prep_with	4	SENT_56	[p3l6t538r301b623],
11	in	IN	O	in	_	0	SENT_56	[p3l351t538r425b600],
12	genetic	JJ	O	genetic	amod	14	SENT_56	[p3l477t538r739b623],
13	laboratory	NN	O	laboratory	nn	14	SENT_56	[p3l788t533r1159b622],
14	techniques	NNS	O	technique	prep_in	10	SENT_56	[p3l1207t533r1607b622],
15	to	TO	O	to	aux	16	SENT_56	[p3l1659t546r1727b601],
16	undertake	VB	O	undertake	xcomp	4	SENT_56	[p3l1778t533r2150b601],
17	genotyping	NN	O	genotyping	dobj	16	SENT_56	[p3l9t647r437b733],
18	.	.	O	.	_	0	SENT_56	[p3l9t647r437b733],

1	We	PRP	O	we	nsubj	2	SENT_57	[p3l466t649r583b711],
2	aimed	VBD	O	aim	_	0	SENT_57	[p3l611t643r839b711],
3	to	TO	O	to	aux	4	SENT_57	[p3l863t656r932b711],
4	assess	VB	O	assess	xcomp	2	SENT_57	[p3l960t667r1182b711],
5	the	DT	O	the	det	7	SENT_57	[p3l1210t643r1325b710],
6	clinical	JJ	O	clinical	amod	7	SENT_57	[p3l1353t643r1612b711],
7	feasibility	NN	O	feasibility	dobj	4	SENT_57	[p3l1638t643r1990b732],
8	and	CC	O	and	_	0	SENT_57	[p3l2016t643r2152b710],
9	pharmacodynamic	JJ	O	pharmacodynamic	amod	10	SENT_57	[p3l7t751r696b841],
10	efficacy	NN	O	efficacy	conj_and	7	SENT_57	[p3l713t751r986b841],
11	of	IN	O	of	_	0	SENT_57	[p3l1002t751r1085b820],
12	personalised	JJ	O	personalised	amod	15	SENT_57	[p3l1088t751r1553b840],
13	dual	JJ	O	dual	amod	15	SENT_57	[p3l1570t751r1727b820],
14	antiplatelet	JJ	O	antiplatelet	amod	15	SENT_57	[p3l1746t751r2152b840],
15	treatment	NN	O	treatment	prep_of	7	SENT_57	[p3l6t873r369b928],
16	in	IN	O	in	_	0	SENT_57	[p3l394t865r468b927],
17	patients	NNS	O	patient	prep_in	4	SENT_57	[p3l495t865r783b949],
18	receiving	VBG	O	receive	partmod	17	SENT_57	[p3l813t865r1146b950],
19	PCI	NNP	O	PCI	dobj	18	SENT_57	[p3l1177t865r1312b928],
20	for	IN	O	for	_	0	SENT_57	[p3l1343t860r1448b928],
21	treatment	NN	O	treatment	prep_for	19	SENT_57	[p3l1473t873r1835b928],
22	of	IN	O	of	_	0	SENT_57	[p3l1862t860r1944b928],
23	acute	JJ	O	acute	amod	25	SENT_57	[p3l1959t873r2150b928],
24	coronary	JJ	O	coronary	amod	25	SENT_57	[p3l8t994r330b1059],
25	syndrome	NN	O	syndrome	prep_of	21	SENT_57	[p3l355t970r720b1059],
26	and	CC	O	and	_	0	SENT_57	[p3l745t970r882b1038],
27	stable	JJ	O	stable	amod	30	SENT_57	[p3l907t969r1114b1038],
28	coronary	JJ	O	coronary	amod	30	SENT_57	[p3l1140t994r1461b1059],
29	artery	NN	O	artery	nn	30	SENT_57	[p3l1484t983r1695b1059],
30	disease	NN	O	disease	prep_of	21	SENT_57	[p3l1717t970r1998b1038],
31	.	.	O	.	_	0	SENT_57	[p3l1717t970r1998b1038],

1	Methods	NNS	O	method	_	0	SENT_58	[p3l12t1179r394b1258],

1	Participants	NNS	O	participant	npadvmod	13	SENT_59	[p3l12t1301r455b1389],
2	In	IN	O	in	_	0	SENT_59	[p3l12t1416r89b1477],
3	our	PRP$	O	we	poss	9	SENT_59	[p3l145t1434r272b1478],
4	prospective	JJ	O	prospective	amod	9	SENT_59	[p3l325t1414r758b1498],
5	,	,	O	,	_	0	SENT_59	[p3l325t1414r758b1498],
6	randomised	JJ	O	randomised	amod	9	SENT_59	[p3l817t1410r1276b1489],
7	,	,	O	,	_	0	SENT_59	[p3l817t1410r1276b1489],
8	proof-of-concept	JJ	O	proof-of-concept	amod	9	SENT_59	[p3l1334t1409r1932b1498],
9	trial	NN	O	trial	prep_in	13	SENT_59	[p3l1984t1410r2147b1488],
10	,	,	O	,	_	0	SENT_59	[p3l1984t1410r2147b1488],
11	patients	NNS	O	patient	nsubjpass	13	SENT_59	[p3l7t1523r295b1607],
12	were	VBD	O	be	auxpass	13	SENT_59	[p3l331t1543r507b1586],
13	enrolled	VBN	O	enrol	_	0	SENT_59	[p3l544t1518r844b1586],
14	at	IN	O	at	_	0	SENT_59	[p3l879t1532r944b1586],
15	the	DT	O	the	det	16	SENT_59	[p3l976t1518r1090b1586],
16	University	NNP	ORGANIZATION	University	prep_at	13	SENT_59	[p3l1130t1523r1509b1608],
17	of	IN	ORGANIZATION	of	_	0	SENT_59	[p3l1543t1518r1626b1586],
18	Ottawa	NNP	ORGANIZATION	Ottawa	nn	20	SENT_59	[p3l1650t1524r1906b1586],
19	Heart	NNP	ORGANIZATION	Heart	nn	20	SENT_59	[p3l1945t1525r2152b1586],
20	Institute	NNP	ORGANIZATION	Institute	prep_of	16	SENT_59	[p3l12t1632r318b1696],
21	between	IN	O	between	_	0	SENT_59	[p3l349t1628r656b1696],
22	Aug	NNP	DATE	Aug	prep_between	20	SENT_59	[p3l686t1633r836b1718],
23	26	CD	DATE	26	num	22	SENT_59	[p3l869t1634r970b1706],
24	,	,	DATE	,	_	0	SENT_59	[p3l869t1634r970b1706],
25	2010	CD	DATE	2010	num	22	SENT_59	[p3l1007t1634r1188b1706],
26	,	,	O	,	_	0	SENT_59	[p3l1007t1634r1188b1706],
27	and	CC	O	and	_	0	SENT_59	[p3l1224t1628r1360b1695],
28	July	NNP	DATE	July	conj_and	20	SENT_59	[p3l1392t1628r1531b1717],
29	7	CD	DATE	7	num	28	SENT_59	[p3l1559t1632r1614b1706],
30	,	,	DATE	,	_	0	SENT_59	[p3l1559t1632r1614b1706],
31	2011	CD	DATE	2011	num	28	SENT_59	[p3l1650t1634r1822b1695],
32	.	.	O	.	_	0	SENT_59	[p3l1650t1634r1822b1695],

1	Patients	NNS	O	patient	nsubj	21	SENT_60	[p3l1862t1632r2148b1696],
2	aged	JJ	O	aged	advmod	5	SENT_60	[p3l8t1736r179b1826],
3	18-75	CD	NUMBER	18-75	num	4	SENT_60	[p3l210t1741r407b1807],
4	years	NNS	NUMBER	year	dep	2	SENT_60	[p3l439t1761r626b1826],
5	undergoing	VBG	O	undergo	partmod	1	SENT_60	[p3l657t1736r1088b1826],
6	PCI	NNP	O	PCI	dobj	5	SENT_60	[p3l1122t1742r1257b1805],
7	for	IN	O	for	_	0	SENT_60	[p3l1290t1736r1395b1805],
8	treatment	NN	O	treatment	prep_for	6	SENT_60	[p3l1422t1750r1785b1805],
9	of	IN	O	of	_	0	SENT_60	[p3l1815t1736r1897b1805],
10	a	DT	O	a	det	14	SENT_60	[p3l1915t1761r1952b1805],
11	nonST-elevation	JJ	O	nonst-elevation	amod	14	SENT_60	[p3l1982t1761r2149b1805, p3l13t1845r454b1913],
12	acute	JJ	O	acute	amod	14	SENT_60	[p3l490t1858r680b1913],
13	coronary	JJ	O	coronary	amod	14	SENT_60	[p3l717t1869r1039b1934],
14	syndrome	NN	O	syndrome	prep_of	8	SENT_60	[p3l1074t1845r1439b1934],
15	or	CC	O	or	_	0	SENT_60	[p3l1475t1869r1551b1913],
16	stable	JJ	O	stable	amod	19	SENT_60	[p3l1587t1845r1794b1913],
17	coronary	JJ	O	coronary	amod	19	SENT_60	[p3l1831t1869r2153b1934],
18	artery	NN	O	artery	nn	19	SENT_60	[p3l9t1968r219b2044],
19	disease	NN	O	disease	conj_or	14	SENT_60	[p3l261t1955r524b2023],
20	were	VBD	O	be	cop	21	SENT_60	[p3l566t1979r741b2023],
21	eligible	JJ	O	eligible	_	0	SENT_60	[p3l786t1955r1050b2045],
22	for	IN	O	for	_	0	SENT_60	[p3l1094t1955r1199b2022],
23	enrolment	NN	O	enrolment	prep_for	21	SENT_60	[p3l1241t1955r1644b2022],
24	.	.	O	.	_	0	SENT_60	[p3l1241t1955r1644b2022],

1	Additionally	RB	O	additionally	advmod	4	SENT_61	[p3l1690t1955r2147b2044],
2	,	,	O	,	_	0	SENT_61	[p3l1690t1955r2147b2044],
3	they	PRP	O	they	nsubj	4	SENT_61	[p3l6t2063r163b2153],
4	had	VBD	O	have	_	0	SENT_61	[p3l197t2063r335b2132],
5	to	TO	O	to	aux	6	SENT_61	[p3l369t2077r437b2132],
6	give	VB	O	give	xcomp	4	SENT_61	[p3l477t2068r621b2153],
7	written	JJ	O	written	amod	9	SENT_61	[p3l657t2068r921b2132],
8	informed	JJ	O	informed	amod	9	SENT_61	[p3l958t2063r1304b2132],
9	consent	NN	O	consent	dobj	6	SENT_61	[p3l1341t2077r1644b2142],
10	,	,	O	,	_	0	SENT_61	[p3l1341t2077r1644b2142],
11	comply	VB	O	comply	conj_and	6	SENT_61	[p3l1686t2063r1955b2153],
12	with	IN	O	with	_	0	SENT_61	[p3l1988t2063r2151b2132],
13	the	DT	O	the	det	16	SENT_61	[p3l6t2172r122b2240],
14	assigned	VBN	O	assign	amod	16	SENT_61	[p3l167t2172r486b2262],
15	treatment	NN	O	treatment	nn	16	SENT_61	[p3l527t2185r890b2240],
16	strategy	NN	O	strategy	prep_with	11	SENT_61	[p3l934t2185r1226b2262],
17	,	,	O	,	_	0	SENT_61	[p3l934t2185r1226b2262],
18	and	CC	O	and	_	0	SENT_61	[p3l1274t2172r1410b2240],
19	attend	VB	O	attend	conj_and	6	SENT_61	[p3l1454t2172r1682b2240],
20	a	DT	O	a	det	22	SENT_61	[p3l1726t2196r1762b2240],
21	follow-up	JJ	O	follow-up	amod	22	SENT_61	[p3l1805t2172r2150b2261],
22	visit	NN	O	visit	dobj	19	SENT_61	[p3l6t2287r158b2351],
23	after	IN	O	after	_	0	SENT_61	[p3l198t2282r363b2351],
24	1	CD	DURATION	1	prep_after	19	SENT_61	[p3l406t2289r437b2350],
25	week	NN	NUMBER	week	tmod	19	SENT_61	[p3l476t2283r682b2351],
26	.	.	O	.	_	0	SENT_61	[p3l476t2283r682b2351],

1	All	DT	O	all	det	2	SENT_62	[p3l726t2282r831b2350],
2	patients	NNS	O	patient	nsubj	3	SENT_62	[p3l872t2287r1160b2371],
3	had	VBD	O	have	_	0	SENT_62	[p3l1203t2282r1341b2351],
4	to	TO	O	to	aux	6	SENT_62	[p3l1380t2296r1449b2351],
5	be	VB	O	be	auxpass	6	SENT_62	[p3l1490t2282r1575b2351],
6	treated	VBN	O	treat	xcomp	3	SENT_62	[p3l1617t2283r1869b2351],
7	with	IN	O	with	_	0	SENT_62	[p3l1908t2282r2071b2351],
8	a	DT	O	a	det	11	SENT_62	[p3l2114t2307r2151b2351],
9	600	CD	NUMBER	600	num	11	SENT_62	[p3l9t2397r137b2460],
10	mg	NN	O	mg	nn	11	SENT_62	[p3l184t2416r305b2481],
11	bolus	NN	O	bolus	prep_with	6	SENT_62	[p3l350t2391r548b2460],
12	of	IN	O	of	_	0	SENT_62	[p3l598t2391r680b2460],
13	clopidogrel	NN	O	clopidogrel	prep_of	11	SENT_62	[p3l715t2391r1121b2481],
14	at	IN	O	at	quantmod	16	SENT_62	[p3l1168t2405r1233b2460],
15	least	JJS	O	least	mwe	14	SENT_62	[p3l1276t2391r1443b2460],
16	24	CD	NUMBER	24	num	17	SENT_62	[p3l1491t2398r1573b2458],
17	h	NN	O	h	dep	11	SENT_62	[p3l1614t2391r1663b2458],
18	before	IN	O	before	_	0	SENT_62	[p3l1709t2391r1940b2460],
19	PCI	NNP	O	PCI	prep_before	17	SENT_62	[p3l1991t2397r2147b2470],
20	,	,	O	,	_	0	SENT_62	[p3l1991t2397r2147b2470],
21	consistent	JJ	O	consistent	amod	11	SENT_62	[p3l8t2506r383b2569],
22	with	IN	O	with	_	0	SENT_62	[p3l429t2501r592b2569],
23	the	DT	O	the	det	25	SENT_62	[p3l641t2501r756b2569],
24	practice	NN	O	practice	nn	25	SENT_62	[p3l807t2506r1092b2590],
25	pattern	NN	O	pattern	prep_with	21	SENT_62	[p3l1143t2514r1406b2590],
26	at	IN	O	at	_	0	SENT_62	[p3l1457t2514r1521b2569],
27	our	PRP$	O	we	poss	28	SENT_62	[p3l1571t2525r1697b2569],
28	institution	NN	O	institution	prep_at	6	SENT_62	[p3l1746t2506r2147b2569],
29	.	.	O	.	_	0	SENT_62	[p3l1746t2506r2147b2569],

1	Patients	NNS	O	patient	nsubjpass	21	SENT_63	[p3l12t2615r298b2679],
2	who	WP	O	who	nsubjpass	5	SENT_63	[p3l332t2610r487b2679],
3	had	VBD	O	have	aux	5	SENT_63	[p3l520t2610r657b2679],
4	been	VBN	O	be	auxpass	5	SENT_63	[p3l687t2611r866b2679],
5	given	VBN	O	give	rcmod	1	SENT_63	[p3l899t2615r1095b2700],
6	antiplatelet	JJ	O	antiplatelet	amod	7	SENT_63	[p3l1129t2610r1536b2699],
7	treatment	NN	O	treatment	iobj	5	SENT_63	[p3l1565t2624r1928b2679],
8	other	JJ	O	other	amod	17	SENT_63	[p3l1960t2610r2152b2679],
9	than	IN	O	than	_	0	SENT_63	[p3l6t2719r173b2787],
10	aspirin	NN	O	aspirin	prep_than	8	SENT_63	[p3l203t2724r458b2808],
11	and	CC	O	and	_	0	SENT_63	[p3l489t2719r625b2787],
12	clopidogrel	NN	O	clopidogrel	conj_and	10	SENT_63	[p3l654t2719r1061b2809],
13	or	CC	O	or	_	0	SENT_63	[p3l1091t2744r1167b2787],
14	anticoagulation	NN	O	anticoagulation	nn	16	SENT_63	[p3l1196t2719r1762b2809],
15	treatment	NN	O	treatment	nn	16	SENT_63	[p3l1790t2733r2152b2787],
16	witl1	NN	O	witl1	prep_than	8	SENT_63	[p3l7t2828r170b2897],
17	warfarin	NN	O	warfarin	dobj	5	SENT_63	[p3l198t2828r510b2897],
18	or	CC	O	or	_	0	SENT_63	[p3l541t2853r617b2897],
19	dabigatran	NN	O	dabigatran	conj_or	17	SENT_63	[p3l647t2828r1037b2918],
20	were	VBD	O	be	auxpass	21	SENT_63	[p3l1065t2853r1241b2897],
21	excluded	VBN	O	exclude	_	0	SENT_63	[p3l1273t2828r1612b2907],
22	,	,	O	,	_	0	SENT_63	[p3l1273t2828r1612b2907],
23	as	IN	O	as	mark	25	SENT_63	[p3l1647t2853r1719b2897],
24	were	VBD	O	be	cop	25	SENT_63	[p3l1749t2853r1925b2897],
25	those	DT	O	those	advcl	21	SENT_63	[p3l1955t2828r2151b2897],
26	who	WP	O	who	nsubj	27	SENT_63	[p3l7t2938r162b3006],
27	had	VBD	O	have	rcmod	25	SENT_63	[p3l185t2938r323b3006],
28	a	DT	O	a	det	29	SENT_63	[p3l345t2962r383b3006],
29	history	NN	O	history	dobj	27	SENT_63	[p3l404t2938r658b3027],
30	of	IN	O	of	_	0	SENT_63	[p3l680t2938r763b3006],
31	stroke	NN	O	stroke	nn	35	SENT_63	[p3l775t2938r995b3006],
32	or	CC	O	or	_	0	SENT_63	[p3l1019t2962r1095b3006],
33	transient	JJ	O	transient	conj_or	31	SENT_63	[p3l1115t2943r1445b3006],
34	ischaemic	JJ	O	ischaemic	amod	35	SENT_63	[p3l1466t2938r1835b3006],
35	attack	NN	O	attack	prep_of	29	SENT_63	[p3l1858t2938r2088b3016],
36	,	,	O	,	_	0	SENT_63	[p3l1858t2938r2088b3016],
37	a	DT	O	a	det	38	SENT_63	[p3l2115t2962r2152b3006],
38	bodyweight	NN	O	bodyweight	appos	35	SENT_63	[p3l7t3047r433b3137],
39	of	IN	O	of	_	0	SENT_63	[p3l464t3047r546b3116],
40	less	JJR	O	less	mwe	41	SENT_63	[p3l563t3048r697b3116],
41	than	IN	O	than	quantmod	42	SENT_63	[p3l729t3047r896b3116],
42	60	CD	NUMBER	60	num	43	SENT_63	[p3l929t3054r1012b3116],
43	kg	NN	O	kg	prep_of	38	SENT_63	[p3l1043t3048r1149b3137],
44	,	,	O	,	_	0	SENT_63	[p3l1043t3048r1149b3137],
45	platelet	NN	O	platelet	nn	46	SENT_63	[p3l1184t3047r1450b3136],
46	count	NN	O	count	appos	35	SENT_63	[p3l1480t3061r1689b3116],
47	of	IN	O	of	_	0	SENT_63	[p3l1720t3047r1802b3116],
48	less	JJR	O	less	mwe	49	SENT_63	[p3l1819t3048r1953b3116],
49	than	IN	O	than	quantmod	50	SENT_63	[p3l1985t3048r2152b3116],
50	100	CD	NUMBER	100	num	51	SENT_63	[p3l12t3162r129b3224],
51	ooo	NN	O	ooo	prep_of	46	SENT_63	[p3l143t3162r272b3224],
52	per	IN	O	per	_	0	SENT_63	[p3l294t3181r415b3245],
53	uL	NN	O	ul	prep_per	51	SENT_63	[p3l435t3163r549b3245],
54	,	,	O	,	_	0	SENT_63	[p3l435t3163r549b3245],
55	known	VBN	O	know	partmod	35	SENT_63	[p3l574t3156r827b3224],
56	bleeding	VBG	O	bleed	amod	57	SENT_63	[p3l848t3156r1165b3246],
57	diathesis	NN	O	diathesis	dobj	55	SENT_63	[p3l1189t3156r1530b3234],
58	,	,	O	,	_	0	SENT_63	[p3l1189t3156r1530b3234],
59	haematocrit	NN	O	haematocrit	dobj	55	SENT_63	[p3l1554t3156r1996b3224],
60	less	JJR	O	less	mwe	61	SENT_63	[p3l2016t3156r2149b3224],
61	than	IN	O	than	quantmod	62	SENT_63	[p3l7t3265r174b3333],
62	30	CD	PERCENT	30	num	63	SENT_63	[p3l203t3269r359b3336],
63	%	NN	PERCENT	%	dep	59	SENT_63	[p3l203t3269r359b3336],
64	or	CC	O	or	_	0	SENT_63	[p3l386t3289r462b3333],
65	more	JJR	O	more	mwe	66	SENT_63	[p3l484t3289r678b3333],
66	than	IN	O	than	quantmod	67	SENT_63	[p3l702t3265r869b3333],
67	52	CD	PERCENT	52	num	68	SENT_63	[p3l897t3269r1073b3343],
68	%	NN	PERCENT	%	conj_or	59	SENT_63	[p3l897t3269r1073b3343],
69	,	,	O	,	_	0	SENT_63	[p3l897t3269r1073b3343],
70	severe	JJ	O	severe	amod	72	SENT_63	[p3l1103t3289r1328b3333],
71	liver	NN	O	liver	nn	72	SENT_63	[p3l1352t3265r1513b3333],
72	dysfunction	NN	O	dysfunction	dobj	55	SENT_63	[p3l1536t3265r1988b3354],
73	,	,	O	,	_	0	SENT_63	[p3l1536t3265r1988b3354],
74	and	CC	O	and	_	0	SENT_63	[p3l2017t3265r2153b3333],
75	renal	JJ	O	renal	amod	79	SENT_63	[p3l8t3375r195b3443],
76	insufficiency	NN	O	insufficiency	nn	79	SENT_63	[p3l245t3374r718b3464],
77	(	NN	O	(	nn	79	SENT_63	[p3l774t3379r1161b3464],
78	creatinine	NN	O	creatinine	nn	79	SENT_63	[p3l774t3379r1161b3464],
79	clearance	NN	O	clearance	dep	80	SENT_63	[p3l1214t3375r1554b3443],
80	<	JJR	O	<	dobj	55	SENT_63	[p3l1608t3381r1740b3443],
81	30	CD	NUMBER	30	num	83	SENT_63	[p3l1608t3381r1740b3443],
82	mL/min	NN	O	ml/min	nn	83	SENT_63	[p3l1792t3379r2148b3464],
83	)	NN	O	)	dep	80	SENT_63	[p3l1792t3379r2148b3464],
84	.	.	O	.	_	0	SENT_63	[p3l1792t3379r2148b3464],

1	Pregnant	JJ	O	pregnant	amod	2	SENT_64	[p3l13t3490r348b3573],
2	women	NNS	O	woman	nsubjpass	5	SENT_64	[p3l382t3508r660b3551],
3	were	VBD	O	be	auxpass	5	SENT_64	[p3l695t3508r870b3551],
4	also	RB	O	also	advmod	5	SENT_64	[p3l910t3483r1051b3551],
5	excluded	VBN	O	exclude	_	0	SENT_64	[p3l1090t3483r1429b3551],
6	.	.	O	.	_	0	SENT_64	[p3l1090t3483r1429b3551],

1	Adjuvant	JJ	O	adjuvant	amod	2	SENT_65	[p3l1469t3483r1804b3573],
2	pharmacotherapy	NN	O	pharmacotherapy	nsubj	6	SENT_65	[p3l1840t3483r2150b3572, p3l9t3593r367b3682],
3	during	IN	O	during	_	0	SENT_65	[p3l390t3593r637b3683],
4	PCI	NN	O	pcus	prep_during	2	SENT_65	[p3l664t3598r799b3661],
5	was	VBD	O	be	cop	6	SENT_65	[p3l825t3617r962b3661],
6	restricted	JJ	O	restricted	_	0	SENT_65	[p3l988t3593r1332b3661],
7	to	TO	O	to	_	0	SENT_65	[p3l1353t3606r1421b3661],
8	bivalirudin	NN	O	bivalirudin	prep_to	6	SENT_65	[p3l1445t3593r1864b3661],
9	.	.	O	.	_	0	SENT_65	[p3l1445t3593r1864b3661],

1	The	DT	O	the	det	3	SENT_66	[p3l78t3702r223b3770],
2	study	NN	O	study	nn	3	SENT_66	[p3l292t3702r493b3791],
3	protocol	NN	O	protocol	nsubjpass	5	SENT_66	[p3l557t3702r863b3790],
4	was	VBD	O	be	auxpass	5	SENT_66	[p3l928t3726r1066b3770],
5	approved	VBN	O	approve	_	0	SENT_66	[p3l1136t3702r1480b3790],
6	by	IN	O	by	_	0	SENT_66	[p3l1544t3702r1632b3791],
7	the	DT	O	the	det	11	SENT_66	[p3l1695t3702r1812b3770],
8	human	JJ	O	human	amod	11	SENT_66	[p3l1877t3701r2152b3770],
9	research	NN	O	research	nn	11	SENT_66	[p4l8t16r326b84],
10	ethics	NNS	O	ethic	nn	11	SENT_66	[p4l361t16r576b84],
11	board	NN	O	board	agent	5	SENT_66	[p4l611t16r827b84],
12	at	IN	O	at	_	0	SENT_66	[p4l861t30r926b84],
13	the	DT	O	the	det	27	SENT_66	[p4l958t16r1075b84],
14	University	NNP	ORGANIZATION	University	dep	27	SENT_66	[p4l1113t21r1502b106],
15	of	IN	ORGANIZATION	of	_	0	SENT_66	[p4l1535t16r1619b84],
16	Ottawa	NNP	ORGANIZATION	Ottawa	nn	18	SENT_66	[p4l1642t22r1904b84],
17	Heart	NNP	ORGANIZATION	Heart	nn	18	SENT_66	[p4l1942t23r2153b84],
18	Institute	NNP	ORGANIZATION	Institute	prep_of	14	SENT_66	[p4l13t130r328b194],
19	and	CC	ORGANIZATION	and	_	0	SENT_66	[p4l379t126r517b193],
20	Health	NNP	ORGANIZATION	Health	nn	21	SENT_66	[p4l569t126r820b194],
21	Canada	NNP	ORGANIZATION	Canada	prep_of	14	SENT_66	[p4l871t126r1147b194],
22	(	CD	NUMBER	(	dep	14	SENT_66	[p4l1202t126r1491b216],
23	clinical	JJ	O	clinical	amod	27	SENT_66	[p4l1202t126r1491b216],
24	trial	NN	O	trial	nn	27	SENT_66	[p4l1538t126r1688b194],
25	application	NN	O	application	nn	27	SENT_66	[p4l1738t126r2152b215],
26	2010017-O1H	NN	O	2010017-o1h	nn	27	SENT_66	[p4l11t239r548b324],
27	)	NN	O	)	prep_at	5	SENT_66	[p4l11t239r548b324],
28	.	.	O	.	_	0	SENT_66	[p4l11t239r548b324],

1	The	DT	O	the	det	5	SENT_67	[p4l605t234r749b303],
2	Spartan	NNP	MISC	Spartan	nn	5	SENT_67	[p4l810t240r1096b323],
3	RX	NNP	MISC	RX	nn	5	SENT_67	[p4l1154t241r1266b301],
4	CYPZCI9	NNP	MISC	CYPZCI9	nn	5	SENT_67	[p4l1321t240r1671b303],
5	device	NN	O	device	nsubjpass	7	SENT_67	[p4l1727t234r1957b303],
6	was	VBD	O	be	auxpass	7	SENT_67	[p4l2010t259r2149b303],
7	authorised	VBN	O	authorise	_	0	SENT_67	[p4l9t343r410b411],
8	for	IN	O	for	_	0	SENT_67	[p4l434t343r542b411],
9	use	NN	O	use	prep_for	7	SENT_67	[p4l564t367r692b411],
10	by	IN	O	by	_	0	SENT_67	[p4l717t343r805b433],
11	the	DT	O	the	det	14	SENT_67	[p4l827t343r944b411],
12	point-oﬁcare	JJ	O	point-oﬁcare	amod	14	SENT_67	[p4l970t343r1443b432],
13	testing	NN	O	testing	nn	14	SENT_67	[p4l1468t348r1724b433],
14	committee	NN	O	committee	agent	7	SENT_67	[p4l1750t348r2151b411],
15	at	IN	O	at	_	0	SENT_67	[p4l9t466r75b520],
16	the	DT	O	the	det	18	SENT_67	[p4l90t453r208b521],
17	Ottawa	NNP	ORGANIZATION	Ottawa	nn	18	SENT_67	[p4l229t459r491b521],
18	Hospital	NNP	ORGANIZATION	Hospital	prep_at	14	SENT_67	[p4l513t453r829b542],
19	and	CC	ORGANIZATION	and	_	0	SENT_67	[p4l848t453r987b521],
20	Health	NNP	ORGANIZATION	Health	nn	25	SENT_67	[p4l1008t453r1260b521],
21	Canada	NNP	ORGANIZATION	Canada	nn	25	SENT_67	[p4l1280t453r1556b521],
22	(	CD	NUMBER	(	num	25	SENT_67	[p4l1580t453r2152b543],
23	investigational	JJ	O	investigational	amod	25	SENT_67	[p4l1580t453r2152b543],
24	testing	NN	O	testing	nn	25	SENT_67	[p4l7t566r262b651],
25	application	NN	O	application	prep_at	14	SENT_67	[p4l290t561r704b650],
26	164382	CD	NUMBER	164382	num	27	SENT_67	[p4l732t567r1030b651],
27	)	NN	O	)	dep	18	SENT_67	[p4l732t567r1030b651],
28	.	.	O	.	_	0	SENT_67	[p4l732t567r1030b651],

1	Randomisation	NN	O	randomisation	csubj	8	SENT_68	[p4l13t780r579b849],
2	and	CC	O	and	_	0	SENT_68	[p4l602t780r741b849],
3	masking	VBG	O	mask	conj_and	1	SENT_68	[p4l765t780r1077b871],
4	The	DT	O	the	det	6	SENT_68	[p4l7t891r150b959],
5	randomisation	NN	O	randomisation	nn	6	SENT_68	[p4l208t891r753b959],
6	sequence	NN	O	sequence	dobj	3	SENT_68	[p4l812t915r1153b980],
7	was	VBD	O	be	cop	8	SENT_68	[p4l1209t915r1347b959],
8	computer-generated	JJ	O	computer-generated	_	0	SENT_68	[p4l1408t891r2153b981],
9	and	CC	O	and	_	0	SENT_68	[p4l9t999r147b1068],
10	blocked	VBD	O	block	conj_and	8	SENT_68	[p4l173t999r460b1068],
11	in	IN	O	in	_	0	SENT_68	[p4l487t1004r562b1066],
12	randomly	RB	O	randomly	advmod	15	SENT_68	[p4l591t999r950b1089],
13	selected	VBN	O	select	amod	15	SENT_68	[p4l979t999r1270b1068],
14	block	NN	O	block	nn	15	SENT_68	[p4l1297t999r1496b1068],
15	sizes	NNS	O	size	prep_in	10	SENT_68	[p4l1526t1004r1699b1068],
16	of	IN	O	of	_	0	SENT_68	[p4l1732t999r1815b1068],
17	four	CD	NUMBER	four	prep_of	15	SENT_68	[p4l1831t999r1987b1068],
18	and	CC	O	and	_	0	SENT_68	[p4l2016t999r2153b1068],
19	six	CD	NUMBER	six	conj_and	17	SENT_68	[p4l11t1113r124b1176],
20	.	.	O	.	_	0	SENT_68	[p4l11t1113r124b1176],

1	Patients	NNS	O	patient	nsubjpass	4	SENT_69	[p4l157t1113r446b1176],
2	were	VBD	O	be	auxpass	4	SENT_69	[p4l471t1133r648b1177],
3	randomly	RB	O	randomly	advmod	4	SENT_69	[p4l673t1108r1031b1198],
4	assigned	VBN	O	assign	_	0	SENT_69	[p4l1055t1108r1377b1198],
5	to	TO	O	to	_	0	SENT_69	[p4l1399t1122r1468b1176],
6	a	DT	O	a	det	7	SENT_69	[p4l1494t1133r1531b1176],
7	strategy	NN	O	strategy	prep_to	4	SENT_69	[p4l1558t1122r1844b1198],
8	of	IN	O	of	_	0	SENT_69	[p4l1867t1108r1950b1176],
9	rapid	JJ	O	rapid	amod	10	SENT_69	[p4l1961t1108r2153b1197],
10	genotyping	NN	O	genotyping	prep_of	7	SENT_69	[p4l10t1222r424b1308],
11	or	CC	O	or	_	0	SENT_69	[p4l481t1242r557b1285],
12	standard	JJ	O	standard	amod	13	SENT_69	[p4l615t1218r935b1286],
13	treatment	NN	O	treatment	conj_or	10	SENT_69	[p4l990t1231r1355b1286],
14	by	IN	O	by	_	0	SENT_69	[p4l1409t1218r1496b1307],
15	use	NN	O	use	agent	4	SENT_69	[p4l1550t1242r1676b1286],
16	of	IN	O	of	_	0	SENT_69	[p4l1735t1218r1818b1285],
17	opaque	JJ	O	opaque	prep_of	15	SENT_69	[p4l1863t1242r2148b1307],
18	,	,	O	,	_	0	SENT_69	[p4l1863t1242r2148b1307],
19	serially	RB	O	serially	advmod	20	SENT_69	[p4l11t1326r271b1416],
20	numbered	VBD	O	number	partmod	17	SENT_69	[p4l294t1326r701b1404],
21	,	,	O	,	_	0	SENT_69	[p4l294t1326r701b1404],
22	sealed	VBN	O	seal	partmod	17	SENT_69	[p4l733t1326r959b1395],
23	envelopes	NNS	O	envelope	dobj	22	SENT_69	[p4l984t1326r1365b1415],
24	.	.	O	.	_	0	SENT_69	[p4l984t1326r1365b1415],

1	Interventional	JJ	O	interventional	amod	2	SENT_70	[p4l1399t1326r1921b1395],
2	cardiologists	NNS	O	cardiologist	nsubjpass	7	SENT_70	[p4l1947t1326r2150b1395, p4l9t1435r287b1525],
3	and	CC	O	and	_	0	SENT_70	[p4l321t1435r458b1503],
4	data	NNS	O	datum	nn	5	SENT_70	[p4l488t1435r639b1503],
5	analysts	NNS	O	analyst	conj_and	2	SENT_70	[p4l670t1435r960b1524],
6	were	VBD	O	be	auxpass	7	SENT_70	[p4l991t1459r1168b1503],
7	masked	VBN	O	mask	_	0	SENT_70	[p4l1199t1435r1488b1503],
8	to	TO	O	to	_	0	SENT_70	[p4l1515t1448r1584b1503],
9	genetic	JJ	O	genetic	amod	11	SENT_70	[p4l1616t1440r1881b1525],
10	carrier	NN	O	carrier	nn	11	SENT_70	[p4l1911t1440r2153b1503],
11	status	NN	O	status	prep_to	7	SENT_70	[p4l11t1559r222b1614],
12	and	CC	O	and	_	0	SENT_70	[p4l261t1546r397b1614],
13	subsequent	JJ	O	subsequent	amod	14	SENT_70	[p4l434t1546r859b1635],
14	treatment	NN	O	treatment	prep_to	7	SENT_70	[p4l891t1559r1257b1614],
15	for	IN	O	for	_	0	SENT_70	[p4l1290t1546r1396b1614],
16	the	DT	O	the	det	17	SENT_70	[p4l1428t1546r1544b1614],
17	duration	NN	O	duration	prep_for	7	SENT_70	[p4l1580t1546r1897b1614],
18	of	IN	O	of	_	0	SENT_70	[p4l1932t1546r2015b1614],
19	the	DT	O	the	det	20	SENT_70	[p4l2035t1546r2151b1614],
20	study	NN	O	study	prep_of	17	SENT_70	[p4l11t1655r218b1744],
21	.	.	O	.	_	0	SENT_70	[p4l11t1655r218b1744],

1	Patients	NNS	O	patient	nsubjpass	4	SENT_71	[p4l250t1660r539b1724],
2	were	VBD	O	be	auxpass	4	SENT_71	[p4l564t1680r741b1724],
3	not	RB	O	not	neg	4	SENT_71	[p4l766t1669r888b1724],
4	masked	VBN	O	mask	_	0	SENT_71	[p4l911t1655r1200b1724],
5	to	TO	O	to	_	0	SENT_71	[p4l1221t1669r1290b1724],
6	treatment	NN	O	treatment	nn	7	SENT_71	[p4l1314t1669r1680b1724],
7	allocation	NN	O	allocation	prep_to	4	SENT_71	[p4l1704t1655r2076b1724],
8	.	.	O	.	_	0	SENT_71	[p4l1704t1655r2076b1724],

1	200	CD	NUMBER	200	num	2	SENT_72	[p4l832t1871r872b1889],
2	patients	NNS	O	patient	nsubj	3	SENT_72	[p4l878t1870r962b1895],
3	enrolled	VBD	O	enrol	_	0	SENT_72	[p4l969t1869r1052b1889],

1	200	CD	NUMBER	200	nsubj	24	SENT_73	[p4l831t1983r870b2000],
2	tested	VBN	O	test	partmod	1	SENT_73	[p4l876t1980r940b2000],
3	for	IN	O	for	_	0	SENT_73	[p4l946t1980r976b2000],
4	baseline	NN	O	baseline	nn	6	SENT_73	[p4l982t1980r1065b2000],
5	platelet	NN	O	platelet	nn	6	SENT_73	[p4l1071t1980r1149b2006],
6	function	NN	O	function	prep_for	2	SENT_73	[p4l1155t1980r1241b2000],
7	a	DT	O	a	det	8	SENT_73	[p4l83t2143r94b2156],
8	ients	NNS	O	ient	nsubj	14	SENT_73	[p4l105t2138r154b2156],
9	excluded	VBN	O	exclude	partmod	8	SENT_73	[p4l160t2136r251b2156],
10	after	IN	O	after	_	0	SENT_73	[p4l257t2136r306b2156],
11	testing	VBG	O	test	prepc_after	9	SENT_73	[p4l310t2138r382b2162],
12	id	NN	O	id	dobj	11	SENT_73	[p4l105t2169r122b2188],
13	not	RB	O	not	neg	12	SENT_73	[p4l129t2172r164b2188],
14	undergo	VBP	O	undergo	rcmod	6	SENT_73	[p4l171t2169r256b2195],
15	PCI	NN	O	pcus	dobj	14	SENT_73	[p4l264t2170r294b2188],
16	2	CD	NUMBER	2	num	15	SENT_73	[p4l73t2204r83b2221],
17	withdrawn	VBN	O	withdraw	partmod	15	SENT_73	[p4l90t2201r201b2221],
18	from	IN	O	from	_	0	SENT_73	[p4l208t2201r258b2221],
19	study	NN	O	study	prep_from	17	SENT_73	[p4l265t2201r322b2227],
20	by	IN	O	by	_	0	SENT_73	[p4l328t2201r352b2227],
21	treating	VBG	O	treat	agent	17	SENT_73	[p4l90t2235r172b2260],
22	physician	NN	O	physician	dobj	21	SENT_73	[p4l179t2234r274b2259],
23	1	CD	NUMBER	1	num	22	SENT_73	[p4l73t2269r83b2286],
24	had	VBD	O	have	_	0	SENT_73	[p4l91t2266r128b2286],
25	coronary	JJ	O	coronary	amod	26	SENT_73	[p4l134t2273r225b2292],
26	dissection	NN	O	dissection	dobj	24	SENT_73	[p4l230t2266r332b2286],
27	and	CC	O	and	_	0	SENT_73	[p4l339t2266r377b2286],
28	underwent	VBD	O	undergo	conj_and	24	SENT_73	[p4l92t2299r204b2318],
29	urgent	JJ	O	urgent	amod	33	SENT_73	[p4l210t2302r278b2325],
30	coronary	JJ	O	coronary	amod	33	SENT_73	[p4l285t2305r375b2324],
31	artery	NN	O	artery	nn	33	SENT_73	[p4l381t2302r441b2324],
32	bypass	NN	O	bypass	nn	33	SENT_73	[p4l92t2331r159b2357],
33	surgery	NN	O	surgery	dobj	28	SENT_73	[p4l166t2338r241b2357],

1	102	CD	NUMBER	102	nsubj	2	SENT_74	[p4l526t2145r563b2162],
2	assigned	VBN	O	assign	_	0	SENT_74	[p4l570t2142r659b2168],
3	to	TO	O	to	_	0	SENT_74	[p4l664t2146r686b2162],
4	rapid	JJ	O	rapid	amod	5	SENT_74	[p4l693t2142r744b2168],
5	genotyping	NN	O	genotyping	prep_to	2	SENT_74	[p4l751t2144r869b2168],
6	98	CD	NUMBER	98	num	5	SENT_74	[p4l1080t2142r1107b2165],
7	assigned	VBN	O	assign	partmod	5	SENT_74	[p4l1114t2142r1203b2169],
8	to	TO	O	to	_	0	SENT_74	[p4l1208t2146r1230b2162],
9	standard	JJ	O	standard	amod	10	SENT_74	[p4l1236t2142r1327b2162],
10	treatment	NN	O	treatment	prep_to	7	SENT_74	[p4l1332t2146r1437b2162],

1	23	CD	NUMBER	23	num	2	SENT_75	[p4l540t2356r564b2376],
2	carriers	NNS	O	carrier	_	0	SENT_75	[p4l571t2355r644b2373],
3	74	CD	NUMBER	74	num	4	SENT_75	[p4l812t2356r837b2376],
4	non-carriers	NNS	O	non-carrier	dep	2	SENT_75	[p4l844t2355r967b2373],
5	of	IN	O	of	_	0	SENT_75	[p4l571t2386r593b2406],
6	CYP2C19	NN	O	cyp2c19	nn	7	SENT_75	[p4l598t2388r686b2409],
7	*	NN	O	*	prep_of	2	SENT_75	[p4l690t2387r711b2406],
8	2	CD	NUMBER	2	num	7	SENT_75	[p4l690t2387r711b2406],
9	of	IN	O	of	dep	2	SENT_75	[p4l843t2386r865b2406],
10	CYP2C19	NN	O	cyp2c19	nn	11	SENT_75	[p4l870t2388r959b2409],
11	*	NN	O	*	pobj	9	SENT_75	[p4l963t2387r984b2406],
12	2	CD	NUMBER	2	num	13	SENT_75	[p4l963t2387r984b2406],
13	l	NN	O	l	tmod	11	SENT_75	[p4l620t2431r640b2477],
14	l	NN	O	l	tmod	9	SENT_75	[p4l889t2431r909b2477],
15	_	IN	O	_	dep	2	SENT_75	[p4l927t2500r930b2503],

1	10	CD	NUMBER	10	num	2	SENT_76	[p4l540t2501r564b2518],
2	m	NN	O	m	_	0	SENT_76	[p4l572t2505r590b2518],
3	rasugrel	NN	O	rasugrel	dep	2	SENT_76	[p4l625t2498r704b2524],

1	75	CD	NUMBER	75	num	3	SENT_77	[p4l1078t2358r1102b2377],
2	mg	NN	O	mg	nn	3	SENT_77	[p4l1110t2361r1142b2381],
3	clopidogrel	NN	O	clopidogrel	npadvmod	4	SENT_77	[p4l1149t2355r1263b2381],
4	daily	RB	SET	daily	_	0	SENT_77	[p4l1270t2355r1318b2381],

1	2	CD	NUMBER	2	num	2	SENT_78	[p4l1383t2508r1393b2525],
2	patients	NNS	O	patient	nsubj	10	SENT_78	[p4l1400t2507r1484b2531],
3	did	VBD	O	do	aux	5	SENT_78	[p4l1490t2505r1522b2525],
4	not	RB	O	not	neg	5	SENT_78	[p4l1529t2509r1564b2525],
5	return	VB	O	return	rcmod	2	SENT_78	[p4l1571t2509r1633b2525],
6	a	DT	O	a	det	7	SENT_78	[p4l1640t2512r1650b2525],
7	da	NN	O	da	dobj	5	SENT_78	[p4l1666t2505r1689b2525],
8	7	CD	NUMBER	7	number	9	SENT_78	[p4l1707t2508r1719b2527],
9	1	CD	NUMBER	1	num	7	SENT_78	[p4l1402t2540r1413b2557],
10	refused	VBD	O	refuse	_	0	SENT_78	[p4l1420t2537r1495b2557],
11	to	TO	O	to	aux	12	SENT_78	[p4l1500t2541r1522b2557],
12	return	VB	O	return	xcomp	10	SENT_78	[p4l1529t2541r1591b2558],
13	for	IN	O	for	_	0	SENT_78	[p4l1597t2537r1627b2557],
14	da	NN	O	da	nn	15	SENT_78	[p4l1633t2538r1657b2557],
15	load	NN	O	load	prep_for	12	SENT_78	[p4l1707t2538r1751b2557],
16	test	NN	O	test	nsubj	18	SENT_78	[p4l1756t2541r1795b2557],
17	1	CD	NUMBER	1	num	16	SENT_78	[p4l1402t2573r1413b2590],
18	lost	VBD	O	lose	rcmod	15	SENT_78	[p4l1420t2570r1457b2590],
19	to	TO	O	to	_	0	SENT_78	[p4l1461t2574r1483b2590],
20	follow-up	JJ	O	follow-up	amod	22	SENT_78	[p4l1489t2570r1590b2596],
21	n	NN	O	n	nn	22	SENT_78	[p4l72t2642r83b2655],
22	n	NN	O	n	prep_to	18	SENT_78	[p4l100t2637r195b2656],
23	—	CD	NUMBER	—	num	24	SENT_78	[p4l100t2637r195b2656],
24	carriers	NNS	O	carrier	dobj	18	SENT_78	[p4l100t2637r195b2656],
25	refused	VBD	O	refuse	rcmod	24	SENT_78	[p4l203t2635r277b2656],
26	to	TO	O	to	aux	27	SENT_78	[p4l282t2639r304b2656],
27	return	VB	O	return	xcomp	25	SENT_78	[p4l312t2639r373b2656],
28	for	IN	O	for	_	0	SENT_78	[p4l380t2636r410b2656],
29	a	DT	O	a	det	32	SENT_78	[p4l85t2675r95b2688],
30	7	CD	NUMBER	7	num	32	SENT_78	[p4l113t2671r125b2691],
31	blood	NN	O	blood	nn	32	SENT_78	[p4l132t2668r190b2688],
32	tests	NNS	O	test	prep_for	27	SENT_78	[p4l195t2672r244b2688],

1	93	CD	NUMBER	93	nsubj	2	SENT_79	[p4l539t2742r564b2762],
2	had	VBD	O	have	_	0	SENT_79	[p4l573t2739r609b2759],
3	platelet-function	JJ	O	platelet-function	amod	4	SENT_79	[p4l616t2739r789b2765],
4	measurements	NNS	O	measurement	nsubj	8	SENT_79	[p4l798t2743r950b2759],
5	96	CD	NUMBER	96	num	8	SENT_79	[p4l1081t2738r1108b2761],
6	ha	NN	O	ha	nn	8	SENT_79	[p4l1116t2738r1139b2758],
7	atelet-function	JJ	O	atelet-function	amod	8	SENT_79	[p4l1178t2738r1333b2758],
8	measurements	NNS	O	measurement	xcomp	2	SENT_79	[p4l1341t2742r1493b2758],
9	taken	VBN	O	take	partmod	8	SENT_79	[p4l571t2771r628b2791],
10	at	IN	O	at	_	0	SENT_79	[p4l636t2775r655b2791],
11	1	CD	DURATION	1	num	12	SENT_79	[p4l662t2774r673b2791],
12	week	NN	NUMBER	week	prep_at	9	SENT_79	[p4l678t2771r732b2791],
13	a	DT	DURATION	a	det	14	SENT_79	[p4l1116t2778r1126b2791],
14	week	NN	DURATION	week	dep	12	SENT_79	[p4l1158t2771r1212b2791],
15	an	DT	O	a	det	16	SENT_79	[p4l1218t2778r1241b2791],
16	oint	NN	O	oint	tmod	9	SENT_79	[p4l1276t2771r1398b2791],
17	—	CD	NUMBER	—	num	20	SENT_79	[p4l1276t2771r1398b2791],
18	of-care	JJ	O	of-care	amod	20	SENT_79	[p4l1276t2771r1398b2791],
19	genetic	JJ	O	genetic	amod	20	SENT_79	[p4l1116t2805r1191b2829],
20	tes	NNS	O	te	dep	16	SENT_79	[p4l1196t2807r1226b2823],
21	ing	VBG	O	ing	xcomp	9	SENT_79	[p4l1237t2805r1268b2829],

1	2	CD	NUMBER	2	num	2	SENT_80	[p4l53t2859r63b2876],
2	non-carriers	NNS	O	non-carrier	nsubj	3	SENT_80	[p4l71t2858r194b2876],
3	had	VBD	O	have	_	0	SENT_80	[p4l202t2856r238b2876],
4	inconclusive	JJ	O	inconclusive	amod	5	SENT_80	[p4l246t2856r371b2876],
5	readings	NNS	O	reading	dobj	3	SENT_80	[p4l73t2889r159b2915],
6	on	IN	O	on	_	0	SENT_80	[p4l165t2895r190b2909],
7	platelet-function	JJ	O	platelet-function	amod	8	SENT_80	[p4l198t2888r371b2915],
8	measurements	NNS	O	measurement	prep_on	5	SENT_80	[p4l73t2925r225b2941],

1	91	CD	NUMBER	91	_	0	SENT_81	[p4l538t2970r563b2990],
2	included	VBN	O	include	partmod	1	SENT_81	[p4l571t2967r657b2987],
3	in	IN	O	in	_	0	SENT_81	[p4l664t2968r681b2986],
4	intention-to-treat	JJ	O	intention-to-treat	amod	5	SENT_81	[p4l689t2968r876b2987],
5	analysis	NN	O	analysis	prep_in	2	SENT_81	[p4l882t2967r961b2993],
6	96	CD	NUMBER	96	nsubj	7	SENT_81	[p4l1081t2966r1108b2989],
7	included	VBD	O	include	rcmod	5	SENT_81	[p4l1116t2966r1202b2986],
8	in	IN	O	in	_	0	SENT_81	[p4l1209t2968r1226b2986],
9	intention-to-treat	JJ	O	intention-to-treat	amod	10	SENT_81	[p4l1234t2968r1421b2986],
10	analysis	NN	O	analysis	prep_in	7	SENT_81	[p4l1427t2966r1506b2992],
11	23	CD	NUMBER	23	num	12	SENT_81	[p4l569t3002r593b3022],
12	carriers	NNS	O	carrier	dep	17	SENT_81	[p4l600t3001r674b3019],
13	of	IN	O	of	_	0	SENT_81	[p4l680t2999r702b3019],
14	CYPZCI	NN	O	cypzcus	prep_of	12	SENT_81	[p4l707t3001r781b3019],
15	*	CD	NUMBER	*	dep	17	SENT_81	[p4l799t3000r808b3009],
16	23	CD	NUMBER	23	num	17	SENT_81	[p4l1114t3001r1138b3021],
17	carriers	NNS	O	carrier	dep	23	SENT_81	[p4l1145t3000r1218b3019],
18	of	IN	O	of	_	0	SENT_81	[p4l1224t2999r1246b3019],
19	CYP2C19	NN	O	cyp2c19	nn	20	SENT_81	[p4l1251t3000r1340b3021],
20	*	NN	O	*	prep_of	17	SENT_81	[p4l1344t3000r1364b3018],
21	2	CD	NUMBER	2	number	22	SENT_81	[p4l1344t3000r1364b3018],
22	68	CD	NUMBER	68	num	23	SENT_81	[p4l570t3032r596b3052],
23	non-carriers	NNS	O	non-carrier	dep	30	SENT_81	[p4l605t3034r727b3052],
24	of	IN	O	of	_	0	SENT_81	[p4l733t3032r755b3052],
25	CY	NNP	O	CY	nn	27	SENT_81	[p4l760t3033r786b3052],
26	9	CD	NUMBER	9	num	27	SENT_81	[p4l837t3033r874b3055],
27	*	NN	O	*	prep_of	23	SENT_81	[p4l837t3033r874b3055],
28	2	CD	NUMBER	2	number	29	SENT_81	[p4l837t3033r874b3055],
29	73	CD	NUMBER	73	num	30	SENT_81	[p4l1113t3034r1137b3054],
30	non-carriers	NNS	O	non-carrier	dep	33	SENT_81	[p4l1145t3033r1268b3051],
31	of	IN	O	of	_	0	SENT_81	[p4l1274t3031r1296b3051],
32	CYP2C19	NN	O	cyp2c19	prep_of	30	SENT_81	[p4l1301t3032r1414b3054],
33	*	NN	O	*	dep	1	SENT_81	[p4l1301t3032r1414b3054],
34	2	CD	NUMBER	2	num	33	SENT_81	[p4l1301t3032r1414b3054],

1	Figure	NNP	O	Figure	_	0	SENT_82	[p4l7t3127r75b3154],
2	1	CD	NUMBER	1	num	1	SENT_82	[p4l81t3129r100b3147],
3	:	:	O	:	_	0	SENT_82	[p4l81t3129r100b3147],
4	Study	NNP	O	Study	nn	7	SENT_82	[p4l108t3126r176b3154],
5	design	NN	O	design	nn	7	SENT_82	[p4l182t3126r258b3154],
6	PC	NN	O	pc	nn	7	SENT_82	[p4l6t3164r53b3184],
7	|	NN	O	|	dep	1	SENT_82	[p4l6t3164r53b3184],
8	=	JJ	O	=	amod	11	SENT_82	[p4l6t3164r53b3184],
9	utaneous	JJ	O	utaneous	amod	11	SENT_82	[p4l103t3166r205b3184],
10	coronary	JJ	O	coronary	amod	11	SENT_82	[p4l212t3169r310b3190],
11	intervention	NN	O	intervention	dep	7	SENT_82	[p4l317t3164r460b3184],
12	.	.	O	.	_	0	SENT_82	[p4l317t3164r460b3184],

1	170	CD	NUMBER	170	num	3	SENT_83	[p4l6t3203r48b3225],
2	www.thelancet.com	NNP	O	www.thelancet.com	nn	3	SENT_83	[p4l1710t3200r1932b3222],
3	Vol	NNP	O	Vol	_	0	SENT_83	[p4l1951t3200r1987b3222],
4	379	CD	NUMBER	379	dep	3	SENT_83	[p4l1995t3203r2038b3225],
5	May	NNP	DATE	May	tmod	4	SENT_83	[p4l2059t3202r2109b3228],
6	5	CD	DATE	5	num	5	SENT_83	[p4l2115t3203r2135b3226],
7	,	,	DATE	,	_	0	SENT_83	[p4l2115t3203r2135b3226],
8	2012	CD	DATE	2012	num	5	SENT_83	[p4l6t3242r63b3261],

1	Articles	NNPS	O	Articles	_	0	SENT_84	[p4l6t3499r156b3535],
2	I	PRP	O	I	dep	1	SENT_84	[p4l204t3336r251b3535],

1	Procedures	NNS	O	procedure	_	0	SENT_85	[p5l13t97r415b165],

1	The	DT	O	the	det	3	SENT_86	[p5l7t207r152b276],
2	point-of-care	JJ	O	point-of-care	amod	3	SENT_86	[p5l187t207r662b296],
3	device	NN	O	device	nsubjpass	5	SENT_86	[p5l698t207r929b276],
4	was	VBD	O	be	auxpass	5	SENT_86	[p5l963t231r1102b276],
5	validated	VBN	O	validate	_	0	SENT_86	[p5l1137t207r1475b276],
6	before	IN	O	before	_	0	SENT_86	[p5l1507t207r1744b276],
7	its	PRP$	O	its	poss	8	SENT_86	[p5l1780t212r1865b276],
8	use	NN	O	use	prep_before	5	SENT_86	[p5l1901t231r2029b276],
9	in	IN	O	in	_	0	SENT_86	[p5l2065t212r2140b274],
10	the	DT	O	the	det	12	SENT_86	[p5l7t317r125b384],
11	clinical	JJ	O	clinical	amod	12	SENT_86	[p5l159t317r426b384],
12	setting	NN	O	setting	prep_in	8	SENT_86	[p5l462t321r733b407],
13	.	.	O	.	_	0	SENT_86	[p5l462t321r733b407],

1	Identiﬁcation	NN	O	identiﬁcation	nsubjpass	9	SENT_87	[p5l774t317r1280b384],
2	of	IN	O	of	_	0	SENT_87	[p5l1314t317r1397b384],
3	CYP2C19	NN	O	cyp2c19	nn	4	SENT_87	[p5l1424t321r1864b385],
4	*	NN	O	*	prep_of	1	SENT_87	[p5l1424t321r1864b385],
5	2	CD	NUMBER	2	num	7	SENT_87	[p5l1424t321r1864b385],
6	carrier	NN	O	carrier	nn	7	SENT_87	[p5l1894t321r2141b384],
7	status	NN	O	status	dep	4	SENT_87	[p5l11t439r226b494],
8	was	VBD	O	be	auxpass	9	SENT_87	[p5l264t450r403b494],
9	compared	VBN	O	compare	_	0	SENT_87	[p5l444t425r819b514],
10	with	IN	O	with	_	0	SENT_87	[p5l852t425r1019b494],
11	conventional	JJ	O	conventional	amod	13	SENT_87	[p5l1057t425r1540b494],
12	genetic	JJ	O	genetic	amod	13	SENT_87	[p5l1579t430r1848b515],
13	testing	NN	O	testing	prep_with	9	SENT_87	[p5l1884t430r2140b515],
14	with	IN	O	with	_	0	SENT_87	[p5l7t534r173b602],
15	direct	JJ	O	direct	amod	17	SENT_87	[p5l229t534r442b602],
16	DNA	NN	O	dna	nn	17	SENT_87	[p5l499t539r687b602],
17	sequencing	NN	O	sequencing	prep_with	13	SENT_87	[p5l743t539r1191b624],
18	.	.	O	.	_	0	SENT_87	[p5l743t539r1191b624],

1	Extraction	NN	O	extraction	nsubjpass	6	SENT_88	[p5l1254t539r1632b602],
2	of	IN	O	of	_	0	SENT_88	[p5l1687t534r1771b602],
3	genomic	JJ	O	genomic	amod	4	SENT_88	[p5l1814t539r2140b624],
4	DNA	NN	MISC	dna	prep_of	1	SENT_88	[p5l13t649r200b711],
5	was	VBD	O	be	auxpass	6	SENT_88	[p5l246t668r385b711],
6	done	VBN	O	do	_	0	SENT_88	[p5l439t644r621b711],
7	with	IN	O	with	_	0	SENT_88	[p5l669t644r835b711],
8	the	DT	O	the	det	11	SENT_88	[p5l884t644r1001b711],
9	Arrow	NNP	MISC	Arrow	nn	11	SENT_88	[p5l1049t649r1288b711],
10	extraction	NN	O	extraction	nn	11	SENT_88	[p5l1337t648r1706b711],
11	robot	NN	O	robot	prep_with	6	SENT_88	[p5l1755t644r1953b711],
12	and	CC	O	and	_	0	SENT_88	[p5l2002t644r2141b711],
13	the	DT	O	the	det	17	SENT_88	[p5l7t752r124b821],
14	Blood	NN	MISC	blood	nn	17	SENT_88	[p5l191t752r404b821],
15	DNA	NN	MISC	dna	nn	17	SENT_88	[p5l469t758r656b821],
16	200	CD	NUMBER	200	num	17	SENT_88	[p5l720t758r849b821],
17	cartridge	NN	O	cartridge	prep_with	6	SENT_88	[p5l913t752r1245b842],
18	(	CD	NUMBER	(	dep	17	SENT_88	[p5l1313t752r1657b842],
19	Nordiag	NNP	O	Nordiag	nn	25	SENT_88	[p5l1313t752r1657b842],
20	,	,	O	,	_	0	SENT_88	[p5l1313t752r1657b842],
21	Alpharetta	NNP	LOCATION	Alpharetta	appos	25	SENT_88	[p5l1721t752r2136b841],
22	,	,	O	,	_	0	SENT_88	[p5l1721t752r2136b841],
23	GA	NNP	O	GA	appos	25	SENT_88	[p5l11t866r152b939],
24	,	,	O	,	_	0	SENT_88	[p5l11t866r152b939],
25	USA	NNP	LOCATION	USA	dep	17	SENT_88	[p5l239t866r461b951],
26	)	CD	NUMBER	)	num	25	SENT_88	[p5l239t866r461b951],
27	.	.	O	.	_	0	SENT_88	[p5l239t866r461b951],

1	Ampliﬁcation	NN	O	ampliﬁcation	_	0	SENT_89	[p5l543t861r1064b950],
2	of	IN	O	of	_	0	SENT_89	[p5l1145t861r1228b929],
3	the	DT	O	the	det	5	SENT_89	[p5l1293t861r1411b929],
4	genomic	JJ	O	genomic	amod	5	SENT_89	[p5l1492t866r1818b951],
5	region	NN	O	region	prep_of	1	SENT_89	[p5l1898t866r2140b951],
6	containing	VBG	O	contain	partmod	5	SENT_89	[p5l9t975r413b1061],
7	the	DT	O	the	det	8	SENT_89	[p5l448t971r566b1038],
8	CYP2C19	NN	O	cyp2c19	dobj	6	SENT_89	[p5l610t975r1051b1039],
9	"	''	O	"	punct	8	SENT_89	[p5l610t975r1051b1039],
10	'	''	O	'	_	0	SENT_89	[p5l610t975r1051b1039],
11	~	FW	O	~	nn	12	SENT_89	[p5l610t975r1051b1039],
12	‘	FW	O	‘	dep	6	SENT_89	[p5l610t975r1051b1039],
13	2	CD	NUMBER	2	num	14	SENT_89	[p5l610t975r1051b1039],
14	allele	NN	O	allele	nsubjpass	19	SENT_89	[p5l1084t971r1277b1038],
15	(	CD	NUMBER	(	num	17	SENT_89	[p5l1320t975r1736b1061],
16	rs4244285	NN	O	rs4244285	nn	17	SENT_89	[p5l1320t975r1736b1061],
17	)	NN	O	)	dep	14	SENT_89	[p5l1320t975r1736b1061],
18	was	VBD	O	be	auxpass	19	SENT_89	[p5l1777t995r1916b1038],
19	done	VBN	O	do	rcmod	12	SENT_89	[p5l1957t971r2139b1038],
20	with	IN	O	with	_	0	SENT_89	[p5l7t1079r173b1148],
21	PCR	NN	O	pcr	prep_with	19	SENT_89	[p5l256t1085r423b1148],
22	with	IN	O	with	_	0	SENT_89	[p5l498t1079r664b1148],
23	two	CD	NUMBER	two	num	25	SENT_89	[p5l742t1093r875b1148],
24	oligonucleotide	NN	O	oligonucleotide	nn	25	SENT_89	[p5l955t1079r1534b1169],
25	primers	NNS	O	primer	prep_with	21	SENT_89	[p5l1613t1084r1931b1168],
26	:	:	O	:	_	0	SENT_89	[p5l1613t1084r1931b1168],
27	forward	RB	O	forward	advmod	25	SENT_89	[p5l2014t1079r2138b1148, p5l7t1188r212b1266],
28	,	,	O	,	_	0	SENT_89	[p5l2014t1079r2138b1148, p5l7t1188r212b1266],
29	5	CD	NUMBER	5	appos	25	SENT_89	[p5l298t1193r1920b1266],
30	'	''	O	'	_	0	SENT_89	[p5l298t1193r1920b1266],
31	-	:	O	-	_	0	SENT_89	[p5l298t1193r1920b1266],
32	TGCAATAATTTTCCCACTATCATTG-3	NN	O	tgcaataattttcccactatcattg-3	dep	21	SENT_89	[p5l298t1193r1920b1266],
33	'	''	O	'	_	0	SENT_89	[p5l298t1193r1920b1266],
34	;	:	O	;	_	0	SENT_89	[p5l298t1193r1920b1266],
35	and	CC	O	and	_	0	SENT_89	[p5l2002t1188r2141b1256],
36	reverse	VB	O	reverse	rcmod	12	SENT_89	[p5l9t1322r296b1376],
37	,	,	O	,	_	0	SENT_89	[p5l9t1322r296b1376],
38	5	CD	NUMBER	5	appos	12	SENT_89	[p5l437t1302r2136b1365],
39	'	''	O	'	_	0	SENT_89	[p5l437t1302r2136b1365],
40	-	:	O	-	_	0	SENT_89	[p5l437t1302r2136b1365],
41	CCAAAATATCACTTTCCATAAAAGCA-3	NN	O	ccaaaatatcactttccataaaagca-3	dep	1	SENT_89	[p5l437t1302r2136b1365],
42	'	''	O	'	_	0	SENT_89	[p5l437t1302r2136b1365],
43	.	.	O	.	_	0	SENT_89	[p5l437t1302r2136b1365],

1	DNA	NN	O	dna	nn	2	SENT_90	[p5l13t1412r200b1474],
2	sequencing	NN	O	sequencing	nsubjpass	4	SENT_90	[p5l234t1411r664b1496],
3	was	VBD	O	be	auxpass	4	SENT_90	[p5l695t1431r834b1475],
4	undertaken	VBN	O	undertake	_	0	SENT_90	[p5l869t1406r1303b1475],
5	with	IN	O	with	_	0	SENT_90	[p5l1334t1406r1501b1475],
6	the	DT	O	the	det	8	SENT_90	[p5l1532t1406r1649b1475],
7	ABI	NNP	O	ABI	nn	8	SENT_90	[p5l1682t1412r1827b1473],
8	PRISM	NNP	O	PRISM	prep_with	4	SENT_90	[p5l1868t1412r2135b1475],
9	dye	VB	O	dye	ccomp	4	SENT_90	[p5l9t1515r134b1605],
10	terminator	NN	O	terminator	nn	12	SENT_90	[p5l158t1520r566b1583],
11	method	NN	O	method	nn	12	SENT_90	[p5l589t1515r880b1583],
12	(	NN	O	(	dobj	9	SENT_90	[p5l909t1515r1223b1605],
13	Applied	NNP	O	Applied	nn	14	SENT_90	[p5l909t1515r1223b1605],
14	Biosystems	NNP	O	Biosystems	dep	12	SENT_90	[p5l1250t1520r1691b1605],
15	,	,	O	,	_	0	SENT_90	[p5l1250t1520r1691b1605],
16	Foster	NNP	LOCATION	Foster	nn	21	SENT_90	[p5l1723t1520r1952b1583],
17	City	NNP	LOCATION	City	nn	21	SENT_90	[p5l1977t1520r2136b1604],
18	,	,	O	,	_	0	SENT_90	[p5l1977t1520r2136b1604],
19	CA	NNP	LOCATION	CA	appos	21	SENT_90	[p5l11t1630r145b1703],
20	,	,	O	,	_	0	SENT_90	[p5l11t1630r145b1703],
21	USA	NNP	LOCATION	USA	appos	14	SENT_90	[p5l185t1630r407b1715],
22	)	CD	NUMBER	)	num	21	SENT_90	[p5l185t1630r407b1715],
23	.	.	O	.	_	0	SENT_90	[p5l185t1630r407b1715],

1	Sensitivity	NN	O	sensitivity	nsubjpass	10	SENT_91	[p5l449t1629r834b1714],
2	and	CC	O	and	_	0	SENT_91	[p5l866t1625r1004b1692],
3	speciﬁcity	NN	O	speciﬁcity	conj_and	1	SENT_91	[p5l1039t1625r1412b1714],
4	of	IN	O	of	_	0	SENT_91	[p5l1444t1625r1527b1692],
5	the	DT	O	the	det	6	SENT_91	[p5l1546t1625r1663b1692],
6	device	NN	O	device	prep_of	1	SENT_91	[p5l1698t1625r1928b1692],
7	were	VBD	O	be	auxpass	8	SENT_91	[p5l1960t1649r2139b1692],
8	established	VBN	O	establish	_	0	SENT_91	[p5l9t1733r431b1802],
9	and	CC	O	and	_	0	SENT_91	[p5l475t1733r614b1802],
10	reviewed	VBN	O	review	conj_and	8	SENT_91	[p5l656t1733r991b1802],
11	by	IN	O	by	_	0	SENT_91	[p5l1031t1733r1119b1823],
12	the	DT	O	the	det	16	SENT_91	[p5l1160t1733r1277b1802],
13	hospital	NN	O	hospital	nn	16	SENT_91	[p5l1320t1733r1621b1822],
14	point-ofcare	NN	O	point-ofcare	nn	16	SENT_91	[p5l1663t1733r2139b1822],
15	device	NN	O	device	nn	16	SENT_91	[p5l9t1842r241b1910],
16	committee	NN	O	committee	agent	8	SENT_91	[p5l269t1847r691b1920],
17	,	,	O	,	_	0	SENT_91	[p5l269t1847r691b1920],
18	ethics	NNS	O	ethic	nn	19	SENT_91	[p5l722t1842r937b1910],
19	board	NN	O	board	agent	8	SENT_91	[p5l965t1842r1199b1920],
20	,	,	O	,	_	0	SENT_91	[p5l965t1842r1199b1920],
21	and	CC	O	and	_	0	SENT_91	[p5l1230t1842r1369b1910],
22	Health	NNP	ORGANIZATION	Health	nn	23	SENT_91	[p5l1398t1842r1650b1910],
23	Canada	NNP	ORGANIZATION	Canada	agent	8	SENT_91	[p5l1679t1842r1974b1910],
24	.	.	O	.	_	0	SENT_91	[p5l1679t1842r1974b1910],

1	The	DT	O	the	det	5	SENT_92	[p5l78t1953r219b2021],
2	Spartan	NNP	MISC	Spartan	nn	5	SENT_92	[p5l258t1958r537b2042],
3	RX	NNP	MISC	RX	nn	5	SENT_92	[p5l574t1960r685b2019],
4	CYPZC19	NN	MISC	cypzc19	nn	5	SENT_92	[p5l719t1958r1060b2021],
5	device	NN	O	device	nsubjpass	8	SENT_92	[p5l1096t1953r1319b2021],
6	was	VBD	O	be	auxpass	8	SENT_92	[p5l1351t1977r1488b2021],
7	initially	RB	O	initially	advmod	8	SENT_92	[p5l1523t1953r1797b2042],
8	assessed	VBN	O	assess	_	0	SENT_92	[p5l1829t1953r2141b2021],
9	with	IN	O	with	_	0	SENT_92	[p5l7t2061r169b2130],
10	267	CD	NUMBER	267	num	11	SENT_92	[p5l209t2066r330b2132],
11	tests	NNS	O	test	prep_with	8	SENT_92	[p5l365t2075r527b2130],
12	in	IN	O	in	_	0	SENT_92	[p5l567t2066r640b2128],
13	37	CD	NUMBER	37	num	15	SENT_92	[p5l682t2066r758b2132],
14	healthy	JJ	O	healthy	amod	15	SENT_92	[p5l792t2061r1061b2151],
15	volunteers	NNS	O	volunteer	prep_in	11	SENT_92	[p5l1095t2061r1475b2130],
16	before	IN	O	before	mark	19	SENT_92	[p5l1514t2061r1744b2130],
17	our	PRP$	O	we	poss	18	SENT_92	[p5l1783t2086r1908b2130],
18	study	NN	O	study	nsubj	19	SENT_92	[p5l1947t2061r2142b2151],
19	began	VBD	O	begin	advcl	8	SENT_92	[p5l7t2170r245b2260],
20	.	.	O	.	_	0	SENT_92	[p5l7t2170r245b2260],

1	Point-of-care	JJ	O	point-of-care	amod	3	SENT_93	[p5l288t2170r744b2238],
2	genetic	JJ	O	genetic	amod	3	SENT_93	[p5l780t2175r1041b2260],
3	testing	NN	O	testing	nsubj	4	SENT_93	[p5l1073t2175r1321b2260],
4	identiﬁed	VBD	O	identiﬁed	_	0	SENT_93	[p5l1356t2170r1704b2238],
5	a	DT	O	a	det	6	SENT_93	[p5l1739t2194r1776b2238],
6	genotype	NN	O	genotype	dobj	4	SENT_93	[p5l1812t2183r2139b2260],
7	in	IN	O	in	_	0	SENT_93	[p5l8t2284r82b2346],
8	266	CD	NUMBER	266	number	9	SENT_93	[p5l105t2286r230b2348],
9	(	CD	NUMBER	(	num	10	SENT_93	[p5l258t2284r510b2369],
10	>	JJR	O	>	prep_in	6	SENT_93	[p5l258t2284r510b2369],
11	99	CD	PERCENT	99	number	12	SENT_93	[p5l258t2284r510b2369],
12	%	NN	PERCENT	%	amod	10	SENT_93	[p5l258t2284r510b2369],
13	)	CD	NUMBER	)	tmod	4	SENT_93	[p5l258t2284r510b2369],
14	of	IN	O	of	_	0	SENT_93	[p5l537t2279r619b2348],
15	267	CD	NUMBER	267	num	16	SENT_93	[p5l629t2284r751b2350],
16	tests	NNS	O	test	prep_of	13	SENT_93	[p5l769t2293r951b2348],
17	.	.	O	.	_	0	SENT_93	[p5l769t2293r951b2348],

1	Of	IN	O	of	_	0	SENT_94	[p5l979t2279r1081b2348],
2	the	DT	O	the	det	3	SENT_94	[p5l1088t2280r1202b2348],
3	genotypes	NNS	O	genotype	pobj	1	SENT_94	[p5l1224t2293r1587b2369],
4	identiﬁed	VBN	O	identiﬁed	partmod	3	SENT_94	[p5l1611t2279r1960b2348],
5	with	IN	O	with	amod	7	SENT_94	[p5l1978t2280r2140b2348],
6	the	DT	O	the	det	7	SENT_94	[p5l7t2388r122b2457],
7	device	NN	O	device	dep	4	SENT_94	[p5l157t2388r399b2467],
8	,	,	O	,	_	0	SENT_94	[p5l157t2388r399b2467],
9	111	CD	PERCENT	111	dep	7	SENT_94	[p5l439t2395r540b2455],
10	(	CD	PERCENT	(	num	12	SENT_94	[p5l579t2393r777b2478],
11	42	CD	PERCENT	42	num	12	SENT_94	[p5l579t2393r777b2478],
12	%	NN	PERCENT	%	nsubj	14	SENT_94	[p5l579t2393r777b2478],
13	)	CD	NUMBER	)	dep	12	SENT_94	[p5l579t2393r777b2478],
14	were	VBD	O	be	rcmod	9	SENT_94	[p5l815t2413r990b2457],
15	homozygous	JJ	O	homozygous	dep	14	SENT_94	[p5l1022t2388r1491b2478],
16	for	IN	O	for	_	0	SENT_94	[p5l1527t2388r1631b2457],
17	the	DT	O	the	det	19	SENT_94	[p5l1662t2388r1776b2457],
18	wild-type	JJ	O	wild-type	amod	19	SENT_94	[p5l1808t2388r2139b2478],
19	allele	NN	O	allele	prep_for	15	SENT_94	[p5l9t2497r195b2565],
20	(	CD	NUMBER	(	num	21	SENT_94	[p5l243t2502r498b2587],
21	*	NN	O	*	dep	19	SENT_94	[p5l243t2502r498b2587],
22	1	CD	NUMBER	1	dep	21	SENT_94	[p5l243t2502r498b2587],
23	/	:	O	/	punct	15	SENT_94	[p5l243t2502r498b2587],
24	"	``	O	"	punct	7	SENT_94	[p5l243t2502r498b2587],
25	'	''	O	'	_	0	SENT_94	[p5l243t2502r498b2587],
26	\	SYM	O	\	dep	36	SENT_94	[p5l243t2502r498b2587],
27	‘	CD	NUMBER	‘	number	28	SENT_94	[p5l243t2502r498b2587],
28	1	CD	NUMBER	1	num	29	SENT_94	[p5l243t2502r498b2587],
29	)	NN	O	)	nsubj	36	SENT_94	[p5l243t2502r498b2587],
30	,	,	O	,	_	0	SENT_94	[p5l243t2502r498b2587],
31	119	CD	PERCENT	119	number	32	SENT_94	[p5l545t2503r654b2565],
32	(	CD	PERCENT	(	appos	29	SENT_94	[p5l702t2501r900b2587],
33	45	CD	PERCENT	45	num	34	SENT_94	[p5l702t2501r900b2587],
34	%	NN	PERCENT	%	dep	32	SENT_94	[p5l702t2501r900b2587],
35	)	CD	NUMBER	)	dep	32	SENT_94	[p5l702t2501r900b2587],
36	were	VBD	O	be	dep	4	SENT_94	[p5l945t2521r1119b2565],
37	heterozygous	JJ	O	heterozygous	amod	39	SENT_94	[p5l1161t2497r1646b2587],
38	(	NN	O	(	nn	39	SENT_94	[p5l1695t2502r1834b2587],
39	‘	NN	O	‘	nsubj	41	SENT_94	[p5l1695t2502r1834b2587],
40	''	''	O	''	_	0	SENT_94	[p5l1695t2502r1834b2587],
41	‘	NN	O	‘	xcomp	36	SENT_94	[p5l1695t2502r1834b2587],
42	2	CD	NUMBER	2	num	41	SENT_94	[p5l1695t2502r1834b2587],
43	/	:	O	/	punct	55	SENT_94	[p5l1695t2502r1834b2587],
44	*	CD	NUMBER	*	number	45	SENT_94	[p5l1842t2502r1959b2587],
45	1	CD	NUMBER	1	num	46	SENT_94	[p5l1842t2502r1959b2587],
46	)	NN	O	)	nsubj	55	SENT_94	[p5l1842t2502r1959b2587],
47	,	,	O	,	_	0	SENT_94	[p5l1842t2502r1959b2587],
48	and	CC	O	and	_	0	SENT_94	[p5l2006t2497r2141b2565],
49	36	CD	PERCENT	36	number	50	SENT_94	[p5l13t2613r92b2675],
50	(	CD	PERCENT	(	conj_and	46	SENT_94	[p5l123t2611r312b2696],
51	14	CD	PERCENT	14	num	52	SENT_94	[p5l123t2611r312b2696],
52	%	NN	PERCENT	%	dep	50	SENT_94	[p5l123t2611r312b2696],
53	)	CD	NUMBER	)	dep	46	SENT_94	[p5l123t2611r312b2696],
54	were	VBD	O	be	cop	55	SENT_94	[p5l338t2631r513b2675],
55	homozygous	JJ	O	homozygous	dep	41	SENT_94	[p5l536t2607r1004b2696],
56	for	IN	O	for	_	0	SENT_94	[p5l1029t2606r1134b2675],
57	the	DT	O	the	prep_for	55	SENT_94	[p5l1154t2607r1268b2675],
58	"	``	O	"	punct	57	SENT_94	[p5l1295t2611r1381b2673],
59	"	``	O	"	punct	61	SENT_94	[p5l1295t2611r1381b2673],
60	2	CD	NUMBER	2	num	61	SENT_94	[p5l1295t2611r1381b2673],
61	allele	NN	O	allele	dep	57	SENT_94	[p5l1401t2607r1586b2675],
62	(	CD	NUMBER	(	num	63	SENT_94	[p5l1615t2611r1889b2696],
63	*	NN	O	*	dep	61	SENT_94	[p5l1615t2611r1889b2696],
64	2	CD	NUMBER	2	tmod	55	SENT_94	[p5l1615t2611r1889b2696],
65	/	:	O	/	punct	55	SENT_94	[p5l1615t2611r1889b2696],
66	"	``	O	"	punct	41	SENT_94	[p5l1615t2611r1889b2696],
67	"	``	O	"	punct	68	SENT_94	[p5l1615t2611r1889b2696],
68	2	CD	NUMBER	2	tmod	36	SENT_94	[p5l1615t2611r1889b2696],
69	)	CD	NUMBER	)	dep	68	SENT_94	[p5l1615t2611r1889b2696],
70	.	.	O	.	_	0	SENT_94	[p5l1615t2611r1889b2696],

1	Direct	JJ	O	direct	amod	3	SENT_95	[p5l1921t2611r2141b2675],
2	DNA	NN	O	dna	nn	3	SENT_95	[p5l13t2720r197b2783],
3	sequencing	NN	O	sequencing	nsubj	4	SENT_95	[p5l258t2720r675b2805],
4	gave	VBD	O	give	_	0	SENT_95	[p5l736t2740r895b2805],
5	identical	JJ	O	identical	amod	6	SENT_95	[p5l955t2715r1266b2783],
6	genotypes	NNS	O	genotype	dobj	4	SENT_95	[p5l1327t2729r1710b2805],
7	,	,	O	,	_	0	SENT_95	[p5l1327t2729r1710b2805],
8	indicating	VBG	O	indicate	partmod	4	SENT_95	[p5l1773t2715r2140b2805],
9	100	CD	PERCENT	100	number	10	SENT_95	[p5l12t2828r204b2895],
10	%	NN	PERCENT	%	amod	11	SENT_95	[p5l12t2828r204b2895],
11	concordance	NN	O	concordance	dobj	8	SENT_95	[p5l224t2824r683b2892],
12	with	IN	O	with	_	0	SENT_95	[p5l700t2824r862b2892],
13	point-of-care	JJ	O	point-of-care	amod	15	SENT_95	[p5l880t2824r1337b2913],
14	genetic	JJ	O	genetic	amod	15	SENT_95	[p5l1358t2829r1618b2914],
15	testing	NN	O	testing	prep_with	8	SENT_95	[p5l1635t2829r1900b2914],
16	.	.	O	.	_	0	SENT_95	[p5l1635t2829r1900b2914],

1	These	DT	O	these	det	2	SENT_96	[p5l1921t2824r2139b2892],
2	results	NNS	O	result	nsubjpass	4	SENT_96	[p5l8t2934r249b3002],
3	were	VBD	O	be	auxpass	4	SENT_96	[p5l295t2958r469b3002],
4	deemed	VBN	O	deem	_	0	SENT_96	[p5l517t2934r808b3002],
5	sufﬁcient	JJ	O	sufﬁcient	acomp	4	SENT_96	[p5l854t2933r1196b3002],
6	by	IN	O	by	_	0	SENT_96	[p5l1238t2934r1324b3023],
7	the	DT	O	the	det	12	SENT_96	[p5l1366t2934r1480b3002],
8	Ottawa	NNP	ORGANIZATION	Ottawa	nn	12	SENT_96	[p5l1529t2939r1783b3002],
9	Hospital	NNP	ORGANIZATION	Hospital	nn	12	SENT_96	[p5l1833t2934r2140b3022],
10	point-of-care	JJ	O	point-of-care	amod	12	SENT_96	[p5l8t3042r466b3131],
11	testing	NN	O	testing	nn	12	SENT_96	[p5l517t3047r765b3132],
12	committee	NN	O	committee	agent	4	SENT_96	[p5l817t3047r1208b3110],
13	and	CC	O	and	_	0	SENT_96	[p5l1261t3042r1397b3110],
14	Health	NNP	ORGANIZATION	Health	nn	15	SENT_96	[p5l1452t3042r1697b3110],
15	Canada	NNP	ORGANIZATION	Canada	agent	4	SENT_96	[p5l1751t3042r2020b3110],
16	to	TO	O	to	aux	17	SENT_96	[p5l2071t3056r2139b3110],
17	proceed	VB	O	proceed	dep	4	SENT_96	[p5l8t3153r297b3242],
18	with	IN	O	with	_	0	SENT_96	[p5l317t3153r479b3221],
19	use	NN	O	use	prep_with	17	SENT_96	[p5l501t3177r627b3221],
20	of	IN	O	of	_	0	SENT_96	[p5l652t3153r734b3221],
21	the	DT	O	the	det	22	SENT_96	[p5l743t3153r858b3221],
22	device	NN	O	device	prep_of	19	SENT_96	[p5l883t3153r1107b3221],
23	in	IN	O	in	_	0	SENT_96	[p5l1131t3157r1204b3219],
24	our	PRP$	O	we	poss	25	SENT_96	[p5l1229t3177r1354b3221],
25	study	NN	O	study	prep_in	22	SENT_96	[p5l1379t3153r1582b3242],
26	.	.	O	.	_	0	SENT_96	[p5l1379t3153r1582b3242],

1	Individuals	NNS	O	individual	nsubjpass	8	SENT_97	[p5l83t3264r488b3332],
2	in	IN	O	in	_	0	SENT_97	[p5l512t3268r585b3330],
3	the	DT	O	the	det	6	SENT_97	[p5l605t3264r719b3332],
4	rapid	JJ	O	rapid	amod	6	SENT_97	[p5l742t3264r932b3352],
5	genotyping	NN	O	genotyping	nn	6	SENT_97	[p5l954t3268r1362b3353],
6	group	NN	O	group	prep_in	1	SENT_97	[p5l1384t3288r1599b3353],
7	were	VBD	O	be	auxpass	8	SENT_97	[p5l1619t3288r1794b3332],
8	screened	VBN	O	screen	_	0	SENT_97	[p5l1819t3264r2141b3332],
9	for	IN	O	for	_	0	SENT_97	[p5l9t3373r113b3442],
10	the	DT	O	the	det	11	SENT_97	[p5l148t3373r262b3442],
11	presence	NN	O	presence	prep_for	8	SENT_97	[p5l300t3397r624b3462],
12	of	IN	O	of	_	0	SENT_97	[p5l663t3373r744b3442],
13	the	DT	O	the	det	15	SENT_97	[p5l768t3373r882b3442],
14	C	NN	O	c	nn	15	SENT_97	[p5l927t3378r981b3442],
15	YP2C19	NN	O	yp2c19	prep_of	11	SENT_97	[p5l987t3378r1356b3442],
16	"	''	O	"	punct	11	SENT_97	[p5l987t3378r1356b3442],
17	'	''	O	'	_	0	SENT_97	[p5l987t3378r1356b3442],
18	~	FW	O	~	nn	19	SENT_97	[p5l987t3378r1356b3442],
19	‘	FW	O	‘	dep	21	SENT_97	[p5l987t3378r1356b3442],
20	2	CD	NUMBER	2	num	21	SENT_97	[p5l987t3378r1356b3442],
21	allele	NN	O	allele	dep	8	SENT_97	[p5l1390t3373r1576b3442],
22	at	IN	O	at	_	0	SENT_97	[p5l1615t3387r1679b3442],
23	the	DT	O	the	det	24	SENT_97	[p5l1714t3373r1828b3442],
24	time	NN	O	time	prep_at	8	SENT_97	[p5l1865t3378r2032b3442],
25	of	IN	O	of	_	0	SENT_97	[p5l2071t3373r2153b3442],
26	randomisation	NN	O	randomisation	prep_of	24	SENT_97	[p6l9t17r563b84],
27	.	.	O	.	_	0	SENT_97	[p6l9t17r563b84],

1	Operation	NN	O	operation	nsubj	8	SENT_98	[p6l630t21r996b106],
2	of	IN	O	of	_	0	SENT_98	[p6l1057t17r1139b84],
3	the	DT	O	the	det	7	SENT_98	[p6l1185t17r1300b84],
4	point-of-care	JJ	O	point-of-care	amod	7	SENT_98	[p6l1360t17r1818b106],
5	genetic	JJ	O	genetic	amod	7	SENT_98	[p6l1880t21r2140b107],
6	testing	NN	O	testing	nn	7	SENT_98	[p6l7t130r255b215],
7	device	NN	O	device	prep_of	1	SENT_98	[p6l283t125r506b194],
8	consisted	VBD	O	consist	_	0	SENT_98	[p6l536t125r877b194],
9	of	IN	O	of	_	0	SENT_98	[p6l904t125r986b194],
10	four	CD	NUMBER	four	prep_of	8	SENT_98	[p6l1000t125r1155b194],
11	separate	JJ	O	separate	amod	12	SENT_98	[p6l1183t139r1481b214],
12	steps	NNS	O	step	dobj	8	SENT_98	[p6l1511t139r1691b214],
13	intended	VBN	O	intend	partmod	12	SENT_98	[p6l1721t125r2046b194],
14	to	TO	O	to	aux	16	SENT_98	[p6l2071t139r2139b194],
15	be	VB	O	be	auxpass	16	SENT_98	[p6l7t235r92b304],
16	done	VBN	O	do	xcomp	13	SENT_98	[p6l124t235r303b304],
17	in	IN	O	in	_	0	SENT_98	[p6l334t240r407b303],
18	less	JJR	DURATION	less	mwe	19	SENT_98	[p6l436t235r570b304],
19	than	IN	DURATION	than	quantmod	20	SENT_98	[p6l601t235r767b304],
20	8	CD	DURATION	8	num	21	SENT_98	[p6l798t242r838b304],
21	min	NN	DURATION	min	prep_in	16	SENT_98	[p6l870t240r1038b304],
22	:	:	O	:	_	0	SENT_98	[p6l870t240r1038b304],
23	acquisition	NN	O	acquisition	dobj	8	SENT_98	[p6l1073t240r1475b324],
24	of	IN	O	of	_	0	SENT_98	[p6l1506t235r1587b304],
25	a	DT	O	a	det	27	SENT_98	[p6l1606t260r1643b304],
26	buccal	JJ	O	buccal	amod	27	SENT_98	[p6l1672t235r1905b304],
27	swab	NN	O	swab	prep_of	23	SENT_98	[p6l1938t235r2136b314],
28	;	:	O	;	_	0	SENT_98	[p6l1938t235r2136b314],
29	insertion	NN	O	insertion	dobj	8	SENT_98	[p6l8t349r337b412],
30	of	IN	O	of	_	0	SENT_98	[p6l368t344r450b412],
31	the	DT	O	the	det	32	SENT_98	[p6l466t344r581b412],
32	swab	NN	O	swab	prep_of	29	SENT_98	[p6l614t344r793b412],
33	into	IN	O	into	_	0	SENT_98	[p6l824t349r967b412],
34	an	DT	O	a	det	36	SENT_98	[p6l999t368r1087b412],
35	assay	NN	O	assay	nn	36	SENT_98	[p6l1119t368r1309b433],
36	cartridge	NN	O	cartridge	prep_into	32	SENT_98	[p6l1338t344r1677b434],
37	;	:	O	;	_	0	SENT_98	[p6l1338t344r1677b434],
38	insertion	NN	O	insertion	dobj	8	SENT_98	[p6l1711t349r2040b412],
39	of	IN	O	of	_	0	SENT_98	[p6l2071t344r2153b412],
40	the	DT	O	the	det	42	SENT_98	[p6l7t454r122b521],
41	reaction	NN	O	reaction	nn	42	SENT_98	[p6l158t458r451b521],
42	solution	NN	O	solution	prep_of	38	SENT_98	[p6l488t454r783b521],
43	into	IN	O	into	_	0	SENT_98	[p6l818t458r960b521],
44	the	DT	O	the	det	47	SENT_98	[p6l995t454r1109b521],
45	genetic	JJ	O	genetic	amod	47	SENT_98	[p6l1146t458r1407b544],
46	testing	NN	O	testing	nn	47	SENT_98	[p6l1441t458r1688b544],
47	device	NN	O	device	prep_into	42	SENT_98	[p6l1723t454r1965b532],
48	;	:	O	;	_	0	SENT_98	[p6l1723t454r1965b532],
49	and	CC	O	and	_	0	SENT_98	[p6l2006t454r2141b521],
50	analysis	NN	O	analysis	dobj	8	SENT_98	[p6l9t562r294b652],
51	of	IN	O	of	_	0	SENT_98	[p6l326t562r408b631],
52	C	NN	O	c	nn	53	SENT_98	[p6l430t568r485b631],
53	YP2C19	NN	O	yp2c19	prep_of	50	SENT_98	[p6l490t567r859b631],
54	"	''	O	"	punct	53	SENT_98	[p6l490t567r859b631],
55	'	''	O	'	_	0	SENT_98	[p6l490t567r859b631],
56	~	FW	O	~	nn	59	SENT_98	[p6l490t567r859b631],
57	‘	FW	O	‘	dep	59	SENT_98	[p6l490t567r859b631],
58	2	CD	NUMBER	2	num	59	SENT_98	[p6l490t567r859b631],
59	genotype	NN	O	genotype	advmod	60	SENT_98	[p6l885t576r1213b652],
60	triggered	VBN	O	trigger	partmod	50	SENT_98	[p6l1241t562r1573b652],
61	by	IN	O	by	_	0	SENT_98	[p6l1599t562r1685b652],
62	a	DT	O	a	det	63	SENT_98	[p6l1712t587r1749b631],
63	button	NN	O	button	agent	60	SENT_98	[p6l1776t562r2019b631],
64	on	IN	O	on	_	0	SENT_98	[p6l2048t587r2140b631],
65	the	DT	O	the	det	66	SENT_98	[p6l7t671r122b738],
66	device	NN	O	device	prep_on	63	SENT_98	[p6l153t671r394b739],
67	.	.	O	.	_	0	SENT_98	[p6l153t671r394b739],

1	C	NN	O	c	dep	2	SENT_99	[p6l434t676r488b738],
2	YP2C19	NN	O	yp2c19	_	0	SENT_99	[p6l494t676r863b739],
3	"	''	O	"	punct	2	SENT_99	[p6l494t676r863b739],
4	"	``	O	"	punct	8	SENT_99	[p6l494t676r863b739],
5	‘	NN	O	‘	nn	8	SENT_99	[p6l494t676r863b739],
6	2	CD	NUMBER	2	num	8	SENT_99	[p6l494t676r863b739],
7	carrier	NN	O	carrier	nn	8	SENT_99	[p6l889t676r1128b739],
8	status	NN	O	status	nsubj	10	SENT_99	[p6l1158t684r1366b739],
9	was	VBD	O	be	cop	10	SENT_99	[p6l1395t695r1531b739],
10	available	JJ	O	available	rcmod	2	SENT_99	[p6l1564t671r1875b739],
11	within	IN	O	within	prep	10	SENT_99	[p6l1903t671r2140b739],

1	60	CD	DURATION	60	num	2	SENT_100	[p6l10t787r93b848],
2	min	NN	DURATION	min	_	0	SENT_100	[p6l120t785r272b847],
3	of	IN	O	of	_	0	SENT_100	[p6l299t781r381b848],
4	activation	NN	O	activation	prepc_of	2	SENT_100	[p6l396t785r744b848],
5	and	CC	O	and	_	0	SENT_100	[p6l771t781r907b848],
6	was	VBD	O	be	auxpass	7	SENT_100	[p6l930t805r1066b848],
7	provided	VBN	O	provide	prepc_of	2	SENT_100	[p6l1095t781r1415b870],
8	as	IN	O	as	_	0	SENT_100	[p6l1442t805r1512b848],
9	homozygous	JJ	O	homozygous	prep_as	7	SENT_100	[p6l1540t781r2008b871],
10	for	IN	O	for	_	0	SENT_100	[p6l2037t781r2141b848],
11	the	DT	O	the	det	13	SENT_100	[p6l7t889r122b958],
12	wild-type	JJ	O	wild-type	amod	13	SENT_100	[p6l187t889r518b979],
13	allele	NN	O	allele	prep_for	9	SENT_100	[p6l586t889r772b958],
14	(	CD	NUMBER	(	num	15	SENT_100	[p6l846t894r1101b979],
15	*	NN	O	*	amod	13	SENT_100	[p6l846t894r1101b979],
16	1	CD	NUMBER	1	dep	15	SENT_100	[p6l846t894r1101b979],
17	/	:	O	/	punct	31	SENT_100	[p6l846t894r1101b979],
18	"	``	O	"	punct	21	SENT_100	[p6l846t894r1101b979],
19	'	''	O	'	_	0	SENT_100	[p6l846t894r1101b979],
20	~	FW	O	~	nn	21	SENT_100	[p6l846t894r1101b979],
21	‘	FW	O	‘	dep	31	SENT_100	[p6l846t894r1101b979],
22	1	CD	NUMBER	1	num	23	SENT_100	[p6l846t894r1101b979],
23	)	NN	O	)	dep	21	SENT_100	[p6l846t894r1101b979],
24	,	,	O	,	_	0	SENT_100	[p6l846t894r1101b979],
25	heterozygous	JJ	O	heterozygous	amod	26	SENT_100	[p6l1170t889r1655b979],
26	(	NN	O	(	appos	21	SENT_100	[p6l1730t894r1995b979],
27	"	''	O	"	punct	26	SENT_100	[p6l1730t894r1995b979],
28	'	''	O	'	_	0	SENT_100	[p6l1730t894r1995b979],
29	~	FW	O	~	nn	30	SENT_100	[p6l1730t894r1995b979],
30	‘	FW	O	‘	amod	21	SENT_100	[p6l1730t894r1995b979],
31	1	CD	NUMBER	1	dep	15	SENT_100	[p6l1730t894r1995b979],
32	/	:	O	/	punct	31	SENT_100	[p6l1730t894r1995b979],
33	*	CD	NUMBER	*	number	34	SENT_100	[p6l1730t894r1995b979],
34	2	CD	NUMBER	2	dep	35	SENT_100	[p6l1730t894r1995b979],
35	)	NN	O	)	amod	13	SENT_100	[p6l1730t894r1995b979],
36	,	,	O	,	_	0	SENT_100	[p6l1730t894r1995b979],
37	or	CC	O	or	_	0	SENT_100	[p6l2066t914r2141b958],
38	homozygous	JJ	O	homozygous	conj_or	35	SENT_100	[p6l7t998r476b1088],
39	for	IN	O	for	_	0	SENT_100	[p6l508t998r613b1066],
40	the	DT	O	the	prep_for	9	SENT_100	[p6l640t998r754b1066],
41	"	``	O	"	punct	40	SENT_100	[p6l787t1003r874b1065],
42	"	``	O	"	punct	44	SENT_100	[p6l787t1003r874b1065],
43	2	CD	NUMBER	2	num	44	SENT_100	[p6l787t1003r874b1065],
44	allele	NN	O	allele	dep	40	SENT_100	[p6l901t998r1087b1066],
45	(	CD	NUMBER	(	dep	44	SENT_100	[p6l1123t1003r1397b1088],
46	"	``	O	"	punct	9	SENT_100	[p6l1123t1003r1397b1088],
47	'	''	O	'	_	0	SENT_100	[p6l1123t1003r1397b1088],
48	\	JJ	O	\	advmod	7	SENT_100	[p6l1123t1003r1397b1088],
49	‘	NN	O	‘	amod	2	SENT_100	[p6l1123t1003r1397b1088],
50	2	CD	NUMBER	2	number	49	SENT_100	[p6l1123t1003r1397b1088],
51	/	:	O	/	punct	54	SENT_100	[p6l1123t1003r1397b1088],
52	*	CD	NUMBER	*	num	53	SENT_100	[p6l1123t1003r1397b1088],
53	2	CD	NUMBER	2	dep	54	SENT_100	[p6l1123t1003r1397b1088],
54	)	NN	O	)	parataxis	2	SENT_100	[p6l1123t1003r1397b1088],
55	.	.	O	.	_	0	SENT_100	[p6l1123t1003r1397b1088],

1	All	DT	O	all	det	2	SENT_101	[p6l1429t998r1533b1065],
2	tests	NNS	O	test	nsubjpass	4	SENT_101	[p6l1562t1011r1724b1066],
3	were	VBD	O	be	auxpass	4	SENT_101	[p6l1754t1022r1929b1066],
4	done	VBN	O	do	_	0	SENT_101	[p6l1961t998r2139b1066],
5	by	IN	O	by	_	0	SENT_101	[p6l7t1109r93b1198],
6	clinical-trial	JJ	O	clinical-trial	amod	7	SENT_101	[p6l117t1109r543b1177],
7	nurses	NNS	O	nurse	agent	4	SENT_101	[p6l568t1133r811b1177],
8	who	WP	O	who	nsubj	17	SENT_101	[p6l836t1109r991b1177],
9	had	VBD	O	have	aux	10	SENT_101	[p6l1016t1109r1153b1177],
10	received	VBN	O	receive	rcmod	7	SENT_101	[p6l1176t1109r1476b1177],
11	a	DT	O	a	det	14	SENT_101	[p6l1500t1133r1537b1177],
12	30-min	JJ	DURATION	30-min	amod	14	SENT_101	[p6l1565t1113r1824b1177],
13	training	NN	O	training	nn	14	SENT_101	[p6l1848t1113r2140b1198],
14	session	NN	O	session	dobj	10	SENT_101	[p6l11t1222r294b1295],
15	,	,	O	,	_	0	SENT_101	[p6l11t1222r294b1295],
16	but	CC	O	but	_	0	SENT_101	[p6l320t1217r443b1286],
17	had	VBD	O	have	conj_but	10	SENT_101	[p6l463t1217r600b1286],
18	no	DT	O	no	det	21	SENT_101	[p6l622t1242r715b1286],
19	previous	JJ	O	previous	amod	21	SENT_101	[p6l739t1222r1049b1306],
20	laboratory	NN	O	laboratory	nn	21	SENT_101	[p6l1073t1217r1442b1307],
21	training	NN	O	training	dobj	17	SENT_101	[p6l1462t1222r1773b1307],
22	.	.	O	.	_	0	SENT_101	[p6l1462t1222r1773b1307],

1	Carriers	NNS	O	carrier	nsubjpass	10	SENT_102	[p6l82t1331r385b1394],
2	of	IN	O	of	_	0	SENT_102	[p6l430t1326r514b1394],
3	the	DT	O	the	det	4	SENT_102	[p6l541t1326r659b1394],
4	CYP2C19	NN	O	cyp2c19	prep_of	1	SENT_102	[p6l708t1331r1154b1394],
5	"	''	O	"	punct	4	SENT_102	[p6l708t1331r1154b1394],
6	"	``	O	"	punct	4	SENT_102	[p6l708t1331r1154b1394],
7	2	CD	NUMBER	2	num	8	SENT_102	[p6l708t1331r1154b1394],
8	allele	NN	O	allele	dep	4	SENT_102	[p6l1192t1326r1388b1394],
9	were	VBD	O	be	auxpass	10	SENT_102	[p6l1428t1350r1609b1394],
10	given	VBN	O	give	_	0	SENT_102	[p6l1652t1331r1856b1416],
11	10	CD	NUMBER	10	num	13	SENT_102	[p6l1900t1332r1976b1394],
12	mg	NN	O	mg	nn	13	SENT_102	[p6l2017t1350r2140b1416],
13	prasugrel	NN	O	prasugrel	dobj	10	SENT_102	[p6l8t1436r371b1525],
14	daily	RB	SET	daily	advmod	10	SENT_102	[p6l453t1436r644b1525],
15	,	,	O	,	_	0	SENT_102	[p6l453t1436r644b1525],
16	with	IN	O	with	_	0	SENT_102	[p6l726t1436r895b1504],
17	the	DT	O	the	det	19	SENT_102	[p6l975t1436r1094b1504],
18	ﬁrst	NN	O	ﬁrst	nn	19	SENT_102	[p6l1175t1435r1328b1504],
19	dose	NN	O	dose	prep_with	10	SENT_102	[p6l1408t1436r1579b1504],
20	immediately	RB	O	immediately	advmod	10	SENT_102	[p6l1661t1436r2142b1525],
21	after	IN	O	after	_	0	SENT_102	[p6l9t1545r182b1614],
22	PCI	NN	O	pcus	prep_after	10	SENT_102	[p6l217t1550r378b1614],
23	.	.	O	.	_	0	SENT_102	[p6l217t1550r378b1614],

1	Non-carriers	NNS	O	non-carrier	nsubj	7	SENT_103	[p6l419t1550r894b1614],
2	and	CC	O	and	_	0	SENT_103	[p6l931t1545r1070b1614],
3	patients	NNS	O	patient	conj_and	1	SENT_103	[p6l1102t1550r1404b1634],
4	allocated	VBN	O	allocate	partmod	1	SENT_103	[p6l1440t1545r1776b1614],
5	standard	JJ	O	standard	amod	6	SENT_103	[p6l1810t1545r2141b1614],
6	treatment	NN	O	treatment	dobj	4	SENT_103	[p6l7t1667r385b1722],
7	received	VBD	O	receive	_	0	SENT_103	[p6l413t1654r728b1722],
8	75	CD	NUMBER	75	num	10	SENT_103	[p6l755t1658r833b1725],
9	mg	NN	O	mg	nn	10	SENT_103	[p6l866t1678r990b1744],
10	clopidogrel	NN	O	clopidogrel	dobj	7	SENT_103	[p6l1019t1654r1446b1744],
11	daily	RB	SET	daily	advmod	7	SENT_103	[p6l1476t1654r1666b1744],
12	.	.	O	.	_	0	SENT_103	[p6l1476t1654r1666b1744],

1	All	DT	O	all	det	2	SENT_104	[p6l1698t1654r1807b1721],
2	patients	NNS	O	patient	nsubj	3	SENT_104	[p6l1836t1659r2138b1743],
3	underwent	VBD	O	undergo	_	0	SENT_104	[p6l7t1764r426b1832],
4	platelet-function	JJ	O	platelet-function	amod	5	SENT_104	[p6l451t1763r1084b1852],
5	testing	NN	O	testing	dobj	3	SENT_104	[p6l1111t1768r1372b1853],
6	with	IN	O	with	_	0	SENT_104	[p6l1397t1764r1566b1832],
7	the	DT	O	the	det	10	SENT_104	[p6l1591t1764r1710b1832],
8	VerifyNow	NNP	O	VerifyNow	nn	10	SENT_104	[p6l1737t1763r2142b1853],
9	P2Y12	NN	O	p2y12	nn	10	SENT_104	[p6l13t1878r242b1939],
10	assay	NN	O	assay	prep_with	3	SENT_104	[p6l317t1896r517b1962],
11	(	CD	NUMBER	(	num	12	SENT_104	[p6l592t1877r1112b1962],
12	Accumetrics	NNS	O	accumetric	dep	10	SENT_104	[p6l592t1877r1112b1962],
13	,	,	O	,	_	0	SENT_104	[p6l592t1877r1112b1962],
14	San	NNP	LOCATION	San	nn	19	SENT_104	[p6l1193t1877r1327b1940],
15	Diego	NNP	LOCATION	Diego	nn	19	SENT_104	[p6l1402t1877r1643b1962],
16	,	,	O	,	_	0	SENT_104	[p6l1402t1877r1643b1962],
17	CA	NNP	LOCATION	CA	appos	19	SENT_104	[p6l1721t1877r1856b1950],
18	,	,	O	,	_	0	SENT_104	[p6l1721t1877r1856b1950],
19	USA	NNP	LOCATION	USA	prep_with	3	SENT_104	[p6l1935t1877r2134b1962],
20	)	CD	NUMBER	)	num	19	SENT_104	[p6l1935t1877r2134b1962],
21	immediately	RB	O	immediately	advmod	19	SENT_104	[p6l9t1983r490b2072],
22	after	IN	O	after	_	0	SENT_104	[p6l516t1983r688b2051],
23	PCI	NN	O	pcus	prep_after	3	SENT_104	[p6l719t1988r880b2051],
24	.	.	O	.	_	0	SENT_104	[p6l719t1988r880b2051],

1	After	IN	O	after	_	0	SENT_105	[p6l78t2091r263b2160],
2	1	CD	DURATION	1	num	3	SENT_105	[p6l334t2098r365b2158],
3	week	NN	NUMBER	week	prep_after	10	SENT_105	[p6l432t2092r621b2160],
4	of	IN	O	of	_	0	SENT_105	[p6l690t2091r772b2160],
5	the	DT	O	the	det	7	SENT_105	[p6l827t2092r941b2160],
6	antiplatelet	JJ	O	antiplatelet	amod	7	SENT_105	[p6l1012t2092r1417b2180],
7	strategy	NN	O	strategy	prep_of	3	SENT_105	[p6l1487t2105r1778b2181],
8	,	,	O	,	_	0	SENT_105	[p6l1487t2105r1778b2181],
9	patients	NNS	O	patient	nsubj	10	SENT_105	[p6l1851t2096r2138b2180],
10	underwent	VBD	O	undergo	_	0	SENT_105	[p6l7t2200r408b2268],
11	repeat	NN	O	repeat	nn	13	SENT_105	[p6l464t2214r689b2289],
12	platelet-function	JJ	O	platelet-function	amod	13	SENT_105	[p6l744t2200r1343b2289],
13	testing	NN	O	testing	dobj	10	SENT_105	[p6l1399t2205r1664b2290],
14	,	,	O	,	_	0	SENT_105	[p6l1399t2205r1664b2290],
15	which	WDT	O	which	nsubjpass	17	SENT_105	[p6l1722t2200r1946b2268],
16	was	VBD	O	be	auxpass	17	SENT_105	[p6l2001t2224r2138b2268],
17	coordinated	VBN	O	coordinate	rcmod	13	SENT_105	[p6l9t2310r441b2377],
18	to	TO	O	to	aux	19	SENT_105	[p6l478t2323r547b2377],
19	obtain	VB	O	obtain	xcomp	17	SENT_105	[p6l589t2310r817b2377],
20	trough	NN	O	trough	nn	21	SENT_105	[p6l856t2310r1102b2400],
21	values	NNS	O	value	dobj	19	SENT_105	[p6l1140t2310r1386b2377],
22	.	.	O	.	_	0	SENT_105	[p6l1140t2310r1386b2377],

1	C	NN	O	c	nsubjpass	14	SENT_106	[p6l1437t2315r1491b2377],
2	YP2C19	NN	O	yp2c19	dep	1	SENT_106	[p6l1497t2314r1866b2378],
3	"	''	O	"	punct	2	SENT_106	[p6l1497t2314r1866b2378],
4	"	``	O	"	punct	2	SENT_106	[p6l1497t2314r1866b2378],
5	2	CD	NUMBER	2	num	7	SENT_106	[p6l1497t2314r1866b2378],
6	carrier	NN	O	carrier	nn	7	SENT_106	[p6l1903t2314r2141b2377],
7	status	NN	O	status	dep	2	SENT_106	[p6l11t2432r219b2487],
8	established	VBN	O	establish	partmod	1	SENT_106	[p6l255t2418r662b2487],
9	by	IN	O	by	_	0	SENT_106	[p6l691t2418r777b2508],
10	the	DT	O	the	det	12	SENT_106	[p6l806t2418r920b2487],
11	point-of-care	JJ	O	point-of-care	amod	12	SENT_106	[p6l952t2418r1410b2507],
12	device	NN	O	device	agent	8	SENT_106	[p6l1443t2418r1667b2487],
13	was	VBD	O	be	auxpass	14	SENT_106	[p6l1697t2443r1834b2487],
14	veriﬁed	VBN	O	veriﬁed	_	0	SENT_106	[p6l1866t2418r2141b2487],
15	through	IN	O	through	_	0	SENT_106	[p6l7t2527r304b2617],
16	direct	JJ	O	direct	amod	18	SENT_106	[p6l372t2527r577b2595],
17	DNA	NN	O	dna	nn	18	SENT_106	[p6l646t2532r831b2595],
18	sequencing	NN	O	sequencing	prep_through	14	SENT_106	[p6l899t2532r1332b2617],
19	.	.	O	.	_	0	SENT_106	[p6l899t2532r1332b2617],

1	CYP2C19	NN	O	cyp2c19	nn	8	SENT_107	[p6l1411t2532r1839b2596],
2	"	''	O	"	punct	1	SENT_107	[p6l1411t2532r1839b2596],
3	'	''	O	'	_	0	SENT_107	[p6l1411t2532r1839b2596],
4	~	FW	O	~	nn	5	SENT_107	[p6l1411t2532r1839b2596],
5	‘	FW	O	‘	advmod	7	SENT_107	[p6l1411t2532r1839b2596],
6	2	CD	NUMBER	2	num	7	SENT_107	[p6l1411t2532r1839b2596],
7	carrier	NN	O	carrier	dep	8	SENT_107	[p6l1903t2532r2141b2595],
8	status	NN	O	status	nsubjpass	11	SENT_107	[p6l11t2650r219b2704],
9	was	VBD	O	be	auxpass	11	SENT_107	[p6l268t2661r405b2704],
10	also	RB	O	also	advmod	11	SENT_107	[p6l457t2637r596b2704],
11	investigated	VBN	O	investigate	_	0	SENT_107	[p6l646t2637r1083b2727],
12	in	IN	O	in	_	0	SENT_107	[p6l1131t2641r1204b2703],
13	the	DT	O	the	det	16	SENT_107	[p6l1252t2637r1366b2704],
14	standard	JJ	O	standard	amod	16	SENT_107	[p6l1418t2637r1734b2704],
15	treatment	NN	O	treatment	nn	16	SENT_107	[p6l1781t2650r2141b2704],
16	group	NN	O	group	prep_in	11	SENT_107	[p6l10t2770r224b2835],
17	by	IN	O	by	_	0	SENT_107	[p6l248t2745r334b2835],
18	both	CC	O	both	preconj	20	SENT_107	[p6l355t2745r521b2814],
19	point-of-care	JJ	O	point-of-care	amod	20	SENT_107	[p6l545t2745r1003b2834],
20	testing	NN	O	testing	agent	11	SENT_107	[p6l1027t2750r1275b2835],
21	and	CC	O	and	_	0	SENT_107	[p6l1300t2745r1435b2814],
22	conventional	JJ	O	conventional	amod	23	SENT_107	[p6l1460t2745r1928b2814],
23	DNA	NN	MISC	dna	agent	11	SENT_107	[p6l1956t2751r2141b2814],

1	www	NN	O	www	_	0	SENT_108	[p6l7t3015r540b3066],
2	.	.	O	.	_	0	SENT_108	[p6l7t3015r540b3066],

1	the	DT	O	the	det	2	SENT_109	[p6l7t3015r540b3066],
2	|	NN	O	|	_	0	SENT_109	[p6l7t3015r540b3066],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_109	[p6l7t3015r540b3066],
4	Vol	NNP	O	Vol	dep	2	SENT_109	[p6l585t3015r672b3066],
5	379	CD	NUMBER	379	num	6	SENT_109	[p6l691t3021r795b3073],
6	May	NNP	DATE	May	dep	2	SENT_109	[p6l844t3020r962b3080],
7	5,2012	CD	DATE	5,2012	num	6	SENT_109	[p6l979t3021r1181b3074],

1	sequencing	NN	O	sequencing	_	0	SENT_110	[p7l10t73r304b133],
2	at	IN	O	at	_	0	SENT_110	[p7l325t80r371b118],
3	the	DT	O	the	det	5	SENT_110	[p7l389t70r470b118],
4	1-week	JJ	DURATION	1-week	amod	5	SENT_110	[p7l493t70r665b118],
5	follow-up	NN	O	follow-up	prep_at	1	SENT_110	[p7l685t70r939b132],
6	.	.	O	.	_	0	SENT_110	[p7l685t70r939b132],

1	Decisions	NNS	O	decision	nsubj	9	SENT_111	[p7l966t73r1214b118],
2	about	IN	O	about	_	0	SENT_111	[p7l1237t70r1382b118],
3	dual	JJ	O	dual	amod	5	SENT_111	[p7l1402t70r1513b118],
4	antiplatelet	JJ	O	antiplatelet	amod	5	SENT_111	[p7l9t147r294b210],
5	treatment	NN	O	treatment	prep_about	1	SENT_111	[p7l317t156r572b195],
6	after	IN	O	after	_	0	SENT_111	[p7l596t147r712b195],
7	study	NN	O	study	nn	8	SENT_111	[p7l737t147r875b210],
8	completion	NN	O	completion	prep_after	5	SENT_111	[p7l899t147r1190b210],
9	were	VBD	O	be	_	0	SENT_111	[p7l1214t164r1337b195],
10	at	IN	O	at	_	0	SENT_111	[p7l1363t156r1408b195],
11	the	DT	O	the	det	12	SENT_111	[p7l1431t147r1512b195],
12	discretion	NN	O	discretion	prep_at	9	SENT_111	[p7l9t223r263b271],
13	of	IN	O	of	_	0	SENT_111	[p7l281t223r338b271],
14	the	DT	O	the	det	16	SENT_111	[p7l345t223r425b271],
15	treating	VBG	O	treat	amod	16	SENT_111	[p7l442t226r642b286],
16	cardiologist	NN	O	cardiologist	prep_of	12	SENT_111	[p7l659t223r968b286],
17	.	.	O	.	_	0	SENT_111	[p7l659t223r968b286],

1	The	DT	O	the	det	3	SENT_112	[p7l57t299r157b347],
2	primary	JJ	O	primary	amod	3	SENT_112	[p7l173t302r380b362],
3	endpoint	NN	O	endpoint	nsubj	6	SENT_112	[p7l395t299r627b362],
4	was	VBD	O	be	cop	6	SENT_112	[p7l641t316r737b347],
5	the	DT	O	the	det	6	SENT_112	[p7l754t299r834b347],
6	proportion	NN	O	proportion	_	0	SENT_112	[p7l850t302r1127b362],
7	of	IN	O	of	_	0	SENT_112	[p7l1143t299r1201b347],
8	CYP2C19	NN	O	cyp2c19	prep_of	6	SENT_112	[p7l1212t302r1515b348],
9	"	''	O	"	punct	8	SENT_112	[p7l1212t302r1515b348],
10	"	``	O	"	punct	8	SENT_112	[p7l1212t302r1515b348],
11	2	CD	NUMBER	2	num	12	SENT_112	[p7l1212t302r1515b348],
12	carriers	NNS	O	carrier	dep	8	SENT_112	[p7l9t380r200b424],
13	with	IN	O	with	_	0	SENT_112	[p7l219t377r334b424],
14	a	DT	O	a	det	15	SENT_112	[p7l353t394r379b424],
15	P2Y12	NN	O	p2y12	prep_with	8	SENT_112	[p7l400t381r556b424],
16	reactivity	NN	O	reactivity	nn	17	SENT_112	[p7l576t380r807b439],
17	units	NNS	O	unit	nsubj	18	SENT_112	[p7l824t380r954b424],
18	(	VBP	O	(	rcmod	15	SENT_112	[p7l978t382r1133b440],
19	PRU	NNP	O	PRU	nn	21	SENT_112	[p7l978t382r1133b440],
20	)	CD	NUMBER	)	num	21	SENT_112	[p7l978t382r1133b440],
21	value	NN	O	value	dobj	18	SENT_112	[p7l1154t377r1289b424],
22	of	IN	O	of	_	0	SENT_112	[p7l1309t377r1367b424],
23	more	JJR	O	more	mwe	24	SENT_112	[p7l1376t394r1512b424],
24	than	IN	O	than	quantmod	25	SENT_112	[p7l7t452r124b500],
25	234	CD	NUMBER	234	prep_of	21	SENT_112	[p7l157t457r246b500],
26	after	IN	O	after	_	0	SENT_112	[p7l276t452r391b500],
27	1	CD	DURATION	1	num	28	SENT_112	[p7l424t457r445b499],
28	week	NN	NUMBER	week	prep_after	18	SENT_112	[p7l475t452r609b500],
29	of	IN	O	of	_	0	SENT_112	[p7l640t452r697b500],
30	dual	JJ	O	dual	amod	32	SENT_112	[p7l721t452r831b500],
31	antiplatelet	JJ	O	antiplatelet	amod	32	SENT_112	[p7l863t452r1149b514],
32	therapy	NN	O	therapy	prep_of	28	SENT_112	[p7l1178t452r1379b515],
33	.	.	O	.	_	0	SENT_112	[p7l1178t452r1379b515],

1	The	DT	O	the	det	2	SENT_113	[p7l1412t452r1512b500],
2	deﬁnition	NN	O	deﬁnition	nsubjpass	9	SENT_113	[p7l9t528r260b575],
3	of	IN	O	of	_	0	SENT_113	[p7l300t528r358b575],
4	high	JJ	O	high	amod	7	SENT_113	[p7l387t528r506b591],
5	on-treatrnent	JJ	O	on-treatrnent	amod	7	SENT_113	[p7l546t537r883b575],
6	platelet	NN	O	platelet	nn	7	SENT_113	[p7l921t528r1108b590],
7	reactivity	NN	O	reactivity	prep_of	2	SENT_113	[p7l1146t531r1378b591],
8	was	VBD	O	be	auxpass	9	SENT_113	[p7l1414t545r1510b575],
9	derived	VBN	O	derive	_	0	SENT_113	[p7l9t604r197b653],
10	from	IN	O	from	_	0	SENT_113	[p7l221t604r349b653],
11	several	JJ	O	several	amod	13	SENT_113	[p7l375t604r549b653],
12	previous	JJ	O	previous	amod	13	SENT_113	[p7l573t608r792b667],
13	studies	NNS	O	study	prep_from	9	SENT_113	[p7l820t605r999b653],
14	that	WDT	O	that	nsubj	16	SENT_113	[p7l1024t604r1124b653],
15	had	VBD	O	have	aux	16	SENT_113	[p7l1146t604r1243b653],
16	identiﬁed	VBN	O	identiﬁed	rcmod	13	SENT_113	[p7l1266t604r1513b653],
17	PRU	NNP	O	PRU	nn	18	SENT_113	[p7l11t686r131b730],
18	values	NNS	O	value	dobj	16	SENT_113	[p7l164t681r324b730],
19	of	IN	O	of	_	0	SENT_113	[p7l359t681r416b730],
20	more	JJR	O	more	mwe	21	SENT_113	[p7l440t699r576b730],
21	than	IN	O	than	quantmod	22	SENT_113	[p7l608t681r725b730],
22	235-240	CD	NUMBER	235-240	prep_of	18	SENT_113	[p7l759t684r969b730],
23	as	IN	O	as	mark	40	SENT_113	[p7l1002t699r1052b730],
24	optimum	JJ	O	optimum	amod	26	SENT_113	[p7l1087t684r1331b744],
25	cutoff	NN	O	cutoff	nn	26	SENT_113	[p7l1364t682r1521b730],
26	values	NNS	O	value	nsubj	40	SENT_113	[p7l7t758r166b805],
27	for	IN	O	for	_	0	SENT_113	[p7l193t758r266b805],
28	prediction	NN	O	prediction	prep_for	26	SENT_113	[p7l289t758r552b820],
29	of	IN	O	of	_	0	SENT_113	[p7l578t758r636b805],
30	increased	VBN	O	increase	amod	31	SENT_113	[p7l651t758r897b805],
31	rates	NNS	O	rate	prep_of	28	SENT_113	[p7l921t767r1041b805],
32	of	IN	O	of	_	0	SENT_113	[p7l1069t758r1126b805],
33	major	JJ	O	major	amod	36	SENT_113	[p7l1142t761r1296b821],
34	adverse	JJ	O	adverse	amod	36	SENT_113	[p7l1320t758r1512b805],
35	cardiovascular	JJ	O	cardiovascular	amod	36	SENT_113	[p7l9t835r377b883],
36	events	NNS	O	event	prep_of	31	SENT_113	[p7l408t844r583b890],
37	,	,	O	,	_	0	SENT_113	[p7l408t844r583b890],
38	a	DT	O	a	det	39	SENT_113	[p7l617t852r643b883],
39	concept	NN	O	concept	appos	36	SENT_113	[p7l674t844r874b897],
40	endorsed	VBN	O	endorse	advcl	16	SENT_113	[p7l904t835r1142b883],
41	by	IN	O	by	_	0	SENT_113	[p7l1171t835r1232b898],
42	an	DT	O	a	det	45	SENT_113	[p7l1262t852r1324b883],
43	expert	NN	O	expert	nn	45	SENT_113	[p7l1356t844r1513b898],
44	consensus	NN	O	consensus	nn	45	SENT_113	[p7l9t929r276b960],
45	statement	NN	O	statement	prep_by	40	SENT_113	[p7l296t921r551b960],
46	in	IN	O	in	_	0	SENT_113	[p7l566t915r618b959],
47	2010.1	CD	NUMBER	2010.1	number	48	SENT_113	[p7l636t916r879b960],
48	°	CD	NUMBER	°	num	49	SENT_113	[p7l636t916r879b960],
49	’	NN	O	’	prep_in	45	SENT_113	[p7l636t916r879b960],
50	2	CD	NUMBER	2	number	51	SENT_113	[p7l636t916r879b960],
51	“	CD	NUMBER	“	num	52	SENT_113	[p7l636t916r879b960],
52	4	CD	NUMBER	4	dobj	40	SENT_113	[p7l636t916r879b960],

1	The	DT	O	the	det	2	SENT_114	[p7l57t988r157b1036],
2	time	NN	O	time	nsubjpass	10	SENT_114	[p7l194t991r311b1036],
3	of	IN	O	of	_	0	SENT_114	[p7l350t988r407b1036],
4	measurement	NN	O	measurement	prep_of	2	SENT_114	[p7l436t998r798b1036],
5	of	IN	O	of	_	0	SENT_114	[p7l835t988r892b1036],
6	the	DT	O	the	det	8	SENT_114	[p7l919t988r1000b1036],
7	primary	JJ	O	primary	amod	8	SENT_114	[p7l1037t992r1245b1051],
8	endpoint	NN	O	endpoint	prep_of	4	SENT_114	[p7l1282t988r1514b1051],
9	was	VBD	O	be	auxpass	10	SENT_114	[p7l7t1081r103b1112],
10	based	VBN	O	base	_	0	SENT_114	[p7l144t1064r293b1112],
11	on	IN	O	on	_	0	SENT_114	[p7l333t1081r398b1112],
12	previous	JJ	O	previous	amod	13	SENT_114	[p7l438t1067r657b1126],
13	work	NN	O	work	prep_on	10	SENT_114	[p7l698t1064r829b1112],
14	suggesting	VBG	O	suggest	xcomp	10	SENT_114	[p7l870t1067r1148b1127],
15	that	IN	O	that	complm	22	SENT_114	[p7l1187t1064r1287b1112],
16	platelet	NN	O	platelet	nn	17	SENT_114	[p7l1327t1064r1514b1126],
17	inhibition	NN	O	inhibition	nsubj	22	SENT_114	[p7l8t1141r265b1188],
18	by	IN	O	by	_	0	SENT_114	[p7l309t1141r370b1203],
19	clopidogrel	NN	O	clopidogrel	prep_by	17	SENT_114	[p7l414t1141r700b1204],
20	and	CC	O	and	_	0	SENT_114	[p7l746t1141r842b1188],
21	prasugrel	NN	O	prasugrel	prep_by	17	SENT_114	[p7l885t1141r1130b1204],
22	stabilises	VBZ	O	stabilise	ccomp	14	SENT_114	[p7l1177t1141r1407b1188],
23	by	IN	O	by	_	0	SENT_114	[p7l1453t1141r1514b1203],
24	7	CD	DURATION	7	num	25	SENT_114	[p7l8t1219r34b1266],
25	days	NNS	NUMBER	day	prep_by	22	SENT_114	[p7l66t1216r223b1279],
26	.	.	O	.	_	0	SENT_114	[p7l66t1216r223b1279],

1	“	NN	O	“	npadvmod	17	SENT_115	[p7l66t1216r223b1279],
2	On	IN	O	on	_	0	SENT_115	[p7l258t1221r338b1264],
3	the	DT	O	the	det	4	SENT_115	[p7l368t1216r449b1264],
4	basis	NN	O	basis	prep_on	17	SENT_115	[p7l481t1216r609b1264],
5	of	IN	O	of	_	0	SENT_115	[p7l643t1216r701b1264],
6	data	NNS	O	datum	prep_of	4	SENT_115	[p7l725t1216r830b1264],
7	that	WDT	O	that	nsubjpass	9	SENT_115	[p7l862t1216r962b1264],
8	were	VBD	O	be	auxpass	9	SENT_115	[p7l992t1233r1115b1264],
9	reported	VBN	O	report	rcmod	6	SENT_115	[p7l1148t1216r1366b1279],
10	after	IN	O	after	_	0	SENT_115	[p7l1398t1216r1514b1264],
11	initiation	NN	O	initiation	prep_after	9	SENT_115	[p7l8t1295r243b1340],
12	of	IN	O	of	_	0	SENT_115	[p7l262t1292r320b1340],
13	our	PRP$	O	we	poss	14	SENT_115	[p7l330t1309r418b1340],
14	study	NN	O	study	prep_of	11	SENT_115	[p7l437t1292r581b1355],
15	,	,	O	,	_	0	SENT_115	[p7l437t1292r581b1355],
16	we	PRP	O	we	nsubj	17	SENT_115	[p7l601t1309r672b1340],
17	did	VBD	O	do	_	0	SENT_115	[p7l692t1292r773b1340],
18	separate	JJ	O	separate	amod	20	SENT_115	[p7l792t1302r1003b1354],
19	secondary	JJ	O	secondary	amod	20	SENT_115	[p7l1023t1292r1281b1355],
20	analyses	NNS	O	analysis	dobj	17	SENT_115	[p7l1299t1292r1511b1355],
21	with	IN	O	with	_	0	SENT_115	[p7l7t1369r121b1416],
22	a	DT	O	a	det	25	SENT_115	[p7l163t1386r189b1416],
23	cutoff	NN	O	cutoff	nn	25	SENT_115	[p7l230t1369r387b1416],
24	PRU	NNP	ORGANIZATION	PRU	nn	25	SENT_115	[p7l422t1374r543b1416],
25	value	NN	O	value	prep_with	20	SENT_115	[p7l584t1369r719b1416],
26	of	IN	O	of	_	0	SENT_115	[p7l761t1369r818b1416],
27	more	JJR	O	more	mwe	28	SENT_115	[p7l850t1386r986b1416],
28	than	IN	O	than	quantmod	29	SENT_115	[p7l1027t1369r1144b1416],
29	208.26	CD	NUMBER	208.26	prep_of	25	SENT_115	[p7l1186t1372r1322b1416],
30	Other	JJ	O	other	amod	32	SENT_115	[p7l1364t1369r1514b1416],
31	secondary	JJ	O	secondary	amod	32	SENT_115	[p7l10t1444r268b1507],
32	outcomes	NNS	O	outcome	nsubj	35	SENT_115	[p7l304t1454r553b1492],
33	were	VBD	O	be	cop	35	SENT_115	[p7l591t1461r714b1492],
34	mean	JJ	O	mean	amod	35	SENT_115	[p7l752t1461r899b1492],
35	PRU	NNP	ORGANIZATION	PRU	rcmod	29	SENT_115	[p7l939t1449r1059b1492],
36	and	CC	O	and	_	0	SENT_115	[p7l1099t1444r1195b1492],
37	percentage	NN	O	percentage	nn	39	SENT_115	[p7l1232t1454r1512b1507],
38	platelet	NN	O	platelet	nn	39	SENT_115	[p7l8t1520r195b1583],
39	inhibition	NN	O	inhibition	conj_and	20	SENT_115	[p7l213t1520r469b1568],
40	in	IN	O	in	_	0	SENT_115	[p7l489t1523r540b1568],
41	carriers	NNS	O	carrier	prep_in	39	SENT_115	[p7l560t1523r752b1569],
42	of	IN	O	of	_	0	SENT_115	[p7l774t1520r832b1568],
43	C	NN	O	c	nn	44	SENT_115	[p7l847t1524r885b1569],
44	YP2C19	NN	O	yp2c19	prep_of	41	SENT_115	[p7l889t1523r1159b1576],
45	*	CD	NUMBER	*	num	46	SENT_115	[p7l889t1523r1159b1576],
46	Z	NN	O	z	dep	39	SENT_115	[p7l889t1523r1159b1576],
47	;	:	O	;	_	0	SENT_115	[p7l889t1523r1159b1576],
48	the	DT	O	the	det	50	SENT_115	[p7l1180t1520r1261b1569],
49	betweengroup	JJ	O	betweengroup	amod	50	SENT_115	[p7l1280t1520r1511b1569, p7l9t1615r160b1661],
50	change	NN	O	change	conj_and	20	SENT_115	[p7l180t1598r363b1661],
51	in	IN	O	in	_	0	SENT_115	[p7l383t1601r434b1645],
52	reactivity	NN	O	reactivity	prep_in	50	SENT_115	[p7l453t1601r684b1660],
53	between	IN	O	between	_	0	SENT_115	[p7l700t1598r916b1645],
54	baseline	NN	O	baseline	prep_between	52	SENT_115	[p7l934t1598r1146b1645],
55	and	CC	O	and	_	0	SENT_115	[p7l1166t1598r1261b1645],
56	1	CD	DATE	1	num	57	SENT_115	[p7l1281t1602r1303b1645],
57	week	NN	DATE	week	prep_between	52	SENT_115	[p7l1320t1598r1465b1653],
58	;	:	O	;	_	0	SENT_115	[p7l1320t1598r1465b1653],
59	a	DT	O	a	det	61	SENT_115	[p7l1487t1615r1513b1645],
60	clinical	JJ	O	clinical	amod	61	SENT_115	[p7l9t1673r190b1722],
61	composite	NN	O	composite	conj_and	20	SENT_115	[p7l242t1676r506b1736],
62	of	IN	O	of	_	0	SENT_115	[p7l558t1673r616b1722],
63	cardiovascular	JJ	O	cardiovascular	amod	64	SENT_115	[p7l658t1673r1027b1722],
64	death	NN	O	death	prep_of	61	SENT_115	[p7l1077t1673r1230b1729],
65	,	,	O	,	_	0	SENT_115	[p7l1077t1673r1230b1729],
66	non-fatal	JJ	O	non-fatal	amod	68	SENT_115	[p7l1283t1673r1513b1722],
67	myocardial	JJ	O	myocardial	amod	68	SENT_115	[p7l8t1750r293b1813],
68	infarction	NN	O	infarction	dobj	17	SENT_115	[p7l317t1750r581b1806],
69	,	,	O	,	_	0	SENT_115	[p7l317t1750r581b1806],
70	readmission	NN	O	readmission	appos	68	SENT_115	[p7l608t1750r928b1798],
71	to	TO	O	to	_	0	SENT_115	[p7l951t1760r999b1798],
72	hospital	NN	O	hospital	prep_to	70	SENT_115	[p7l1023t1750r1241b1813],
73	,	,	O	,	_	0	SENT_115	[p7l1023t1750r1241b1813],
74	and	CC	O	and	_	0	SENT_115	[p7l1268t1750r1364b1798],
75	stent	NN	O	stent	nn	76	SENT_115	[p7l1389t1760r1514b1798],
76	thrombosis	NN	O	thrombosis	dobj	17	SENT_115	[p7l7t1828r300b1875],
77	(	CD	NUMBER	(	num	81	SENT_115	[p7l356t1828r624b1891],
78	Academic	NNP	O	Academic	nn	81	SENT_115	[p7l356t1828r624b1891],
79	Research	NNP	O	Research	nn	81	SENT_115	[p7l676t1828r907b1875],
80	Consortium	NNP	O	Consortium	nn	81	SENT_115	[p7l957t1831r1268b1875],
81	deﬁnite	NN	O	deﬁnite	dep	76	SENT_115	[p7l1317t1828r1512b1875],

1	Rapid	JJ	O	rapid	amod	4	SENT_116	[p8l842t117r953b164],
2	genotyping	NN	O	genotyping	nn	4	SENT_116	[p8l964t118r1194b164],
3	(	NN	O	(	nn	4	SENT_116	[p8l1208t119r1338b162],
4	n	NN	O	n	_	0	SENT_116	[p8l1208t119r1338b162],
5	=	JJ	O	=	amod	4	SENT_116	[p8l1208t119r1338b162],
6	91	CD	NUMBER	91	tmod	5	SENT_116	[p8l1208t119r1338b162],
7	)	CD	NUMBER	)	num	9	SENT_116	[p8l1208t119r1338b162],
8	Standard	JJ	O	standard	amod	9	SENT_116	[p8l1486t117r1667b153],
9	treatment	NN	O	treatment	dep	4	SENT_116	[p8l1675t123r1881b153],
10	(	NN	O	(	nn	11	SENT_116	[p8l1893t117r2027b163],
11	n	NN	O	n	dep	4	SENT_116	[p8l1893t117r2027b163],
12	=	JJ	O	=	amod	14	SENT_116	[p8l1893t117r2027b163],
13	96	CD	NUMBER	96	tmod	12	SENT_116	[p8l1893t117r2027b163],
14	)	NN	O	)	dep	11	SENT_116	[p8l1893t117r2027b163],

1	Age	NNP	O	Age	dep	281	SENT_117	[p8l70t215r142b260],
2	(	CD	NUMBER	(	dep	281	SENT_117	[p8l155t214r277b259],
3	years	NNS	NUMBER	year	dep	281	SENT_117	[p8l155t214r277b259],
4	)	VBP	O	)	dep	281	SENT_117	[p8l155t214r277b259],
5	59-5	CD	NUMBER	59-5	dep	281	SENT_117	[p8l848t217r929b254],
6	(	CD	NUMBER	(	dep	281	SENT_117	[p8l944t214r1030b258],
7	9-3	CD	NUMBER	9-3	dep	281	SENT_117	[p8l944t214r1030b258],
8	)	NN	O	)	dep	281	SENT_117	[p8l944t214r1030b258],
9	60-8	CD	NUMBER	60-8	dep	281	SENT_117	[p8l1493t212r1577b248],
10	(	CD	NUMBER	(	dep	281	SENT_117	[p8l1592t212r1677b258],
11	8-7	CD	NUMBER	8-7	dep	281	SENT_117	[p8l1592t212r1677b258],
12	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1592t212r1677b258],
13	Women	NNS	O	woman	dep	281	SENT_117	[p8l69t295r215b328],
14	19	CD	PERCENT	19	dep	281	SENT_117	[p8l850t297r894b333],
15	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t294r1014b337],
16	21	CD	PERCENT	21	dep	281	SENT_117	[p8l909t294r1014b337],
17	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t294r1014b337],
18	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t294r1014b337],
19	22	CD	NUMBER	22	dep	281	SENT_117	[p8l1497t297r1540b327],
20	(	NN	O	(	dep	281	SENT_117	[p8l1554t294r1661b337],
21	23	CD	PERCENT	23	dep	281	SENT_117	[p8l1554t294r1661b337],
22	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t294r1661b337],
23	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t294r1661b337],
24	White	NNP	O	White	dep	281	SENT_117	[p8l69t371r181b407],
25	ethnic	JJ	O	ethnic	dep	281	SENT_117	[p8l193t371r309b407],
26	origin	NN	O	origin	dep	281	SENT_117	[p8l320t374r428b419],
27	85	CD	PERCENT	85	dep	281	SENT_117	[p8l849t371r894b413],
28	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t373r1018b417],
29	93	CD	PERCENT	93	dep	281	SENT_117	[p8l909t373r1018b417],
30	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t373r1018b417],
31	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t373r1018b417],
32	92	CD	NUMBER	92	dep	281	SENT_117	[p8l1495t376r1540b413],
33	(	NN	O	(	dep	281	SENT_117	[p8l1554t371r1667b417],
34	96	CD	PERCENT	96	dep	281	SENT_117	[p8l1554t371r1667b417],
35	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t371r1667b417],
36	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t371r1667b417],
37	Previous	JJ	O	previous	dep	281	SENT_117	[p8l72t454r228b487],
38	myocardial	JJ	O	myocardial	dep	281	SENT_117	[p8l242t451r444b498],
39	infarction	NN	O	infarction	dep	281	SENT_117	[p8l459t450r637b487],
40	17	CD	PERCENT	17	dep	281	SENT_117	[p8l854t456r896b491],
41	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t453r1017b496],
42	19	CD	PERCENT	19	dep	281	SENT_117	[p8l909t453r1017b496],
43	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t453r1017b496],
44	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t453r1017b496],
45	13	CD	NUMBER	13	dep	281	SENT_117	[p8l1498t455r1540b492],
46	(	NN	O	(	dep	281	SENT_117	[p8l1554t453r1662b496],
47	14	CD	PERCENT	14	dep	281	SENT_117	[p8l1554t453r1662b496],
48	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t453r1662b496],
49	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t453r1662b496],
50	Bodyweight	NNP	O	Bodyweight	dep	281	SENT_117	[p8l72t530r296b577],
51	(	CD	NUMBER	(	dep	281	SENT_117	[p8l309t530r380b577],
52	kg	NN	O	kg	dep	281	SENT_117	[p8l309t530r380b577],
53	)	NN	O	)	dep	281	SENT_117	[p8l309t530r380b577],
54	88-9	CD	NUMBER	88-9	dep	281	SENT_117	[p8l846t530r931b571],
55	(	CD	NUMBER	(	dep	281	SENT_117	[p8l946t532r1055b576],
56	15-4	CD	NUMBER	15-4	dep	281	SENT_117	[p8l946t532r1055b576],
57	)	NN	O	)	dep	281	SENT_117	[p8l946t532r1055b576],
58	832	CD	NUMBER	832	dep	281	SENT_117	[p8l1495t530r1574b571],
59	(	NN	O	(	dep	281	SENT_117	[p8l1589t530r1701b576],
60	16-9	CD	NUMBER	16-9	dep	281	SENT_117	[p8l1589t530r1701b576],
61	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1589t530r1701b576],
62	Acute	JJ	O	acute	dep	281	SENT_117	[p8l70t613r177b645],
63	coronary	JJ	O	coronary	dep	281	SENT_117	[p8l189t622r354b656],
64	syndrome	NN	O	syndrome	dep	281	SENT_117	[p8l365t609r551b656],
65	33	CD	PERCENT	33	dep	281	SENT_117	[p8l851t614r894b651],
66	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t609r1018b655],
67	36	CD	PERCENT	36	dep	281	SENT_117	[p8l909t609r1018b655],
68	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t609r1018b655],
69	)	CD	PERCENT	)	dep	281	SENT_117	[p8l909t609r1018b655],
70	37	CD	PERCENT	37	dep	281	SENT_117	[p8l1497t614r1541b651],
71	(	CD	PERCENT	(	dep	281	SENT_117	[p8l1554t612r1664b655],
72	39	CD	PERCENT	39	dep	281	SENT_117	[p8l1554t612r1664b655],
73	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t612r1664b655],
74	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t612r1664b655],
75	Cardiac	JJ	O	cardiac	dep	281	SENT_117	[p8l71t689r205b725],
76	risk	NN	O	risk	dep	281	SENT_117	[p8l219t689r280b725],
77	factors	NNS	O	factor	dep	281	SENT_117	[p8l290t689r418b725],
78	Hypertension	NN	O	hypertension	dep	281	SENT_117	[p8l112t771r360b815],
79	56	CD	PERCENT	56	dep	281	SENT_117	[p8l848t768r894b810],
80	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t768r1019b814],
81	62	CD	PERCENT	62	dep	281	SENT_117	[p8l909t768r1019b814],
82	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t768r1019b814],
83	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t768r1019b814],
84	63	CD	NUMBER	63	dep	281	SENT_117	[p8l1495t768r1540b810],
85	(	NN	O	(	dep	281	SENT_117	[p8l1554t768r1667b814],
86	66	CD	PERCENT	66	dep	281	SENT_117	[p8l1554t768r1667b814],
87	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t768r1667b814],
88	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t768r1667b814],
89	Diabetes	NNP	O	Diabetes	dep	281	SENT_117	[p8l112t848r271b884],
90	mellitus	NN	O	mellitus	dep	281	SENT_117	[p8l285t848r432b884],
91	23	CD	PERCENT	23	dep	281	SENT_117	[p8l851t853r894b889],
92	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t850r1016b893],
93	25	CD	PERCENT	25	dep	281	SENT_117	[p8l909t850r1016b893],
94	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t850r1016b893],
95	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t850r1016b893],
96	19	CD	NUMBER	19	dep	281	SENT_117	[p8l1495t853r1540b889],
97	(	NN	O	(	dep	281	SENT_117	[p8l1554t850r1663b893],
98	20	CD	PERCENT	20	dep	281	SENT_117	[p8l1554t850r1663b893],
99	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t850r1663b893],
100	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t850r1663b893],
101	Hypercholesterolaemia	NN	ORGANIZATION	hypercholesterolaemia	dep	281	SENT_117	[p8l112t927r541b974],
102	77	CD	PERCENT	77	dep	281	SENT_117	[p8l852t933r896b968],
103	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t927r1019b973],
104	85	CD	PERCENT	85	dep	281	SENT_117	[p8l909t927r1019b973],
105	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t927r1019b973],
106	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t927r1019b973],
107	75	CD	NUMBER	75	dep	281	SENT_117	[p8l1496t933r1540b969],
108	(	NN	O	(	dep	281	SENT_117	[p8l1554t927r1663b973],
109	78	CD	PERCENT	78	dep	281	SENT_117	[p8l1554t927r1663b973],
110	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t927r1663b973],
111	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t927r1663b973],
112	Current	JJ	DATE	current	dep	281	SENT_117	[p8l111t1010r251b1043],
113	smoking	NN	O	smoking	dep	281	SENT_117	[p8l262t1007r422b1054],
114	23	CD	PERCENT	23	dep	281	SENT_117	[p8l851t1012r894b1048],
115	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t1009r1016b1052],
116	25	CD	PERCENT	25	dep	281	SENT_117	[p8l909t1009r1016b1052],
117	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t1009r1016b1052],
118	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t1009r1016b1052],
119	35	CD	NUMBER	35	dep	281	SENT_117	[p8l1496t1012r1540b1048],
120	(	NN	O	(	dep	281	SENT_117	[p8l1554t1009r1660b1052],
121	37	CD	PERCENT	37	dep	281	SENT_117	[p8l1554t1009r1660b1052],
122	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t1009r1660b1052],
123	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t1009r1660b1052],
124	Past	JJ	DATE	past	dep	281	SENT_117	[p8l112t1090r187b1122],
125	smoking	NN	O	smoking	dep	281	SENT_117	[p8l199t1086r358b1133],
126	28	CD	PERCENT	28	dep	281	SENT_117	[p8l848t1086r894b1122],
127	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t1088r1014b1132],
128	31	CD	PERCENT	31	dep	281	SENT_117	[p8l909t1088r1014b1132],
129	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t1088r1014b1132],
130	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t1088r1014b1132],
131	16	CD	NUMBER	16	dep	281	SENT_117	[p8l1495t1086r1540b1122],
132	(	NN	O	(	dep	281	SENT_117	[p8l1554t1088r1659b1132],
133	17	CD	PERCENT	17	dep	281	SENT_117	[p8l1554t1088r1659b1132],
134	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t1088r1659b1132],
135	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t1088r1659b1132],
136	Drugs	NNS	O	drug	dep	281	SENT_117	[p8l72t1169r178b1213],
137	Previous	JJ	O	previous	dep	281	SENT_117	[p8l112t1248r268b1281],
138	aspirin	NN	O	aspirin	dep	281	SENT_117	[p8l280t1248r402b1292],
139	use	NN	O	use	dep	281	SENT_117	[p8l416t1257r476b1281],
140	84	CD	PERCENT	84	dep	281	SENT_117	[p8l847t1245r896b1286],
141	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t1247r1018b1291],
142	92	CD	PERCENT	92	dep	281	SENT_117	[p8l909t1247r1018b1291],
143	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t1247r1018b1291],
144	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t1247r1018b1291],
145	88	CD	NUMBER	88	dep	281	SENT_117	[p8l1492t1245r1540b1281],
146	(	NN	O	(	dep	281	SENT_117	[p8l1554t1247r1664b1291],
147	92	CD	PERCENT	92	dep	281	SENT_117	[p8l1554t1247r1664b1291],
148	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t1247r1664b1291],
149	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t1247r1664b1291],
150	Statin	NN	ORGANIZATION	statin	dep	281	SENT_117	[p8l110t1327r219b1361],
151	81	CD	PERCENT	81	dep	281	SENT_117	[p8l851t1324r895b1361],
152	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t1324r1021b1370],
153	89	CD	PERCENT	89	dep	281	SENT_117	[p8l909t1324r1021b1370],
154	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t1324r1021b1370],
155	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t1324r1021b1370],
156	83	CD	NUMBER	83	dep	281	SENT_117	[p8l1495t1324r1540b1366],
157	(	NN	O	(	dep	281	SENT_117	[p8l1554t1324r1667b1370],
158	86	CD	PERCENT	86	dep	281	SENT_117	[p8l1554t1324r1667b1370],
159	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t1324r1667b1370],
160	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t1324r1667b1370],
161	Angiotensin	NN	O	angiotensin	dep	281	SENT_117	[p8l109t1407r571b1451],
162	—	CD	NUMBER	—	dep	281	SENT_117	[p8l109t1407r571b1451],
163	converting	VBG	O	convert	dep	281	SENT_117	[p8l109t1407r571b1451],
164	41	CD	PERCENT	41	dep	281	SENT_117	[p8l849t1409r895b1445],
165	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t1406r1018b1449],
166	45	CD	PERCENT	45	dep	281	SENT_117	[p8l909t1406r1018b1449],
167	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t1406r1018b1449],
168	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t1406r1018b1449],
169	43	CD	NUMBER	43	dep	281	SENT_117	[p8l1493t1409r1540b1445],
170	(	NN	O	(	dep	281	SENT_117	[p8l1554t1406r1663b1449],
171	45	CD	PERCENT	45	dep	281	SENT_117	[p8l1554t1406r1663b1449],
172	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t1406r1663b1449],
173	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t1406r1663b1449],
174	enzyme	NN	O	enzyme	dep	281	SENT_117	[p8l110t1476r257b1511],
175	inhibitor	NN	O	inhibitor	dep	281	SENT_117	[p8l272t1464r438b1500],
176	[	NN	O	[	dep	281	SENT_117	[p8l112t1543r132b1590],
177	3	CD	NUMBER	3	dep	281	SENT_117	[p8l112t1543r132b1590],
178	blocker	NN	O	blocker	dep	281	SENT_117	[p8l146t1543r280b1579],
179	70	CD	PERCENT	70	dep	281	SENT_117	[p8l849t1548r895b1584],
180	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t1545r1013b1589],
181	77	CD	PERCENT	77	dep	281	SENT_117	[p8l909t1545r1013b1589],
182	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t1545r1013b1589],
183	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t1545r1013b1589],
184	69	CD	NUMBER	69	dep	281	SENT_117	[p8l1492t1543r1540b1585],
185	(	NN	O	(	dep	281	SENT_117	[p8l1554t1545r1660b1589],
186	72	CD	PERCENT	72	dep	281	SENT_117	[p8l1554t1545r1660b1589],
187	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t1545r1660b1589],
188	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t1545r1660b1589],
189	Proton	NNP	ORGANIZATION	Proton	dep	281	SENT_117	[p8l112t1626r366b1670],
190	—	CD	NUMBER	—	dep	281	SENT_117	[p8l112t1626r366b1670],
191	pump	NN	O	pump	dep	281	SENT_117	[p8l112t1626r366b1670],
192	inhibitor	NN	O	inhibitor	dep	281	SENT_117	[p8l380t1623r541b1659],
193	19	CD	PERCENT	19	dep	281	SENT_117	[p8l850t1627r894b1664],
194	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t1625r1014b1668],
195	21	CD	PERCENT	21	dep	281	SENT_117	[p8l909t1625r1014b1668],
196	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t1625r1014b1668],
197	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t1625r1014b1668],
198	18	CD	NUMBER	18	dep	281	SENT_117	[p8l1495t1622r1540b1659],
199	(	NN	O	(	dep	281	SENT_117	[p8l1554t1625r1662b1668],
200	19	CD	PERCENT	19	dep	281	SENT_117	[p8l1554t1625r1662b1668],
201	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t1625r1662b1668],
202	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t1625r1662b1668],
203	Vessels	NNS	O	vessel	dep	281	SENT_117	[p8l69t1702r200b1738],
204	stented	VBD	O	stent	dep	281	SENT_117	[p8l211t1702r353b1738],
205	Left	VBN	O	leave	dep	281	SENT_117	[p8l112t1781r181b1818],
206	main	JJ	O	main	dep	281	SENT_117	[p8l195t1785r286b1818],
207	artery	NN	O	artery	dep	281	SENT_117	[p8l299t1788r408b1829],
208	2	CD	NUMBER	2	dep	281	SENT_117	[p8l875t1786r894b1817],
209	(	NN	O	(	dep	281	SENT_117	[p8l909t1784r992b1827],
210	2	CD	PERCENT	2	dep	281	SENT_117	[p8l909t1784r992b1827],
211	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t1784r992b1827],
212	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t1784r992b1827],
213	o	NN	O	o	dep	281	SENT_117	[p8l1519t1787r1541b1818],
214	Left	VBN	O	leave	dep	281	SENT_117	[p8l112t1861r181b1897],
215	anterior	JJ	O	anterior	dep	281	SENT_117	[p8l193t1864r342b1897],
216	descending	VBG	O	descend	dep	281	SENT_117	[p8l352t1861r562b1908],
217	artery	NN	O	artery	dep	281	SENT_117	[p8l576t1868r685b1908],
218	42	CD	PERCENT	42	dep	281	SENT_117	[p8l848t1866r894b1902],
219	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t1861r1021b1907],
220	46	CD	PERCENT	46	dep	281	SENT_117	[p8l909t1861r1021b1907],
221	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t1861r1021b1907],
222	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t1861r1021b1907],
223	42	CD	NUMBER	42	dep	281	SENT_117	[p8l1493t1866r1540b1902],
224	(	NN	O	(	dep	281	SENT_117	[p8l1554t1863r1666b1907],
225	44	CD	PERCENT	44	dep	281	SENT_117	[p8l1554t1863r1666b1907],
226	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t1863r1666b1907],
227	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t1863r1666b1907],
228	Circumflex	NNP	O	Circumflex	dep	281	SENT_117	[p8l110t1940r309b1977],
229	artery	NN	O	artery	dep	281	SENT_117	[p8l320t1947r430b1988],
230	32	CD	PERCENT	32	dep	281	SENT_117	[p8l850t1945r894b1982],
231	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t1942r1016b1986],
232	35	CD	PERCENT	35	dep	281	SENT_117	[p8l909t1942r1016b1986],
233	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t1942r1016b1986],
234	)	CD	NUMBER	)	dep	281	SENT_117	[p8l909t1942r1016b1986],
235	33	CD	NUMBER	33	dep	281	SENT_117	[p8l1496t1945r1540b1982],
236	(	NN	O	(	dep	281	SENT_117	[p8l1554t1942r1663b1986],
237	34	CD	PERCENT	34	dep	281	SENT_117	[p8l1554t1942r1663b1986],
238	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t1942r1663b1986],
239	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t1942r1663b1986],
240	Right	NNP	O	Right	dep	281	SENT_117	[p8l112t2020r210b2067],
241	coronary	JJ	O	coronary	dep	281	SENT_117	[p8l221t2032r386b2067],
242	artery	NN	O	artery	dep	281	SENT_117	[p8l397t2027r506b2067],
243	32	CD	PERCENT	32	dep	281	SENT_117	[p8l850t2025r894b2061],
244	(	CD	PERCENT	(	dep	281	SENT_117	[p8l909t2022r1016b2065],
245	35	CD	PERCENT	35	dep	281	SENT_117	[p8l909t2022r1016b2065],
246	%	NN	PERCENT	%	dep	281	SENT_117	[p8l909t2022r1016b2065],
247	)	CD	PERCENT	)	dep	281	SENT_117	[p8l909t2022r1016b2065],
248	37	CD	PERCENT	37	dep	281	SENT_117	[p8l1497t2025r1541b2061],
249	(	CD	PERCENT	(	dep	281	SENT_117	[p8l1554t2022r1664b2065],
250	39	CD	PERCENT	39	dep	281	SENT_117	[p8l1554t2022r1664b2065],
251	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t2022r1664b2065],
252	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1554t2022r1664b2065],
253	Saphenous	NNP	MISC	Saphenous	dep	281	SENT_117	[p8l70t2099r274b2146],
254	vein	NN	O	vein	dep	281	SENT_117	[p8l285t2102r362b2135],
255	graft	NN	O	graft	dep	281	SENT_117	[p8l376t2099r466b2146],
256	4	CD	NUMBER	4	dep	281	SENT_117	[p8l872t2104r896b2140],
257	(	NN	O	(	dep	281	SENT_117	[p8l909t2101r947b2145],
258	4	CD	PERCENT	4	dep	281	SENT_117	[p8l909t2101r947b2145],
259	%	NN	PERCENT	%	dep	281	SENT_117	[p8l959t2101r1003b2145],
260	)	CD	NUMBER	)	dep	281	SENT_117	[p8l959t2101r1003b2145],
261	2	CD	NUMBER	2	dep	281	SENT_117	[p8l1521t2104r1540b2135],
262	(	NN	O	(	dep	281	SENT_117	[p8l1554t2101r1588b2145],
263	2	CD	PERCENT	2	dep	281	SENT_117	[p8l1554t2101r1588b2145],
264	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1602t2101r1647b2145],
265	)	CD	NUMBER	)	dep	281	SENT_117	[p8l1602t2101r1647b2145],
266	Drug	NN	O	drug	dep	281	SENT_117	[p8l72t2179r309b2226],
267	—	NN	O	—	dep	281	SENT_117	[p8l72t2179r309b2226],
268	e	SYM	O	e	dep	281	SENT_117	[p8l72t2179r309b2226],
269	|	SYM	O	|	dep	281	SENT_117	[p8l72t2179r309b2226],
270	uting	VBG	O	ute	dep	281	SENT_117	[p8l72t2179r309b2226],
271	stent	NN	O	stent	dep	281	SENT_117	[p8l322t2185r418b2215],
272	71	CD	NUMBER	71	dep	281	SENT_117	[p8l852t2184r895b2219],
273	(	NN	O	(	dep	281	SENT_117	[p8l909t2178r968b2224],
274	78	CD	PERCENT	78	dep	281	SENT_117	[p8l909t2178r968b2224],
275	%	NN	PERCENT	%	dep	281	SENT_117	[p8l982t2181r1027b2224],
276	)	CD	NUMBER	)	dep	281	SENT_117	[p8l982t2181r1027b2224],
277	73	CD	NUMBER	73	dep	281	SENT_117	[p8l1496t2183r1540b2220],
278	(	NN	O	(	dep	281	SENT_117	[p8l1554t2178r1663b2224],
279	76	CD	PERCENT	76	dep	281	SENT_117	[p8l1554t2178r1663b2224],
280	%	NN	PERCENT	%	dep	281	SENT_117	[p8l1554t2178r1663b2224],
281	)	CD	NUMBER	)	_	0	SENT_117	[p8l1554t2178r1663b2224],

1	Data	NNS	O	datum	nsubj	8	SENT_118	[p8l52t2300r130b2330],
2	are	VBP	O	be	cop	3	SENT_118	[p8l141t2308r192b2330],
3	n	NN	O	n	_	0	SENT_118	[p8l205t2308r223b2330],
4	(	CD	PERCENT	(	num	5	SENT_118	[p8l237t2299r292b2339],
5	%	NN	PERCENT	%	dep	3	SENT_118	[p8l237t2299r292b2339],
6	)	CD	NUMBER	)	dep	5	SENT_118	[p8l237t2299r292b2339],
7	or	CC	O	or	_	0	SENT_118	[p8l303t2308r339b2330],
8	mean	VB	O	mean	conj_or	3	SENT_118	[p8l351t2308r445b2330],
9	(	JJ	O	(	amod	11	SENT_118	[p8l458t2299r540b2339],
10	SD	NN	O	sd	nn	11	SENT_118	[p8l458t2299r540b2339],
11	)	NN	O	)	dobj	8	SENT_118	[p8l458t2299r540b2339],
12	.	.	O	.	_	0	SENT_118	[p8l458t2299r540b2339],

1	Table	NNP	O	Table	_	0	SENT_119	[p8l50t2407r149b2444],
2	1	CD	NUMBER	1	num	1	SENT_119	[p8l160t2413r192b2443],
3	:	:	O	:	_	0	SENT_119	[p8l160t2413r192b2443],
4	Baseline	NN	O	baseline	nn	5	SENT_119	[p8l206t2407r366b2444],
5	characteristics	NNS	O	characteristic	dep	1	SENT_119	[p8l377t2407r660b2444],

1	Articles	NNPS	O	Articles	_	0	SENT_120	[p8l101t2884r251b2920],
2	and	CC	O	and	_	0	SENT_120	[p8l645t3125r740b3173],
3	probable	JJ	O	probable	amod	4	SENT_120	[p8l777t3125r1015b3188],
4	)	NN	O	)	conj_and	1	SENT_120	[p8l777t3125r1015b3188],
5	;	:	O	;	_	0	SENT_120	[p8l1022t3128r1063b3180],
6	27	CD	NUMBER	27	conj_and	1	SENT_120	[p8l1022t3128r1063b3180],
7	a	DT	O	a	dep	18	SENT_120	[p8l1100t3142r1126b3173],
8	safety	NN	O	safety	nn	9	SENT_120	[p8l1165t3125r1310b3188],
9	outcome	NN	O	outcome	dep	18	SENT_120	[p8l1347t3135r1569b3173],
10	of	IN	O	of	_	0	SENT_120	[p8l1607t3125r1665b3173],
11	Thrombolysis	NNP	O	Thrombolysis	prep_of	9	SENT_120	[p8l1692t3125r2047b3188],
12	In	IN	O	in	_	0	SENT_120	[p8l2089t3130r2143b3172],
13	Myocardial	JJ	O	myocardial	amod	14	SENT_120	[p8l646t3201r929b3264],
14	Infarction	NN	O	infarction	prep_in	9	SENT_120	[p8l955t3201r1209b3249],
15	(	CD	NUMBER	(	num	16	SENT_120	[p8l1236t3204r1402b3264],
16	TIMI	NNP	ORGANIZATION	TIMI	dep	14	SENT_120	[p8l1236t3204r1402b3264],
17	)	CD	NUMBER	)	num	16	SENT_120	[p8l1236t3204r1402b3264],
18	major	JJ	O	major	dep	6	SENT_120	[p8l1430t3204r1583b3264],
19	and	CC	O	and	_	0	SENT_120	[p8l1606t3201r1701b3249],
20	minor	JJ	O	minor	amod	21	SENT_120	[p8l1723t3204r1885b3249],
21	bleeding	NN	O	bleeding	conj_and	18	SENT_120	[p8l1906t3201r2140b3264],
22	;	:	O	;	_	0	SENT_120	[p8l1906t3201r2140b3264],
23	and	CC	O	and	_	0	SENT_120	[p8l645t3278r740b3325],
24	concordance	NN	O	concordance	conj_and	1	SENT_120	[p8l787t3278r1110b3325],
25	of	IN	O	of	_	0	SENT_120	[p8l1157t3278r1215b3325],
26	point-of-care	JJ	O	point-of-care	amod	28	SENT_120	[p8l1252t3278r1574b3340],
27	genetic	JJ	O	genetic	amod	28	SENT_120	[p8l1622t3281r1805b3341],
28	testing	NN	O	testing	prep_of	24	SENT_120	[p8l1850t3281r2024b3341],
29	for	IN	O	for	_	0	SENT_120	[p8l2071t3278r2144b3325],
30	C	NN	O	c	nn	31	SENT_120	[p8l649t3357r687b3401],
31	YP2C1	NN	O	yp2c1	prep_for	28	SENT_120	[p8l691t3357r856b3401],
32	97	CD	NUMBER	97	num	31	SENT_120	[p8l863t3356r951b3401],
33	'	''	O	'	_	0	SENT_120	[p8l863t3356r951b3401],
34	~	FW	O	~	nn	35	SENT_120	[p8l863t3356r951b3401],
35	‘	FW	O	‘	amod	28	SENT_120	[p8l863t3356r951b3401],
36	2	CD	NUMBER	2	num	38	SENT_120	[p8l863t3356r951b3401],
37	carrier	NN	O	carrier	nn	38	SENT_120	[p8l965t3356r1133b3401],
38	status	NN	O	status	dep	1	SENT_120	[p8l1150t3363r1296b3401],
39	and	CC	O	and	_	0	SENT_120	[p8l1315t3353r1411b3401],
40	direct	JJ	O	direct	amod	42	SENT_120	[p8l1427t3353r1572b3401],
41	DNA	NN	O	dna	nn	42	SENT_120	[p8l1590t3357r1720b3401],
42	sequencing	NN	O	sequencing	dep	1	SENT_120	[p8l1737t3356r2043b3416],
43	.	.	O	.	_	0	SENT_120	[p8l1737t3356r2043b3416],

1	Statistical	JJ	O	statistical	amod	2	SENT_121	[p9l645t52r901b100],
2	analysis	NN	O	analysis	nsubj	11	SENT_121	[p9l917t52r1121b115],
3	This	DT	O	this	det	4	SENT_121	[p9l643t128r758b176],
4	study	NN	O	study	nsubjpass	6	SENT_121	[p9l792t128r932b191],
5	Was	VBD	O	be	auxpass	6	SENT_121	[p9l959t145r1057b176],
6	designed	VBN	O	design	rcmod	2	SENT_121	[p9l1090t128r1326b191],
7	as	IN	O	as	_	0	SENT_121	[p9l1356t145r1407b176],
8	a	DT	O	a	det	10	SENT_121	[p9l1439t145r1465b176],
9	proof-oﬁconcept	JJ	O	proof-oﬁconcept	amod	10	SENT_121	[p9l1495t128r1924b191],
10	investigation	NN	O	investigation	prep_as	6	SENT_121	[p9l1953t132r2141b176, p9l645t207r808b267],
11	powered	VBD	O	power	_	0	SENT_121	[p9l820t204r1044b266],
12	for	IN	O	for	_	0	SENT_121	[p9l1055t204r1130b252],
13	the	DT	O	the	det	15	SENT_121	[p9l1140t204r1222b252],
14	primary	JJ	O	primary	amod	15	SENT_121	[p9l1234t207r1445b267],
15	outcome	NN	O	outcome	prep_for	11	SENT_121	[p9l1456t214r1697b252],
16	.	.	O	.	_	0	SENT_121	[p9l1456t214r1697b252],

1	With	IN	O	with	_	0	SENT_122	[p9l1711t204r1839b252],
2	clopidogrel	NN	O	clopidogrel	nn	3	SENT_122	[p9l1851t204r2143b267],
3	pretreatment	NN	O	pretreatment	prep_with	6	SENT_122	[p9l644t290r1002b343],
4	,	,	O	,	_	0	SENT_122	[p9l644t290r1002b343],
5	we	PRP	O	we	nsubj	6	SENT_122	[p9l1029t298r1102b328],
6	assumed	VBD	O	assume	_	0	SENT_122	[p9l1129t281r1363b328],
7	a	DT	O	a	det	11	SENT_122	[p9l1389t298r1415b328],
8	60	CD	PERCENT	60	number	9	SENT_122	[p9l1442t284r1555b331],
9	%	NN	PERCENT	%	amod	11	SENT_122	[p9l1442t284r1555b331],
10	non-response	JJ	O	non-response	amod	11	SENT_122	[p9l1582t298r1939b343],
11	rate	NN	O	rate	dobj	6	SENT_122	[p9l1966t290r2064b328],
12	in	IN	O	in	_	0	SENT_122	[p9l2091t284r2143b327],
13	CYP2C19	NN	O	cyp2c19	nn	15	SENT_122	[p9l649t359r957b405],
14	*	CD	NUMBER	*	num	15	SENT_122	[p9l649t359r957b405],
15	‘	NN	O	‘	prep_in	6	SENT_122	[p9l649t359r957b405],
16	2	CD	NUMBER	2	num	17	SENT_122	[p9l649t359r957b405],
17	carriers	NNS	O	carrier	dep	15	SENT_122	[p9l986t359r1182b404],
18	and	CC	O	and	_	0	SENT_122	[p9l1215t356r1312b404],
19	a	DT	O	a	det	24	SENT_122	[p9l1343t374r1369b404],
20	75	CD	PERCENT	75	number	21	SENT_122	[p9l1399t359r1509b406],
21	%	NN	PERCENT	%	amod	24	SENT_122	[p9l1399t359r1509b406],
22	relative	JJ	O	relative	amod	24	SENT_122	[p9l1540t356r1730b404],
23	risk	NN	O	risk	nn	24	SENT_122	[p9l1761t356r1861b404],
24	reduction	NN	O	reduction	prep_in	6	SENT_122	[p9l1890t356r2143b404],
25	with	IN	O	with	_	0	SENT_122	[p9l643t433r759b481],
26	alteration	NN	O	alteration	prep_with	24	SENT_122	[p9l779t433r1028b480],
27	from	IN	O	from	_	0	SENT_122	[p9l1048t433r1177b480],
28	clopidogrel	NN	O	clopidogrel	prep_from	6	SENT_122	[p9l1197t433r1489b496],
29	to	TO	O	to	_	0	SENT_122	[p9l1508t442r1556b480],
30	prasugrel	NN	O	prasugrel	prep_to	6	SENT_122	[p9l1576t433r1838b496],
31	.	.	O	.	_	0	SENT_122	[p9l1576t433r1838b496],

1	At	IN	O	at	_	0	SENT_123	[p9l1860t436r1917b480],
2	a	DT	O	a	det	3	SENT_123	[p9l1936t450r1962b480],
3	power	NN	O	power	prep_at	9	SENT_123	[p9l1982t450r2144b495],
4	of	IN	O	of	_	0	SENT_123	[p9l645t510r703b558],
5	90	CD	PERCENT	90	num	6	SENT_123	[p9l727t513r854b565],
6	%	NN	PERCENT	%	prep_of	3	SENT_123	[p9l727t513r854b565],
7	,	,	O	,	_	0	SENT_123	[p9l727t513r854b565],
8	we	PRP	O	we	nsubj	9	SENT_123	[p9l887t527r959b558],
9	calculated	VBD	O	calculate	_	0	SENT_123	[p9l992t510r1253b558],
10	that	IN	O	that	complm	12	SENT_123	[p9l1284t510r1386b558],
11	we	PRP	O	we	nsubj	12	SENT_123	[p9l1415t527r1487b558],
12	needed	VBD	O	need	ccomp	9	SENT_123	[p9l1520t510r1710b558],
13	23	CD	NUMBER	23	num	14	SENT_123	[p9l1742t514r1799b558],
14	CYP2C19	NN	O	cyp2c19	nsubj	18	SENT_123	[p9l1838t513r2145b558],
15	*	CD	NUMBER	*	num	18	SENT_123	[p9l1838t513r2145b558],
16	‘	NN	O	‘	nn	18	SENT_123	[p9l1838t513r2145b558],
17	2	CD	NUMBER	2	num	18	SENT_123	[p9l1838t513r2145b558],
18	carriers	NNS	O	carrier	xcomp	12	SENT_123	[p9l645t590r841b635],
19	per	IN	O	per	_	0	SENT_123	[p9l897t604r983b649],
20	group	NN	O	group	prep_per	18	SENT_123	[p9l1038t604r1205b650],
21	.	.	O	.	_	0	SENT_123	[p9l1038t604r1205b650],

1	Assuming	VBG	O	assume	partmod	27	SENT_124	[p9l1262t590r1534b650],
2	25	CD	PERCENT	25	num	3	SENT_124	[p9l1591t590r1703b637],
3	%	NN	PERCENT	%	dobj	1	SENT_124	[p9l1591t590r1703b637],
4	prevalence	NN	O	prevalence	dep	11	SENT_124	[p9l1758t587r2038b649],
5	of	IN	O	of	_	0	SENT_124	[p9l2094t587r2152b635],
6	C	NN	O	c	nn	7	SENT_124	[p9l649t666r687b710],
7	YP2C1	NN	O	yp2c1	prep_of	4	SENT_124	[p9l692t666r860b710],
8	9	CD	NUMBER	9	num	9	SENT_124	[p9l868t666r957b711],
9	*	NN	O	*	dep	11	SENT_124	[p9l868t666r957b711],
10	2	CD	NUMBER	2	num	11	SENT_124	[p9l868t666r957b711],
11	carriers	NNS	O	carrier	dep	1	SENT_124	[p9l971t666r1167b710],
12	in	IN	O	in	_	0	SENT_124	[p9l1186t666r1238b710],
13	a	DT	O	a	det	14	SENT_124	[p9l1255t680r1281b710],
14	population	NN	O	population	prep_in	11	SENT_124	[p9l1297t663r1582b725],
15	of	IN	O	of	_	0	SENT_124	[p9l1600t663r1658b710],
16	western	JJ	O	western	amod	18	SENT_124	[p9l1664t672r1872b710],
17	European	JJ	MISC	european	amod	18	SENT_124	[p9l1891t666r2143b725],
18	descent	NN	O	descent	prep_of	14	SENT_124	[p9l645t739r844b787],
19	and	CC	O	and	_	0	SENT_124	[p9l900t739r997b787],
20	8	CD	PERCENT	8	number	21	SENT_124	[p9l1054t742r1135b789],
21	%	NN	PERCENT	%	amod	22	SENT_124	[p9l1054t742r1135b789],
22	loss	NN	O	loss	dep	1	SENT_124	[p9l1191t739r1290b787],
23	to	TO	O	to	_	0	SENT_124	[p9l1347t749r1396b787],
24	follow-up	NN	O	follow-up	prep_to	22	SENT_124	[p9l1453t739r1714b802],
25	,	,	O	,	_	0	SENT_124	[p9l1453t739r1714b802],
26	we	PRP	O	we	nsubj	27	SENT_124	[p9l1771t756r1843b787],
27	projected	VBD	O	project	_	0	SENT_124	[p9l1900t739r2144b802],
28	200	CD	NUMBER	200	num	29	SENT_124	[p9l646t820r736b863],
29	patients	NNS	O	patient	nsubj	32	SENT_124	[p9l754t818r961b877],
30	would	MD	O	would	aux	32	SENT_124	[p9l980t815r1143b863],
31	be	VB	O	be	cop	32	SENT_124	[p9l1159t815r1219b863],
32	necessary	JJ	O	necessary	ccomp	27	SENT_124	[p9l1238t832r1499b878],
33	.	.	O	.	_	0	SENT_124	[p9l1238t832r1499b878],

1	Rapid	JJ	O	rapid	_	0	SENT_125	[p9l845t996r955b1043],
2	genotyping	VBG	O	genotype	dep	1	SENT_125	[p9l966t998r1195b1044],
3	Standard	JJ	O	standard	amod	6	SENT_125	[p9l1349t996r1529b1032],
4	treatment	NN	O	treatment	nn	6	SENT_125	[p9l1537t1002r1742b1032],
5	p	NN	O	p	nn	6	SENT_125	[p9l1854t1008r1879b1043],
6	value	NN	O	value	dobj	2	SENT_125	[p9l1889t996r1994b1032],
7	(	CD	NUMBER	(	num	8	SENT_125	[p9l844t1058r971b1101],
8	n	NN	O	n	dep	6	SENT_125	[p9l844t1058r971b1101],
9	=	JJ	O	=	quantmod	11	SENT_125	[p9l844t1058r971b1101],
10	23	CD	NUMBER	23	number	11	SENT_125	[p9l844t1058r971b1101],
11	)	CD	NUMBER	)	num	16	SENT_125	[p9l844t1058r971b1101],
12	(	NN	O	(	nn	16	SENT_125	[p9l1350t1058r1477b1101],
13	n	NN	O	n	nn	16	SENT_125	[p9l1350t1058r1477b1101],
14	=	JJ	O	=	amod	16	SENT_125	[p9l1350t1058r1477b1101],
15	23	CD	NUMBER	23	num	16	SENT_125	[p9l1350t1058r1477b1101],
16	)	NN	O	)	dep	8	SENT_125	[p9l1350t1058r1477b1101],

1	Primary	JJ	O	primary	dep	100	SENT_126	[p9l72t1153r225b1198],
2	outcome	NN	O	outcome	dep	100	SENT_126	[p9l235t1157r410b1187],
3	Patients	NNS	O	patient	dep	100	SENT_126	[p9l72t1234r221b1266],
4	with	IN	O	with	dep	100	SENT_126	[p9l231t1230r313b1266],
5	PRU	NN	ORGANIZATION	pru	dep	100	SENT_126	[p9l329t1234r401b1266],
6	values	NNS	O	value	dep	100	SENT_126	[p9l414t1230r530b1266],
7	>	JJR	O	>	dep	100	SENT_126	[p9l543t1235r638b1271],
8	234	CD	NUMBER	234	dep	100	SENT_126	[p9l543t1235r638b1271],
9	at	IN	O	at	dep	100	SENT_126	[p9l649t1237r685b1266],
10	day	NN	DURATION	day	dep	100	SENT_126	[p9l695t1230r760b1277],
11	7	CD	NUMBER	7	dep	100	SENT_126	[p9l770t1236r791b1271],
12	o	NN	O	o	dep	100	SENT_126	[p9l897t1235r918b1266],
13	7	CD	PERCENT	7	dep	100	SENT_126	[p9l1404t1236r1425b1271],
14	(	CD	PERCENT	(	dep	100	SENT_126	[p9l1438t1232r1546b1275],
15	30	CD	PERCENT	30	dep	100	SENT_126	[p9l1438t1232r1546b1275],
16	%	NN	PERCENT	%	dep	100	SENT_126	[p9l1438t1232r1546b1275],
17	)	CD	NUMBER	)	dep	100	SENT_126	[p9l1438t1232r1546b1275],
18	0-0092	CD	NUMBER	0-0092	dep	100	SENT_126	[p9l1888t1235r2020b1271],
19	Secondary	JJ	O	secondary	dep	100	SENT_126	[p9l70t1310r274b1356],
20	outcomes	NNS	O	outcome	dep	100	SENT_126	[p9l284t1315r478b1345],
21	Patients	NNS	O	patient	dep	100	SENT_126	[p9l72t1392r221b1424],
22	with	IN	O	with	dep	100	SENT_126	[p9l231t1389r313b1424],
23	PRU	NN	ORGANIZATION	pru	dep	100	SENT_126	[p9l329t1392r401b1424],
24	values	NNS	O	value	dep	100	SENT_126	[p9l414t1389r530b1424],
25	>	JJR	O	>	dep	100	SENT_126	[p9l543t1388r638b1424],
26	208	CD	NUMBER	208	dep	100	SENT_126	[p9l543t1388r638b1424],
27	at	IN	O	at	dep	100	SENT_126	[p9l651t1395r686b1424],
28	day	NN	DURATION	day	dep	100	SENT_126	[p9l697t1389r762b1435],
29	7	CD	PERCENT	7	dep	100	SENT_126	[p9l773t1394r794b1429],
30	1	CD	PERCENT	1	dep	100	SENT_126	[p9l900t1394r919b1424],
31	(	NN	PERCENT	(	dep	100	SENT_126	[p9l932t1391r1017b1434],
32	4	CD	PERCENT	4	dep	100	SENT_126	[p9l932t1391r1017b1434],
33	%	NN	PERCENT	%	dep	100	SENT_126	[p9l932t1391r1017b1434],
34	)	CD	NUMBER	)	dep	100	SENT_126	[p9l932t1391r1017b1434],
35	11	CD	NUMBER	11	dep	100	SENT_126	[p9l1383t1394r1425b1424],
36	(	NN	O	(	dep	100	SENT_126	[p9l1438t1388r1550b1434],
37	48	CD	PERCENT	48	dep	100	SENT_126	[p9l1438t1388r1550b1434],
38	%	NN	PERCENT	%	dep	100	SENT_126	[p9l1438t1388r1550b1434],
39	)	CD	NUMBER	)	dep	100	SENT_126	[p9l1438t1388r1550b1434],
40	0-0017	CD	NUMBER	0-0017	dep	100	SENT_126	[p9l1888t1394r2017b1429],
41	Baseline	NNP	O	Baseline	dep	100	SENT_126	[p9l72t1468r222b1504],
42	PRU	NNP	O	PRU	dep	100	SENT_126	[p9l236t1471r308b1504],
43	198-7	CD	NUMBER	198-7	dep	100	SENT_126	[p9l847t1468r952b1509],
44	(	NN	O	(	dep	100	SENT_126	[p9l965t1468r1076b1513],
45	807	CD	NUMBER	807	dep	100	SENT_126	[p9l965t1468r1076b1513],
46	)	CD	NUMBER	)	dep	100	SENT_126	[p9l965t1468r1076b1513],
47	1987	CD	DATE	1987	dep	100	SENT_126	[p9l1352t1468r1459b1509],
48	(	NN	O	(	dep	100	SENT_126	[p9l1471t1470r1583b1513],
49	91-9	CD	NUMBER	91-9	dep	100	SENT_126	[p9l1471t1470r1583b1513],
50	)	CD	NUMBER	)	dep	100	SENT_126	[p9l1471t1470r1583b1513],
51	0-9986	CD	NUMBER	0-9986	dep	100	SENT_126	[p9l1888t1468r2026b1509],
52	PRU	NNP	O	PRU	dep	100	SENT_126	[p9l72t1550r144b1583],
53	at	IN	O	at	dep	100	SENT_126	[p9l158t1554r194b1583],
54	day7	CD	NUMBER	day7	dep	100	SENT_126	[p9l204t1547r301b1594],
55	75-6	CD	NUMBER	75-6	dep	100	SENT_126	[p9l874t1547r955b1588],
56	(	NN	O	(	dep	100	SENT_126	[p9l969t1549r1075b1592],
57	57-3	CD	NUMBER	57-3	dep	100	SENT_126	[p9l969t1549r1075b1592],
58	)	CD	NUMBER	)	dep	100	SENT_126	[p9l969t1549r1075b1592],
59	207-3	CD	NUMBER	207-3	dep	100	SENT_126	[p9l1356t1552r1458b1588],
60	(	NN	O	(	dep	100	SENT_126	[p9l1472t1547r1583b1592],
61	55-8	CD	NUMBER	55-8	dep	100	SENT_126	[p9l1472t1547r1583b1592],
62	)	NN	O	)	dep	100	SENT_126	[p9l1472t1547r1583b1592],
63	<	JJR	O	<	dep	100	SENT_126	[p9l1864t1552r2018b1583],
64	0-0001	CD	NUMBER	0-0001	dep	100	SENT_126	[p9l1864t1552r2018b1583],
65	Platelet	NN	O	platelet	dep	100	SENT_126	[p9l72t1626r210b1662],
66	inhibition	NN	O	inhibition	dep	100	SENT_126	[p9l223t1626r403b1662],
67	at	IN	O	at	dep	100	SENT_126	[p9l416t1633r452b1662],
68	day	NN	DURATION	day	dep	100	SENT_126	[p9l462t1626r527b1673],
69	7	CD	PERCENT	7	dep	100	SENT_126	[p9l538t1632r559b1667],
70	73-3	CD	PERCENT	73-3	dep	100	SENT_126	[p9l874t1631r986b1667],
71	%	NN	PERCENT	%	dep	100	SENT_126	[p9l874t1631r986b1667],
72	(	CD	NUMBER	(	dep	100	SENT_126	[p9l1000t1628r1109b1671],
73	20-3	CD	NUMBER	20-3	dep	100	SENT_126	[p9l1000t1628r1109b1671],
74	)	NN	O	)	dep	100	SENT_126	[p9l1000t1628r1109b1671],
75	27-0	CD	PERCENT	27-0	dep	100	SENT_126	[p9l1382t1631r1494b1667],
76	%	NN	PERCENT	%	dep	100	SENT_126	[p9l1382t1631r1494b1667],
77	(	CD	NUMBER	(	dep	100	SENT_126	[p9l1508t1628r1616b1671],
78	13-4	CD	NUMBER	13-4	dep	100	SENT_126	[p9l1508t1628r1616b1671],
79	)	NN	O	)	dep	100	SENT_126	[p9l1508t1628r1616b1671],
80	<	JJR	O	<	dep	100	SENT_126	[p9l1864t1631r2018b1662],
81	0-0001	CD	NUMBER	0-0001	dep	100	SENT_126	[p9l1864t1631r2018b1662],
82	Change	NNP	O	Change	dep	100	SENT_126	[p9l71t1705r209b1753],
83	in	IN	O	in	dep	100	SENT_126	[p9l223t1708r253b1741],
84	PRU	NNP	ORGANIZATION	PRU	dep	100	SENT_126	[p9l269t1709r341b1741],
85	from	IN	O	from	dep	100	SENT_126	[p9l354t1705r444b1741],
86	baseline	NN	O	baseline	dep	100	SENT_126	[p9l459t1705r608b1741],
87	to	TO	O	to	dep	100	SENT_126	[p9l617t1712r657b1741],
88	day	NN	DURATION	day	dep	100	SENT_126	[p9l668t1705r733b1752],
89	7	CD	NUMBER	7	dep	100	SENT_126	[p9l743t1711r765b1746],
90	123-09	CD	NUMBER	123-09	dep	100	SENT_126	[p9l852t1710r980b1746],
91	(	NN	O	(	dep	100	SENT_126	[p9l995t1707r1100b1750],
92	772	CD	NUMBER	772	dep	100	SENT_126	[p9l995t1707r1100b1750],
93	)	CD	NUMBER	)	dep	100	SENT_126	[p9l995t1707r1100b1750],
94	-8	CD	NUMBER	-8	dep	100	SENT_126	[p9l1381t1705r1487b1746],
95	-48	CD	NUMBER	-48	dep	100	SENT_126	[p9l1381t1705r1487b1746],
96	(	CD	NUMBER	(	dep	100	SENT_126	[p9l1501t1707r1609b1750],
97	74-0	CD	NUMBER	74-0	dep	100	SENT_126	[p9l1501t1707r1609b1750],
98	)	NN	O	)	dep	100	SENT_126	[p9l1501t1707r1609b1750],
99	<	JJR	O	<	dep	100	SENT_126	[p9l1864t1710r2018b1741],
100	0-0001	CD	NUMBER	0-0001	_	0	SENT_126	[p9l1864t1710r2018b1741],

1	Data	NNS	O	datum	nsubj	8	SENT_127	[p9l52t1826r129b1856],
2	are	VBP	O	be	cop	3	SENT_127	[p9l140t1834r192b1856],
3	n	NN	O	n	_	0	SENT_127	[p9l205t1834r222b1856],
4	(	CD	PERCENT	(	num	5	SENT_127	[p9l236t1825r291b1865],
5	%	NN	PERCENT	%	dep	3	SENT_127	[p9l236t1825r291b1865],
6	)	CD	NUMBER	)	dep	5	SENT_127	[p9l236t1825r291b1865],
7	or	CC	O	or	_	0	SENT_127	[p9l302t1834r338b1856],
8	mean	VB	O	mean	conj_or	3	SENT_127	[p9l349t1834r443b1856],
9	(	JJ	O	(	amod	11	SENT_127	[p9l457t1825r538b1865],
10	SD	NN	O	sd	nn	11	SENT_127	[p9l457t1825r538b1865],
11	)	NN	O	)	dobj	8	SENT_127	[p9l457t1825r538b1865],
12	.	.	O	.	_	0	SENT_127	[p9l457t1825r538b1865],

1	PRU	NN	ORGANIZATION	pru	_	0	SENT_128	[p9l552t1826r753b1856],
2	=	JJ	O	=	amod	5	SENT_128	[p9l552t1826r753b1856],
3	P2Y12	NN	O	p2y12	nn	5	SENT_128	[p9l552t1826r753b1856],
4	reactivity	NN	O	reactivity	nn	5	SENT_128	[p9l768t1825r926b1866],
5	unit	NN	O	unit	dep	1	SENT_128	[p9l937t1825r1014b1856],
6	.	.	O	.	_	0	SENT_128	[p9l937t1825r1014b1856],

1	Table	NNP	O	Table	_	0	SENT_129	[p9l50t1933r148b1969],
2	2	CD	NUMBER	2	num	1	SENT_129	[p9l158t1938r192b1969],
3	:	:	O	:	_	0	SENT_129	[p9l158t1938r192b1969],
4	Primary	JJ	O	primary	amod	7	SENT_129	[p9l205t1935r359b1980],
5	and	CC	O	and	_	0	SENT_129	[p9l369t1933r442b1969],
6	secondary	JJ	O	secondary	amod	7	SENT_129	[p9l454t1933r654b1980],
7	outcomes	NNS	O	outcome	dep	1	SENT_129	[p9l663t1939r858b1969],
8	in	IN	O	in	_	0	SENT_129	[p9l870t1935r904b1969],
9	CYP2C19	NN	O	cyp2c19	nn	10	SENT_129	[p9l917t1935r1134b1974],
10	*	NN	O	*	prep_in	7	SENT_129	[p9l917t1935r1134b1974],
11	2	CD	NUMBER	2	num	12	SENT_129	[p9l917t1935r1134b1974],
12	carriers	NNS	O	carrier	dep	7	SENT_129	[p9l1147t1935r1289b1969],

1	A	DT	O	a	det	4	SENT_130	[p9l144t2093r179b2132],
2	Rapid	JJ	ORGANIZATION	rapid	amod	4	SENT_130	[p9l271t2101r373b2145],
3	Standard	JJ	ORGANIZATION	standard	amod	4	SENT_130	[p9l579t2101r746b2135],
4	B	NN	ORGANIZATION	b	_	0	SENT_130	[p9l831t2095r857b2134],
5	Rapid	JJ	ORGANIZATION	rapid	amod	7	SENT_130	[p9l941t2101r1042b2145],
6	Standard	JJ	ORGANIZATION	standard	amod	7	SENT_130	[p9l1249t2101r1415b2135],
7	C	NN	ORGANIZATION	c	dep	4	SENT_130	[p9l1487t2095r1514b2135],
8	Rapid	JJ	ORGANIZATION	rapid	amod	10	SENT_130	[p9l1600t2101r1702b2145],
9	Standard	JJ	ORGANIZATION	standard	amod	10	SENT_130	[p9l1908t2101r2074b2135],
10	genotyping	NN	O	genotyping	dep	7	SENT_130	[p9l214t2157r427b2200],
11	treatment	NN	O	treatment	nn	15	SENT_130	[p9l566t2161r757b2189],
12	genotyping	NN	O	genotyping	nn	15	SENT_130	[p9l884t2157r1096b2200],
13	treatment	NN	O	treatment	nn	15	SENT_130	[p9l1236t2161r1427b2189],
14	genotyping	NN	O	genotyping	nn	15	SENT_130	[p9l1543t2157r1756b2200],
15	treatment	NN	O	treatment	dep	4	SENT_130	[p9l1895t2161r2086b2189],

1	300	CD	NUMBER	300	num	2	SENT_131	[p9l112t2246r179b2280],
2	p	NN	O	p	_	0	SENT_131	[p9l410t2230r574b2269],
3	=	JJ	O	=	amod	5	SENT_131	[p9l410t2230r574b2269],
4	O-0137	NN	O	o-0137	nn	5	SENT_131	[p9l410t2230r574b2269],
5	p	NN	O	p	dep	2	SENT_131	[p9l1077t2225r1247b2269],
6	=	JJ	O	=	amod	8	SENT_131	[p9l1077t2225r1247b2269],
7	O-9827	NN	O	o-9827	nn	8	SENT_131	[p9l1077t2225r1247b2269],
8	p	NN	O	p	dep	9	SENT_131	[p9l1737t2230r1905b2269],
9	<	JJR	O	<	dep	5	SENT_131	[p9l1737t2230r1905b2269],
10	O-0001	CD	NUMBER	o-0001	dep	2	SENT_131	[p9l1737t2230r1905b2269],

1	D	NN	O	d	_	0	SENT_132	[p9l47t2385r77b2407],
2	200	CD	MONEY	200	num	1	SENT_132	[p9l113t2350r179b2379],
3	$	$	PERCENT	$	amod	1	SENT_132	[p9l1598t2276r1637b2447],
4	%	JJ	PERCENT	%	dep	3	SENT_132	[p9l1873t2275r1912b2447],
5	§	CD	NUMBER	§	num	6	SENT_132	[p9l2014t2292r2053b2413],
6	E	NN	O	e	dep	1	SENT_132	[p9l47t2411r77b2453],
7	100	CD	PERCENT	100	number	8	SENT_132	[p9l114t2453r179b2482],
8	%	NN	PERCENT	%	amod	9	SENT_132	[p9l402t2350r441b2517],
9	¥	NN	O	¥	dep	6	SENT_132	[p9l1731t2416r1769b2548],

1	.	.	O	.	_	0	SENT_133	[p9l238t2624r243b2629],

1	’	NN	O	’	_	0	SENT_134	[p9l407t2593r433b2627],
2	\	NN	O	\	dep	1	SENT_134	[p9l407t2593r433b2627],
3	.	.	O	.	_	0	SENT_134	[p9l529t2624r534b2629],

1	’	NN	O	’	_	0	SENT_135	[p9l688t2593r715b2627],
2	\	NN	O	\	dep	1	SENT_135	[p9l688t2593r715b2627],
3	.	.	O	.	_	0	SENT_135	[p9l911t2624r916b2629],

1	’	NN	O	’	_	0	SENT_136	[p9l1080t2593r1107b2627],
2	\	NN	O	\	dep	1	SENT_136	[p9l1080t2593r1107b2627],
3	.	.	O	.	_	0	SENT_136	[p9l1203t2624r1207b2629],

1	’	NN	O	’	_	0	SENT_137	[p9l1362t2593r1388b2627],
2	\	NN	O	\	dep	1	SENT_137	[p9l1362t2593r1388b2627],
3	.	.	O	.	_	0	SENT_137	[p9l1580t2624r1585b2629],

1	’	NN	O	’	_	0	SENT_138	[p9l1749t2593r1775b2627],
2	\	NN	O	\	dep	1	SENT_138	[p9l1749t2593r1775b2627],
3	.	.	O	.	_	0	SENT_138	[p9l1871t2624r1876b2629],

1	’	NN	O	’	dep	7	SENT_139	[p9l2031t2593r2057b2627],
2	\	CD	NUMBER	\	num	1	SENT_139	[p9l2031t2593r2057b2627],
3	$	$	MONEY	$	dep	1	SENT_139	[p9l198t2601r292b2693],
4	\	CD	MONEY	\	num	3	SENT_139	[p9l198t2601r292b2693],
5	~	NN	O	~	dep	7	SENT_139	[p9l198t2601r292b2693],
6	“	CD	NUMBER	“	num	5	SENT_139	[p9l198t2601r292b2693],
7	®	CD	NUMBER	®	dep	12	SENT_139	[p9l198t2601r292b2693],
8	Q	NNP	O	Q	dep	7	SENT_139	[p9l355t2618r416b2677],
9	»	CD	NUMBER	»	num	8	SENT_139	[p9l355t2618r416b2677],
10	:	:	O	:	_	0	SENT_139	[p9l355t2618r416b2677],
11	-4	CD	NUMBER	-4	num	12	SENT_139	[p9l355t2618r416b2677],
12	»	CD	NUMBER	»	_	0	SENT_139	[p9l355t2618r416b2677],
13	?	.	O	?	_	0	SENT_139	[p9l489t2601r583b2693],

1	$	$	MONEY	$	_	0	SENT_140	[p9l489t2601r583b2693],
2	§	CD	MONEY	§	num	1	SENT_140	[p9l489t2601r583b2693],
3	\	CD	MONEY	\	number	4	SENT_140	[p9l489t2601r583b2693],
4	°	CD	MONEY	°	num	7	SENT_140	[p9l489t2601r583b2693],
5	Q	NNP	O	Q	poss	7	SENT_140	[p9l489t2601r583b2693],
6	'	POS	O	'	_	0	SENT_140	[p9l489t2601r583b2693],
7	Q7	NN	O	q7	dep	1	SENT_140	[p9l636t2618r698b2677],
8	?	.	O	?	_	0	SENT_140	[p9l636t2618r698b2677],
9	)	SYM	O	)	dep	1	SENT_140	[p9l636t2618r698b2677],

1	$	$	MONEY	$	_	0	SENT_141	[p9l871t2601r966b2693],
2	\	CD	MONEY	\	num	1	SENT_141	[p9l871t2601r966b2693],
3	\	CD	MONEY	\	number	4	SENT_141	[p9l871t2601r966b2693],
4	°	CD	MONEY	°	num	5	SENT_141	[p9l871t2601r966b2693],
5	Q	NNP	O	Q	dep	1	SENT_141	[p9l871t2601r966b2693],
6	'	POS	DATE	'	_	0	SENT_141	[p9l871t2601r966b2693],
7	97	CD	DATE	97	num	5	SENT_141	[p9l1028t2618r1089b2677],
8	;	:	O	;	_	0	SENT_141	[p9l1028t2618r1089b2677],
9	)	CD	NUMBER	)	dep	1	SENT_141	[p9l1028t2618r1089b2677],
10	Q	NNP	O	Q	dep	9	SENT_141	[p9l1162t2601r1257b2694],
11	?	.	O	?	_	0	SENT_141	[p9l1162t2601r1257b2694],

1	®	NN	O	®	nn	3	SENT_142	[p9l1162t2601r1257b2694],
2	\	CD	NUMBER	\	num	3	SENT_142	[p9l1162t2601r1257b2694],
3	\	NN	O	\	_	0	SENT_142	[p9l1162t2601r1257b2694],
4	°	CD	NUMBER	°	number	5	SENT_142	[p9l1162t2601r1257b2694],
5	®	CD	NUMBER	®	dep	3	SENT_142	[p9l1162t2601r1257b2694],
6	Q	NNP	O	Q	dep	5	SENT_142	[p9l1309t2618r1371b2677],
7	»	CD	NUMBER	»	number	8	SENT_142	[p9l1309t2618r1371b2677],
8	)	CD	NUMBER	)	dep	3	SENT_142	[p9l1309t2618r1371b2677],
9	§	NN	O	§	dep	8	SENT_142	[p9l1540t2601r1634b2694],
10	.	.	O	.	_	0	SENT_142	[p9l1540t2601r1634b2694],

1	§	RB	O	§	amod	3	SENT_143	[p9l1540t2601r1634b2694],
2	\	CD	NUMBER	\	tmod	1	SENT_143	[p9l1540t2601r1634b2694],
3	°	CD	NUMBER	°	_	0	SENT_143	[p9l1540t2601r1634b2694],
4	°	NN	O	°	dep	3	SENT_143	[p9l1540t2601r1634b2694],
5	'	''	O	'	_	0	SENT_143	[p9l1540t2601r1634b2694],
6	9	CD	PERCENT	9	number	7	SENT_143	[p9l1697t2618r1758b2677],
7	%	NN	PERCENT	%	amod	4	SENT_143	[p9l1697t2618r1758b2677],
8	’	CD	NUMBER	’	dep	3	SENT_143	[p9l1831t2601r1925b2694],
9	$	$	MONEY	$	dep	8	SENT_143	[p9l1831t2601r1925b2694],
10	°	CD	MONEY	°	num	9	SENT_143	[p9l1831t2601r1925b2694],
11	.	.	O	.	_	0	SENT_143	[p9l1831t2601r1925b2694],

1	§	NN	O	§	_	0	SENT_144	[p9l1831t2601r1925b2694],
2	\	SYM	O	\	dep	3	SENT_144	[p9l1831t2601r1925b2694],
3	°	CD	NUMBER	°	ccomp	1	SENT_144	[p9l1831t2601r1925b2694],
4	?	.	O	?	_	0	SENT_144	[p9l1831t2601r1925b2694],
5	'	''	O	'	_	0	SENT_144	[p9l1831t2601r1925b2694],

1	923	CD	NUMBER	923	number	2	SENT_145	[p9l1978t2618r2040b2677],
2	»	CD	NUMBER	»	num	4	SENT_145	[p9l1978t2618r2040b2677],
3	‘	NN	O	‘	nn	4	SENT_145	[p9l174t2680r205b2710],
4	b	NN	O	b	npadvmod	5	SENT_145	[p9l174t2680r205b2710],
5	<	JJR	O	<	amod	12	SENT_145	[p9l465t2680r496b2710],
6	17	CD	NUMBER	17	npadvmod	7	SENT_145	[p9l465t2680r496b2710],
7	<	JJR	O	<	dep	5	SENT_145	[p9l848t2680r878b2710],
8	2	CD	NUMBER	2	num	9	SENT_145	[p9l848t2680r878b2710],
9	)	NN	O	)	npadvmod	10	SENT_145	[p9l848t2680r878b2710],
10	<	JJR	O	<	dep	7	SENT_145	[p9l1139t2680r1169b2710],
11	2	CD	NUMBER	2	dep	5	SENT_145	[p9l1139t2680r1169b2710],
12	)	NN	O	)	_	0	SENT_145	[p9l1139t2680r1169b2710],
13	<	JJR	O	<	dep	12	SENT_145	[p9l1516t2680r1547b2710],
14	17	CD	NUMBER	17	num	15	SENT_145	[p9l1516t2680r1547b2710],
15	<	JJR	O	<	dep	12	SENT_145	[p9l1808t2680r1838b2710],
16	17	CD	NUMBER	17	dep	15	SENT_145	[p9l1808t2680r1838b2710],

1	Figure	NN	O	figure	_	0	SENT_146	[p9l8t2782r122b2828],
2	2	CD	NUMBER	2	num	1	SENT_146	[p9l132t2786r166b2817],
3	:	:	O	:	_	0	SENT_146	[p9l132t2786r166b2817],
4	PRU	NNP	ORGANIZATION	PRU	nn	5	SENT_146	[p9l179t2784r256b2817],
5	values	NNS	O	value	dep	1	SENT_146	[p9l269t2781r392b2817],
6	at	IN	O	at	_	0	SENT_146	[p9l403t2787r443b2817],
7	baseline	NN	O	baseline	prep_at	5	SENT_146	[p9l455t2781r613b2817],
8	and	CC	O	and	_	0	SENT_146	[p9l625t2781r698b2817],
9	at	IN	O	at	_	0	SENT_146	[p9l709t2787r749b2817],
10	day	NN	DURATION	day	conj_and	7	SENT_146	[p9l759t2781r829b2827],
11	7	CD	NUMBER	7	num	12	SENT_146	[p9l840t2786r862b2821],
12	Values	NNS	O	value	dep	5	SENT_146	[p9l8t2842r127b2878],
13	given	VBN	O	give	partmod	5	SENT_146	[p9l139t2845r239b2889],
14	forthe	JJ	O	forthe	amod	16	SENT_146	[p9l251t2842r374b2878],
15	whole	JJ	O	whole	amod	16	SENT_146	[p9l385t2842r498b2878],
16	cohort	NN	O	cohort	iobj	13	SENT_146	[p9l510t2842r632b2878],
17	(	NN	O	(	nn	19	SENT_146	[p9l645t2844r710b2887],
18	A	NN	O	a	nn	19	SENT_146	[p9l645t2844r710b2887],
19	)	NN	O	)	dobj	13	SENT_146	[p9l645t2844r710b2887],
20	,	,	O	,	_	0	SENT_146	[p9l645t2844r710b2887],
21	non	JJ	O	non	amod	23	SENT_146	[p9l725t2845r947b2878],
22	—	NN	O	—	nn	23	SENT_146	[p9l725t2845r947b2878],
23	carriers	NNS	O	carrier	conj_and	19	SENT_146	[p9l725t2845r947b2878],
24	of	IN	O	of	_	0	SENT_146	[p9l958t2842r998b2878],
25	CYP2C19	NN	O	cyp2c19	nn	26	SENT_146	[p9l1007t2843r1215b2883],
26	*	NN	O	*	prep_of	23	SENT_146	[p9l1007t2843r1215b2883],
27	2	CD	NUMBER	2	num	30	SENT_146	[p9l1007t2843r1215b2883],
28	(	NN	O	(	nn	30	SENT_146	[p9l1228t2844r1290b2887],
29	B	NN	O	b	nn	30	SENT_146	[p9l1228t2844r1290b2887],
30	)	NN	O	)	dep	23	SENT_146	[p9l1228t2844r1290b2887],
31	,	,	O	,	_	0	SENT_146	[p9l1228t2844r1290b2887],
32	and	CC	O	and	_	0	SENT_146	[p9l1303t2842r1372b2878],
33	carriers	NNS	O	carrier	dobj	13	SENT_146	[p9l1383t2845r1516b2878],
34	of	IN	O	of	_	0	SENT_146	[p9l1527t2842r1567b2878],
35	CYP2C19	NN	O	cyp2c19	nn	36	SENT_146	[p9l1576t2843r1784b2883],
36	*	NN	O	*	prep_of	33	SENT_146	[p9l1576t2843r1784b2883],
37	2	CD	NUMBER	2	num	40	SENT_146	[p9l1576t2843r1784b2883],
38	(	NN	O	(	nn	40	SENT_146	[p9l1797t2844r1859b2887],
39	C	NN	O	c	nn	40	SENT_146	[p9l1797t2844r1859b2887],
40	)	NN	O	)	dep	33	SENT_146	[p9l1797t2844r1859b2887],
41	.	.	O	.	_	0	SENT_146	[p9l1797t2844r1859b2887],

1	p	NN	O	p	nn	2	SENT_147	[p9l1872t2854r1894b2888],
2	values	NNS	O	value	nsubj	3	SENT_147	[p9l1905t2842r2021b2878],
3	correspond	VBP	O	correspond	_	0	SENT_147	[p9l9t2902r217b2948],
4	to	TO	O	to	_	0	SENT_147	[p9l226t2909r266b2938],
5	analyses	NNS	O	analysis	prep_to	3	SENT_147	[p9l278t2902r432b2948],
6	for	IN	O	for	_	0	SENT_147	[p9l443t2902r497b2938],
7	comparison	NN	O	comparison	prep_for	5	SENT_147	[p9l508t2905r725b2948],
8	of	IN	O	of	_	0	SENT_147	[p9l738t2902r778b2938],
9	change	NN	O	change	prep_of	7	SENT_147	[p9l787t2902r919b2949],
10	in	IN	O	in	_	0	SENT_147	[p9l933t2905r964b2937],
11	platelet	NN	O	platelet	nn	12	SENT_147	[p9l977t2902r1118b2948],
12	reactivity	NN	O	reactivity	prep_in	9	SENT_147	[p9l1131t2905r1302b2948],
13	from	IN	O	from	_	0	SENT_147	[p9l1311t2902r1402b2938],
14	baseline	NN	O	baseline	prep_from	12	SENT_147	[p9l1416t2902r1566b2938],
15	to	TO	O	to	_	0	SENT_147	[p9l1575t2908r1614b2938],
16	day	NN	DURATION	day	prep_to	3	SENT_147	[p9l1626t2902r1691b2948],
17	7	CD	NUMBER	7	num	16	SENT_147	[p9l1701t2907r1722b2942],
18	between	IN	O	between	_	0	SENT_147	[p9l1735t2902r1893b2938],
19	rapid	JJ	O	rapid	amod	20	SENT_147	[p9l1909t2902r2001b2948],
20	genotyping	NN	O	genotyping	prep_between	16	SENT_147	[p9l9t2965r222b3009],
21	and	CC	O	and	_	0	SENT_147	[p9l236t2962r304b2998],
22	standard	JJ	O	standard	amod	24	SENT_147	[p9l316t2962r479b2998],
23	treatment	NN	O	treatment	nn	24	SENT_147	[p9l489t2969r680b2998],
24	groups	NNS	O	group	conj_and	20	SENT_147	[p9l692t2974r829b3009],
25	.	.	O	.	_	0	SENT_147	[p9l692t2974r829b3009],

1	PRU	NN	ORGANIZATION	pru	_	0	SENT_148	[p9l844t2965r1061b2998],
2	=	JJ	O	=	amod	5	SENT_148	[p9l844t2965r1061b2998],
3	P2Y12	NN	O	p2y12	nn	5	SENT_148	[p9l844t2965r1061b2998],
4	reactivity	NN	O	reactivity	nn	5	SENT_148	[p9l1076t2965r1247b3008],
5	units	NNS	O	unit	dep	1	SENT_148	[p9l1258t2965r1359b2998],
6	.	.	O	.	_	0	SENT_148	[p9l1258t2965r1359b2998],

1	Rapid	JJ	O	rapid	amod	2	SENT_149	[p10l845t89r955b136],
2	genotyping	NN	O	genotyping	dep	10	SENT_149	[p10l966t91r1195b137],
3	Standard	NNP	O	Standard	nn	5	SENT_149	[p10l1239t89r1418b125],
4	p	NN	O	p	nn	5	SENT_149	[p10l1633t101r1657b136],
5	value	NN	O	value	dep	2	SENT_149	[p10l1668t89r1792b125],
6	*	CD	NUMBER	*	num	7	SENT_149	[p10l1668t89r1792b125],
7	p	NN	O	p	dep	10	SENT_149	[p10l1878t101r1902b136],
8	valuei	FW	O	valuei	nn	10	SENT_149	[p10l1913t89r2040b128],
9	(	FW	O	(	nn	10	SENT_149	[p10l844t151r973b194],
10	n	NN	O	n	dep	19	SENT_149	[p10l844t151r973b194],
11	=	JJ	O	=	amod	14	SENT_149	[p10l844t151r973b194],
12	91	CD	NUMBER	91	tmod	11	SENT_149	[p10l844t151r973b194],
13	)	NN	O	)	nn	14	SENT_149	[p10l844t151r973b194],
14	treatment	NN	O	treatment	dep	10	SENT_149	[p10l1237t155r1442b185],
15	(	CD	NUMBER	(	num	16	SENT_149	[p10l1454t149r1588b194],
16	n	NN	O	n	npadvmod	17	SENT_149	[p10l1454t149r1588b194],
17	=	JJ	O	=	amod	14	SENT_149	[p10l1454t149r1588b194],
18	96	CD	NUMBER	96	num	19	SENT_149	[p10l1454t149r1588b194],
19	)	NN	O	)	_	0	SENT_149	[p10l1454t149r1588b194],

1	Baseline	NN	O	baseline	_	0	SENT_150	[p10l72t244r222b280],
2	PRU	NNP	O	PRU	dep	1	SENT_150	[p10l236t247r308b280],
3	1547	CD	DATE	1547	num	2	SENT_150	[p10l850t249r952b285],
4	(	CD	NUMBER	(	number	5	SENT_150	[p10l965t244r1080b289],
5	98.0	CD	NUMBER	98.0	num	6	SENT_150	[p10l965t244r1080b289],
6	)	NN	O	)	dep	2	SENT_150	[p10l965t244r1080b289],
7	160.2	CD	NUMBER	160.2	number	8	SENT_150	[p10l1243t244r1347b280],
8	(	CD	NUMBER	(	num	6	SENT_150	[p10l1362t246r1490b289],
9	1017	CD	DATE	1017	number	10	SENT_150	[p10l1362t246r1490b289],
10	)	CD	NUMBER	)	dep	87	SENT_150	[p10l1362t246r1490b289],
11	07098	CD	NUMBER	07098	number	12	SENT_150	[p10l1634t244r1767b285],
12	0.2646	CD	NUMBER	0.2646	num	13	SENT_150	[p10l1911t244r2046b285],
13	PRU	NNP	ORGANIZATION	PRU	npadvmod	87	SENT_150	[p10l72t327r144b359],
14	at	IN	O	at	_	0	SENT_150	[p10l158t330r194b359],
15	day	NN	DURATION	day	prep_at	13	SENT_150	[p10l204t323r270b370],
16	7	CD	NUMBER	7	num	15	SENT_150	[p10l279t328r301b363],
17	12	CD	NUMBER	12	num	19	SENT_150	[p10l852t328r893b358],
18	5-3	CD	NUMBER	5-3	num	19	SENT_150	[p10l898t328r952b364],
19	(	NN	O	(	dep	27	SENT_150	[p10l966t323r1075b368],
20	74.8	CD	NUMBER	74.8	number	21	SENT_150	[p10l966t323r1075b368],
21	)	CD	NUMBER	)	dep	19	SENT_150	[p10l966t323r1075b368],
22	1639	CD	DATE	1639	num	23	SENT_150	[p10l1245t323r1350b364],
23	(	NN	O	(	dep	21	SENT_150	[p10l1365t323r1476b368],
24	784	CD	NUMBER	784	num	25	SENT_150	[p10l1365t323r1476b368],
25	)	NN	O	)	dep	27	SENT_150	[p10l1365t323r1476b368],
26	00007	CD	NUMBER	00007	num	27	SENT_150	[p10l1635t328r1767b363],
27	<	JJR	O	<	dep	44	SENT_150	[p10l1888t328r2043b359],
28	0-0001	CD	NUMBER	0-0001	num	29	SENT_150	[p10l1888t328r2043b359],
29	Patients	NNS	O	patient	npadvmod	33	SENT_150	[p10l72t405r221b438],
30	with	IN	O	with	_	0	SENT_150	[p10l231t402r313b438],
31	PRU	NN	ORGANIZATION	pru	nn	32	SENT_150	[p10l329t406r401b438],
32	values	NNS	O	value	prep_with	29	SENT_150	[p10l414t402r530b438],
33	>	JJR	O	>	amod	39	SENT_150	[p10l543t407r637b443],
34	234	CD	NUMBER	234	dep	33	SENT_150	[p10l543t407r637b443],
35	at	IN	O	at	dep	34	SENT_150	[p10l648t409r685b438],
36	day	NN	DURATION	day	pobj	35	SENT_150	[p10l695t402r760b449],
37	7	CD	PERCENT	7	number	38	SENT_150	[p10l770t408r791b443],
38	9	CD	PERCENT	9	amod	39	SENT_150	[p10l896t407r917b443],
39	(	NN	PERCENT	(	dep	27	SENT_150	[p10l932t404r1039b447],
40	10	CD	PERCENT	10	number	41	SENT_150	[p10l932t404r1039b447],
41	%	NN	PERCENT	%	amod	39	SENT_150	[p10l932t404r1039b447],
42	)	CD	NUMBER	)	number	43	SENT_150	[p10l932t404r1039b447],
43	16	CD	NUMBER	16	num	44	SENT_150	[p10l1268t402r1313b438],
44	(	NN	O	(	dep	50	SENT_150	[p10l1327t404r1431b447],
45	17	CD	PERCENT	17	num	46	SENT_150	[p10l1327t404r1431b447],
46	%	NN	PERCENT	%	dep	44	SENT_150	[p10l1327t404r1431b447],
47	)	CD	NUMBER	)	num	50	SENT_150	[p10l1327t404r1431b447],
48	0-1735	CD	NUMBER	0-1735	num	50	SENT_150	[p10l1635t407r1758b443],
49	0-0672	CD	NUMBER	0-0672	num	50	SENT_150	[p10l1911t402r2041b443],
50	Patients	NNS	O	patient	dep	54	SENT_150	[p10l72t485r221b517],
51	with	IN	O	with	_	0	SENT_150	[p10l231t481r313b517],
52	PRU	NN	ORGANIZATION	pru	nn	53	SENT_150	[p10l329t485r401b517],
53	values	NNS	O	value	prep_with	50	SENT_150	[p10l414t481r530b517],
54	>	JJR	O	>	dep	60	SENT_150	[p10l543t481r638b517],
55	208	CD	NUMBER	208	dep	54	SENT_150	[p10l543t481r638b517],
56	at	IN	O	at	_	0	SENT_150	[p10l651t488r686b517],
57	day	NN	DURATION	day	prep_at	55	SENT_150	[p10l697t481r762b528],
58	7	CD	PERCENT	7	num	57	SENT_150	[p10l773t487r794b522],
59	14	CD	PERCENT	14	num	60	SENT_150	[p10l874t487r919b522],
60	(	NN	PERCENT	(	dep	62	SENT_150	[p10l932t484r1037b527],
61	15	CD	PERCENT	15	num	62	SENT_150	[p10l932t484r1037b527],
62	%	NN	PERCENT	%	dep	68	SENT_150	[p10l932t484r1037b527],
63	)	CD	NUMBER	)	number	64	SENT_150	[p10l932t484r1037b527],
64	30	CD	NUMBER	30	num	65	SENT_150	[p10l1268t487r1314b522],
65	(	NN	O	(	dep	62	SENT_150	[p10l1327t483r1432b527],
66	31	CD	PERCENT	31	num	67	SENT_150	[p10l1327t483r1432b527],
67	%	NN	PERCENT	%	dep	65	SENT_150	[p10l1327t483r1432b527],
68	)	CD	NUMBER	)	dep	72	SENT_150	[p10l1327t483r1432b527],
69	0-0106	CD	NUMBER	0-0106	num	72	SENT_150	[p10l1635t481r1766b517],
70	O-0008	NN	O	o-0008	nn	72	SENT_150	[p10l1911t481r2045b517],
71	Platelet	NN	O	platelet	nn	72	SENT_150	[p10l72t561r210b596],
72	inhibition	NN	O	inhibition	dep	77	SENT_150	[p10l223t561r403b596],
73	at	IN	O	at	_	0	SENT_150	[p10l416t567r452b596],
74	day	NN	DURATION	day	prep_at	72	SENT_150	[p10l462t561r527b607],
75	7	CD	PERCENT	7	num	77	SENT_150	[p10l538t566r559b601],
76	56-5	CD	PERCENT	56-5	num	77	SENT_150	[p10l871t560r986b602],
77	%	NN	PERCENT	%	dep	85	SENT_150	[p10l871t560r986b602],
78	(	CD	NUMBER	(	num	80	SENT_150	[p10l1000t562r1110b606],
79	24-5	CD	NUMBER	24-5	num	80	SENT_150	[p10l1000t562r1110b606],
80	)	NN	O	)	dep	77	SENT_150	[p10l1000t562r1110b606],
81	43-9	CD	PERCENT	43-9	num	82	SENT_150	[p10l1267t565r1385b602],
82	%	NN	PERCENT	%	dep	80	SENT_150	[p10l1267t565r1385b602],
83	(	CD	NUMBER	(	number	84	SENT_150	[p10l1399t562r1508b606],
84	22-9	CD	NUMBER	22-9	num	82	SENT_150	[p10l1399t562r1508b606],
85	)	NN	O	)	dep	13	SENT_150	[p10l1399t562r1508b606],
86	0-0003	CD	NUMBER	0-0003	num	85	SENT_150	[p10l1635t565r1766b602],
87	<	JJR	O	<	amod	6	SENT_150	[p10l1888t566r2043b596],
88	0-0001	CD	NUMBER	0-0001	dep	1	SENT_150	[p10l1888t566r2043b596],

1	Data	NNS	O	datum	nsubj	6	SENT_151	[p10l52t681r129b711],
2	are	VBP	O	be	cop	6	SENT_151	[p10l140t689r192b711],
3	mean	JJ	O	mean	amod	6	SENT_151	[p10l205t689r298b711],
4	(	JJ	O	(	amod	6	SENT_151	[p10l312t680r383b720],
5	SD	NN	O	sd	nn	6	SENT_151	[p10l312t680r383b720],
6	)	NN	O	)	_	0	SENT_151	[p10l312t680r383b720],
7	or	CC	O	or	_	0	SENT_151	[p10l395t689r430b711],
8	n	NN	O	n	conj_or	6	SENT_151	[p10l442t689r460b711],
9	(	CD	PERCENT	(	num	10	SENT_151	[p10l473t680r538b720],
10	%	NN	PERCENT	%	dep	8	SENT_151	[p10l473t680r538b720],
11	)	CD	NUMBER	)	dep	8	SENT_151	[p10l473t680r538b720],
12	.	.	O	.	_	0	SENT_151	[p10l473t680r538b720],

1	PRU	NN	ORGANIZATION	pru	_	0	SENT_152	[p10l552t681r753b711],
2	=	JJ	O	=	amod	5	SENT_152	[p10l552t681r753b711],
3	P2Y12	NN	O	p2y12	nn	5	SENT_152	[p10l552t681r753b711],
4	reactivity	NN	O	reactivity	nn	5	SENT_152	[p10l768t681r926b722],
5	unit	NN	O	unit	dep	1	SENT_152	[p10l937t681r1014b711],
6	.	.	O	.	_	0	SENT_152	[p10l937t681r1014b711],

1	*	NN	O	*	_	0	SENT_153	[p10l1027t678r1243b722],
2	Unadjusted	JJ	O	unadjusted	amod	4	SENT_153	[p10l1027t678r1243b722],
3	p	NN	O	p	nn	4	SENT_153	[p10l1254t689r1274b721],
4	value	NN	O	value	dep	1	SENT_153	[p10l1285t678r1384b711],
5	.	.	O	.	_	0	SENT_153	[p10l1285t678r1384b711],

1	Tp	NN	O	tp	nn	2	SENT_154	[p10l1398t680r1437b721],
2	value	NN	O	value	nsubj	11	SENT_154	[p10l1447t678r1538b711],
3	based	VBN	O	base	_	0	SENT_154	[p10l1550t678r1648b711],
4	on	IN	O	on	_	0	SENT_154	[p10l1658t689r1701b711],
5	imputation	NN	O	imputation	nn	6	SENT_154	[p10l1715t681r1908b722],
6	analysis	NN	O	analysis	prep_on	3	SENT_154	[p10l1921t678r2054b722],
7	for	IN	O	for	_	0	SENT_154	[p10l49t737r99b771],
8	missing	VBG	O	miss	amod	9	SENT_154	[p10l111t741r241b781],
9	data	NNS	O	datum	prep_for	6	SENT_154	[p10l252t738r328b771],
10	and	CC	O	and	_	0	SENT_154	[p10l338t738r402b771],
11	adjusted	VBN	O	adjust	conj_and	3	SENT_154	[p10l413t738r561b781],
12	for	IN	O	for	_	0	SENT_154	[p10l570t737r621b771],
13	acute	JJ	O	acute	amod	15	SENT_154	[p10l630t744r723b771],
14	coronary	JJ	O	coronary	amod	15	SENT_154	[p10l734t749r887b781],
15	syndrome	NN	O	syndrome	prep_for	11	SENT_154	[p10l897t738r1078b781],
16	,	,	O	,	_	0	SENT_154	[p10l897t738r1078b781],
17	diabetes	NN	O	diabetes	prep_for	11	SENT_154	[p10l1090t738r1243b777],
18	,	,	O	,	_	0	SENT_154	[p10l1090t738r1243b777],
19	smoking	NN	O	smoking	nn	20	SENT_154	[p10l1255t738r1403b781],
20	status	NN	O	status	prep_for	11	SENT_154	[p10l1415t744r1528b777],
21	,	,	O	,	_	0	SENT_154	[p10l1415t744r1528b777],
22	bodyweig	NN	O	bodyweig	nn	23	SENT_154	[p10l1541t738r1707b781],
23	ht	NN	O	ht	prep_for	11	SENT_154	[p10l1713t738r1756b777],
24	,	,	O	,	_	0	SENT_154	[p10l1713t738r1756b777],
25	and	CC	O	and	_	0	SENT_154	[p10l1768t738r1832b771],
26	use	NN	O	use	conj_and	15	SENT_154	[p10l1843t749r1898b771],
27	of	IN	O	of	_	0	SENT_154	[p10l1909t737r1946b771],
28	proton-pump	NN	O	proton-pump	nn	29	SENT_154	[p10l50t804r288b841],
29	inhibitor	NN	O	inhibitor	prep_of	26	SENT_154	[p10l300t797r456b831],
30	.	.	O	.	_	0	SENT_154	[p10l300t797r456b831],

1	Table	NNP	O	Table	_	0	SENT_155	[p10l50t907r148b943],
2	3	CD	NUMBER	3	num	1	SENT_155	[p10l157t912r192b949],
3	:	:	O	:	_	0	SENT_155	[p10l157t912r192b949],
4	Platelet-function	NN	O	platelet-function	nn	5	SENT_155	[p10l206t907r540b943],
5	outcomes	NNS	O	outcome	dep	1	SENT_155	[p10l552t913r746b944],
6	in	IN	O	in	_	0	SENT_155	[p10l759t909r792b943],
7	all	DT	O	all	det	8	SENT_155	[p10l805t907r847b943],
8	patients	NNS	O	patient	prep_in	5	SENT_155	[p10l859t909r1023b954],

1	We	PRP	O	we	nsubj	2	SENT_156	[p10l78t1336r195b1398],
2	did	VBD	O	do	_	0	SENT_156	[p10l221t1329r336b1398],
3	analyses	NNS	O	analysis	dobj	2	SENT_156	[p10l361t1329r661b1419],
4	with	IN	O	with	_	0	SENT_156	[p10l687t1329r849b1398],
5	the	DT	O	the	det	7	SENT_156	[p10l871t1329r986b1398],
6	intention-to-treat	JJ	O	intention-to-treat	amod	7	SENT_156	[p10l1011t1334r1630b1398],
7	principle	NN	O	principle	prep_with	2	SENT_156	[p10l1652t1329r1995b1418],
8	.	.	O	.	_	0	SENT_156	[p10l1652t1329r1995b1418],

1	We	PRP	O	we	nsubj	2	SENT_157	[p10l2022t1336r2139b1398],
2	used	VBD	O	use	_	0	SENT_157	[p10l7t1439r181b1507],
3	a	DT	O	a	det	4	SENT_157	[p10l220t1463r257b1507],
4	Student	NN	O	student	poss	7	SENT_157	[p10l301t1439r636b1507],
5	’s	POS	O	’s	_	0	SENT_157	[p10l301t1439r636b1507],
6	t	NN	O	t	nn	7	SENT_157	[p10l679t1452r703b1507],
7	test	NN	O	test	dobj	2	SENT_157	[p10l738t1452r868b1507],
8	to	TO	O	to	aux	9	SENT_157	[p10l903t1452r972b1507],
9	compare	VB	O	compare	xcomp	2	SENT_157	[p10l1013t1463r1329b1528],
10	continuous	JJ	O	continuous	amod	11	SENT_157	[p10l1370t1444r1779b1507],
11	variables	NNS	O	variable	dobj	9	SENT_157	[p10l1819t1439r2138b1507],
12	between	IN	O	between	_	0	SENT_157	[p10l7t1550r313b1618],
13	groups	NNS	O	group	prep_between	11	SENT_157	[p10l336t1574r604b1639],
14	.	.	O	.	_	0	SENT_157	[p10l336t1574r604b1639],

1	Categorical	JJ	O	categorical	amod	2	SENT_158	[p10l633t1550r1037b1639],
2	variables	NNS	O	variable	nsubjpass	4	SENT_158	[p10l1056t1550r1375b1618],
3	were	VBD	O	be	auxpass	4	SENT_158	[p10l1397t1574r1572b1618],
4	compared	VBN	O	compare	_	0	SENT_158	[p10l1595t1550r1959b1638],
5	with	IN	O	with	_	0	SENT_158	[p10l1978t1550r2140b1618],
6	Fisher	NNP	PERSON	Fisher	poss	9	SENT_158	[p10l13t1658r292b1727],
7	’s	POS	O	’s	_	0	SENT_158	[p10l13t1658r292b1727],
8	exact	JJ	O	exact	amod	9	SENT_158	[p10l326t1672r506b1727],
9	test	NN	O	test	prep_with	4	SENT_158	[p10l534t1672r679b1727],
10	.	.	O	.	_	0	SENT_158	[p10l534t1672r679b1727],

1	Because	IN	O	because	mark	6	SENT_159	[p10l718t1665r1011b1727],
2	the	DT	O	the	det	3	SENT_159	[p10l1041t1658r1155b1727],
3	study	NN	O	study	nsubjpass	6	SENT_159	[p10l1189t1658r1385b1748],
4	was	VBD	O	be	auxpass	6	SENT_159	[p10l1411t1683r1548b1727],
5	not	RB	O	not	neg	6	SENT_159	[p10l1581t1672r1701b1727],
6	powered	VBN	O	power	advcl	21	SENT_159	[p10l1729t1658r2043b1747],
7	to	TO	O	to	aux	8	SENT_159	[p10l2071t1672r2139b1727],
8	assess	VB	O	assess	xcomp	6	SENT_159	[p10l9t1791r231b1835],
9	differences	NNS	O	difference	dobj	8	SENT_159	[p10l276t1767r675b1835],
10	between	IN	O	between	_	0	SENT_159	[p10l718t1767r1023b1835],
11	the	DT	O	the	det	14	SENT_159	[p10l1064t1767r1178b1835],
12	overall	JJ	O	overall	amod	14	SENT_159	[p10l1221t1767r1459b1835],
13	rapid	JJ	O	rapid	amod	14	SENT_159	[p10l1501t1767r1690b1856],
14	genotyping	NN	O	genotyping	prep_between	9	SENT_159	[p10l1732t1772r2140b1857],
15	and	CC	O	and	_	0	SENT_159	[p10l9t1878r145b1946],
16	standard	JJ	O	standard	amod	18	SENT_159	[p10l168t1878r484b1946],
17	treatment	NN	O	treatment	nn	18	SENT_159	[p10l503t1891r864b1946],
18	groups	NNS	O	group	conj_and	14	SENT_159	[p10l885t1902r1155b1967],
19	,	,	O	,	_	0	SENT_159	[p10l885t1902r1155b1967],
20	we	PRP	O	we	nsubj	21	SENT_159	[p10l1177t1902r1279b1946],
21	used	VBD	O	use	_	0	SENT_159	[p10l1301t1878r1474b1946],
22	logistic	JJ	O	logistic	amod	26	SENT_159	[p10l1493t1878r1753b1967],
23	and	CC	O	and	_	0	SENT_159	[p10l1775t1878r1910b1946],
24	linear	JJ	O	linear	conj_and	22	SENT_159	[p10l1930t1878r2141b1946],
25	regression	NN	O	regression	nn	26	SENT_159	[p10l8t1991r390b2076],
26	models	NNS	O	model	dobj	21	SENT_159	[p10l438t1986r701b2054],
27	with	IN	O	with	_	0	SENT_159	[p10l749t1986r912b2054],
28	a-priori	JJ	O	a-priori	amod	29	SENT_159	[p10l960t1991r1226b2075],
29	factors	NNS	O	factor	prep_with	26	SENT_159	[p10l1273t1986r1513b2054],
30	associated	VBN	O	associate	partmod	29	SENT_159	[p10l1564t1986r1934b2054],
31	with	IN	O	with	_	0	SENT_159	[p10l1978t1986r2140b2054],
32	high	JJ	O	high	amod	35	SENT_159	[p10l7t2095r175b2185],
33	on-treatment	JJ	O	on-treatment	amod	35	SENT_159	[p10l237t2108r714b2163],
34	platelet	NN	O	platelet	nn	35	SENT_159	[p10l773t2095r1038b2184],
35	reactivity	NN	O	reactivity	prep_with	30	SENT_159	[p10l1097t2100r1433b2184],
36	.	.	O	.	_	0	SENT_159	[p10l1097t2100r1433b2184],

1	Variables	NNS	O	variable	nsubj	8	SENT_160	[p10l1497t2095r1829b2164],
2	in	IN	O	in	_	0	SENT_160	[p10l1892t2100r1965b2162],
3	the	DT	O	the	det	4	SENT_160	[p10l2025t2095r2139b2163],
4	models	NNS	O	model	prep_in	1	SENT_160	[p10l8t2206r273b2274],
5	were	VBD	O	be	cop	8	SENT_160	[p10l299t2230r474b2274],
6	acute	JJ	O	acute	amod	8	SENT_160	[p10l501t2219r691b2274],
7	coronary	JJ	O	coronary	amod	8	SENT_160	[p10l718t2230r1038b2295],
8	syndrome	NN	O	syndrome	_	0	SENT_160	[p10l1064t2206r1445b2295],
9	,	,	O	,	_	0	SENT_160	[p10l1064t2206r1445b2295],
10	diabetes	NN	O	diabetes	conj_and	8	SENT_160	[p10l1475t2206r1790b2284],
11	,	,	O	,	_	0	SENT_160	[p10l1475t2206r1790b2284],
12	smoking	NN	O	smoking	nn	13	SENT_160	[p10l1821t2206r2140b2295],
13	status	NN	O	status	conj_and	8	SENT_160	[p10l11t2328r239b2392],
14	,	,	O	,	_	0	SENT_160	[p10l11t2328r239b2392],
15	bodyweight	NN	O	bodyweight	conj_and	8	SENT_160	[p10l284t2314r724b2404],
16	,	,	O	,	_	0	SENT_160	[p10l284t2314r724b2404],
17	and	CC	O	and	_	0	SENT_160	[p10l772t2314r907b2382],
18	use	NN	O	use	conj_and	8	SENT_160	[p10l948t2338r1073b2382],
19	of	IN	O	of	_	0	SENT_160	[p10l1117t2314r1199b2382],
20	proton-pump	NN	O	proton-pump	nn	21	SENT_160	[p10l1229t2328r1718b2403],
21	inhibitors	NNS	O	inhibitor	prep_of	18	SENT_160	[p10l1761t2314r2136b2382],
22	.	.	O	.	_	0	SENT_160	[p10l1761t2314r2136b2382],

1	For	IN	O	for	_	0	SENT_161	[p10l13t2428r132b2491],
2	the	DT	O	the	det	4	SENT_161	[p10l173t2424r287b2491],
3	intention-to-treat	NN	O	intention-to-treat	nn	4	SENT_161	[p10l332t2428r951b2491],
4	analysis	NN	O	analysis	prep_for	7	SENT_161	[p10l995t2424r1300b2513],
5	,	,	O	,	_	0	SENT_161	[p10l995t2424r1300b2513],
6	we	PRP	O	we	nsubj	7	SENT_161	[p10l1345t2448r1447b2491],
7	imputed	JJ	O	imputed	_	0	SENT_161	[p10l1492t2424r1804b2513],
8	missing	VBG	O	miss	amod	9	SENT_161	[p10l1846t2428r2140b2514],
9	data	NNS	O	datum	dobj	7	SENT_161	[p10l9t2534r159b2602],
10	with	IN	O	with	_	0	SENT_161	[p10l182t2534r344b2602],
11	multiple	JJ	O	multiple	amod	12	SENT_161	[p10l368t2534r676b2622],
12	imputation	NN	O	imputation	prep_with	9	SENT_161	[p10l702t2538r1111b2622],
13	(	CD	NUMBER	(	num	15	SENT_161	[p10l1140t2539r1313b2623],
14	SAS	NNP	O	SAS	nn	15	SENT_161	[p10l1140t2539r1313b2623],
15	procedures	NNS	O	procedure	dep	12	SENT_161	[p10l1341t2534r1746b2622],
16	PROC	NNP	O	PROC	nn	17	SENT_161	[p10l1777t2539r2003b2602],
17	MI	NNP	O	MI	dep	12	SENT_161	[p10l2033t2540r2136b2600],
18	and	CC	O	and	_	0	SENT_161	[p10l9t2642r145b2710],
19	PROC	NNP	O	PROC	nn	20	SENT_161	[p10l172t2647r398b2710],
20	MIANALYZE	NNP	O	MIANALYZE	conj_and	12	SENT_161	[p10l427t2647r964b2732],
21	)	NN	O	)	dep	20	SENT_161	[p10l427t2647r964b2732],
22	.	.	O	.	_	0	SENT_161	[p10l427t2647r964b2732],

1	We	PRP	O	we	nsubj	2	SENT_162	[p10l78t2758r195b2820],
2	compared	VBD	O	compare	conj_and	2	SENT_162	[p10l231t2752r596b2841],
3	the	DT	O	the	det	4	SENT_162	[p10l627t2752r742b2819],
4	change	NN	O	change	dobj	2	SENT_162	[p10l778t2752r1037b2842],
5	in	IN	O	in	_	0	SENT_162	[p10l1072t2756r1145b2818],
6	platelet	NN	O	platelet	nn	7	SENT_162	[p10l1179t2752r1443b2841],
7	reactivity	NN	O	reactivity	prep_in	2	SENT_162	[p10l1476t2756r1804b2841],
8	between	IN	O	between	_	0	SENT_162	[p10l1834t2752r2140b2819],
9	baseline	NN	O	baseline	prep_between	7	SENT_162	[p10l7t2860r308b2929],
10	and	CC	O	and	_	0	SENT_162	[p10l368t2860r504b2929],
11	after	IN	O	after	_	0	SENT_162	[p10l563t2860r727b2929],
12	7	CD	DURATION	7	num	13	SENT_162	[p10l785t2865r822b2931],
13	days	NNS	NUMBER	day	prep_after	2	SENT_162	[p10l881t2860r1037b2950],
14	of	IN	O	of	_	0	SENT_162	[p10l1100t2860r1182b2929],
15	treatment	NN	O	treatment	prep_of	13	SENT_162	[p10l1227t2874r1587b2929],
16	in	IN	O	in	_	0	SENT_162	[p10l1645t2865r1719b2927],
17	the	DT	O	the	det	19	SENT_162	[p10l1777t2860r1891b2929],
18	rapid	JJ	O	rapid	amod	19	SENT_162	[p10l1952t2860r2141b2949],
19	genotyping	NN	O	genotyping	prep_in	15	SENT_162	[p10l10t2974r418b3059],
20	and	CC	O	and	_	0	SENT_162	[p10l483t2969r619b3037],
21	standard	JJ	O	standard	amod	23	SENT_162	[p10l684t2969r1000b3037],
22	treatment	NN	O	treatment	nn	23	SENT_162	[p10l1062t2983r1422b3037],
23	groups	NNS	O	group	prep_in	15	SENT_162	[p10l1486t2993r1736b3059],
24	with	IN	O	with	_	0	SENT_162	[p10l1800t2969r1963b3037],
25	the	DT	O	the	det	26	SENT_162	[p10l2025t2969r2139b3037],
26	Student	NN	O	student	poss	29	SENT_162	[p10l14t3079r348b3146],
27	’s	POS	O	’s	_	0	SENT_162	[p10l14t3079r348b3146],
28	t	NN	O	t	nn	29	SENT_162	[p10l404t3092r428b3146],
29	test	NN	O	test	prep_with	2	SENT_162	[p10l476t3092r605b3146],
30	for	IN	O	for	_	0	SENT_162	[p10l654t3079r759b3146],
31	the	DT	O	the	det	32	SENT_162	[p10l807t3079r922b3146],
32	non-carriers	NNS	O	non-carrier	prep_for	29	SENT_162	[p10l974t3083r1437b3157],
33	,	,	O	,	_	0	SENT_162	[p10l974t3083r1437b3157],
34	carriers	NNS	O	carrier	conj_and	32	SENT_162	[p10l1493t3083r1785b3157],
35	,	,	O	,	_	0	SENT_162	[p10l1493t3083r1785b3157],
36	and	CC	O	and	_	0	SENT_162	[p10l1840t3079r1976b3146],
37	the	DT	O	the	det	39	SENT_162	[p10l2025t3079r2139b3146],
38	combined	JJ	O	combined	amod	39	SENT_162	[p10l9t3187r376b3256],
39	group	NN	O	group	conj_and	32	SENT_162	[p10l393t3212r626b3277],
40	.	.	O	.	_	0	SENT_162	[p10l393t3212r626b3277],

1	Point	NN	O	point	nsubjpass	12	SENT_163	[p10l651t3192r841b3256],
2	and	CC	O	and	_	0	SENT_163	[p10l858t3187r994b3256],
3	95	CD	PERCENT	95	number	4	SENT_163	[p10l1011t3192r1169b3258],
4	%	NN	PERCENT	%	amod	6	SENT_163	[p10l1011t3192r1169b3258],
5	CI	NN	O	ci	nn	6	SENT_163	[p10l1190t3193r1272b3256],
6	estimates	NNS	O	estimate	nsubjpass	12	SENT_163	[p10l1295t3192r1636b3256],
7	for	IN	O	for	_	0	SENT_163	[p10l1656t3187r1761b3256],
8	sensitivity	NN	O	sensitivity	prep_for	6	SENT_163	[p10l1778t3192r2142b3277],
9	and	CC	O	and	_	0	SENT_163	[p10l9t3297r145b3365],
10	speciﬁcity	NN	O	speciﬁcity	conj_and	8	SENT_163	[p10l196t3297r556b3386],
11	were	VBD	O	be	auxpass	12	SENT_163	[p10l602t3321r776b3365],
12	calculated	VBN	O	calculate	_	0	SENT_163	[p10l827t3297r1188b3365],
13	with	IN	O	with	_	0	SENT_163	[p10l1234t3297r1397b3365],
14	an	DT	O	a	det	17	SENT_163	[p10l1446t3321r1534b3365],
15	exact	JJ	O	exact	amod	17	SENT_163	[p10l1584t3310r1764b3365],
16	binomial	JJ	O	binomial	amod	17	SENT_163	[p10l1809t3297r2140b3365],
17	procedure	NN	O	procedure	prep_with	12	SENT_163	[p10l8t3408r396b3497],
18	.	.	O	.	_	0	SENT_163	[p10l8t3408r396b3497],

1	All	DT	O	all	det	3	SENT_164	[p10l433t3408r537b3474],
2	p	NN	O	p	nn	3	SENT_164	[p10l572t3432r616b3497],
3	values	NNS	O	value	nsubj	5	SENT_164	[p10l650t3408r875b3476],
4	were	VBD	O	be	cop	5	SENT_164	[p10l910t3432r1085b3476],
5	two-tailed	JJ	O	two-tailed	_	0	SENT_164	[p10l1119t3408r1476b3476],
6	with	IN	O	with	_	0	SENT_164	[p10l1507t3408r1669b3476],
7	an	DT	O	a	det	10	SENT_164	[p10l1704t3432r1793b3476],
8	accepted	VBN	O	accept	amod	10	SENT_164	[p10l1828t3408r2141b3497],
9	signiﬁcance	NN	O	signiﬁcance	nn	10	SENT_164	[p10l11t3516r444b3606],
10	level	NN	O	level	prep_with	5	SENT_164	[p10l465t3516r630b3585],
11	of	IN	O	of	_	0	SENT_164	[p10l652t3516r734b3585],
12	O	NN	O	o	prep_of	10	SENT_164	[p10l743t3522r783b3585],
13	-	:	O	-	_	0	SENT_164	[p10l800t3556r811b3567],
14	05	CD	DATE	05	dep	12	SENT_164	[p10l828t3521r930b3585],
15	.	.	O	.	_	0	SENT_164	[p10l828t3521r930b3585],

1	All	DT	O	all	det	2	SENT_165	[p10l955t3516r1059b3583],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_165	[p10l1082t3516r1382b3606],
3	were	VBD	O	be	auxpass	4	SENT_165	[p10l1404t3541r1579b3585],
4	done	VBN	O	do	_	0	SENT_165	[p10l1602t3516r1781b3585],
5	with	IN	O	with	_	0	SENT_165	[p10l1801t3516r1963b3585],
6	SAS	NNP	O	SAS	nn	8	SENT_165	[p10l1990t3522r2135b3585],
7	(	CD	NUMBER	(	num	8	SENT_165	[p10l14t3630r301b3715],
8	version	NN	O	version	prep_with	4	SENT_165	[p10l14t3630r301b3715],
9	9.2	CD	NUMBER	9.2	num	10	SENT_165	[p10l326t3631r475b3715],
10	)	NN	O	)	dep	8	SENT_165	[p10l326t3631r475b3715],
11	.	.	O	.	_	0	SENT_165	[p10l326t3631r475b3715],

1	This	DT	O	this	det	2	SENT_166	[p11l78t17r238b85],
2	study	NN	O	study	nsubjpass	4	SENT_166	[p11l340t17r535b106],
3	is	VBZ	O	be	auxpass	4	SENT_166	[p11l628t21r685b85],
4	registered	VBN	O	register	_	0	SENT_166	[p11l783t17r1147b106],
5	with	IN	O	with	_	0	SENT_166	[p11l1240t17r1402b85],
6	ClinicalTrials	NNS	O	clinicaltrial	prep_with	4	SENT_166	[p11l1500t17r2136b106],
7	.	.	O	.	_	0	SENT_166	[p11l1500t17r2136b106],

1	gov	NN	O	gov	_	0	SENT_167	[p11l1500t17r2136b106],
2	,	,	O	,	_	0	SENT_167	[p11l1500t17r2136b106],

1	NCT01184300	NN	O	nct01184300	_	0	SENT_168	[p11l11t129r529b192],
2	.	.	O	.	_	0	SENT_168	[p11l11t129r529b192],

1	Role	NN	O	role	nsubj	11	SENT_169	[p11l13t342r165b411],
2	of	IN	O	of	_	0	SENT_169	[p11l185t342r265b411],
3	the	DT	O	the	det	5	SENT_169	[p11l275t342r399b411],
4	funding	NN	O	funding	nn	5	SENT_169	[p11l417t342r712b433],
5	source	NN	O	source	prep_of	1	SENT_169	[p11l735t365r972b411],
6	The	DT	O	the	det	7	SENT_169	[p11l7t453r148b520],
7	sponsor	NN	O	sponsor	dep	5	SENT_169	[p11l175t477r464b542],
8	of	IN	O	of	_	0	SENT_169	[p11l487t453r569b520],
9	this	DT	O	this	det	10	SENT_169	[p11l578t453r711b520],
10	study	NN	O	study	prep_of	7	SENT_169	[p11l739t453r934b542],
11	had	VBD	O	have	_	0	SENT_169	[p11l954t453r1090b520],
12	no	DT	O	no	det	13	SENT_169	[p11l1113t477r1204b520],
13	role	NN	O	role	dobj	11	SENT_169	[p11l1229t453r1366b520],
14	in	IN	O	in	_	0	SENT_169	[p11l1389t457r1463b519],
15	study	NN	O	study	nn	16	SENT_169	[p11l1488t453r1683b542],
16	design	NN	O	design	prep_in	13	SENT_169	[p11l1705t453r1964b543],
17	,	,	O	,	_	0	SENT_169	[p11l1705t453r1964b543],
18	data	NNS	O	datum	nn	19	SENT_169	[p11l1991t453r2140b520],
19	collection	NN	O	collection	prep_in	13	SENT_169	[p11l9t561r375b639],
20	,	,	O	,	_	0	SENT_169	[p11l9t561r375b639],
21	data	NN	O	datum	nn	22	SENT_169	[p11l411t561r560b630],
22	analysis	NN	O	analysis	prep_in	13	SENT_169	[p11l592t561r898b651],
23	,	,	O	,	_	0	SENT_169	[p11l592t561r898b651],
24	data	NNS	O	datum	nn	25	SENT_169	[p11l933t561r1083b630],
25	interpretation	NN	O	interpretation	prep_in	13	SENT_169	[p11l1114t566r1635b650],
26	,	,	O	,	_	0	SENT_169	[p11l1114t566r1635b650],
27	or	CC	O	or	_	0	SENT_169	[p11l1671t586r1746b630],
28	writing	NN	O	writing	prep_in	13	SENT_169	[p11l1774t566r2039b651],
29	of	IN	O	of	_	0	SENT_169	[p11l2071t561r2153b630],
30	the	DT	O	the	det	31	SENT_169	[p11l7t670r122b738],
31	report	NN	O	report	prep_of	28	SENT_169	[p11l148t684r386b759],
32	.	.	O	.	_	0	SENT_169	[p11l148t684r386b759],

1	The	DT	O	the	det	3	SENT_170	[p11l414t670r555b738],
2	corresponding	JJ	O	corresponding	amod	3	SENT_170	[p11l583t670r1113b760],
3	author	NN	O	author	nsubj	14	SENT_170	[p11l1139t670r1380b738],
4	had	VBD	O	have	_	0	SENT_170	[p11l1403t670r1540b738],
5	full	JJ	O	full	amod	6	SENT_170	[p11l1564t670r1686b738],
6	access	NN	O	access	dobj	4	SENT_170	[p11l1712t694r1935b738],
7	to	TO	O	to	_	0	SENT_170	[p11l1962t684r2030b738],
8	all	DT	O	all	det	9	SENT_170	[p11l2057t670r2140b738],
9	data	NNS	O	datum	prep_to	4	SENT_170	[p11l9t781r159b849],
10	in	IN	O	in	_	0	SENT_170	[p11l209t785r283b847],
11	the	DT	O	the	det	12	SENT_170	[p11l332t781r446b849],
12	study	NN	O	study	prep_in	4	SENT_170	[p11l500t781r695b870],
13	and	CC	O	and	_	0	SENT_170	[p11l745t781r881b849],
14	had	VBD	O	have	conj_and	4	SENT_170	[p11l929t781r1066b849],
15	ﬁnal	JJ	O	ﬁnal	amod	16	SENT_170	[p11l1115t781r1278b849],
16	responsibility	NN	O	responsibility	dobj	14	SENT_170	[p11l1329t781r1824b870],
17	for	IN	O	for	_	0	SENT_170	[p11l1873t781r1977b849],
18	the	DT	O	the	det	19	SENT_170	[p11l2025t781r2139b849],
19	decision	NN	O	decision	prep_for	16	SENT_170	[p11l9t890r311b959],
20	to	TO	O	to	aux	21	SENT_170	[p11l334t904r402b959],
21	submit	VB	O	submit	infmod	19	SENT_170	[p11l429t890r687b959],
22	for	IN	O	for	_	0	SENT_170	[p11l709t890r813b959],
23	publication	NN	O	publication	prep_for	21	SENT_170	[p11l835t890r1264b979],
24	.	.	O	.	_	0	SENT_170	[p11l835t890r1264b979],

1	Results	NNS	O	result	nsubj	4	SENT_171	[p11l14t1098r313b1177],
2	187	CD	NUMBER	187	num	3	SENT_171	[p11l12t1224r124b1290],
3	patients	NNS	O	patient	dep	1	SENT_171	[p11l165t1224r452b1308],
4	had	VBD	O	have	_	0	SENT_171	[p11l496t1220r633b1288],
5	complete	JJ	O	complete	amod	6	SENT_171	[p11l675t1220r1008b1308],
6	follow-up	NN	O	follow-up	dobj	4	SENT_171	[p11l1052t1219r1412b1308],
7	:	:	O	:	_	0	SENT_171	[p11l1052t1219r1412b1308],
8	91	CD	NUMBER	91	num	9	SENT_171	[p11l1460t1226r1536b1288],
9	patients	NNS	O	patient	dep	6	SENT_171	[p11l1578t1224r1865b1308],
10	in	IN	O	in	_	0	SENT_171	[p11l1910t1224r1983b1287],
11	the	DT	O	the	det	14	SENT_171	[p11l2025t1220r2139b1288],
12	rapid	JJ	O	rapid	amod	14	SENT_171	[p11l9t1328r199b1417],
13	genotyping	NN	O	genotyping	nn	14	SENT_171	[p11l231t1333r639b1418],
14	group	NN	O	group	prep_in	9	SENT_171	[p11l672t1353r886b1418],
15	and	CC	O	and	_	0	SENT_171	[p11l920t1328r1056b1396],
16	96	CD	NUMBER	96	conj_and	6	SENT_171	[p11l1089t1334r1171b1397],
17	given	VBN	O	give	partmod	16	SENT_171	[p11l1206t1333r1401b1418],
18	standard	JJ	O	standard	amod	21	SENT_171	[p11l1436t1328r1751b1396],
19	treatment	NN	O	treatment	nn	21	SENT_171	[p11l1781t1342r2141b1396],
20	(	NN	O	(	nn	21	SENT_171	[p11l14t1438r251b1528],
21	ﬁgure	NN	O	ﬁgure	iobj	17	SENT_171	[p11l14t1438r251b1528],
22	1	CD	NUMBER	1	num	23	SENT_171	[p11l286t1444r360b1528],
23	)	NN	O	)	dobj	17	SENT_171	[p11l286t1444r360b1528],
24	.	.	O	.	_	0	SENT_171	[p11l286t1444r360b1528],

1	Baseline	NN	O	baseline	nn	2	SENT_172	[p11l399t1438r704b1505],
2	characteristics	NNS	O	characteristic	nsubj	19	SENT_172	[p11l736t1438r1272b1516],
3	,	,	O	,	_	0	SENT_172	[p11l736t1438r1272b1516],
4	such	JJ	O	such	_	0	SENT_172	[p11l1309t1438r1479b1505],
5	as	IN	O	as	_	0	SENT_172	[p11l1511t1462r1582b1505],
6	comorbidities	NNS	O	comorbidity	prep_such_as	2	SENT_172	[p11l1617t1438r2136b1516],
7	,	,	O	,	_	0	SENT_172	[p11l1617t1438r2136b1516],
8	indications	NNS	O	indication	prep_such_as	2	SENT_172	[p11l8t1546r409b1615],
9	for	IN	O	for	_	0	SENT_172	[p11l439t1546r544b1615],
10	PCI	NNP	O	PCI	prep_for	8	SENT_172	[p11l573t1552r729b1625],
11	,	,	O	,	_	0	SENT_172	[p11l573t1552r729b1625],
12	drugs	NNS	O	drug	prep_such_as	2	SENT_172	[p11l761t1546r986b1636],
13	,	,	O	,	_	0	SENT_172	[p11l761t1546r986b1636],
14	and	CC	O	and	_	0	SENT_172	[p11l1018t1546r1154b1615],
15	procedural	JJ	O	procedural	amod	16	SENT_172	[p11l1179t1546r1572b1635],
16	characteristics	NNS	O	characteristic	conj_and	6	SENT_172	[p11l1600t1546r2136b1624],
17	,	,	O	,	_	0	SENT_172	[p11l1600t1546r2136b1624],
18	were	VBD	O	be	cop	19	SENT_172	[p11l7t1679r181b1723],
19	similar	JJ	O	similar	_	0	SENT_172	[p11l208t1655r464b1723],
20	in	IN	O	in	_	0	SENT_172	[p11l486t1660r559b1722],
21	both	DT	O	both	det	26	SENT_172	[p11l581t1655r747b1723],
22	groups	NNS	O	group	dep	26	SENT_172	[p11l772t1679r1021b1745],
23	(	RB	O	(	dep	22	SENT_172	[p11l1053t1655r1246b1745],
24	table	NN	O	table	nn	26	SENT_172	[p11l1053t1655r1246b1745],
25	1	CD	NUMBER	1	num	26	SENT_172	[p11l1273t1661r1347b1745],
26	)	NN	O	)	prep_in	19	SENT_172	[p11l1273t1661r1347b1745],
27	.	.	O	.	_	0	SENT_172	[p11l1273t1661r1347b1745],

1	23	CD	PERCENT	23	number	2	SENT_173	[p11l82t1771r160b1832],
2	(	CD	PERCENT	(	nsubj	36	SENT_173	[p11l196t1769r398b1855],
3	25	CD	PERCENT	25	num	4	SENT_173	[p11l196t1769r398b1855],
4	%	NN	PERCENT	%	dep	2	SENT_173	[p11l196t1769r398b1855],
5	)	CD	NUMBER	)	nsubj	15	SENT_173	[p11l196t1769r398b1855],
6	of	IN	O	of	_	0	SENT_173	[p11l430t1765r512b1832],
7	91	CD	NUMBER	91	num	8	SENT_173	[p11l526t1771r602b1833],
8	patients	NNS	O	patient	prep_of	5	SENT_173	[p11l627t1769r913b1854],
9	assigned	VBN	O	assign	partmod	8	SENT_173	[p11l942t1765r1260b1855],
10	to	TO	O	to	_	0	SENT_173	[p11l1283t1778r1351b1832],
11	the	DT	O	the	det	14	SENT_173	[p11l1376t1765r1490b1832],
12	rapid	JJ	O	rapid	amod	14	SENT_173	[p11l1517t1765r1707b1854],
13	genotyping	NN	O	genotyping	nn	14	SENT_173	[p11l1732t1769r2140b1855],
14	group	NN	O	group	prep_to	9	SENT_173	[p11l10t1898r224b1963],
15	carried	VBD	O	carry	rcmod	2	SENT_173	[p11l261t1873r513b1942],
16	at	IN	O	at	advmod	19	SENT_173	[p11l548t1887r612b1942],
17	least	JJS	O	least	pobj	16	SENT_173	[p11l644t1873r810b1942],
18	one	CD	NUMBER	one	num	19	SENT_173	[p11l845t1898r976b1942],
19	copy	NN	O	copy	dobj	15	SENT_173	[p11l1012t1898r1179b1963],
20	of	IN	O	of	_	0	SENT_173	[p11l1213t1873r1295b1942],
21	the	DT	O	the	det	23	SENT_173	[p11l1315t1873r1429b1942],
22	C	NN	O	c	nn	23	SENT_173	[p11l1472t1879r1526b1942],
23	YP2C19	NN	O	yp2c19	prep_of	19	SENT_173	[p11l1532t1878r1901b1942],
24	"	''	O	"	punct	23	SENT_173	[p11l1532t1878r1901b1942],
25	'	''	O	'	_	0	SENT_173	[p11l1532t1878r1901b1942],
26	~	FW	O	~	nn	27	SENT_173	[p11l1532t1878r1901b1942],
27	‘	FW	O	‘	dep	19	SENT_173	[p11l1532t1878r1901b1942],
28	2	CD	NUMBER	2	num	29	SENT_173	[p11l1532t1878r1901b1942],
29	allele	NN	O	allele	dep	27	SENT_173	[p11l1933t1873r2136b1951],
30	,	,	O	,	_	0	SENT_173	[p11l1933t1873r2136b1951],
31	compared	VBN	O	compare	_	0	SENT_173	[p11l9t1982r374b2071],
32	with	IN	O	with	prepc_compared_with	15	SENT_173	[p11l414t1982r576b2050],
33	23	CD	PERCENT	23	num	34	SENT_173	[p11l620t1988r699b2050],
34	(	CD	PERCENT	(	pobj	15	SENT_173	[p11l751t1987r949b2072],
35	24	CD	PERCENT	24	num	36	SENT_173	[p11l751t1987r949b2072],
36	%	NN	PERCENT	%	_	0	SENT_173	[p11l751t1987r949b2072],
37	)	CD	NUMBER	)	dobj	36	SENT_173	[p11l751t1987r949b2072],
38	of	IN	O	of	_	0	SENT_173	[p11l998t1982r1080b2050],
39	96	CD	NUMBER	96	prep_of	37	SENT_173	[p11l1110t1988r1193b2050],
40	in	IN	O	in	_	0	SENT_173	[p11l1236t1987r1310b2049],
41	the	DT	O	the	det	44	SENT_173	[p11l1351t1982r1465b2050],
42	standard	JJ	O	standard	amod	44	SENT_173	[p11l1510t1982r1826b2050],
43	therapy	NN	O	therapy	nn	44	SENT_173	[p11l1866t1982r2142b2072],
44	group	NN	O	group	prep_in	36	SENT_173	[p11l10t2116r243b2181],
45	.	.	O	.	_	0	SENT_173	[p11l10t2116r243b2181],

1	Of	IN	O	of	_	0	SENT_174	[p11l293t2091r395b2160],
2	the	DT	O	the	det	3	SENT_174	[p11l425t2092r539b2160],
3	individuals	NNS	O	individual	nsubj	4	SENT_174	[p11l584t2092r984b2160],
4	carrying	VBG	O	carry	prepc_of	35	SENT_174	[p11l1031t2096r1330b2181],
5	a	DT	O	a	det	8	SENT_174	[p11l1375t2116r1412b2160],
6	C	NN	O	c	nn	8	SENT_174	[p11l1463t2097r1517b2160],
7	YP2C19	NN	O	yp2c19	nn	8	SENT_174	[p11l1522t2096r1891b2160],
8	*	NN	O	*	dobj	4	SENT_174	[p11l1522t2096r1891b2160],
9	2	CD	NUMBER	2	num	10	SENT_174	[p11l1522t2096r1891b2160],
10	allele	NN	O	allele	dep	8	SENT_174	[p11l1933t2092r2136b2170],
11	,	,	O	,	_	0	SENT_174	[p11l1933t2092r2136b2170],
12	four	CD	NUMBER	four	num	13	SENT_174	[p11l9t2200r163b2269],
13	(	NN	O	(	dobj	4	SENT_174	[p11l189t2205r343b2290],
14	4	CD	PERCENT	4	number	15	SENT_174	[p11l189t2205r343b2290],
15	%	NN	PERCENT	%	amod	13	SENT_174	[p11l189t2205r343b2290],
16	)	CD	NUMBER	)	num	17	SENT_174	[p11l189t2205r343b2290],
17	patients	NNS	O	patient	dep	13	SENT_174	[p11l371t2205r658b2289],
18	in	IN	O	in	_	0	SENT_174	[p11l682t2205r756b2267],
19	the	DT	O	the	det	22	SENT_174	[p11l777t2200r891b2269],
20	rapid	JJ	O	rapid	amod	22	SENT_174	[p11l914t2200r1104b2289],
21	genotyping	NN	O	genotyping	nn	22	SENT_174	[p11l1126t2205r1534b2290],
22	group	NN	O	group	prep_in	17	SENT_174	[p11l1558t2225r1772b2290],
23	and	CC	O	and	_	0	SENT_174	[p11l1796t2200r1932b2269],
24	three	CD	PERCENT	three	number	25	SENT_174	[p11l1952t2200r2139b2269],
25	(	CD	PERCENT	(	conj_and	8	SENT_174	[p11l14t2314r172b2399],
26	3	CD	PERCENT	3	num	27	SENT_174	[p11l14t2314r172b2399],
27	%	NN	PERCENT	%	dep	25	SENT_174	[p11l14t2314r172b2399],
28	)	CD	NUMBER	)	nsubj	35	SENT_174	[p11l14t2314r172b2399],
29	in	IN	O	in	_	0	SENT_174	[p11l210t2314r283b2376],
30	the	DT	O	the	det	33	SENT_174	[p11l313t2309r427b2377],
31	standard	JJ	O	standard	amod	33	SENT_174	[p11l462t2309r778b2377],
32	treatment	NN	O	treatment	nn	33	SENT_174	[p11l806t2322r1167b2377],
33	group	NN	O	group	prep_in	28	SENT_174	[p11l1198t2333r1412b2399],
34	were	VBD	O	be	cop	35	SENT_174	[p11l1442t2333r1617b2377],
35	homozygous	JJ	O	homozygous	_	0	SENT_174	[p11l1648t2309r2135b2399],
36	.	.	O	.	_	0	SENT_174	[p11l1648t2309r2135b2399],

1	When	WRB	O	when	advmod	2	SENT_175	[p11l7t2420r231b2488],
2	compared	VBN	O	compare	advcl	18	SENT_175	[p11l256t2420r621b2508],
3	with	IN	O	with	_	0	SENT_175	[p11l642t2420r804b2488],
4	direct	JJ	O	direct	amod	6	SENT_175	[p11l829t2420r1034b2488],
5	DNA	NN	O	dna	nn	6	SENT_175	[p11l1061t2425r1246b2488],
6	sequencing	NN	O	sequencing	prep_with	2	SENT_175	[p11l1271t2424r1706b2509],
7	,	,	O	,	_	0	SENT_175	[p11l1271t2424r1706b2509],
8	one	CD	NUMBER	one	num	9	SENT_175	[p11l1734t2444r1866b2488],
9	case	NN	O	case	nsubjpass	18	SENT_175	[p11l1892t2444r2042b2488],
10	in	IN	O	in	_	0	SENT_175	[p11l2067t2424r2140b2486],
11	the	DT	O	the	det	14	SENT_175	[p11l7t2528r122b2596],
12	rapid	JJ	O	rapid	amod	14	SENT_175	[p11l145t2528r335b2617],
13	genotyping	NN	O	genotyping	nn	14	SENT_175	[p11l358t2533r766b2618],
14	group	NN	O	group	prep_in	9	SENT_175	[p11l790t2553r1004b2618],
15	had	VBD	O	have	aux	18	SENT_175	[p11l1026t2528r1163b2596],
16	been	VBN	O	be	auxpass	18	SENT_175	[p11l1183t2528r1361b2596],
17	incorrectly	RB	O	incorrectly	advmod	18	SENT_175	[p11l1383t2528r1771b2618],
18	identiﬁed	VBN	O	identiﬁed	_	0	SENT_175	[p11l1791t2528r2141b2596],
19	as	IN	O	as	_	0	SENT_175	[p11l9t2662r80b2706],
20	a	DT	O	a	det	25	SENT_175	[p11l124t2662r162b2706],
21	C	NN	O	c	nn	25	SENT_175	[p11l208t2643r262b2706],
22	YP2C19	NN	O	yp2c19	nn	25	SENT_175	[p11l268t2643r637b2707],
23	*	NN	O	*	nn	25	SENT_175	[p11l268t2643r637b2707],
24	2	CD	NUMBER	2	num	25	SENT_175	[p11l268t2643r637b2707],
25	carrier	NN	O	carrier	prep_as	18	SENT_175	[p11l675t2643r922b2706],
26	.	.	O	.	_	0	SENT_175	[p11l675t2643r922b2706],

1	The	DT	O	the	det	2	SENT_176	[p11l964t2638r1106b2706],
2	device	NN	O	device	nsubj	3	SENT_176	[p11l1148t2638r1372b2706],
3	had	VBD	O	have	_	0	SENT_176	[p11l1412t2638r1548b2706],
4	a	DT	O	a	det	5	SENT_176	[p11l1589t2662r1625b2706],
5	sensitivity	NN	O	sensitivity	dobj	3	SENT_176	[p11l1668t2643r2031b2727],
6	of	IN	O	of	_	0	SENT_176	[p11l2071t2638r2153b2706],
7	100	CD	PERCENT	100	number	8	SENT_176	[p11l12t2752r204b2819],
8	%	NN	PERCENT	%	amod	11	SENT_176	[p11l12t2752r204b2819],
9	(	CD	PERCENT	(	number	10	SENT_176	[p11l228t2752r409b2837],
10	95	CD	PERCENT	95	num	11	SENT_176	[p11l228t2752r409b2837],
11	%	NN	PERCENT	%	prep_of	5	SENT_176	[p11l228t2752r409b2837],
12	CI	NN	O	ci	dep	11	SENT_176	[p11l431t2753r514b2816],
13	92	CD	NUMBER	92	num	12	SENT_176	[p11l537t2754r649b2816],
14	-	:	O	-	_	0	SENT_176	[p11l537t2754r649b2816],
15	3-100	CD	NUMBER	3-100	num	16	SENT_176	[p11l669t2754r918b2837],
16	)	NN	O	)	dep	11	SENT_176	[p11l669t2754r918b2837],
17	,	,	O	,	_	0	SENT_176	[p11l669t2754r918b2837],
18	a	DT	O	a	det	19	SENT_176	[p11l940t2772r978b2816],
19	speciﬁcity	NN	O	speciﬁcity	appos	16	SENT_176	[p11l998t2747r1359b2837],
20	of	IN	O	of	_	0	SENT_176	[p11l1376t2747r1458b2816],
21	99	CD	NUMBER	99	prep_of	19	SENT_176	[p11l1465t2754r1547b2816],
22	-	:	O	-	_	0	SENT_176	[p11l1565t2787r1576b2798],
23	3	CD	PERCENT	3	num	24	SENT_176	[p11l1596t2752r1708b2819],
24	%	NN	PERCENT	%	dep	11	SENT_176	[p11l1596t2752r1708b2819],
25	(	CD	NUMBER	(	number	26	SENT_176	[p11l1734t2754r1838b2837],
26	96	CD	NUMBER	96	dep	24	SENT_176	[p11l1734t2754r1838b2837],
27	-	:	O	-	_	0	SENT_176	[p11l1856t2787r1867b2798],
28	3-100	CD	NUMBER	3-100	num	29	SENT_176	[p11l1887t2754r2136b2837],
29	)	NN	O	)	dep	11	SENT_176	[p11l1887t2754r2136b2837],
30	,	,	O	,	_	0	SENT_176	[p11l1887t2754r2136b2837],
31	and	CC	O	and	_	0	SENT_176	[p11l9t2857r145b2926],
32	a	DT	O	a	det	34	SENT_176	[p11l168t2882r206b2926],
33	conclusive	JJ	O	conclusive	amod	34	SENT_176	[p11l230t2857r609b2926],
34	rate	NN	O	rate	dep	11	SENT_176	[p11l634t2871r770b2926],
35	of	IN	O	of	_	0	SENT_176	[p11l795t2857r876b2926],
36	93	CD	NUMBER	93	prep_of	34	SENT_176	[p11l889t2864r968b2926],
37	-	:	O	-	_	0	SENT_176	[p11l989t2897r1000b2908],
38	6	CD	PERCENT	6	number	39	SENT_176	[p11l1018t2862r1150b2928],
39	%	NN	PERCENT	%	amod	29	SENT_176	[p11l1018t2862r1150b2928],
40	.	.	O	.	_	0	SENT_176	[p11l1018t2862r1150b2928],

1	At	IN	O	at	_	0	SENT_177	[p11l78t2972r158b3034],
2	baseline	NN	O	baseline	prep_at	19	SENT_177	[p11l196t2967r515b3045],
3	,	,	O	,	_	0	SENT_177	[p11l196t2967r515b3045],
4	the	DT	O	the	det	7	SENT_177	[p11l558t2967r672b3034],
5	mean	NN	O	mean	nn	7	SENT_177	[p11l714t2991r922b3034],
6	PRU	NN	ORGANIZATION	pru	nn	7	SENT_177	[p11l966t2973r1137b3034],
7	values	NNS	O	value	nsubj	19	SENT_177	[p11l1178t2967r1404b3034],
8	in	IN	O	in	_	0	SENT_177	[p11l1447t2971r1520b3033],
9	the	DT	O	the	det	11	SENT_177	[p11l1560t2967r1674b3034],
10	two	CD	NUMBER	two	num	11	SENT_177	[p11l1715t2980r1844b3034],
11	groups	NNS	O	group	prep_in	7	SENT_177	[p11l1888t2991r2138b3057],
12	were	VBD	O	be	cop	19	SENT_177	[p11l7t3100r181b3144],
13	not	RB	O	not	neg	19	SENT_177	[p11l216t3089r337b3144],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	19	SENT_177	[p11l372t3075r817b3165],
15	different	JJ	O	different	amod	19	SENT_177	[p11l851t3076r1165b3144],
16	(	NN	O	(	nn	19	SENT_177	[p11l1204t3076r1397b3165],
17	table	NN	O	table	nn	19	SENT_177	[p11l1204t3076r1397b3165],
18	2	CD	NUMBER	2	num	19	SENT_177	[p11l1435t3082r1518b3165],
19	)	NN	O	)	_	0	SENT_177	[p11l1435t3082r1518b3165],
20	.	.	O	.	_	0	SENT_177	[p11l1435t3082r1518b3165],

1	However	RB	O	however	advmod	3	SENT_178	[p11l1560t3082r1895b3154],
2	,	,	O	,	_	0	SENT_178	[p11l1560t3082r1895b3154],
3	mean	VB	O	mean	_	0	SENT_178	[p11l1933t3100r2140b3144],

1	PRU	NNP	ORGANIZATION	PRU	nsubj	8	SENT_179	[p12l13t21r183b82],
2	in	IN	O	in	_	0	SENT_179	[p12l250t19r323b81],
3	CYP2C19	NNP	O	CYP2C19	prep_in	1	SENT_179	[p12l395t19r824b83],
4	"	``	O	"	punct	3	SENT_179	[p12l395t19r824b83],
5	"	``	O	"	punct	6	SENT_179	[p12l395t19r824b83],
6	2	CD	NUMBER	2	dep	3	SENT_179	[p12l395t19r824b83],
7	carriers	NNS	O	carrier	dep	6	SENT_179	[p12l885t19r1157b82],
8	(	VBP	O	(	_	0	SENT_179	[p12l1230t20r1455b104],
9	198-8	CD	NUMBER	198-8	num	11	SENT_179	[p12l1230t20r1455b104],
10	[	CD	NUMBER	[	num	11	SENT_179	[p12l1526t19r1653b103],
11	SD	NN	O	sd	nsubj	17	SENT_179	[p12l1526t19r1653b103],
12	85-6	CD	NUMBER	85-6	num	14	SENT_179	[p12l1721t19r1933b104],
13	]	CD	NUMBER	]	num	14	SENT_179	[p12l1721t19r1933b104],
14	)	NN	O	)	dep	11	SENT_179	[p12l1721t19r1933b104],
15	was	VBD	O	be	cop	17	SENT_179	[p12l2001t38r2137b82],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_179	[p12l11t124r456b214],
17	higher	JJR	O	higher	ccomp	8	SENT_179	[p12l497t124r740b214],
18	than	IN	O	than	prep	17	SENT_179	[p12l781t124r947b191],
19	in	IN	O	in	pcomp	18	SENT_179	[p12l991t128r1064b190],
20	non-carriers	JJ	O	non-carriers	amod	21	SENT_179	[p12l1108t128r1551b191],
21	(	NN	O	(	dep	19	SENT_179	[p12l1603t130r1824b214],
22	143-8	CD	NUMBER	143-8	num	21	SENT_179	[p12l1603t130r1824b214],
23	[	NN	O	[	dep	21	SENT_179	[p12l1874t130r2039b213],
24	100	CD	NUMBER	100	num	23	SENT_179	[p12l1874t130r2039b213],
25	-	:	O	-	_	0	SENT_179	[p12l1874t130r2039b213],
26	5	CD	NUMBER	5	num	27	SENT_179	[p12l2060t128r2136b213],
27	]	NN	O	]	dep	21	SENT_179	[p12l2060t128r2136b213],
28	;	:	O	;	_	0	SENT_179	[p12l2060t128r2136b213],
29	p	NN	O	p	dep	27	SENT_179	[p12l8t238r389b322],
30	=	JJ	O	=	amod	32	SENT_179	[p12l8t238r389b322],
31	0-0011	CD	NUMBER	0-0011	tmod	30	SENT_179	[p12l8t238r389b322],
32	)	NN	O	)	dep	29	SENT_179	[p12l8t238r389b322],
33	.	.	O	.	_	0	SENT_179	[p12l8t238r389b322],

1	Analysis	NN	O	analysis	nsubj	6	SENT_180	[p12l429t232r735b322],
2	of	IN	O	of	_	0	SENT_180	[p12l776t232r858b301],
3	the	DT	O	the	det	5	SENT_180	[p12l881t232r995b301],
4	primary	JJ	O	primary	amod	5	SENT_180	[p12l1032t237r1326b322],
5	outcome	NN	O	outcome	prep_of	1	SENT_180	[p12l1363t246r1679b301],
6	identiﬁed	VBD	O	identiﬁed	_	0	SENT_180	[p12l1717t232r2066b301],
7	a	DT	O	a	det	9	SENT_180	[p12l2103t257r2140b301],
8	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_180	[p12l11t341r394b431],
9	reduction	NN	O	reduction	dobj	6	SENT_180	[p12l444t341r795b409],
10	in	IN	O	in	_	0	SENT_180	[p12l846t346r919b408],
11	the	DT	O	the	det	12	SENT_180	[p12l969t341r1083b409],
12	rate	NN	O	rate	prep_in	6	SENT_180	[p12l1136t355r1272b409],
13	of	IN	O	of	_	0	SENT_180	[p12l1325t341r1407b409],
14	high	JJ	O	high	amod	17	SENT_180	[p12l1444t341r1612b431],
15	on-treatment	JJ	O	on-treatment	amod	17	SENT_180	[p12l1664t355r2141b409],
16	platelet	NN	O	platelet	nn	17	SENT_180	[p12l8t451r273b540],
17	reactivity	NN	O	reactivity	prep_of	12	SENT_180	[p12l299t455r626b540],
18	in	IN	O	in	_	0	SENT_180	[p12l651t455r724b517],
19	C	NN	O	c	nn	20	SENT_180	[p12l758t456r812b518],
20	YP2C19	NN	O	yp2c19	prep_in	17	SENT_180	[p12l817t455r1187b519],
21	"	''	O	"	punct	20	SENT_180	[p12l817t455r1187b519],
22	"	``	O	"	punct	12	SENT_180	[p12l817t455r1187b519],
23	2	CD	NUMBER	2	num	24	SENT_180	[p12l817t455r1187b519],
24	carriers	NNS	O	carrier	dep	12	SENT_180	[p12l1211t455r1482b518],
25	assigned	VBN	O	assign	partmod	24	SENT_180	[p12l1513t451r1831b541],
26	to	TO	O	to	_	0	SENT_180	[p12l1855t464r1923b518],
27	rapid	JJ	O	rapid	amod	28	SENT_180	[p12l1952t451r2141b540],
28	genotyping	NN	O	genotyping	prep_to	25	SENT_180	[p12l10t564r418b649],
29	compared	VBN	O	compare	_	0	SENT_180	[p12l441t559r806b648],
30	with	IN	O	with	prepc_compared_with	25	SENT_180	[p12l824t559r986b628],
31	those	DT	O	those	det	34	SENT_180	[p12l1007t559r1202b628],
32	given	VBN	O	give	amod	34	SENT_180	[p12l1226t564r1422b649],
33	standard	NN	O	standard	nn	34	SENT_180	[p12l1445t559r1762b628],
34	treatment	NN	O	treatment	pobj	25	SENT_180	[p12l1781t573r2141b628],

1	Articles	NNPS	O	Articles	_	0	SENT_181	[p12l6t1132r156b1168],
2	I	PRP	O	I	dep	1	SENT_181	[p12l204t969r252b1167],

1	(	RB	O	(	advmod	2	SENT_182	[p12l14t1427r207b1517],
2	table	NN	O	table	_	0	SENT_182	[p12l14t1427r207b1517],
3	2	CD	NUMBER	2	dep	2	SENT_182	[p12l268t1434r352b1517],
4	)	NN	O	)	dep	3	SENT_182	[p12l268t1434r352b1517],
5	.	.	O	.	_	0	SENT_182	[p12l268t1434r352b1517],

1	The	DT	O	the	det	4	SENT_183	[p12l412t1428r553b1496],
2	mean	NN	O	mean	nn	4	SENT_183	[p12l611t1452r819b1496],
3	platelet	NN	O	platelet	nn	4	SENT_183	[p12l876t1427r1141b1516],
4	reactivity	NN	O	reactivity	nsubj	27	SENT_183	[p12l1197t1432r1525b1517],
5	of	IN	O	of	_	0	SENT_183	[p12l1582t1427r1664b1496],
6	C	NN	O	c	nn	7	SENT_183	[p12l1715t1433r1769b1496],
7	YP2C19	NN	O	yp2c19	prep_of	4	SENT_183	[p12l1775t1432r2144b1496],
8	"	''	O	"	punct	7	SENT_183	[p12l1775t1432r2144b1496],
9	'	''	O	'	_	0	SENT_183	[p12l1775t1432r2144b1496],
10	~	FW	O	~	nn	13	SENT_183	[p12l1775t1432r2144b1496],
11	‘	FW	O	‘	dep	13	SENT_183	[p12l1775t1432r2144b1496],
12	2	CD	NUMBER	2	num	13	SENT_183	[p12l1775t1432r2144b1496],
13	carriers	NNS	O	carrier	advmod	22	SENT_183	[p12l9t1542r281b1605],
14	at	IN	O	at	advmod	22	SENT_183	[p12l320t1551r384b1605],
15	1	CD	DURATION	1	num	16	SENT_183	[p12l422t1543r452b1604],
16	week	NN	NUMBER	week	pobj	14	SENT_183	[p12l486t1537r675b1605],
17	in	IN	O	in	_	0	SENT_183	[p12l709t1542r783b1604],
18	the	DT	O	the	det	21	SENT_183	[p12l817t1537r931b1605],
19	rapid	JJ	O	rapid	amod	21	SENT_183	[p12l968t1537r1158b1626],
20	genotyping	NN	O	genotyping	nn	21	SENT_183	[p12l1194t1542r1602b1627],
21	group	NN	O	group	prep_in	14	SENT_183	[p12l1639t1562r1854b1627],
22	treated	VBN	O	treat	partmod	4	SENT_183	[p12l1889t1537r2141b1605],
23	with	IN	O	with	_	0	SENT_183	[p12l7t1647r169b1715],
24	prasugrel	NN	O	prasugrel	prep_with	22	SENT_183	[p12l243t1647r588b1737],
25	was	VBD	O	be	cop	27	SENT_183	[p12l660t1671r796b1715],
26	signiﬁcantly	RB	O	signiﬁcantly	advmod	27	SENT_183	[p12l876t1647r1320b1737],
27	lower	JJR	O	lower	_	0	SENT_183	[p12l1392t1647r1594b1715],
28	and	CC	O	and	_	0	SENT_183	[p12l1668t1647r1804b1715],
29	platelet	NN	O	platelet	nn	30	SENT_183	[p12l1876t1647r2141b1736],
30	inhibition	NN	O	inhibition	nsubj	31	SENT_183	[p12l8t1755r372b1824],
31	was	VBD	O	be	conj_and	27	SENT_183	[p12l422t1780r558b1824],
32	higher	JJR	O	higher	dep	33	SENT_183	[p12l611t1755r854b1845],
33	than	IN	O	than	advmod	31	SENT_183	[p12l903t1755r1069b1824],
34	in	IN	O	in	_	0	SENT_183	[p12l1121t1760r1195b1822],
35	carriers	NNS	O	carrier	prep_in	31	SENT_183	[p12l1248t1760r1519b1824],
36	given	VBN	O	give	partmod	35	SENT_183	[p12l1575t1760r1770b1845],
37	standard	JJ	O	standard	amod	39	SENT_183	[p12l1825t1755r2141b1824],
38	treatment	NN	O	treatment	nn	39	SENT_183	[p12l7t1877r368b1932],
39	(	NN	O	(	iobj	36	SENT_183	[p12l396t1864r589b1954],
40	table	NN	O	table	dobj	36	SENT_183	[p12l396t1864r589b1954],
41	2	CD	NUMBER	2	num	40	SENT_183	[p12l615t1870r672b1942],
42	,	,	O	,	_	0	SENT_183	[p12l615t1870r672b1942],
43	ﬁgure	NN	O	ﬁgure	nn	45	SENT_183	[p12l700t1864r916b1954],
44	2	CD	NUMBER	2	num	45	SENT_183	[p12l942t1870r1025b1954],
45	)	NN	O	)	appos	40	SENT_183	[p12l942t1870r1025b1954],
46	.	.	O	.	_	0	SENT_183	[p12l942t1870r1025b1954],

1	In	IN	O	in	_	0	SENT_184	[p12l83t1980r161b2040],
2	the	DT	O	the	det	4	SENT_184	[p12l175t1974r290b2041],
3	whole	JJ	O	whole	amod	4	SENT_184	[p12l305t1974r523b2042],
4	cohort	NN	O	cohort	prep_in	7	SENT_184	[p12l541t1974r790b2052],
5	,	,	O	,	_	0	SENT_184	[p12l541t1974r790b2052],
6	there	EX	O	there	expl	7	SENT_184	[p12l809t1974r996b2042],
7	was	VBD	O	be	_	0	SENT_184	[p12l1011t1998r1147b2042],
8	a	DT	O	a	det	10	SENT_184	[p12l1167t1998r1204b2041],
9	non-signiﬁcant	JJ	O	non-signiﬁcant	amod	10	SENT_184	[p12l1219t1974r1775b2064],
10	reduction	NN	O	reduction	nsubj	7	SENT_184	[p12l1789t1974r2140b2042],
11	in	IN	O	in	_	0	SENT_184	[p12l8t2087r82b2149],
12	the	DT	O	the	det	13	SENT_184	[p12l102t2082r216b2151],
13	proportion	NN	O	proportion	prep_in	10	SENT_184	[p12l238t2087r630b2171],
14	of	IN	O	of	_	0	SENT_184	[p12l652t2082r735b2151],
15	patients	NNS	O	patient	prep_of	13	SENT_184	[p12l742t2087r1029b2171],
16	in	IN	O	in	_	0	SENT_184	[p12l1053t2087r1126b2149],
17	the	DT	O	the	det	20	SENT_184	[p12l1146t2082r1260b2151],
18	rapid	JJ	O	rapid	amod	20	SENT_184	[p12l1283t2082r1472b2171],
19	genotyping	NN	O	genotyping	nn	20	SENT_184	[p12l1494t2087r1902b2172],
20	group	NN	O	group	prep_in	15	SENT_184	[p12l1924t2107r2139b2172],
21	with	IN	O	with	_	0	SENT_184	[p12l7t2191r169b2259],
22	PRU	NN	ORGANIZATION	pru	nn	23	SENT_184	[p12l202t2198r372b2259],
23	values	NNS	O	value	prep_with	20	SENT_184	[p12l402t2191r628b2259],
24	of	IN	O	of	_	0	SENT_184	[p12l661t2191r743b2259],
25	more	JJR	O	more	mwe	26	SENT_184	[p12l759t2215r952b2259],
26	than	IN	O	than	quantmod	27	SENT_184	[p12l981t2191r1147b2259],
27	234	CD	NUMBER	234	prep_of	23	SENT_184	[p12l1178t2197r1305b2259],
28	after	IN	O	after	_	0	SENT_184	[p12l1331t2191r1494b2259],
29	7	CD	DURATION	7	num	30	SENT_184	[p12l1521t2195r1558b2262],
30	days	NNS	NUMBER	day	prep_after	7	SENT_184	[p12l1587t2191r1744b2281],
31	compared	VBN	O	compare	_	0	SENT_184	[p12l1776t2191r2141b2280],
32	with	IN	O	with	prepc_compared_with	7	SENT_184	[p12l7t2300r169b2369],
33	those	DT	O	those	pobj	7	SENT_184	[p12l192t2301r388b2369],
34	given	VBN	O	give	partmod	33	SENT_184	[p12l415t2305r610b2390],
35	standard	JJ	O	standard	amod	38	SENT_184	[p12l637t2300r953b2369],
36	treatment	NN	O	treatment	nn	38	SENT_184	[p12l975t2314r1336b2369],
37	(	NN	O	(	nn	38	SENT_184	[p12l1365t2301r1558b2390],
38	table	NN	O	table	iobj	34	SENT_184	[p12l1365t2301r1558b2390],
39	3	CD	NUMBER	3	num	40	SENT_184	[p12l1588t2307r1669b2390],
40	)	NN	O	)	dobj	34	SENT_184	[p12l1588t2307r1669b2390],
41	.	.	O	.	_	0	SENT_184	[p12l1588t2307r1669b2390],

1	With	IN	O	with	_	0	SENT_185	[p12l1697t2301r1876b2369],
2	a	DT	O	a	det	4	SENT_185	[p12l1901t2325r1938b2369],
3	PRU	NNP	O	PRU	nn	4	SENT_185	[p12l1967t2307r2138b2369],
4	cutoff	NN	O	cutoff	prep_with	16	SENT_185	[p12l9t2410r232b2478],
5	of	IN	O	of	_	0	SENT_185	[p12l269t2409r351b2478],
6	208	CD	NUMBER	208	prep_of	4	SENT_185	[p12l390t2415r534b2488],
7	,	,	O	,	_	0	SENT_185	[p12l390t2415r534b2488],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_185	[p12l588t2409r1033b2499],
9	fewer	JJR	O	fewer	amod	10	SENT_185	[p12l1080t2409r1283b2478],
10	patients	NNS	O	patient	appos	4	SENT_185	[p12l1329t2414r1616b2498],
11	in	IN	O	in	_	0	SENT_185	[p12l1667t2414r1741b2476],
12	the	DT	O	the	det	15	SENT_185	[p12l1788t2409r1902b2478],
13	rapid	JJ	O	rapid	amod	15	SENT_185	[p12l1952t2409r2141b2498],
14	genotyping	NN	O	genotyping	nn	15	SENT_185	[p12l10t2523r418b2608],
15	group	NN	O	group	prep_in	10	SENT_185	[p12l442t2542r657b2608],
16	had	VBD	O	have	_	0	SENT_185	[p12l680t2518r816b2586],
17	high	JJ	O	high	amod	20	SENT_185	[p12l837t2518r1005b2608],
18	on-treatment	JJ	O	on-treatment	amod	20	SENT_185	[p12l1029t2531r1507b2586],
19	platelet	NN	O	platelet	nn	20	SENT_185	[p12l1528t2518r1793b2607],
20	reactivity	NN	O	reactivity	dobj	16	SENT_185	[p12l1814t2523r2142b2608],
21	at	IN	O	at	_	0	SENT_185	[p12l9t2641r74b2696],
22	7	CD	DURATION	7	num	23	SENT_185	[p12l105t2632r143b2698],
23	days	NNS	NUMBER	day	prep_at	20	SENT_185	[p12l176t2628r333b2717],
24	than	IN	O	than	prep	16	SENT_185	[p12l368t2627r534b2696],
25	in	IN	O	in	pcomp	24	SENT_185	[p12l568t2632r641b2694],
26	the	DT	O	the	det	29	SENT_185	[p12l674t2627r788b2696],
27	standard	JJ	O	standard	amod	29	SENT_185	[p12l826t2627r1142b2696],
28	treatment	NN	O	treatment	nn	29	SENT_185	[p12l1173t2641r1533b2696],
29	group	NN	O	group	pobj	25	SENT_185	[p12l1567t2652r1782b2717],
30	(	CD	NUMBER	(	num	33	SENT_185	[p12l1822t2627r2016b2717],
31	table	NN	O	table	nn	33	SENT_185	[p12l1822t2627r2016b2717],
32	3	CD	NUMBER	3	num	33	SENT_185	[p12l2054t2634r2136b2717],
33	)	NN	O	)	nsubj	16	SENT_185	[p12l2054t2634r2136b2717],
34	.	.	O	.	_	0	SENT_185	[p12l2054t2634r2136b2717],

1	The	DT	O	the	det	3	SENT_186	[p12l7t2737r148b2806],
2	mean	NN	O	mean	nn	3	SENT_186	[p12l183t2762r390b2806],
3	PRU	NNP	ORGANIZATION	PRU	dep	9	SENT_186	[p12l428t2744r599b2806],
4	after	IN	O	after	_	0	SENT_186	[p12l636t2737r800b2806],
5	1	CD	DURATION	1	num	6	SENT_186	[p12l834t2743r865b2804],
6	week	NN	NUMBER	week	prep_after	9	SENT_186	[p12l896t2737r1086b2806],
7	was	VBD	O	be	cop	9	SENT_186	[p12l1115t2761r1252b2806],
8	also	RB	O	also	advmod	9	SENT_186	[p12l1289t2737r1428b2806],
9	lower	JJR	O	lower	_	0	SENT_186	[p12l1462t2737r1665b2806],
10	in	IN	O	in	_	0	SENT_186	[p12l1697t2742r1770b2804],
11	the	DT	O	the	det	14	SENT_186	[p12l1803t2737r1917b2806],
12	rapid	JJ	O	rapid	amod	14	SENT_186	[p12l1952t2737r2141b2826],
13	genotyping	NN	O	genotyping	nn	14	SENT_186	[p12l10t2851r418b2936],
14	group	NN	O	group	prep_in	9	SENT_186	[p12l457t2870r671b2936],
15	than	IN	O	than	prep	9	SENT_186	[p12l708t2846r874b2914],
16	in	IN	O	in	pcomp	15	SENT_186	[p12l912t2851r985b2913],
17	the	DT	O	the	det	20	SENT_186	[p12l1021t2846r1135b2914],
18	standard	JJ	O	standard	amod	20	SENT_186	[p12l1176t2846r1492b2914],
19	treatment	NN	O	treatment	nn	20	SENT_186	[p12l1527t2859r1887b2914],
20	group	NN	O	group	pobj	16	SENT_186	[p12l1925t2870r2139b2936],
21	(	CD	NUMBER	(	num	24	SENT_186	[p12l14t2955r207b3045],
22	table	NN	O	table	nn	24	SENT_186	[p12l14t2955r207b3045],
23	3	CD	NUMBER	3	num	24	SENT_186	[p12l250t2962r331b3045],
24	)	NN	O	)	nsubj	9	SENT_186	[p12l250t2962r331b3045],
25	.	.	O	.	_	0	SENT_186	[p12l250t2962r331b3045],

1	18	CD	PERCENT	18	nsubj	12	SENT_187	[p12l376t2962r449b3024],
2	(	CD	PERCENT	(	num	4	SENT_187	[p12l494t2960r687b3045],
3	13	CD	PERCENT	13	num	4	SENT_187	[p12l494t2960r687b3045],
4	%	NN	PERCENT	%	dep	1	SENT_187	[p12l494t2960r687b3045],
5	)	CD	NUMBER	)	dep	1	SENT_187	[p12l494t2960r687b3045],
6	of	IN	O	of	_	0	SENT_187	[p12l732t2955r814b3024],
7	141	CD	NUMBER	141	num	8	SENT_187	[p12l841t2962r947b3022],
8	non-carriers	NNS	O	non-carrier	prep_of	5	SENT_187	[p12l984t2960r1427b3024],
9	from	IN	O	from	_	0	SENT_187	[p12l1466t2955r1648b3024],
10	both	DT	O	both	det	11	SENT_187	[p12l1684t2955r1849b3024],
11	groups	NNS	O	group	prep_from	8	SENT_187	[p12l1888t2980r2137b3045],
12	had	VBD	O	have	_	0	SENT_187	[p12l7t3064r144b3132],
13	high	JJ	O	high	amod	16	SENT_187	[p12l184t3064r352b3154],
14	on-treatment	JJ	O	on-treatment	amod	16	SENT_187	[p12l395t3078r872b3132],
15	platelet	NN	O	platelet	nn	16	SENT_187	[p12l912t3064r1177b3153],
16	reactivity	NN	O	reactivity	dobj	12	SENT_187	[p12l1217t3069r1545b3154],
17	after	IN	O	after	_	0	SENT_187	[p12l1587t3064r1750b3132],
18	7	CD	DURATION	7	num	19	SENT_187	[p12l1790t3069r1828b3135],
19	days	NNS	NUMBER	day	prep_after	16	SENT_187	[p12l1869t3064r2025b3154],
20	of	IN	O	of	_	0	SENT_187	[p12l2071t3064r2153b3132],
21	clopidogrel	NN	O	clopidogrel	nn	22	SENT_187	[p12l9t3174r414b3264],
22	treatment	NN	O	treatment	prep_of	19	SENT_187	[p12l489t3187r865b3241],
23	.	.	O	.	_	0	SENT_187	[p12l489t3187r865b3241],

1	By	IN	O	by	_	0	SENT_188	[p12l949t3180r1036b3263],
2	contrast	NN	O	contrast	prep_by	11	SENT_188	[p12l1111t3187r1419b3252],
3	,	,	O	,	_	0	SENT_188	[p12l1111t3187r1419b3252],
4	seven	CD	PERCENT	seven	nsubj	11	SENT_188	[p12l1502t3198r1704b3242],
5	(	CD	PERCENT	(	num	7	SENT_188	[p12l1785t3178r1988b3264],
6	30	CD	PERCENT	30	num	7	SENT_188	[p12l1785t3178r1988b3264],
7	%	NN	PERCENT	%	dep	4	SENT_188	[p12l1785t3178r1988b3264],
8	)	CD	NUMBER	)	dep	4	SENT_188	[p12l1785t3178r1988b3264],
9	of	IN	O	of	_	0	SENT_188	[p12l2071t3174r2153b3241],
10	23	CD	NUMBER	23	prep_of	8	SENT_188	[p12l11t3289r90b3351],
11	C	NN	O	c	_	0	SENT_188	[p12l166t3288r220b3351],
12	YP2C19	NN	O	yp2c19	dobj	11	SENT_188	[p12l226t3287r595b3351],
13	"	''	O	"	punct	12	SENT_188	[p12l226t3287r595b3351],
14	"	``	O	"	punct	12	SENT_188	[p12l226t3287r595b3351],
15	2	CD	NUMBER	2	num	16	SENT_188	[p12l226t3287r595b3351],
16	carriers	NNS	O	carrier	nsubj	20	SENT_188	[p12l657t3287r928b3351],
17	treated	VBN	O	treat	partmod	16	SENT_188	[p12l994t3283r1246b3351],
18	with	IN	O	with	_	0	SENT_188	[p12l1308t3282r1471b3351],
19	clopidogrel	NN	O	clopidogrel	prep_with	17	SENT_188	[p12l1536t3283r1940b3372],
20	had	VBD	O	have	rcmod	12	SENT_188	[p12l2004t3282r2141b3351],
21	high	JJ	O	high	amod	24	SENT_188	[p12l7t3391r175b3481],
22	on-treatment	JJ	O	on-treatment	amod	24	SENT_188	[p12l200t3405r677b3459],
23	platelet	NN	O	platelet	nn	24	SENT_188	[p12l699t3391r963b3480],
24	reactivity	NN	O	reactivity	dobj	20	SENT_188	[p12l985t3396r1313b3481],
25	(	CD	NUMBER	(	num	26	SENT_188	[p12l1340t3397r1497b3481],
26	p	NN	O	p	npadvmod	27	SENT_188	[p12l1340t3397r1497b3481],
27	=	JJ	O	=	amod	28	SENT_188	[p12l1340t3397r1497b3481],
28	o	NN	O	o	dep	24	SENT_188	[p12l1340t3397r1497b3481],
29	-	:	O	-	_	0	SENT_188	[p12l1515t3430r1526b3442],
30	O5	NN	O	o5	nn	31	SENT_188	[p12l1542t3396r1671b3481],
31	)	NN	O	)	dep	24	SENT_188	[p12l1542t3396r1671b3481],
32	.	.	O	.	_	0	SENT_188	[p12l1542t3396r1671b3481],

1	wvvw	NN	O	wvvw	_	0	SENT_189	[p12l936t829r1469b880],
2	.	.	O	.	_	0	SENT_189	[p12l936t829r1469b880],

1	the	DT	O	the	det	2	SENT_190	[p12l936t829r1469b880],
2	|	NN	O	|	_	0	SENT_190	[p12l936t829r1469b880],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_190	[p12l936t829r1469b880],
4	Vol	NNP	O	Vol	dep	2	SENT_190	[p12l1514t829r1600b880],
5	379	CD	NUMBER	379	num	6	SENT_190	[p12l1620t835r1723b887],
6	May	NNP	DATE	May	dep	2	SENT_190	[p12l1772t834r1891b894],
7	5,2012	CD	DATE	5,2012	num	6	SENT_190	[p12l1908t835r2110b888],

1	All	DT	O	all	det	2	SENT_191	[p13l78t17r182b84],
2	patients	NNS	O	patient	nsubjpass	7	SENT_191	[p13l240t21r527b106],
3	who	WP	O	who	nsubj	4	SENT_191	[p13l586t17r742b85],
4	underwent	VBD	O	undergo	rcmod	2	SENT_191	[p13l800t17r1201b85],
5	PCI	NNP	O	PCI	dobj	4	SENT_191	[p13l1262t22r1396b85],
6	were	VBD	O	be	auxpass	7	SENT_191	[p13l1457t41r1631b85],
7	included	VBN	O	include	_	0	SENT_191	[p13l1691t17r2009b85],
8	in	IN	O	in	_	0	SENT_191	[p13l2067t21r2140b84],
9	the	DT	O	the	det	10	SENT_191	[p13l7t125r122b194],
10	analyses	NNS	O	analysis	prep_in	7	SENT_191	[p13l148t125r449b215],
11	of	IN	O	of	_	0	SENT_191	[p13l477t125r559b194],
12	clinical	JJ	O	clinical	amod	13	SENT_191	[p13l571t125r828b194],
13	outcomes	NNS	O	outcome	prep_of	10	SENT_191	[p13l854t139r1205b194],
14	and	CC	O	and	_	0	SENT_191	[p13l1234t125r1369b194],
15	bleeding	NN	O	bleeding	conj_and	13	SENT_191	[p13l1391t125r1723b215],
16	.	.	O	.	_	0	SENT_191	[p13l1391t125r1723b215],

1	No	DT	O	no	det	5	SENT_192	[p13l1755t132r1856b194],
2	clinical	JJ	O	clinical	amod	5	SENT_192	[p13l1883t125r2140b194],
3	adverse	JJ	O	adverse	amod	5	SENT_192	[p13l9t234r281b302],
4	ischaemic	JJ	O	ischaemic	amod	5	SENT_192	[p13l304t234r671b302],
5	outcomes	NNS	O	outcome	nsubjpass	7	SENT_192	[p13l694t248r1045b302],
6	were	VBD	O	be	auxpass	7	SENT_192	[p13l1068t259r1242b302],
7	noted	VBN	O	note	_	0	SENT_192	[p13l1265t234r1472b302],
8	in	IN	O	in	prep	7	SENT_192	[p13l1493t239r1567b301],
9	either	CC	O	either	dep	7	SENT_192	[p13l1590t234r1802b302],
10	assigned	VBN	O	assign	conj	7	SENT_192	[p13l1823t234r2141b324],
11	group	NN	O	group	dobj	10	SENT_192	[p13l10t368r224b434],
12	at	IN	O	at	_	0	SENT_192	[p13l247t357r311b411],
13	7	CD	NUMBER	7	num	16	SENT_192	[p13l329t348r366b415],
14	or	CC	O	or	_	0	SENT_192	[p13l387t368r462b411],
15	30	CD	DURATION	30	num	16	SENT_192	[p13l486t350r566b411],
16	days	NNS	NUMBER	day	prep_at	10	SENT_192	[p13l588t344r765b433],
17	.	.	O	.	_	0	SENT_192	[p13l588t344r765b433],

1	Frequency	NN	O	frequency	nsubj	7	SENT_193	[p13l793t348r1171b433],
2	of	IN	O	of	_	0	SENT_193	[p13l1191t344r1272b412],
3	minor	JJ	O	minor	amod	4	SENT_193	[p13l1280t348r1510b412],
4	bleeding	NN	O	bleeding	prep_of	1	SENT_193	[p13l1528t344r1843b434],
5	was	VBD	O	be	cop	7	SENT_193	[p13l1862t368r1998b412],
6	not	RB	O	not	neg	7	SENT_193	[p13l2021t357r2141b411],
7	different	JJ	O	different	_	0	SENT_193	[p13l9t452r325b521],
8	in	IN	O	in	_	0	SENT_193	[p13l351t457r424b519],
9	the	DT	O	the	det	11	SENT_193	[p13l451t452r565b521],
10	two	CD	NUMBER	two	num	11	SENT_193	[p13l592t466r722b521],
11	groups	NNS	O	group	prep_in	7	SENT_193	[p13l752t477r1021b542],
12	:	:	O	:	_	0	SENT_193	[p13l752t477r1021b542],
13	ﬁve	FW	O	ﬁve	nn	14	SENT_193	[p13l1053t452r1180b521],
14	(	FW	O	(	dep	11	SENT_193	[p13l1214t457r1373b542],
15	6	CD	PERCENT	6	number	16	SENT_193	[p13l1214t457r1373b542],
16	%	NN	PERCENT	%	amod	14	SENT_193	[p13l1214t457r1373b542],
17	)	CD	NUMBER	)	nsubj	26	SENT_193	[p13l1214t457r1373b542],
18	of	IN	O	of	_	0	SENT_193	[p13l1407t452r1490b521],
19	91	CD	NUMBER	91	num	20	SENT_193	[p13l1506t458r1581b521],
20	patients	NNS	O	patient	prep_of	17	SENT_193	[p13l1608t457r1895b541],
21	in	IN	O	in	_	0	SENT_193	[p13l1925t457r1999b519],
22	the	DT	O	the	det	25	SENT_193	[p13l2025t452r2139b521],
23	rapid	JJ	O	rapid	amod	25	SENT_193	[p13l8t561r199b650],
24	genotyping	NN	O	genotyping	nn	25	SENT_193	[p13l219t566r627b651],
25	group	NN	O	group	prep_in	20	SENT_193	[p13l648t585r863b651],
26	had	VBD	O	have	rcmod	14	SENT_193	[p13l883t561r1020b629],
27	a	DT	O	a	det	28	SENT_193	[p13l1040t585r1077b629],
28	TIMI	NNP	O	TIMI	nsubj	30	SENT_193	[p13l1096t565r1288b628],
29	minor	JJ	O	minor	dep	30	SENT_193	[p13l1312t566r1542b629],
30	bleed	VB	O	bleed	xcomp	26	SENT_193	[p13l1559t561r1756b629],
31	compared	VBN	O	compare	_	0	SENT_193	[p13l1776t561r2141b650],
32	with	IN	O	with	prepc_compared_with	30	SENT_193	[p13l7t671r169b739],
33	two	CD	NUMBER	two	num	34	SENT_193	[p13l195t684r324b739],
34	(	NN	O	(	pobj	30	SENT_193	[p13l359t675r517b761],
35	2	CD	PERCENT	2	number	36	SENT_193	[p13l359t675r517b761],
36	%	NN	PERCENT	%	amod	34	SENT_193	[p13l359t675r517b761],
37	)	CD	NUMBER	)	tmod	26	SENT_193	[p13l359t675r517b761],
38	of	IN	O	of	_	0	SENT_193	[p13l551t671r633b738],
39	96	CD	NUMBER	96	prep_of	37	SENT_193	[p13l648t677r730b739],
40	given	VBN	O	give	partmod	14	SENT_193	[p13l760t675r956b761],
41	standard	JJ	O	standard	amod	43	SENT_193	[p13l985t671r1301b739],
42	treatment	NN	O	treatment	nn	43	SENT_193	[p13l1326t684r1686b739],
43	(	NN	O	(	iobj	40	SENT_193	[p13l1717t677r1875b761],
44	p	NN	O	p	nn	46	SENT_193	[p13l1717t677r1875b761],
45	=	JJ	O	=	amod	46	SENT_193	[p13l1717t677r1875b761],
46	O	NN	O	o	dobj	40	SENT_193	[p13l1717t677r1875b761],
47	-	:	O	-	_	0	SENT_193	[p13l1892t710r1903b721],
48	2693	CD	DATE	2693	num	49	SENT_193	[p13l1922t677r2136b761],
49	)	CD	NUMBER	)	dep	46	SENT_193	[p13l1922t677r2136b761],
50	.	.	O	.	_	0	SENT_193	[p13l1922t677r2136b761],

1	TIMI	NNP	ORGANIZATION	TIMI	nn	3	SENT_194	[p13l7t784r200b846],
2	major	JJ	O	major	amod	3	SENT_194	[p13l266t784r485b869],
3	bleeding	NN	O	bleeding	nsubj	4	SENT_194	[p13l544t779r859b869],
4	occurred	VBD	O	occur	_	0	SENT_194	[p13l923t779r1243b848],
5	in	IN	O	in	_	0	SENT_194	[p13l1304t784r1378b846],
6	two	CD	NUMBER	two	num	7	SENT_194	[p13l1439t793r1569b848],
7	(	CD	NUMBER	(	prep_in	4	SENT_194	[p13l1639t786r1699b869],
8	2	LS	NUMBER	2	dep	7	SENT_194	[p13l1639t786r1699b869],
9	-	:	O	-	_	0	SENT_194	[p13l1718t819r1729b830],
10	2	CD	PERCENT	2	num	11	SENT_194	[p13l1748t784r1883b869],
11	%	NN	PERCENT	%	dep	24	SENT_194	[p13l1748t784r1883b869],
12	)	CD	NUMBER	)	num	15	SENT_194	[p13l1748t784r1883b869],
13	rapid	JJ	O	rapid	amod	15	SENT_194	[p13l1952t779r2141b868],
14	genotyping	NN	O	genotyping	nn	15	SENT_194	[p13l10t893r418b978],
15	patients	NNS	O	patient	dep	11	SENT_194	[p13l472t893r759b977],
16	and	CC	O	and	_	0	SENT_194	[p13l817t888r953b956],
17	one	CD	NUMBER	one	num	18	SENT_194	[p13l1007t912r1139b956],
18	(	NN	O	(	dep	11	SENT_194	[p13l1200t892r1350b978],
19	1	CD	PERCENT	1	num	20	SENT_194	[p13l1200t892r1350b978],
20	%	NN	PERCENT	%	dep	24	SENT_194	[p13l1200t892r1350b978],
21	)	CD	NUMBER	)	num	24	SENT_194	[p13l1200t892r1350b978],
22	standard	JJ	O	standard	amod	24	SENT_194	[p13l1413t888r1729b956],
23	treatment	NN	O	treatment	nn	24	SENT_194	[p13l1781t901r2141b956],
24	patient	NN	O	patient	dep	29	SENT_194	[p13l8t1002r262b1086],
25	(	CD	NUMBER	(	num	26	SENT_194	[p13l324t1004r730b1087],
26	p	NN	O	p	dep	24	SENT_194	[p13l324t1004r730b1087],
27	=	JJ	O	=	amod	29	SENT_194	[p13l324t1004r730b1087],
28	O-6134	NN	O	o-6134	nn	29	SENT_194	[p13l324t1004r730b1087],
29	)	NN	O	)	dep	4	SENT_194	[p13l324t1004r730b1087],
30	.	.	O	.	_	0	SENT_194	[p13l324t1004r730b1087],

1	Of	IN	O	of	_	0	SENT_195	[p13l795t997r897b1066],
2	the	DT	O	the	det	4	SENT_195	[p13l940t998r1055b1066],
3	two	CD	NUMBER	two	num	4	SENT_195	[p13l1112t1011r1242b1066],
4	patients	NNS	O	patient	prep_of	19	SENT_195	[p13l1301t1002r1588b1086],
5	in	IN	O	in	_	0	SENT_195	[p13l1648t1002r1722b1064],
6	the	DT	O	the	det	9	SENT_195	[p13l1778t997r1892b1066],
7	rapid	JJ	O	rapid	amod	9	SENT_195	[p13l1952t998r2141b1086],
8	genotyping	NN	O	genotyping	nn	9	SENT_195	[p13l10t1111r418b1196],
9	group	NN	O	group	prep_in	4	SENT_195	[p13l451t1131r665b1196],
10	who	WP	O	who	nsubj	11	SENT_195	[p13l695t1106r850b1175],
11	had	VBD	O	have	rcmod	9	SENT_195	[p13l882t1106r1018b1175],
12	a	DT	O	a	det	13	SENT_195	[p13l1049t1131r1087b1175],
13	TIMI	NNP	O	TIMI	nsubj	15	SENT_195	[p13l1116t1111r1308b1174],
14	major	JJ	O	major	dep	15	SENT_195	[p13l1344t1111r1562b1196],
15	bleed	VB	O	bleed	xcomp	11	SENT_195	[p13l1590t1106r1804b1185],
16	,	,	O	,	_	0	SENT_195	[p13l1590t1106r1804b1185],
17	one	CD	NUMBER	one	nsubj	19	SENT_195	[p13l1839t1131r1971b1175],
18	was	VBD	O	be	aux	19	SENT_195	[p13l2001t1131r2138b1175],
19	receiving	VBG	O	receive	_	0	SENT_195	[p13l8t1220r340b1305],
20	clopidogrel	NN	O	clopidogrel	dobj	19	SENT_195	[p13l365t1215r786b1305],
21	.	.	O	.	_	0	SENT_195	[p13l365t1215r786b1305],

1	Discussion	NN	O	discussion	_	0	SENT_196	[p13l14t1427r455b1502],

1	As	IN	O	as	mark	6	SENT_197	[p13l7t1550r100b1613],
2	far	RB	O	far	advmod	6	SENT_197	[p13l138t1544r238b1613],
3	as	IN	O	as	_	0	SENT_197	[p13l273t1569r344b1613],
4	we	PRP	O	we	prep_as	2	SENT_197	[p13l380t1569r482b1613],
5	are	VBP	O	be	cop	6	SENT_197	[p13l519t1569r628b1613],
6	aware	JJ	O	aware	advcl	10	SENT_197	[p13l665t1569r895b1623],
7	,	,	O	,	_	0	SENT_197	[p13l665t1569r895b1623],
8	we	PRP	O	we	nsubj	10	SENT_197	[p13l932t1569r1034b1613],
9	have	VBP	O	have	aux	10	SENT_197	[p13l1070t1544r1236b1613],
10	reported	VBN	O	report	_	0	SENT_197	[p13l1273t1545r1582b1633],
11	the	DT	O	the	det	13	SENT_197	[p13l1615t1544r1729b1613],
12	successful	JJ	O	successful	amod	13	SENT_197	[p13l1768t1544r2140b1613],
13	validation	NN	O	validation	dobj	10	SENT_197	[p13l7t1654r364b1723],
14	and	CC	O	and	_	0	SENT_197	[p13l393t1654r529b1723],
15	clinical	JJ	O	clinical	amod	16	SENT_197	[p13l556t1654r814b1723],
16	application	NN	O	application	conj_and	13	SENT_197	[p13l842t1654r1244b1743],
17	of	IN	O	of	_	0	SENT_197	[p13l1272t1654r1354b1723],
18	the	DT	O	the	det	22	SENT_197	[p13l1368t1654r1482b1723],
19	ﬁrst	JJ	O	ﬁrst	amod	22	SENT_197	[p13l1510t1654r1656b1723],
20	point-of-care	JJ	O	point-of-care	amod	22	SENT_197	[p13l1681t1654r2139b1743],
21	genetic	JJ	O	genetic	amod	22	SENT_197	[p13l10t1768r271b1854],
22	test	NN	O	test	prep_of	13	SENT_197	[p13l315t1777r444b1832],
23	in	IN	O	in	_	0	SENT_197	[p13l489t1768r563b1830],
24	medicine	NN	O	medicine	prep_in	22	SENT_197	[p13l609t1764r967b1832],
25	.	.	O	.	_	0	SENT_197	[p13l609t1764r967b1832],

1	We	PRP	O	we	nsubj	3	SENT_198	[p13l1016t1770r1132b1832],
2	have	VBP	O	have	aux	3	SENT_198	[p13l1179t1764r1345b1832],
3	shown	VBN	O	show	_	0	SENT_198	[p13l1395t1764r1635b1831],
4	that	IN	O	that	complm	14	SENT_198	[p13l1680t1764r1822b1832],
5	a	DT	O	a	det	8	SENT_198	[p13l1868t1788r1905b1831],
6	rapid	JJ	O	rapid	amod	8	SENT_198	[p13l1952t1764r2141b1853],
7	genetic	JJ	O	genetic	amod	8	SENT_198	[p13l10t1877r271b1962],
8	test	NN	O	test	nsubj	14	SENT_198	[p13l307t1886r436b1941],
9	coupled	VBN	O	couple	partmod	8	SENT_198	[p13l474t1872r761b1961],
10	with	IN	O	with	_	0	SENT_198	[p13l796t1872r958b1941],
11	subsequent	JJ	O	subsequent	amod	13	SENT_198	[p13l999t1872r1418b1961],
12	personalised	JJ	O	personalised	amod	13	SENT_198	[p13l1454t1872r1917b1961],
13	treatment	NN	O	treatment	prep_with	9	SENT_198	[p13l1953t1886r2138b1941, p13l9t1994r203b2049],
14	reduces	VBZ	O	reduce	ccomp	3	SENT_198	[p13l233t1981r513b2049],
15	the	DT	O	the	det	16	SENT_198	[p13l545t1981r660b2049],
16	number	NN	O	number	iobj	14	SENT_198	[p13l692t1981r990b2049],
17	of	IN	O	of	_	0	SENT_198	[p13l1021t1981r1102b2049],
18	CYP2C19	NN	O	cyp2c19	prep_of	16	SENT_198	[p13l1128t1986r1557b2049],
19	"	''	O	"	punct	18	SENT_198	[p13l1128t1986r1557b2049],
20	"	``	O	"	punct	23	SENT_198	[p13l1128t1986r1557b2049],
21	‘	NN	O	‘	nn	23	SENT_198	[p13l1128t1986r1557b2049],
22	2	CD	NUMBER	2	num	23	SENT_198	[p13l1128t1986r1557b2049],
23	carriers	NNS	O	carrier	dobj	14	SENT_198	[p13l1585t1985r1857b2049],
24	treated	VBN	O	treat	partmod	23	SENT_198	[p13l1889t1981r2141b2049],
25	with	IN	O	with	_	0	SENT_198	[p13l7t2091r169b2159],
26	PCI	NN	O	pcus	prep_with	24	SENT_198	[p13l212t2096r346b2159],
27	that	WDT	O	that	nsubj	28	SENT_198	[p13l389t2091r530b2158],
28	have	VBP	O	have	rcmod	26	SENT_198	[p13l567t2091r735b2159],
29	high	JJ	O	high	amod	32	SENT_198	[p13l774t2091r942b2181],
30	on-treatment	JJ	O	on-treatment	amod	32	SENT_198	[p13l982t2104r1459b2159],
31	platelet	NN	O	platelet	nn	32	SENT_198	[p13l1497t2091r1762b2180],
32	reactivity	NN	O	reactivity	dobj	28	SENT_198	[p13l1800t2095r2136b2180],
33	.	.	O	.	_	0	SENT_198	[p13l1800t2095r2136b2180],

1	Point-of-care	JJ	O	point-of-care	amod	3	SENT_199	[p13l13t2199r468b2268],
2	genetic	JJ	O	genetic	amod	3	SENT_199	[p13l501t2204r762b2289],
3	testing	NN	O	testing	nsubj	20	SENT_199	[p13l791t2204r1039b2289],
4	after	IN	O	after	mark	8	SENT_199	[p13l1070t2199r1234b2268],
5	PCI	NNP	O	PCI	nsubjpass	8	SENT_199	[p13l1267t2205r1401b2268],
6	can	MD	O	can	aux	8	SENT_199	[p13l1437t2224r1562b2268],
7	be	VB	O	be	auxpass	8	SENT_199	[p13l1591t2199r1677b2268],
8	done	VBN	O	do	dep	3	SENT_199	[p13l1709t2199r1887b2268],
9	effectively	RB	O	effectively	advmod	8	SENT_199	[p13l1920t2200r2138b2268, p13l8t2308r173b2398],
10	at	IN	O	at	_	0	SENT_199	[p13l191t2321r255b2376],
11	the	DT	O	the	det	12	SENT_199	[p13l271t2308r385b2376],
12	bedside	NN	O	bedside	prep_at	8	SENT_199	[p13l403t2308r683b2376],
13	and	CC	O	and	_	0	SENT_199	[p13l704t2308r839b2376],
14	treatment	NN	O	treatment	conj_and	12	SENT_199	[p13l856t2321r1216b2376],
15	of	IN	O	of	_	0	SENT_199	[p13l1235t2308r1317b2376],
16	carriers	NNS	O	carrier	prep_of	12	SENT_199	[p13l1323t2313r1595b2376],
17	with	IN	O	with	_	0	SENT_199	[p13l1614t2308r1776b2376],
18	prasugrel	NN	O	prasugrel	prep_with	16	SENT_199	[p13l1795t2308r2140b2398],
19	can	MD	O	can	aux	20	SENT_199	[p13l9t2442r135b2486],
20	decrease	VB	O	decrease	_	0	SENT_199	[p13l153t2417r464b2486],
21	the	DT	O	the	det	22	SENT_199	[p13l481t2418r596b2486],
22	rate	NN	O	rate	dobj	20	SENT_199	[p13l614t2431r749b2486],
23	of	IN	O	of	_	0	SENT_199	[p13l769t2417r851b2486],
24	high	JJ	O	high	amod	27	SENT_199	[p13l854t2417r1022b2507],
25	on-treatment	JJ	O	on-treatment	amod	27	SENT_199	[p13l1041t2431r1518b2486],
26	platelet	NN	O	platelet	nn	27	SENT_199	[p13l1533t2417r1798b2506],
27	reactivity	NN	O	reactivity	prep_of	22	SENT_199	[p13l1814t2422r2142b2507],
28	compared	VBN	O	compare	_	0	SENT_199	[p13l9t2526r375b2615],
29	with	IN	O	with	prepc_compared_with	20	SENT_199	[p13l395t2526r557b2595],
30	standard	JJ	O	standard	amod	32	SENT_199	[p13l583t2526r899b2595],
31	clopidogrel	NN	O	clopidogrel	nn	32	SENT_199	[p13l922t2526r1326b2616],
32	treatment	NN	O	treatment	pobj	20	SENT_199	[p13l1349t2540r1725b2595],
33	.	.	O	.	_	0	SENT_199	[p13l1349t2540r1725b2595],

1	In	IN	O	in	_	0	SENT_200	[p13l83t2642r160b2702],
2	our	PRP$	O	we	poss	3	SENT_200	[p13l204t2659r329b2703],
3	study	NN	O	study	prep_in	16	SENT_200	[p13l373t2635r576b2725],
4	,	,	O	,	_	0	SENT_200	[p13l373t2635r576b2725],
5	personalisation	NN	O	personalisation	nsubjpass	16	SENT_200	[p13l622t2635r1181b2724],
6	of	IN	O	of	_	0	SENT_200	[p13l1225t2635r1307b2703],
7	antiplatelet	JJ	O	antiplatelet	amod	8	SENT_200	[p13l1337t2635r1741b2724],
8	treatment	NN	O	treatment	prep_of	5	SENT_200	[p13l1781t2648r2141b2703],
9	with	IN	O	with	_	0	SENT_200	[p13l7t2744r169b2813],
10	selective	JJ	O	selective	amod	11	SENT_200	[p13l236t2744r537b2813],
11	provision	NN	O	provision	prep_with	8	SENT_200	[p13l602t2749r944b2833],
12	of	IN	O	of	_	0	SENT_200	[p13l1009t2744r1091b2813],
13	prasugrel	NN	O	prasugrel	prep_of	11	SENT_200	[p13l1142t2744r1506b2834],
14	,	,	O	,	_	0	SENT_200	[p13l1142t2744r1506b2834],
15	was	VBD	O	be	auxpass	16	SENT_200	[p13l1571t2769r1708b2813],
16	based	VBN	O	base	_	0	SENT_200	[p13l1773t2744r1983b2813],
17	on	IN	O	on	_	0	SENT_200	[p13l2048t2769r2140b2813],
18	C	NN	O	c	nn	19	SENT_200	[p13l15t2858r69b2921],
19	YP2C19	NN	O	yp2c19	prep_on	16	SENT_200	[p13l75t2858r444b2921],
20	"	''	O	"	punct	19	SENT_200	[p13l75t2858r444b2921],
21	"	``	O	"	punct	16	SENT_200	[p13l75t2858r444b2921],
22	2	CD	NUMBER	2	num	24	SENT_200	[p13l75t2858r444b2921],
23	carrier	NN	O	carrier	nn	24	SENT_200	[p13l484t2858r723b2921],
24	status	NN	O	status	dobj	16	SENT_200	[p13l768t2867r995b2921],
25	.	.	O	.	_	0	SENT_200	[p13l768t2867r995b2921],

1	The	DT	O	the	det	3	SENT_201	[p13l1041t2853r1183b2921],
2	clinical	JJ	O	clinical	amod	3	SENT_201	[p13l1228t2853r1485b2921],
3	relevance	NN	O	relevance	_	0	SENT_201	[p13l1528t2853r1869b2921],
4	of	IN	O	of	_	0	SENT_201	[p13l1914t2853r1996b2921],
5	the	DT	O	the	prep_of	3	SENT_201	[p13l2025t2853r2139b2921],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_202	[p13l15t2967r444b3030],
2	*	NN	O	*	nsubj	12	SENT_202	[p13l15t2967r444b3030],
3	2	CD	NUMBER	2	num	4	SENT_202	[p13l15t2967r444b3030],
4	allele	NN	O	allele	dep	2	SENT_202	[p13l460t2962r645b3030],
5	in	IN	O	in	_	0	SENT_202	[p13l665t2967r739b3029],
6	association	NN	O	association	prep_in	2	SENT_202	[p13l759t2967r1160b3030],
7	with	IN	O	with	_	0	SENT_202	[p13l1177t2962r1339b3030],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_202	[p13l1359t2962r1763b3052],
9	treatment	NN	O	treatment	prep_with	6	SENT_202	[p13l1781t2975r2141b3030],
10	could	MD	O	could	aux	12	SENT_202	[p13l9t3072r209b3141],
11	be	VB	O	be	cop	12	SENT_202	[p13l250t3072r334b3141],
12	restricted	JJ	O	restricted	_	0	SENT_202	[p13l378t3072r720b3141],
13	to	TO	O	to	_	0	SENT_202	[p13l761t3086r829b3141],
14	the	DT	O	the	det	15	SENT_202	[p13l872t3072r986b3141],
15	context	NN	O	context	prep_to	12	SENT_202	[p13l1031t3086r1292b3141],
16	of	IN	O	of	_	0	SENT_202	[p13l1334t3072r1417b3141],
17	PCI	NN	O	pcus	prep_of	15	SENT_202	[p13l1450t3078r1606b3141],
18	.	.	O	.	_	0	SENT_202	[p13l1450t3078r1606b3141],

1	Retrospective	JJ	O	retrospective	amod	3	SENT_203	[p13l1657t3077r2139b3161],
2	genetic	JJ	O	genetic	amod	3	SENT_203	[p13l10t3186r271b3271],
3	analyses	NNS	O	analysis	nsubj	36	SENT_203	[p13l324t3181r670b3271],
4	”	CD	NUMBER	”	nsubj	32	SENT_203	[p13l324t3181r670b3271],
5	of	IN	O	of	_	0	SENT_203	[p13l725t3181r807b3250],
6	the	DT	O	the	det	7	SENT_203	[p13l846t3182r960b3250],
7	ACTIVE-A	NN	O	active-a	prep_of	4	SENT_203	[p13l1012t3186r1408b3250],
8	(	CD	NUMBER	(	num	12	SENT_203	[p13l1465t3182r1684b3271],
9	Atrial	NNP	O	Atrial	nn	12	SENT_203	[p13l1465t3182r1684b3271],
10	Fibrillation	NNP	O	Fibrillation	nn	12	SENT_203	[p13l1740t3181r2140b3250],
11	Clopidogrel	NNP	O	Clopidogrel	nn	12	SENT_203	[p13l11t3290r435b3380],
12	Trial	NN	O	trial	dep	7	SENT_203	[p13l452t3290r615b3358],
13	with	IN	O	with	_	0	SENT_203	[p13l630t3290r793b3359],
14	Irbesartan	NNP	MISC	Irbesartan	prep_with	12	SENT_203	[p13l815t3290r1186b3358],
15	for	IN	O	for	_	0	SENT_203	[p13l1204t3290r1309b3358],
16	Prevention	NNP	O	Prevention	prep_for	14	SENT_203	[p13l1329t3295r1724b3358],
17	of	IN	O	of	_	0	SENT_203	[p13l1743t3290r1825b3358],
18	Vascular	JJ	O	vascular	amod	20	SENT_203	[p13l1829t3290r2141b3359],
19	Events	NNS	O	event	nn	20	SENT_203	[p13l13t3404r269b3490],
20	)	NN	O	)	prep_of	16	SENT_203	[p13l13t3404r269b3490],
21	and	CC	O	and	_	0	SENT_203	[p13l319t3400r455b3467],
22	CURE	VB	O	cure	conj_and	12	SENT_203	[p13l500t3404r728b3468],
23	(	CD	NUMBER	(	num	24	SENT_203	[p13l780t3400r1228b3490],
24	Clopidogrel	NNP	O	Clopidogrel	dobj	22	SENT_203	[p13l780t3400r1228b3490],
25	in	IN	O	in	_	0	SENT_203	[p13l1271t3404r1345b3466],
26	Unstable	NNP	O	Unstable	nn	27	SENT_203	[p13l1392t3400r1717b3468],
27	Angina	NNP	O	Angina	prep_in	24	SENT_203	[p13l1759t3404r2029b3490],
28	to	TO	O	to	aux	29	SENT_203	[p13l2071t3413r2139b3467],
29	Prevent	VB	O	prevent	xcomp	22	SENT_203	[p13l13t3515r290b3577],
30	Recurrent	JJ	O	recurrent	amod	31	SENT_203	[p13l347t3515r708b3577],
31	Events	NNS	O	event	dobj	29	SENT_203	[p13l766t3513r1022b3598],
32	)	VBP	O	)	rcmod	3	SENT_203	[p13l766t3513r1022b3598],
33	trials	NNS	O	trial	dobj	32	SENT_203	[p13l1081t3508r1260b3577],
34	did	VBD	O	do	aux	36	SENT_203	[p13l1318t3508r1434b3577],
35	not	RB	O	not	neg	36	SENT_203	[p13l1487t3522r1608b3577],
36	show	VB	O	show	_	0	SENT_203	[p13l1663t3508r1854b3577],
37	a	DT	O	a	det	38	SENT_203	[p13l1908t3533r1945b3577],
38	link	NN	O	link	dobj	36	SENT_203	[p13l1998t3508r2142b3575],
39	between	IN	O	between	_	0	SENT_203	[p13l7t3617r313b3685],
40	C	NN	O	c	nn	41	SENT_203	[p13l348t3622r402b3685],
41	YP2C19	NN	O	yp2c19	prep_between	38	SENT_203	[p13l408t3622r777b3685],
42	*	CD	NUMBER	*	num	41	SENT_203	[p13l408t3622r777b3685],
43	‘	NN	O	‘	nn	46	SENT_203	[p13l408t3622r777b3685],
44	2	CD	NUMBER	2	num	46	SENT_203	[p13l408t3622r777b3685],
45	carrier	NN	O	carrier	nn	46	SENT_203	[p13l802t3622r1041b3685],
46	status	NN	O	status	tmod	36	SENT_203	[p13l1070t3631r1277b3685],
47	and	CC	O	and	_	0	SENT_203	[p13l1309t3617r1445b3685],
48	adverse	JJ	O	adverse	amod	50	SENT_203	[p13l1473t3617r1745b3685],
49	ischaemic	JJ	O	ischaemic	amod	50	SENT_203	[p13l1773t3617r2140b3685],
50	events	NNS	O	event	tmod	36	SENT_203	[p14l9t41r256b96],
51	.	.	O	.	_	0	SENT_203	[p14l9t41r256b96],

1	ACTIVE-A	NN	O	active-a	nn	2	SENT_204	[p14l302t32r698b96],
2	investigators	NNS	O	investigator	nsubj	3	SENT_204	[p14l739t32r1199b118],
3	assessed	VBD	O	assess	_	0	SENT_204	[p14l1246t28r1558b96],
4	the	DT	O	the	det	5	SENT_204	[p14l1599t28r1713b96],
5	efﬁcacy	NN	O	efﬁcacy	dobj	3	SENT_204	[p14l1758t28r2029b117],
6	of	IN	O	of	_	0	SENT_204	[p14l2071t28r2153b95],
7	clopidogrel	NN	O	clopidogrel	prep_of	5	SENT_204	[p14l9t136r414b226],
8	in	IN	O	in	_	0	SENT_204	[p14l440t141r514b203],
9	stroke	NN	O	stroke	nn	10	SENT_204	[p14l543t136r762b205],
10	prevention	NN	O	prevention	prep_in	3	SENT_204	[p14l789t141r1201b225],
11	,	,	O	,	_	0	SENT_204	[p14l789t141r1201b225],
12	and	CC	O	and	_	0	SENT_204	[p14l1232t136r1368b205],
13	only	RB	O	only	quantmod	14	SENT_204	[p14l1395t136r1550b226],
14	15	CD	PERCENT	15	num	15	SENT_204	[p14l1578t141r1726b207],
15	%	NN	PERCENT	%	nsubjpass	23	SENT_204	[p14l1578t141r1726b207],
16	of	IN	O	of	_	0	SENT_204	[p14l1755t136r1837b205],
17	patients	NNS	O	patient	prep_of	15	SENT_204	[p14l1851t141r2137b225],
18	in	IN	O	in	_	0	SENT_204	[p14l8t250r82b312],
19	the	DT	O	the	det	21	SENT_204	[p14l119t245r233b313],
20	CURE	NN	O	cure	nn	21	SENT_204	[p14l275t249r503b313],
21	trial	NN	O	trial	prep_in	17	SENT_204	[p14l543t245r688b313],
22	were	VBD	O	be	auxpass	23	SENT_204	[p14l725t269r899b313],
23	treated	VBN	O	treat	conj_and	3	SENT_204	[p14l937t245r1189b313],
24	with	IN	O	with	_	0	SENT_204	[p14l1224t245r1386b313],
25	PCI	NN	O	pcus	prep_with	23	SENT_204	[p14l1429t250r1562b313],
26	and	CC	O	and	_	0	SENT_204	[p14l1605t245r1741b313],
27	stenting	NN	O	stenting	conj_and	25	SENT_204	[p14l1781t250r2140b335],
28	.	.	O	.	_	0	SENT_204	[p14l1781t250r2140b335],

1	”	NN	O	”	_	0	SENT_205	[p14l1781t250r2140b335],
2	Consistent	JJ	O	consistent	amod	1	SENT_205	[p14l11t360r401b424],
3	with	IN	O	with	_	0	SENT_205	[p14l420t356r582b424],
4	these	DT	O	these	det	5	SENT_205	[p14l603t356r795b424],
5	reports	NNS	O	report	prep_with	1	SENT_205	[p14l818t369r1094b445],
6	,	,	O	,	_	0	SENT_205	[p14l818t369r1094b445],
7	a	DT	O	a	det	8	SENT_205	[p14l1121t380r1158b424],
8	meta-analysis	NN	O	meta-analysis	appos	1	SENT_205	[p14l1181t356r1674b445],
9	that	WDT	O	that	nsubj	12	SENT_205	[p14l1698t356r1840b424],
10	was	VBD	O	be	cop	12	SENT_205	[p14l1860t380r1995b424],
11	not	RB	O	not	neg	12	SENT_205	[p14l2021t369r2141b424],
12	www	NN	O	www	rcmod	8	SENT_205	[p14l7t625r540b676],
13	.	.	O	.	_	0	SENT_205	[p14l7t625r540b676],

1	the	DT	O	the	det	2	SENT_206	[p14l7t625r540b676],
2	|	NN	O	|	_	0	SENT_206	[p14l7t625r540b676],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_206	[p14l7t625r540b676],
4	Vol	NNP	O	Vol	dep	2	SENT_206	[p14l585t625r672b676],
5	379	CD	NUMBER	379	num	6	SENT_206	[p14l691t631r795b683],
6	May	NNP	DATE	May	dep	2	SENT_206	[p14l844t629r962b690],
7	5,2012	CD	DATE	5,2012	num	6	SENT_206	[p14l979t631r1181b685],

1	restricted	JJ	O	restricted	csubj	11	SENT_207	[p14l9t818r253b867],
2	to	TO	O	to	_	0	SENT_207	[p14l269t828r318b867],
3	the	DT	O	the	det	4	SENT_207	[p14l335t818r417b867],
4	context	NN	O	context	prep_to	1	SENT_207	[p14l436t828r623b867],
5	of	IN	O	of	_	0	SENT_207	[p14l640t818r699b867],
6	PCI	NN	O	pcus	prep_of	4	SENT_207	[p14l710t822r806b867],
7	with	IN	O	with	_	0	SENT_207	[p14l825t818r941b867],
8	stenting	VBG	O	stent	prep_with	6	SENT_207	[p14l961t822r1171b882],
9	did	VBD	O	do	aux	11	SENT_207	[p14l1190t818r1272b867],
10	not	RB	O	not	neg	11	SENT_207	[p14l1289t828r1375b867],
11	show	VB	O	show	_	0	SENT_207	[p14l1394t818r1530b867],
12	an	DT	O	a	det	13	SENT_207	[p14l10t913r72b945],
13	association	NN	O	association	dobj	11	SENT_207	[p14l87t899r374b945],
14	between	IN	O	between	_	0	SENT_207	[p14l387t896r605b945],
15	the	DT	O	the	det	18	SENT_207	[p14l618t896r699b945],
16	C	NN	O	c	nn	18	SENT_207	[p14l719t900r757b945],
17	YP2C19	NN	O	yp2c19	nn	18	SENT_207	[p14l761t900r962b945],
18	genotype	NN	O	genotype	prep_between	13	SENT_207	[p14l974t906r1208b960],
19	and	CC	O	and	_	0	SENT_207	[p14l1224t896r1320b945],
20	adverse	JJ	O	adverse	amod	22	SENT_207	[p14l1334t896r1528b945],
21	clinical	JJ	O	clinical	amod	22	SENT_207	[p14l10t974r193b1022],
22	outcomes	NNS	O	outcome	prep_between	13	SENT_207	[p14l236t977r535b1022],
23	.	.	O	.	_	0	SENT_207	[p14l236t977r535b1022],

1	”	NN	O	”	ccomp	16	SENT_208	[p14l236t977r535b1022],
2	Therefore	RB	O	therefore	advmod	1	SENT_208	[p14l576t974r846b1030],
3	,	,	O	,	_	0	SENT_208	[p14l576t974r846b1030],
4	the	DT	O	the	det	5	SENT_208	[p14l890t974r971b1022],
5	importance	NN	O	importance	nsubjpass	16	SENT_208	[p14l1014t977r1312b1037],
6	of	IN	O	of	_	0	SENT_208	[p14l1356t974r1414b1022],
7	the	DT	O	the	det	10	SENT_208	[p14l1446t974r1528b1022],
8	CYP2C19	NN	O	cyp2c19	nn	10	SENT_208	[p14l14t1054r320b1100],
9	*	CD	NUMBER	*	num	10	SENT_208	[p14l14t1054r320b1100],
10	‘	NN	O	‘	prep_of	5	SENT_208	[p14l14t1054r320b1100],
11	2	CD	NUMBER	2	num	12	SENT_208	[p14l14t1054r320b1100],
12	allele	NN	O	allele	dep	10	SENT_208	[p14l342t1051r474b1100],
13	should	MD	O	should	aux	16	SENT_208	[p14l501t1051r677b1100],
14	not	RB	O	not	neg	16	SENT_208	[p14l701t1061r787b1100],
15	be	VB	O	be	auxpass	16	SENT_208	[p14l809t1051r870b1100],
16	extrapolated	VBN	O	extrapolate	_	0	SENT_208	[p14l895t1051r1210b1114],
17	beyond	IN	O	beyond	_	0	SENT_208	[p14l1233t1051r1424b1115],
18	the	DT	O	the	det	19	SENT_208	[p14l1446t1051r1528b1100],
19	setting	NN	O	setting	prep_beyond	16	SENT_208	[p14l11t1132r185b1193],
20	of	IN	O	of	_	0	SENT_208	[p14l202t1129r260b1178],
21	PCI	NN	O	pcus	prep_of	19	SENT_208	[p14l271t1133r366b1178],
22	until	IN	O	until	mark	26	SENT_208	[p14l385t1129r508b1178],
23	further	JJ	O	further	amod	24	SENT_208	[p14l525t1129r710b1178],
24	evidence	NN	O	evidence	nsubj	26	SENT_208	[p14l726t1129r951b1178],
25	is	VBZ	O	be	cop	26	SENT_208	[p14l968t1132r1008b1178],
26	available	JJ	O	available	advcl	16	SENT_208	[p14l1027t1129r1262b1178],
27	.	.	O	.	_	0	SENT_208	[p14l1027t1129r1262b1178],

1	Although	IN	O	although	mark	7	SENT_209	[p14l58t1208r305b1272],
2	our	PRP$	O	we	poss	5	SENT_209	[p14l324t1225r413b1256],
3	point-of-care	JJ	O	point-of-care	amod	5	SENT_209	[p14l430t1208r756b1271],
4	genetic	JJ	O	genetic	amod	5	SENT_209	[p14l776t1211r961b1272],
5	test	NN	O	test	nsubjpass	7	SENT_209	[p14l978t1217r1070b1256],
6	was	VBD	O	be	auxpass	7	SENT_209	[p14l1086t1225r1183b1256],
7	designed	VBN	O	design	advcl	24	SENT_209	[p14l1204t1208r1438b1272],
8	for	IN	O	for	_	0	SENT_209	[p14l1455t1208r1529b1256],
9	the	DT	O	the	det	11	SENT_209	[p14l8t1285r90b1334],
10	C	NN	O	c	nn	11	SENT_209	[p14l125t1289r164b1334],
11	YP2C19	NN	O	yp2c19	prep_for	7	SENT_209	[p14l167t1288r431b1334],
12	"	''	O	"	punct	11	SENT_209	[p14l167t1288r431b1334],
13	'	''	O	'	_	0	SENT_209	[p14l167t1288r431b1334],
14	~	FW	O	~	nn	17	SENT_209	[p14l167t1288r431b1334],
15	‘	FW	O	‘	dep	17	SENT_209	[p14l167t1288r431b1334],
16	2	CD	NUMBER	2	num	17	SENT_209	[p14l167t1288r431b1334],
17	allele	NN	O	allele	advmod	7	SENT_209	[p14l459t1285r604b1341],
18	,	,	O	,	_	0	SENT_209	[p14l459t1285r604b1341],
19	other	JJ	O	other	amod	21	SENT_209	[p14l638t1285r774b1334],
20	genetic	JJ	O	genetic	amod	21	SENT_209	[p14l804t1288r990b1349],
21	variants	NNS	O	variant	nsubjpass	24	SENT_209	[p14l1018t1288r1222b1334],
22	have	VBP	O	have	aux	24	SENT_209	[p14l1253t1285r1372b1334],
23	been	VBN	O	be	auxpass	24	SENT_209	[p14l1402t1285r1529b1334],
24	associated	VBN	O	associate	dep	43	SENT_209	[p14l10t1363r274b1412],
25	with	IN	O	with	_	0	SENT_209	[p14l306t1363r422b1412],
26	adverse	JJ	O	adverse	amod	27	SENT_209	[p14l457t1363r651b1412],
27	outcomes	NNS	O	outcome	prep_with	24	SENT_209	[p14l687t1373r937b1412],
28	after	IN	O	after	_	0	SENT_209	[p14l974t1363r1091b1412],
29	treatment	NN	O	treatment	prep_after	24	SENT_209	[p14l1124t1373r1381b1412],
30	with	IN	O	with	_	0	SENT_209	[p14l1413t1363r1529b1412],
31	clopidogrel	NN	O	clopidogrel	prep_with	29	SENT_209	[p14l10t1442r298b1506],
32	after	IN	O	after	_	0	SENT_209	[p14l318t1442r434b1490],
33	PCI	NNP	O	PCI	prep_after	24	SENT_209	[p14l455t1445r636b1490],
34	.13	CD	NUMBER	.13	num	33	SENT_209	[p14l455t1445r636b1490],
35	’	CD	NUMBER	’	number	36	SENT_209	[p14l455t1445r636b1490],
36	3	CD	NUMBER	3	num	40	SENT_209	[p14l455t1445r636b1490],
37	°	NN	O	°	nn	40	SENT_209	[p14l455t1445r636b1490],
38	Additional	JJ	O	additional	amod	40	SENT_209	[p14l654t1442r926b1490],
39	loss-of-function	NN	O	loss-of-function	nn	40	SENT_209	[p14l945t1442r1350b1490],
40	alleles	NNS	O	allele	nsubj	43	SENT_209	[p14l1370t1442r1527b1490],
41	of	IN	O	of	_	0	SENT_209	[p14l10t1519r68b1568],
42	CYP2C19	NN	O	cyp2c19	prep_of	40	SENT_209	[p14l75t1523r318b1568],
43	diminish	VBP	O	diminish	_	0	SENT_209	[p14l327t1519r564b1568],
44	the	DT	O	the	det	46	SENT_209	[p14l574t1519r656b1568],
45	therapeutic	JJ	O	therapeutic	amod	46	SENT_209	[p14l666t1519r961b1582],
46	beneﬁt	NN	O	beneﬁt	dobj	43	SENT_209	[p14l971t1519r1153b1568],
47	of	IN	O	of	_	0	SENT_209	[p14l1164t1519r1222b1568],
48	clopidogrel	NN	O	clopidogrel	prep_of	46	SENT_209	[p14l1225t1519r1525b1583],
49	.	.	O	.	_	0	SENT_209	[p14l1225t1519r1525b1583],

1	However	RB	O	however	advmod	14	SENT_210	[p14l12t1601r251b1651],
2	,	,	O	,	_	0	SENT_210	[p14l12t1601r251b1651],
3	unlike	IN	O	unlike	_	0	SENT_210	[p14l271t1596r436b1644],
4	the	DT	O	the	det	9	SENT_210	[p14l454t1596r536b1644],
5	C	NN	O	c	nn	9	SENT_210	[p14l560t1599r598b1644],
6	YP2C19	NN	O	yp2c19	nn	9	SENT_210	[p14l602t1599r865b1644],
7	*	NN	O	*	nn	9	SENT_210	[p14l602t1599r865b1644],
8	2	CD	NUMBER	2	num	9	SENT_210	[p14l602t1599r865b1644],
9	allele	NN	O	allele	prep_unlike	14	SENT_210	[p14l882t1596r1027b1651],
10	,	,	O	,	_	0	SENT_210	[p14l882t1596r1027b1651],
11	the	DT	O	the	det	12	SENT_210	[p14l1047t1596r1129b1644],
12	others	NNS	O	other	nsubj	17	SENT_210	[p14l1149t1596r1308b1644],
13	are	VBP	O	be	cop	14	SENT_210	[p14l1329t1613r1407b1644],
14	rare	JJ	O	rare	_	0	SENT_210	[p14l1426t1613r1528b1644],
15	and	CC	O	and	_	0	SENT_210	[p14l10t1675r107b1723],
16	generally	RB	O	generally	advmod	17	SENT_210	[p14l142t1675r378b1739],
17	occur	VBP	O	occur	conj_and	14	SENT_210	[p14l412t1692r555b1723],
18	in	IN	O	in	_	0	SENT_210	[p14l589t1678r641b1722],
19	less	JJR	O	less	mwe	20	SENT_210	[p14l675t1675r770b1723],
20	than	IN	O	than	quantmod	21	SENT_210	[p14l806t1675r924b1723],
21	1	CD	PERCENT	1	num	22	SENT_210	[p14l961t1678r1036b1725],
22	%	NN	PERCENT	%	prep_in	17	SENT_210	[p14l961t1678r1036b1725],
23	of	IN	O	of	_	0	SENT_210	[p14l1072t1675r1131b1723],
24	individuals	NNS	O	individual	prep_of	22	SENT_210	[p14l1156t1675r1442b1723],
25	of	IN	O	of	_	0	SENT_210	[p14l1479t1675r1538b1723],
26	western	JJ	O	western	amod	28	SENT_210	[p14l8t1762r214b1801],
27	European	JJ	MISC	european	amod	28	SENT_210	[p14l246t1755r496b1815],
28	ancestry	NN	O	ancestry	prep_of	24	SENT_210	[p14l525t1756r776b1816],
29	.	.	O	.	_	0	SENT_210	[p14l525t1756r776b1816],

1	“	NN	O	“	dep	9	SENT_211	[p14l525t1756r776b1816],
2	Because	IN	O	because	dep	9	SENT_211	[p14l809t1757r1019b1801],
3	95	CD	PERCENT	95	num	4	SENT_211	[p14l1049t1755r1162b1803],
4	%	NN	PERCENT	%	nsubj	9	SENT_211	[p14l1049t1755r1162b1803],
5	of	IN	O	of	_	0	SENT_211	[p14l1193t1752r1251b1801],
6	our	PRP$	O	we	poss	8	SENT_211	[p14l1271t1770r1361b1801],
7	study	NN	O	study	nn	8	SENT_211	[p14l1391t1752r1530b1816],
8	population	NN	O	population	prep_of	4	SENT_211	[p14l9t1830r291b1893],
9	were	VBD	O	be	advcl	16	SENT_211	[p14l312t1847r437b1879],
10	of	IN	O	of	_	0	SENT_211	[p14l461t1830r519b1879],
11	this	DT	O	this	det	13	SENT_211	[p14l532t1830r627b1879],
12	ethnic	JJ	O	ethnic	amod	13	SENT_211	[p14l653t1830r814b1879],
13	origin	NN	O	origin	prep_of	9	SENT_211	[p14l837t1833r1005b1894],
14	,	,	O	,	_	0	SENT_211	[p14l837t1833r1005b1894],
15	we	PRP	O	we	nsubj	16	SENT_211	[p14l1029t1848r1102b1879],
16	expect	VBP	O	expect	_	0	SENT_211	[p14l1126t1840r1289b1893],
17	that	IN	O	that	complm	25	SENT_211	[p14l1309t1830r1411b1879],
18	less	JJR	O	less	nsubj	25	SENT_211	[p14l1432t1830r1527b1879],
19	than	IN	O	than	_	0	SENT_211	[p14l8t1908r127b1956],
20	ﬁve	JJ	O	ﬁve	amod	21	SENT_211	[p14l147t1908r237b1956],
21	patients	NNS	O	patient	prep_than	18	SENT_211	[p14l258t1911r462b1971],
22	would	MD	O	would	aux	25	SENT_211	[p14l483t1908r645b1956],
23	have	VB	O	have	aux	25	SENT_211	[p14l664t1908r783b1956],
24	been	VBN	O	be	cop	25	SENT_211	[p14l803t1908r929b1956],
25	carriers	NNS	O	carrier	ccomp	16	SENT_211	[p14l950t1911r1144b1956],
26	of	IN	O	of	_	0	SENT_211	[p14l1166t1908r1225b1956],
27	these	DT	O	these	det	30	SENT_211	[p14l1235t1908r1371b1956],
28	other	JJ	O	other	amod	30	SENT_211	[p14l1393t1908r1529b1956],
29	genetic	JJ	O	genetic	amod	30	SENT_211	[p14l10t1989r196b2050],
30	variants	NNS	O	variant	prep_of	25	SENT_211	[p14l211t1989r429b2035],
31	.	.	O	.	_	0	SENT_211	[p14l211t1989r429b2035],

1	By	IN	O	by	_	0	SENT_212	[p14l62t2069r124b2128],
2	contrast	NN	O	contrast	prep_by	12	SENT_212	[p14l148t2074r368b2120],
3	,	,	O	,	_	0	SENT_212	[p14l148t2074r368b2120],
4	the	DT	O	the	det	6	SENT_212	[p14l395t2064r476b2112],
5	C	NN	O	c	nn	6	SENT_212	[p14l506t2067r545b2112],
6	YP2C19	NN	O	yp2c19	nsubj	20	SENT_212	[p14l549t2067r837b2113],
7	"	''	O	"	punct	6	SENT_212	[p14l549t2067r837b2113],
8	"	``	O	"	punct	6	SENT_212	[p14l549t2067r837b2113],
9	‘	CD	NUMBER	‘	dep	6	SENT_212	[p14l549t2067r837b2113],
10	17	CD	NUMBER	17	num	11	SENT_212	[p14l549t2067r837b2113],
11	allele	NN	O	allele	dep	6	SENT_212	[p14l857t2064r989b2112],
12	results	VBZ	O	result	_	0	SENT_212	[p14l1014t2064r1186b2112],
13	in	IN	O	in	_	0	SENT_212	[p14l1213t2067r1265b2112],
14	a	DT	O	a	det	15	SENT_212	[p14l1290t2081r1317b2112],
15	gain	NN	O	gain	prep_in	12	SENT_212	[p14l1342t2067r1454b2128],
16	of	IN	O	of	_	0	SENT_212	[p14l1479t2064r1538b2112],
17	function	NN	O	function	prep_of	15	SENT_212	[p14l9t2143r230b2191],
18	and	CC	O	and	_	0	SENT_212	[p14l263t2143r360b2191],
19	might	MD	O	might	aux	20	SENT_212	[p14l392t2143r550b2207],
20	improve	VB	O	improve	conj_and	12	SENT_212	[p14l582t2146r798b2206],
21	the	DT	O	the	det	23	SENT_212	[p14l830t2143r912b2191],
22	ischaemic	JJ	O	ischaemic	amod	23	SENT_212	[p14l945t2143r1207b2191],
23	beneﬁts	NNS	O	beneﬁts	dobj	20	SENT_212	[p14l1238t2143r1444b2191],
24	of	IN	O	of	_	0	SENT_212	[p14l1479t2143r1538b2191],
25	clopidogrel	NN	O	clopidogrel	prep_of	23	SENT_212	[p14l10t2220r298b2284],
26	while	IN	O	while	_	0	SENT_212	[p14l335t2220r477b2269],
27	simultaneously	RB	O	simultaneously	advmod	28	SENT_212	[p14l519t2220r917b2284],
28	increasing	VBG	O	increase	prepc_while	20	SENT_212	[p14l955t2223r1226b2284],
29	associated	VBN	O	associate	dep	28	SENT_212	[p14l1265t2220r1529b2269],
30	bleeding	JJ	O	bleeding	amod	31	SENT_212	[p14l8t2298r233b2362],
31	risks	NNS	O	risk	dobj	29	SENT_212	[p14l249t2298r455b2346],
32	?	.	O	?	_	0	SENT_212	[p14l249t2298r455b2346],

1	“	NN	O	“	nsubj	21	SENT_213	[p14l249t2298r455b2346],
2	Despite	IN	O	despite	_	0	SENT_213	[p14l474t2301r669b2361],
3	being	VBG	O	be	cop	6	SENT_213	[p14l684t2298r831b2362],
4	a	DT	O	a	det	6	SENT_213	[p14l848t2315r875b2347],
5	common	JJ	O	common	amod	6	SENT_213	[p14l892t2315r1127b2347],
6	allele	NN	O	allele	prepc_despite	21	SENT_213	[p14l1144t2298r1289b2354],
7	,	,	O	,	_	0	SENT_213	[p14l1144t2298r1289b2354],
8	the	DT	O	the	det	11	SENT_213	[p14l1307t2298r1389b2347],
9	ideal	JJ	O	ideal	amod	11	SENT_213	[p14l1406t2298r1529b2347],
10	treatment	NN	O	treatment	nn	11	SENT_213	[p14l8t2386r265b2425],
11	strategy	NN	O	strategy	appos	6	SENT_213	[p14l289t2386r489b2441],
12	for	IN	O	for	_	0	SENT_213	[p14l510t2377r585b2425],
13	C	NN	O	c	nn	14	SENT_213	[p14l611t2380r650b2425],
14	YP2C19	NN	O	yp2c19	prep_for	11	SENT_213	[p14l654t2380r942b2426],
15	"	''	O	"	punct	11	SENT_213	[p14l654t2380r942b2426],
16	"	``	O	"	punct	11	SENT_213	[p14l654t2380r942b2426],
17	17	CD	NUMBER	17	num	18	SENT_213	[p14l654t2380r942b2426],
18	carriers	NNS	O	carrier	dep	11	SENT_213	[p14l959t2380r1153b2425],
19	after	IN	O	after	_	0	SENT_213	[p14l1178t2377r1295b2425],
20	PCI	NNP	O	PCI	prep_after	18	SENT_213	[p14l1319t2380r1414b2425],
21	has	VBZ	O	have	_	0	SENT_213	[p14l1439t2377r1527b2425],
22	yet	RB	O	yet	advmod	21	SENT_213	[p14l8t2464r83b2518],
23	to	TO	O	to	aux	25	SENT_213	[p14l111t2464r159b2503],
24	be	VB	O	be	auxpass	25	SENT_213	[p14l189t2454r249b2503],
25	clariﬁed	VBN	O	clariﬁed	xcomp	21	SENT_213	[p14l280t2454r501b2503],
26	.	.	O	.	_	0	SENT_213	[p14l280t2454r501b2503],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_214	[p14l536t2454r987b2518],
2	guidelines	NNS	O	guideline	nsubj	3	SENT_214	[p14l1017t2454r1317b2518],
3	”	VBP	O	”	_	0	SENT_214	[p14l1017t2454r1317b2518],
4	recommend	VB	O	recommend	dep	3	SENT_214	[p14l1347t2472r1527b2503, p14l9t2532r163b2581],
5	that	IN	O	that	complm	13	SENT_214	[p14l213t2532r315b2581],
6	CYP2C19	NN	O	cyp2c19	nn	8	SENT_214	[p14l371t2535r702b2581],
7	’	CD	NUMBER	’	num	8	SENT_214	[p14l371t2535r702b2581],
8	~	NN	O	~	nsubjpass	13	SENT_214	[p14l371t2535r702b2581],
9	‘	CD	NUMBER	‘	num	11	SENT_214	[p14l371t2535r702b2581],
10	17	CD	NUMBER	17	num	11	SENT_214	[p14l371t2535r702b2581],
11	carriers	NNS	O	carrier	dep	8	SENT_214	[p14l749t2535r942b2581],
12	be	VB	O	be	auxpass	13	SENT_214	[p14l996t2532r1056b2581],
13	given	VBN	O	give	ccomp	4	SENT_214	[p14l1110t2535r1250b2596],
14	standard	JJ	O	standard	amod	15	SENT_214	[p14l1304t2532r1529b2581],
15	treatment	NN	O	treatment	dobj	13	SENT_214	[p14l8t2620r265b2659],
16	with	IN	O	with	_	0	SENT_214	[p14l302t2611r418b2659],
17	75	CD	NUMBER	75	num	19	SENT_214	[p14l457t2614r511b2661],
18	mg	NN	O	mg	nn	19	SENT_214	[p14l553t2628r639b2675],
19	clopidogrel	NN	O	clopidogrel	prep_with	15	SENT_214	[p14l679t2611r968b2675],
20	daily	RB	SET	daily	advmod	13	SENT_214	[p14l1008t2611r1136b2674],
21	,	,	O	,	_	0	SENT_214	[p14l1008t2611r1136b2674],
22	but	CC	O	but	_	0	SENT_214	[p14l1177t2611r1265b2659],
23	the	DT	O	the	det	26	SENT_214	[p14l1302t2611r1384b2659],
24	best	JJS	O	best	amod	26	SENT_214	[p14l1423t2611r1529b2659],
25	possible	JJ	O	possible	amod	26	SENT_214	[p14l9t2688r220b2751],
26	approach	NN	O	approach	nsubj	30	SENT_214	[p14l249t2688r489b2751],
27	for	IN	O	for	_	0	SENT_214	[p14l516t2688r591b2737],
28	compound	NN	O	compound	nn	29	SENT_214	[p14l619t2688r902b2751],
29	heterozygotes	NNS	O	heterozygote	prep_for	26	SENT_214	[p14l928t2688r1285b2752],
30	carrying	VBG	O	carry	conj_but	3	SENT_214	[p14l1316t2691r1529b2752],
31	both	CC	O	both	dep	34	SENT_214	[p14l8t2766r126b2815],
32	the	DT	O	the	det	34	SENT_214	[p14l153t2766r235b2815],
33	C	NN	O	c	nn	34	SENT_214	[p14l268t2769r307b2815],
34	YP2C19	NN	O	yp2c19	dobj	30	SENT_214	[p14l311t2769r599b2815],
35	"	''	O	"	punct	34	SENT_214	[p14l311t2769r599b2815],
36	"	``	O	"	punct	38	SENT_214	[p14l311t2769r599b2815],
37	17	CD	NUMBER	17	num	38	SENT_214	[p14l311t2769r599b2815],
38	allele	NN	O	allele	nsubj	43	SENT_214	[p14l622t2766r754b2815],
39	and	CC	O	and	_	0	SENT_214	[p14l783t2766r880b2815],
40	a	DT	O	a	det	42	SENT_214	[p14l908t2783r935b2815],
41	loss-oﬁfunction	JJ	O	loss-oﬁfunction	amod	42	SENT_214	[p14l962t2766r1367b2815],
42	allele	NN	O	allele	nsubj	43	SENT_214	[p14l1396t2766r1528b2815],
43	has	VBZ	O	have	rcmod	34	SENT_214	[p14l8t2845r96b2893],
44	yet	RB	O	yet	advmod	43	SENT_214	[p14l117t2854r193b2908],
45	to	TO	O	to	aux	47	SENT_214	[p14l211t2854r260b2893],
46	be	VB	O	be	auxpass	47	SENT_214	[p14l280t2845r341b2893],
47	addressed	VBN	O	address	xcomp	43	SENT_214	[p14l362t2845r667b2893],
48	.	.	O	.	_	0	SENT_214	[p14l362t2845r667b2893],

1	”	NN	O	”	nsubj	6	SENT_215	[p14l362t2845r667b2893],
2	Other	JJ	O	other	amod	5	SENT_215	[p14l690t2845r841b2893],
3	common	JJ	O	common	amod	5	SENT_215	[p14l861t2862r1097b2893],
4	genetic	JJ	O	genetic	amod	5	SENT_215	[p14l1118t2848r1304b2909],
5	variants	NNS	O	variant	dep	1	SENT_215	[p14l1322t2848r1527b2893],
6	implicated	VBN	O	implicate	_	0	SENT_215	[p14l9t2922r284b2985],
7	in	IN	O	in	_	0	SENT_215	[p14l314t2925r366b2970],
8	adverse	JJ	O	adverse	amod	9	SENT_215	[p14l397t2922r591b2971],
9	events	NNS	O	event	prep_in	6	SENT_215	[p14l622t2932r784b2971],
10	with	IN	O	with	_	0	SENT_215	[p14l815t2922r931b2971],
11	clopidogrel	NN	O	clopidogrel	prep_with	6	SENT_215	[p14l962t2922r1250b2986],
12	after	IN	O	after	mark	14	SENT_215	[p14l1281t2922r1398b2971],
13	PCI	NNP	O	PCI	nsubj	14	SENT_215	[p14l1430t2926r1525b2971],
14	include	VBP	O	include	advcl	6	SENT_215	[p14l9t3000r202b3049],
15	AB	NNP	O	AB	nn	19	SENT_215	[p14l218t3004r299b3048],
16	C	NNP	O	C	nn	19	SENT_215	[p14l306t3004r344b3049],
17	B1	NN	O	b1	nn	19	SENT_215	[p14l347t3005r407b3048],
18	343	CD	NUMBER	343	num	19	SENT_215	[p14l425t3005r508b3049],
19	5C	NN	O	5c	nsubj	22	SENT_215	[p14l515t3003r685b3049],
20	—	CD	NUMBER	—	num	22	SENT_215	[p14l515t3003r685b3049],
21	>	JJR	O	>	amod	22	SENT_215	[p14l515t3003r685b3049],
22	T	NN	O	t	xcomp	14	SENT_215	[p14l515t3003r685b3049],
23	and	CC	O	and	_	0	SENT_215	[p14l701t3000r798b3049],
24	PON1	NN	O	pon1	nn	25	SENT_215	[p14l818t3004r970b3049],
25	Gln192Arg	NN	O	gln192arg	conj_and	22	SENT_215	[p14l987t3000r1281b3064],
26	;	:	O	;	_	0	SENT_215	[p14l987t3000r1281b3064],
27	however	RB	O	however	advmod	37	SENT_215	[p14l1299t3000r1526b3056],
28	,	,	O	,	_	0	SENT_215	[p14l1299t3000r1526b3056],
29	the	DT	O	the	det	30	SENT_215	[p14l8t3078r90b3126],
30	importance	NN	O	importance	nsubjpass	37	SENT_215	[p14l156t3081r454b3141],
31	of	IN	O	of	_	0	SENT_215	[p14l522t3078r580b3126],
32	both	DT	O	both	predet	34	SENT_215	[p14l636t3078r754b3126],
33	these	DT	O	these	det	34	SENT_215	[p14l819t3078r956b3126],
34	alleles	NNS	O	allele	prep_of	30	SENT_215	[p14l1023t3078r1180b3126],
35	has	VBZ	O	have	aux	37	SENT_215	[p14l1247t3078r1335b3126],
36	been	VBN	O	be	auxpass	37	SENT_215	[p14l1402t3078r1529b3126],
37	challenged	VBN	O	challenge	parataxis	6	SENT_215	[p14l10t3155r493b3219],
38	.	.	O	.	_	0	SENT_215	[p14l10t3155r493b3219],

1	”’	NN	O	”’	nn	3	SENT_216	[p14l10t3155r493b3219],
2	21	CD	NUMBER	21	num	3	SENT_216	[p14l10t3155r493b3219],
3	’	NN	O	’	nsubj	14	SENT_216	[p14l10t3155r493b3219],
4	3	CD	NUMBER	3	num	5	SENT_216	[p14l10t3155r493b3219],
5	°	NN	O	°	dep	3	SENT_216	[p14l10t3155r493b3219],
6	’	CD	NUMBER	’	number	7	SENT_216	[p14l10t3155r493b3219],
7	33	CD	NUMBER	33	dep	3	SENT_216	[p14l10t3155r493b3219],
8	'35	CD	NUMBER	'35	dep	7	SENT_216	[p14l10t3155r493b3219],
9	As	IN	O	as	_	0	SENT_216	[p14l505t3159r571b3204],
10	a	DT	O	a	det	11	SENT_216	[p14l585t3173r612b3204],
11	result	NN	O	result	prep_as	14	SENT_216	[p14l624t3155r784b3211],
12	,	,	O	,	_	0	SENT_216	[p14l624t3155r784b3211],
13	we	PRP	O	we	nsubj	14	SENT_216	[p14l796t3173r869b3204],
14	elected	VBD	O	elect	_	0	SENT_216	[p14l882t3155r1062b3204],
15	not	RB	O	not	neg	17	SENT_216	[p14l1073t3165r1159b3204],
16	to	TO	O	to	aux	17	SENT_216	[p14l1169t3165r1218b3204],
17	incorporate	VB	O	incorporate	xcomp	14	SENT_216	[p14l1230t3158r1528b3218],
18	these	DT	O	these	det	20	SENT_216	[p14l8t3233r145b3282],
19	additional	JJ	O	additional	amod	20	SENT_216	[p14l163t3233r421b3282],
20	alleles	NNS	O	allele	dobj	17	SENT_216	[p14l439t3233r596b3282],
21	into	IN	O	into	_	0	SENT_216	[p14l614t3236r715b3282],
22	our	PRP$	O	we	poss	23	SENT_216	[p14l734t3251r823b3282],
23	trial	NN	O	trial	prep_into	17	SENT_216	[p14l838t3233r953b3282],
24	.	.	O	.	_	0	SENT_216	[p14l838t3233r953b3282],

1	A	DT	O	a	det	2	SENT_217	[p15l59t24r101b68],
2	method	NN	O	method	nsubj	23	SENT_217	[p15l139t21r342b69],
3	to	TO	O	to	aux	4	SENT_217	[p15l379t30r427b69],
4	detect	VB	O	detect	infmod	2	SENT_217	[p15l467t21r620b69],
5	several	JJ	O	several	amod	6	SENT_217	[p15l660t21r836b69],
6	alleles	NNS	O	allele	nsubj	10	SENT_217	[p15l875t21r1032b69],
7	will	MD	O	will	aux	10	SENT_217	[p15l1071t21r1166b69],
8	probably	RB	O	probably	advmod	10	SENT_217	[p15l1204t21r1431b84],
9	be	VB	O	be	cop	10	SENT_217	[p15l1467t21r1528b69],
10	necessary	JJ	O	necessary	conj_and	10	SENT_217	[p15l9t115r261b162],
11	for	IN	O	for	_	0	SENT_217	[p15l287t98r361b147],
12	large	JJ	O	large	amod	13	SENT_217	[p15l386t98r513b162],
13	studies	NNS	O	study	prep_for	10	SENT_217	[p15l542t98r723b147],
14	and	CC	O	and	_	0	SENT_217	[p15l752t98r849b147],
15	as	IN	O	as	_	0	SENT_217	[p15l875t115r926b147],
16	further	JJ	O	further	amod	17	SENT_217	[p15l955t98r1139b147],
17	evidence	NN	O	evidence	prep_as	10	SENT_217	[p15l1166t98r1390b147],
18	supporting	VBG	O	support	partmod	17	SENT_217	[p15l1419t115r1527b161, p15l9t179r200b240],
19	other	JJ	O	other	amod	21	SENT_217	[p15l215t176r352b224],
20	genetic	JJ	O	genetic	amod	21	SENT_217	[p15l367t179r552b240],
21	variants	NNS	O	variant	dobj	18	SENT_217	[p15l565t179r769b224],
22	becomes	VBZ	O	become	cop	23	SENT_217	[p15l785t176r1013b224],
23	available	JJ	O	available	_	0	SENT_217	[p15l1031t176r1265b224],
24	.	.	O	.	_	0	SENT_217	[p15l1031t176r1265b224],

1	Although	IN	O	although	mark	10	SENT_218	[p15l1282t176r1529b240],
2	the	DT	O	the	det	6	SENT_218	[p15l8t254r90b302],
3	CYP2C19	NN	O	cyp2c19	nn	6	SENT_218	[p15l115t257r416b302],
4	*	NN	O	*	nn	6	SENT_218	[p15l115t257r416b302],
5	2	CD	NUMBER	2	num	6	SENT_218	[p15l115t257r416b302],
6	allele	NN	O	allele	nsubj	10	SENT_218	[p15l438t254r570b302],
7	is	VBZ	O	be	cop	10	SENT_218	[p15l590t257r630b302],
8	a	DT	O	a	det	10	SENT_218	[p15l652t271r679b302],
9	powerful	JJ	O	powerful	amod	10	SENT_218	[p15l698t254r930b317],
10	predictor	NN	O	predictor	advcl	32	SENT_218	[p15l949t254r1186b317],
11	of	IN	O	of	_	0	SENT_218	[p15l1205t254r1263b302],
12	treatment	NN	O	treatment	nn	13	SENT_218	[p15l1272t263r1529b302],
13	failures	NNS	O	failure	prep_of	10	SENT_218	[p15l9t331r202b380],
14	with	IN	O	with	_	0	SENT_218	[p15l226t331r342b380],
15	clopidogrel	NN	O	clopidogrel	prep_with	13	SENT_218	[p15l367t331r655b395],
16	after	IN	O	after	_	0	SENT_218	[p15l680t331r797b380],
17	PCI	NNP	O	PCI	prep_after	15	SENT_218	[p15l823t335r934b387],
18	,	,	O	,	_	0	SENT_218	[p15l823t335r934b387],
19	the	DT	O	the	det	20	SENT_218	[p15l959t331r1041b380],
20	development	NN	O	development	nsubj	32	SENT_218	[p15l1066t331r1404b394],
21	of	IN	O	of	_	0	SENT_218	[p15l1428t331r1486b380],
22	a	DT	O	a	det	25	SENT_218	[p15l1502t349r1529b380],
23	genetic	JJ	O	genetic	amod	25	SENT_218	[p15l10t412r196b473],
24	risk	NN	O	risk	nn	25	SENT_218	[p15l231t409r329b457],
25	score	NN	NUMBER	score	prep_of	20	SENT_218	[p15l365t426r498b457],
26	that	WDT	O	that	nsubj	27	SENT_218	[p15l533t409r634b457],
27	incorporates	VBZ	O	incorporate	rcmod	25	SENT_218	[p15l668t412r990b472],
28	several	JJ	O	several	amod	29	SENT_218	[p15l1029t409r1205b457],
29	alleles	NNS	O	allele	dobj	27	SENT_218	[p15l1241t409r1398b457],
30	will	MD	O	will	aux	32	SENT_218	[p15l1434t409r1529b457],
31	probably	RB	O	probably	advmod	32	SENT_218	[p15l9t487r236b551],
32	improve	VB	O	improve	_	0	SENT_218	[p15l253t491r469b551],
33	the	DT	O	the	det	34	SENT_218	[p15l487t487r569b536],
34	ability	NN	O	ability	dobj	32	SENT_218	[p15l589t487r746b551],
35	to	TO	O	to	aux	36	SENT_218	[p15l762t497r811b536],
36	identify	VB	O	identify	infmod	34	SENT_218	[p15l830t487r1029b551],
37	at-risk	JJ	O	at-risk	amod	38	SENT_218	[p15l1047t487r1209b536],
38	individuals	NNS	O	individual	dobj	36	SENT_218	[p15l1226t487r1525b536],
39	.	.	O	.	_	0	SENT_218	[p15l1226t487r1525b536],

1	This	DT	O	this	det	2	SENT_219	[p15l8t565r122b614],
2	notion	NN	O	notion	nsubjpass	5	SENT_219	[p15l139t568r309b614],
3	was	VBD	O	be	auxpass	5	SENT_219	[p15l322t582r419b614],
4	retrospectively	RB	O	retrospectively	advmod	5	SENT_219	[p15l436t565r812b629],
5	supported	VBN	O	support	_	0	SENT_219	[p15l828t565r1089b628],
6	by	IN	O	by	_	0	SENT_219	[p15l1102t565r1164b629],
7	a	DT	O	a	det	10	SENT_219	[p15l1178t583r1204b614],
8	case-control	JJ	O	case-control	amod	10	SENT_219	[p15l1219t565r1529b614],
9	study	NN	O	study	nn	10	SENT_219	[p15l11t643r179b707],
10	”	NN	O	”	agent	5	SENT_219	[p15l11t643r179b707],
11	that	WDT	O	that	nsubj	12	SENT_219	[p15l196t643r297b692],
12	showed	VBD	O	show	rcmod	10	SENT_219	[p15l314t643r512b692],
13	that	IN	O	that	complm	18	SENT_219	[p15l527t643r628b692],
14	risk	NN	O	risk	nsubj	18	SENT_219	[p15l643t643r742b692],
15	of	IN	O	of	_	0	SENT_219	[p15l758t643r816b692],
16	stent	JJ	O	stent	amod	17	SENT_219	[p15l826t653r952b692],
17	thrombosis	NN	O	thrombosis	prep_of	14	SENT_219	[p15l966t643r1262b692],
18	increased	VBD	O	increase	ccomp	12	SENT_219	[p15l1281t643r1529b692],
19	witli	NNS	O	witlus	iobj	18	SENT_219	[p15l8t721r123b769],
20	the	DT	O	the	det	21	SENT_219	[p15l141t721r222b769],
21	number	NN	O	number	dobj	18	SENT_219	[p15l241t721r453b769],
22	of	IN	O	of	_	0	SENT_219	[p15l471t721r530b769],
23	at-risk	JJ	O	at-risk	amod	24	SENT_219	[p15l539t721r701b769],
24	alleles	NNS	O	allele	prep_of	21	SENT_219	[p15l718t721r875b769],
25	carried	VBN	O	carry	partmod	24	SENT_219	[p15l896t721r1076b769],
26	by	IN	O	by	_	0	SENT_219	[p15l1092t721r1153b784],
27	an	DT	O	a	det	28	SENT_219	[p15l1171t738r1234b769],
28	individual	NN	O	individual	agent	25	SENT_219	[p15l1252t721r1525b769],
29	.	.	O	.	_	0	SENT_219	[p15l1252t721r1525b769],

1	An	DT	O	a	det	3	SENT_220	[p15l8t802r86b846],
2	improved	VBN	O	improve	amod	3	SENT_220	[p15l104t798r355b861],
3	ability	NN	O	ability	nsubj	17	SENT_220	[p15l373t798r530b862],
4	to	TO	O	to	aux	5	SENT_220	[p15l546t808r595b847],
5	discriminate	VB	O	discriminate	infmod	3	SENT_220	[p15l614t798r941b847],
6	between	IN	O	between	_	0	SENT_220	[p15l958t798r1176b847],
7	patients	NNS	O	patient	prep_between	5	SENT_220	[p15l1194t801r1398b861],
8	who	WP	O	who	nsubj	13	SENT_220	[p15l1417t798r1528b847],
9	will	MD	O	will	aux	13	SENT_220	[p15l8t876r102b925],
10	and	CC	O	and	cc	13	SENT_220	[p15l121t876r217b925],
11	will	MD	O	will	aux	13	SENT_220	[p15l233t876r327b925],
12	not	RB	O	not	neg	13	SENT_220	[p15l345t886r431b925],
13	respond	VB	O	respond	rcmod	7	SENT_220	[p15l448t876r661b939],
14	to	TO	O	to	_	0	SENT_220	[p15l677t886r725b925],
15	clopidogrel	NN	O	clopidogrel	prep_to	13	SENT_220	[p15l745t876r1033b940],
16	should	MD	O	should	aux	17	SENT_220	[p15l1053t876r1229b925],
17	strengthen	VB	O	strengthen	_	0	SENT_220	[p15l1248t876r1529b940],
18	the	DT	O	the	det	20	SENT_220	[p15l8t955r90b1003],
19	clinical	JJ	O	clinical	amod	20	SENT_220	[p15l120t955r303b1003],
20	potential	NN	O	potential	dobj	17	SENT_220	[p15l332t955r560b1018],
21	of	IN	O	of	_	0	SENT_220	[p15l589t955r648b1003],
22	a	DT	O	a	det	24	SENT_220	[p15l668t972r694b1003],
23	pharmacogenetic	JJ	O	pharmacogenetic	amod	24	SENT_220	[p15l723t955r1173b1019],
24	strategy	NN	O	strategy	prep_of	20	SENT_220	[p15l1203t964r1404b1019],
25	and	CC	O	and	_	0	SENT_220	[p15l1432t955r1529b1003],
26	emphasise	VB	O	emphasise	conj_and	17	SENT_220	[p15l10t1032r287b1095],
27	the	DT	O	the	det	28	SENT_220	[p15l304t1032r385b1081],
28	need	NN	O	need	dobj	26	SENT_220	[p15l403t1032r529b1081],
29	for	IN	O	for	_	0	SENT_220	[p15l545t1032r620b1081],
30	future	JJ	DATE	future	amod	31	SENT_220	[p15l635t1032r795b1081],
31	investigations	NNS	O	investigation	prep_for	28	SENT_220	[p15l812t1035r1185b1096],
32	.	.	O	.	_	0	SENT_220	[p15l812t1035r1185b1096],

1	An	DT	O	a	det	3	SENT_221	[p15l59t1113r138b1158],
2	alternative	JJ	O	alternative	amod	3	SENT_221	[p15l177t1110r459b1158],
3	strategy	NN	O	strategy	nsubj	11	SENT_221	[p15l500t1120r710b1174],
4	for	IN	O	for	_	0	SENT_221	[p15l748t1110r824b1158],
5	personalisation	NN	O	personalisation	prep_for	3	SENT_221	[p15l862t1110r1279b1173],
6	of	IN	O	of	_	0	SENT_221	[p15l1318t1110r1378b1158],
7	antiplatelet	JJ	O	antiplatelet	amod	8	SENT_221	[p15l1408t1113r1527b1158, p15l9t1189r207b1252],
8	treatment	NN	O	treatment	prep_of	5	SENT_221	[p15l227t1198r494b1237],
9	is	VBZ	O	be	cop	11	SENT_221	[p15l516t1192r557b1237],
10	platelet-function	JJ	O	platelet-function	amod	11	SENT_221	[p15l581t1189r1029b1252],
11	testing	NN	O	testing	_	0	SENT_221	[p15l1050t1192r1248b1253],
12	.	.	O	.	_	0	SENT_221	[p15l1050t1192r1248b1253],

1	Its	PRP$	O	its	poss	2	SENT_222	[p15l1276t1194r1340b1237],
2	ability	NN	O	ability	nsubj	17	SENT_222	[p15l1365t1189r1530b1253],
3	to	TO	O	to	aux	5	SENT_222	[p15l8t1276r58b1315],
4	simultaneously	RB	O	simultaneously	advmod	5	SENT_222	[p15l109t1266r524b1330],
5	account	VB	O	account	infmod	2	SENT_222	[p15l572t1276r782b1315],
6	for	IN	O	for	_	0	SENT_222	[p15l829t1266r906b1315],
7	all	PDT	O	all	predet	9	SENT_222	[p15l955t1266r1016b1315],
8	the	DT	O	the	det	9	SENT_222	[p15l1063t1266r1147b1315],
9	factors	NNS	O	factor	prep_for	5	SENT_222	[p15l1196t1266r1375b1315],
10	that	WDT	O	that	nsubj	11	SENT_222	[p15l1424t1266r1530b1315],
11	modulate	VBP	O	modulate	ccomp	9	SENT_222	[p15l9t1344r264b1392],
12	platelet	NN	O	platelet	nn	13	SENT_222	[p15l280t1344r478b1407],
13	activity	NN	O	activity	dobj	11	SENT_222	[p15l493t1347r683b1408],
14	is	VBZ	O	be	cop	17	SENT_222	[p15l697t1347r739b1392],
15	its	PRP$	O	its	poss	17	SENT_222	[p15l756t1347r817b1392],
16	main	JJ	O	main	amod	17	SENT_222	[p15l835t1347r975b1392],
17	advantage	NN	O	advantage	_	0	SENT_222	[p15l992t1344r1274b1408],
18	.	.	O	.	_	0	SENT_222	[p15l992t1344r1274b1408],

1	Genetics	NNP	O	Genetics	nsubj	6	SENT_223	[p15l1295t1347r1527b1392],
2	is	VBZ	O	be	aux	6	SENT_223	[p15l9t1426r50b1471],
3	only	RB	O	only	advmod	6	SENT_223	[p15l93t1422r208b1486],
4	one	CD	NUMBER	one	num	5	SENT_223	[p15l247t1440r343b1471],
5	factor	NN	O	factor	pobj	3	SENT_223	[p15l383t1422r537b1471],
6	affecting	VBG	O	affect	_	0	SENT_223	[p15l577t1423r811b1486],
7	platelet	NN	O	platelet	nn	8	SENT_223	[p15l850t1422r1048b1486],
8	activity	NN	O	activity	dobj	6	SENT_223	[p15l1087t1426r1285b1486],
9	,	,	O	,	_	0	SENT_223	[p15l1087t1426r1285b1486],
10	and	CC	O	and	_	0	SENT_223	[p15l1328t1422r1427b1471],
11	its	PRP$	O	its	poss	12	SENT_223	[p15l1465t1426r1527b1471],
12	correlation	NN	O	correlation	nsubj	20	SENT_223	[p15l10t1499r303b1548],
13	with	IN	O	with	_	0	SENT_223	[p15l333t1499r453b1548],
14	instantaneous	JJ	O	instantaneous	amod	16	SENT_223	[p15l485t1502r866b1548],
15	platelet	NN	O	platelet	nn	16	SENT_223	[p15l900t1499r1098b1562],
16	inhibition	NN	O	inhibition	prep_with	12	SENT_223	[p15l1129t1499r1400b1548],
17	will	MD	O	will	aux	20	SENT_223	[p15l1430t1499r1529b1548],
18	not	RB	O	not	neg	20	SENT_223	[p15l9t1586r98b1625],
19	be	VB	O	be	cop	20	SENT_223	[p15l126t1577r188b1625],
20	absolute	JJ	O	absolute	conj_and	6	SENT_223	[p15l220t1577r459b1625],
21	.	.	O	.	_	0	SENT_223	[p15l220t1577r459b1625],

1	However	RB	O	however	advmod	6	SENT_224	[p15l495t1582r743b1633],
2	,	,	O	,	_	0	SENT_224	[p15l495t1582r743b1633],
3	platelet	NN	O	platelet	nn	4	SENT_224	[p15l776t1577r973b1640],
4	activity	NN	O	activity	nsubj	9	SENT_224	[p15l1004t1580r1193b1641],
5	is	VBZ	O	be	cop	6	SENT_224	[p15l1223t1580r1264b1625],
6	dynamic	JJ	O	dynamic	_	0	SENT_224	[p15l1297t1577r1529b1641],
7	and	CC	O	and	_	0	SENT_224	[p15l10t1655r109b1704],
8	could	MD	O	could	aux	9	SENT_224	[p15l126t1655r274b1704],
9	have	VB	O	have	conj_and	6	SENT_224	[p15l289t1655r412b1704],
10	large	JJ	O	large	amod	12	SENT_224	[p15l429t1655r562b1719],
11	temporal	JJ	O	temporal	amod	12	SENT_224	[p15l579t1655r824b1719],
12	ﬂuctuations	NNS	O	ﬂuctuations	dobj	9	SENT_224	[p15l841t1655r1178b1711],
13	,	,	O	,	_	0	SENT_224	[p15l841t1655r1178b1711],
14	especially	RB	O	especially	rcmod	12	SENT_224	[p15l1198t1655r1459b1719],
15	in	IN	O	in	dep	14	SENT_224	[p15l1475t1659r1529b1703],
16	the	DT	O	the	det	17	SENT_224	[p15l8t1733r92b1782],
17	context	NN	O	context	pobj	15	SENT_224	[p15l114t1743r309b1782],
18	of	IN	O	of	_	0	SENT_224	[p15l329t1733r389b1782],
19	acute	JJ	O	acute	amod	21	SENT_224	[p15l401t1743r541b1782],
20	coronary	JJ	O	coronary	amod	21	SENT_224	[p15l564t1750r801b1797],
21	syndrome	NN	O	syndrome	prep_of	17	SENT_224	[p15l822t1733r1104b1797],
22	;	:	O	;	_	0	SENT_224	[p15l822t1733r1104b1797],
23	by	IN	O	by	_	0	SENT_224	[p15l1127t1733r1190b1797],
24	contrast	NN	O	contrast	prep_by	31	SENT_224	[p15l1210t1743r1440b1789],
25	,	,	O	,	_	0	SENT_224	[p15l1210t1743r1440b1789],
26	an	DT	O	a	det	27	SENT_224	[p15l1464t1750r1529b1782],
27	individual	JJ	O	individual	poss	29	SENT_224	[p15l9t1811r321b1859],
28	’s	POS	O	’s	_	0	SENT_224	[p15l9t1811r321b1859],
29	genotype	NN	O	genotype	nsubj	31	SENT_224	[p15l345t1821r588b1875],
30	is	VBZ	O	be	cop	31	SENT_224	[p15l610t1814r651b1859],
31	constant	JJ	O	constant	parataxis	6	SENT_224	[p15l675t1821r918b1859],
32	.	.	O	.	_	0	SENT_224	[p15l675t1821r918b1859],

1	Another	DT	O	another	det	2	SENT_225	[p15l941t1811r1165b1859],
2	advantage	NN	O	advantage	nsubj	5	SENT_225	[p15l1186t1811r1455b1875],
3	of	IN	O	of	_	0	SENT_225	[p15l1478t1811r1538b1859],
4	genetics	NNS	O	genetics	prep_of	2	SENT_225	[p15l10t1893r229b1953],
5	is	VBZ	O	be	_	0	SENT_225	[p15l249t1893r290b1938],
6	that	IN	O	that	complm	11	SENT_225	[p15l310t1889r415b1938],
7	an	DT	O	a	det	9	SENT_225	[p15l433t1907r497b1938],
8	on-treatment	JJ	O	on-treatment	amod	9	SENT_225	[p15l516t1899r870b1938],
9	analysis	NN	O	analysis	nsubj	11	SENT_225	[p15l888t1889r1100b1953],
10	is	VBZ	O	be	cop	11	SENT_225	[p15l1120t1893r1161b1938],
11	unnecessary	JJ	O	unnecessary	ccomp	5	SENT_225	[p15l1180t1907r1525b1953],
12	.	.	O	.	_	0	SENT_225	[p15l1180t1907r1525b1953],
13	'	''	O	'	_	0	SENT_225	[p15l6t2193r54b2392],

1	Articles	NNPS	O	Articles	_	0	SENT_226	[p15l101t2356r251b2392],

1	Patients	NNS	O	patient	nsubj	7	SENT_227	[p15l645t2601r855b2645],
2	with	IN	O	with	_	0	SENT_227	[p15l902t2598r1021b2645],
3	acute	JJ	O	acute	amod	5	SENT_227	[p15l1068t2607r1207b2645],
4	coronary	JJ	O	coronary	amod	5	SENT_227	[p15l1256t2615r1490b2660],
5	syndrome	NN	O	syndrome	prep_with	1	SENT_227	[p15l1538t2598r1802b2660],
6	sometimes	RB	O	sometimes	advmod	7	SENT_227	[p15l1852t2601r2142b2645],
7	undergo	VBP	O	undergo	_	0	SENT_227	[p15l641t2673r866b2736],
8	urgent	JJ	O	urgent	amod	11	SENT_227	[p15l891t2683r1070b2736],
9	or	CC	O	or	_	0	SENT_227	[p15l1096t2690r1151b2721],
10	emergent	JJ	O	emergent	amod	11	SENT_227	[p15l1176t2683r1433b2736],
11	PCI	NN	O	pcus	dobj	7	SENT_227	[p15l1461t2676r1558b2721],
12	shortly	RB	O	shortly	advmod	13	SENT_227	[p15l1588t2673r1771b2736],
13	after	IN	O	after	prep	7	SENT_227	[p15l1796t2673r1917b2721],
14	or	CC	O	or	cc	13	SENT_227	[p15l1942t2690r1997b2721],
15	even	RB	O	even	advmod	13	SENT_227	[p15l2022t2690r2144b2721],
16	before	IN	O	before	dep	13	SENT_227	[p15l641t2750r810b2797],
17	single	JJ	O	single	amod	19	SENT_227	[p15l827t2750r984b2813],
18	bolus	NN	O	bolus	nn	19	SENT_227	[p15l998t2750r1142b2797],
19	doses	NNS	O	dose	pobj	16	SENT_227	[p15l1159t2750r1305b2797],
20	of	IN	O	of	_	0	SENT_227	[p15l1322t2750r1381b2797],
21	antiplatelet	JJ	O	antiplatelet	amod	22	SENT_227	[p15l1388t2750r1687b2812],
22	therapy	NN	O	therapy	prep_of	19	SENT_227	[p15l1699t2750r1908b2812],
23	.	.	O	.	_	0	SENT_227	[p15l1699t2750r1908b2812],

1	Because	IN	O	because	mark	4	SENT_228	[p15l1928t2755r2143b2797],
2	platelet	NN	O	platelet	nn	3	SENT_228	[p15l642t2825r837b2887],
3	activity	NN	O	activity	nsubj	4	SENT_228	[p15l868t2828r1055b2888],
4	has	VBZ	O	have	advcl	17	SENT_228	[p15l1084t2825r1173b2873],
5	yet	RB	O	yet	advmod	4	SENT_228	[p15l1204t2835r1281b2888],
6	to	TO	O	to	aux	7	SENT_228	[p15l1310t2835r1359b2873],
7	reach	VB	O	reach	xcomp	4	SENT_228	[p15l1391t2825r1536b2873],
8	steady	JJ	O	steady	amod	9	SENT_228	[p15l1568t2825r1733b2888],
9	state	NN	O	state	dobj	7	SENT_228	[p15l1764t2835r1899b2880],
10	,	,	O	,	_	0	SENT_228	[p15l1764t2835r1899b2880],
11	plateletfunction	NN	O	plateletfunction	nn	12	SENT_228	[p15l1932t2825r2143b2887, p15l642t2901r870b2948],
12	testing	NN	O	testing	nsubj	17	SENT_228	[p15l893t2904r1075b2964],
13	in	IN	O	in	_	0	SENT_228	[p15l1100t2904r1152b2948],
14	this	DT	O	this	det	15	SENT_228	[p15l1176t2901r1274b2948],
15	period	NN	O	period	prep_in	12	SENT_228	[p15l1300t2901r1472b2963],
16	is	VBZ	O	be	cop	17	SENT_228	[p15l1496t2904r1537b2948],
17	unlikely	JJ	O	unlikely	_	0	SENT_228	[p15l1562t2901r1780b2963],
18	to	TO	O	to	aux	20	SENT_228	[p15l1802t2910r1851b2948],
19	accurately	RB	O	accurately	advmod	20	SENT_228	[p15l1877t2901r2145b2963],
20	show	VB	O	show	xcomp	17	SENT_228	[p15l644t2978r782b3025],
21	platelet	NN	O	platelet	nn	22	SENT_228	[p15l803t2978r999b3040],
22	inhibition	NN	O	inhibition	dobj	20	SENT_228	[p15l1021t2978r1289b3025],
23	during	IN	O	during	_	0	SENT_228	[p15l1312t2978r1492b3041],
24	chronic	JJ	O	chronic	amod	25	SENT_228	[p15l1516t2978r1717b3025],
25	treatment	NN	O	treatment	prep_during	20	SENT_228	[p15l1740t2987r2016b3025],
26	.	.	O	.	_	0	SENT_228	[p15l1740t2987r2016b3025],

1	The	DT	O	the	det	4	SENT_229	[p15l2041t2978r2143b3025],
2	most	RBS	O	most	advmod	3	SENT_229	[p15l642t3063r776b3101],
3	effective	JJ	O	effective	amod	4	SENT_229	[p15l800t3054r1020b3101],
4	strategy	NN	O	strategy	nsubj	13	SENT_229	[p15l1047t3063r1254b3116],
5	to	TO	O	to	aux	6	SENT_229	[p15l1277t3063r1326b3101],
6	identify	VB	O	identify	infmod	4	SENT_229	[p15l1352t3053r1557b3116],
7	high-risk	JJ	O	high-risk	amod	8	SENT_229	[p15l1580t3053r1824b3116],
8	individuals	NNS	O	individual	dobj	6	SENT_229	[p15l1847t3053r2142b3101],
9	could	MD	O	could	aux	13	SENT_229	[p15l643t3129r789b3177],
10	be	VB	O	be	cop	13	SENT_229	[p15l820t3129r881b3176],
11	a	DT	O	a	det	13	SENT_229	[p15l915t3146r941b3176],
12	hybrid	JJ	O	hybrid	amod	13	SENT_229	[p15l973t3129r1148b3192],
13	approach	NN	O	approach	_	0	SENT_229	[p15l1181t3129r1426b3191],
14	using	VBG	O	use	partmod	13	SENT_229	[p15l1459t3132r1608b3192],
15	both	CC	O	both	preconj	16	SENT_229	[p15l1640t3129r1761b3176],
16	genetics	NNS	O	genetics	dobj	14	SENT_229	[p15l1795t3132r2011b3192],
17	and	CC	O	and	_	0	SENT_229	[p15l2047t3129r2145b3176],
18	platelet-function	JJ	O	platelet-function	amod	19	SENT_229	[p15l642t3205r1084b3267],
19	testing	NN	O	testing	conj_and	16	SENT_229	[p15l1112t3209r1308b3268],
20	,	,	O	,	_	0	SENT_229	[p15l1112t3209r1308b3268],
21	because	IN	O	because	mark	23	SENT_229	[p15l1339t3205r1550b3253],
22	both	DT	O	both	nsubj	23	SENT_229	[p15l1579t3205r1700b3253],
23	predict	VBP	O	predict	advcl	13	SENT_229	[p15l1729t3205r1915b3267],
24	adverse	JJ	O	adverse	amod	25	SENT_229	[p15l1945t3205r2143b3253],
25	events	NNS	O	event	dobj	23	SENT_229	[p15l643t3291r809b3329],
26	after	IN	O	after	_	0	SENT_229	[p15l831t3281r951b3329],
27	PCI	NN	O	pcus	prep_after	23	SENT_229	[p15l972t3285r1085b3329],
28	.	.	O	.	_	0	SENT_229	[p15l972t3285r1085b3329],

1	Our	PRP$	O	we	poss	2	SENT_230	[p16l694t25r797b68],
2	study	NN	O	study	nsubj	3	SENT_230	[p16l837t21r976b84],
3	provides	VBZ	O	provide	_	0	SENT_230	[p16l1014t21r1231b83],
4	further	JJ	O	further	amod	5	SENT_230	[p16l1273t21r1457b68],
5	evidence	NN	O	evidence	dobj	3	SENT_230	[p16l1496t21r1720b68],
6	that	IN	O	that	complm	9	SENT_230	[p16l1759t21r1860b68],
7	prasugrel	NN	O	prasugrel	nsubj	9	SENT_230	[p16l1898t21r2144b84],
8	can	MD	O	can	aux	9	SENT_230	[p16l643t115r732b145],
9	overcome	VB	O	overcome	ccomp	3	SENT_230	[p16l771t115r1021b145],
10	high	JJ	O	high	amod	13	SENT_230	[p16l1060t98r1179b160],
11	on-treatment	JJ	O	on-treatment	amod	13	SENT_230	[p16l1218t107r1557b145],
12	platelet	NN	O	platelet	nn	13	SENT_230	[p16l1595t98r1783b159],
13	reactivity	NN	O	reactivity	dobj	9	SENT_230	[p16l1821t101r2055b160],
14	in	IN	O	in	_	0	SENT_230	[p16l2092t101r2144b144],
15	CYP2C19	NN	O	cyp2c19	prep_in	13	SENT_230	[p16l647t176r951b222],
16	"	''	O	"	punct	15	SENT_230	[p16l647t176r951b222],
17	"	``	O	"	punct	15	SENT_230	[p16l647t176r951b222],
18	2	CD	NUMBER	2	num	19	SENT_230	[p16l647t176r951b222],
19	carriers	NNS	O	carrier	dep	15	SENT_230	[p16l998t176r1205b222],
20	.	.	O	.	_	0	SENT_230	[p16l998t176r1205b222],

1	Previous	JJ	O	previous	amod	3	SENT_231	[p16l1261t176r1481b222],
2	reports2	JJ	O	reports2	amod	3	SENT_231	[p16l1532t177r1832b236],
3	°	NN	O	°	dep	10	SENT_231	[p16l1532t177r1832b236],
4	’	CD	NUMBER	’	num	5	SENT_231	[p16l1532t177r1832b236],
5	36	CD	NUMBER	36	dep	3	SENT_231	[p16l1532t177r1832b236],
6	'	''	O	'	_	0	SENT_231	[p16l1532t177r1832b236],
7	3	CD	NUMBER	3	nsubj	10	SENT_231	[p16l1532t177r1832b236],
8	"	``	O	"	punct	10	SENT_231	[p16l1532t177r1832b236],
9	have	VB	O	have	dep	10	SENT_231	[p16l1880t174r1999b222],
10	had	VBD	O	have	_	0	SENT_231	[p16l2048t174r2145b222],
11	similar	JJ	O	similar	amod	12	SENT_231	[p16l644t250r826b298],
12	results	NNS	O	result	dobj	10	SENT_231	[p16l860t250r1031b298],
13	when	WRB	O	when	advmod	17	SENT_231	[p16l1067t250r1211b298],
14	genetic	JJ	O	genetic	amod	15	SENT_231	[p16l1247t253r1432b313],
15	analysis	NN	O	analysis	nsubjpass	17	SENT_231	[p16l1469t250r1671b313],
16	was	VBD	O	be	auxpass	17	SENT_231	[p16l1707t267r1803b298],
17	done	VBN	O	do	advcl	10	SENT_231	[p16l1841t250r1968b298],
18	retrospectively	RB	O	retrospectively	advmod	17	SENT_231	[p16l2004t260r2142b298, p16l644t327r898b389],
19	.	.	O	.	_	0	SENT_231	[p16l2004t260r2142b298, p16l644t327r898b389],

1	One	CD	NUMBER	one	num	4	SENT_232	[p16l932t331r1039b374],
2	small	JJ	O	small	amod	4	SENT_232	[p16l1071t327r1210b374],
3	prospective	JJ	O	prospective	amod	4	SENT_232	[p16l1239t330r1532b389],
4	study	NN	O	study	nsubj	27	SENT_232	[p16l1563t327r1702b389],
5	involving	VBG	O	involve	partmod	4	SENT_232	[p16l1730t327r1969b390],
6	seven	CD	NUMBER	seven	num	7	SENT_232	[p16l2000t344r2144b374],
7	survivors	NNS	O	survivor	dobj	5	SENT_232	[p16l644t405r877b450],
8	of	IN	O	of	_	0	SENT_232	[p16l896t402r954b450],
9	stent	NN	O	stent	nn	10	SENT_232	[p16l964t412r1089b450],
10	thrombosis	NN	O	thrombosis	prep_of	7	SENT_232	[p16l1104t402r1399b450],
11	(	CD	NUMBER	(	number	12	SENT_232	[p16l1422t405r1507b465],
12	six	CD	NUMBER	six	nsubj	15	SENT_232	[p16l1422t405r1507b465],
13	of	IN	O	of	_	0	SENT_232	[p16l1523t402r1581b450],
14	whom	WP	O	whom	prep_of	12	SENT_232	[p16l1587t402r1753b450],
15	carried	VBD	O	carry	rcmod	7	SENT_232	[p16l1771t402r1950b450],
16	at	IN	O	at	advmod	19	SENT_232	[p16l1966t412r2012b450],
17	least	JJS	O	least	pobj	16	SENT_232	[p16l2027t402r2145b450],
18	one	CD	NUMBER	one	num	19	SENT_232	[p16l643t495r736b525],
19	copy	NN	O	copy	dobj	15	SENT_232	[p16l761t495r879b541],
20	of	IN	O	of	_	0	SENT_232	[p16l901t478r959b525],
21	CYP2C19	NN	O	cyp2c19	prep_of	19	SENT_232	[p16l978t481r1329b541],
22	"	''	O	"	punct	19	SENT_232	[p16l978t481r1329b541],
23	"	``	O	"	punct	24	SENT_232	[p16l978t481r1329b541],
24	2	CD	NUMBER	2	dep	19	SENT_232	[p16l978t481r1329b541],
25	)	CD	NUMBER	)	num	26	SENT_232	[p16l978t481r1329b541],
26	”	NN	O	”	dep	24	SENT_232	[p16l978t481r1329b541],
27	showed	VBD	O	show	_	0	SENT_232	[p16l1355t478r1551b526],
28	that	IN	O	that	complm	32	SENT_232	[p16l1572t478r1673b526],
29	substitution	NN	O	substitution	nsubj	32	SENT_232	[p16l1697t478r2007b526],
30	with	IN	O	with	_	0	SENT_232	[p16l2029t478r2144b526],
31	prasugrel	NN	O	prasugrel	prep_with	29	SENT_232	[p16l642t555r887b618],
32	overcame	VBD	O	overcome	ccomp	27	SENT_232	[p16l915t572r1162b602],
33	high	JJ	O	high	amod	36	SENT_232	[p16l1188t555r1307b618],
34	on-treatment	JJ	O	on-treatment	amod	36	SENT_232	[p16l1334t564r1673b602],
35	platelet	NN	O	platelet	nn	36	SENT_232	[p16l1698t555r1887b617],
36	reactivity	NN	O	reactivity	dobj	32	SENT_232	[p16l1912t558r2146b617],
37	in	IN	O	in	_	0	SENT_232	[p16l642t633r694b677],
38	four	CD	NUMBER	four	num	39	SENT_232	[p16l734t630r844b678],
39	patients	NNS	O	patient	prep_in	36	SENT_232	[p16l883t633r1087b692],
40	who	WP	O	who	nsubj	43	SENT_232	[p16l1127t630r1237b678],
41	did	VBD	O	do	aux	43	SENT_232	[p16l1279t630r1361b678],
42	not	RB	O	not	neg	43	SENT_232	[p16l1401t640r1486b678],
43	have	VB	O	have	rcmod	39	SENT_232	[p16l1525t630r1643b678],
44	adequate	JJ	O	adequate	amod	46	SENT_232	[p16l1685t630r1916b692],
45	platelet	NN	O	platelet	nn	46	SENT_232	[p16l1956t630r2145b692],
46	inhibition	NN	O	inhibition	dobj	43	SENT_232	[p16l642t706r900b754],
47	despite	IN	O	despite	_	0	SENT_232	[p16l949t706r1132b768],
48	clopidogrel	NN	O	clopidogrel	nn	50	SENT_232	[p16l1181t706r1468b769],
49	maintenance	NN	O	maintenance	nn	50	SENT_232	[p16l1516t709r1854b754],
50	doses	NNS	O	dose	prep_despite	43	SENT_232	[p16l1903t706r2044b754],
51	of	IN	O	of	_	0	SENT_232	[p16l2095t706r2153b754],
52	225	CD	NUMBER	225	num	53	SENT_232	[p16l644t786r731b830],
53	mg	NN	O	mg	prep_of	50	SENT_232	[p16l750t800r835b846],
54	every	DT	SET	every	det	55	SENT_232	[p16l852t800r987b845],
55	day	NN	SET	day	dep	53	SENT_232	[p16l1003t783r1097b845],
56	.	.	O	.	_	0	SENT_232	[p16l1003t783r1097b845],

1	The	DT	O	the	det	4	SENT_233	[p16l1115t783r1215b830],
2	potential	JJ	O	potential	amod	4	SENT_233	[p16l1232t783r1459b845],
3	clinical	JJ	O	clinical	amod	4	SENT_233	[p16l1476t783r1659b830],
4	importance	NN	O	importance	nsubjpass	9	SENT_233	[p16l1675t786r1972b845],
5	of	IN	O	of	_	0	SENT_233	[p16l1990t783r2048b830],
6	our	PRP$	O	we	poss	7	SENT_233	[p16l2056t800r2145b830],
7	ﬁndings	NNS	O	ﬁndings	prep_of	4	SENT_233	[p16l642t858r855b921],
8	is	VBZ	O	be	auxpass	9	SENT_233	[p16l898t861r937b906],
9	supported	VBN	O	support	_	0	SENT_233	[p16l981t858r1242b920],
10	by	IN	O	by	_	0	SENT_233	[p16l1281t858r1342b921],
11	the	DT	O	the	det	13	SENT_233	[p16l1380t858r1461b906],
12	genetic	JJ	O	genetic	amod	13	SENT_233	[p16l1503t861r1688b921],
13	analysis	NN	O	analysis	agent	9	SENT_233	[p16l1729t858r1931b921],
14	of	IN	O	of	_	0	SENT_233	[p16l1974t858r2032b906],
15	the	DT	O	the	det	18	SENT_233	[p16l2062t858r2143b906],
16	TRITON-TIMI-38	NN	O	triton-timi-38	nn	18	SENT_233	[p16l641t937r1107b981],
17	(	CD	NUMBER	(	num	18	SENT_233	[p16l1166t934r1296b997],
18	Trial	NN	O	trial	prep_of	13	SENT_233	[p16l1166t934r1296b997],
19	to	TO	O	to	aux	20	SENT_233	[p16l1348t943r1397b981],
20	Assess	VB	O	assess	xcomp	9	SENT_233	[p16l1450t937r1623b981],
21	Improvement	NN	O	improvement	dobj	20	SENT_233	[p16l1681t939r2039b996],
22	in	IN	O	in	_	0	SENT_233	[p16l2092t937r2144b981],
23	Therapeutic	JJ	O	therapeutic	amod	24	SENT_233	[p16l641t1011r954b1073],
24	Outcomes	NNS	O	outcome	prep_in	21	SENT_233	[p16l977t1015r1241b1058],
25	by	IN	O	by	_	0	SENT_233	[p16l1263t1011r1324b1073],
26	Optimizing	VBG	O	optimize	prepc_by	20	SENT_233	[p16l1346t1014r1646b1074],
27	Platelet	NN	O	platelet	nn	28	SENT_233	[p16l1670t1011r1859b1058],
28	Inhibition	NN	O	inhibition	dobj	26	SENT_233	[p16l1883t1011r2144b1058],
29	with	IN	O	with	_	0	SENT_233	[p16l641t1086r756b1134],
30	Prasugrel	NNP	O	Prasugrel	nn	31	SENT_233	[p16l791t1086r1037b1149],
31	Thrombolysis	NNP	O	Thrombolysis	prep_with	26	SENT_233	[p16l1069t1086r1427b1149],
32	in	IN	O	in	_	0	SENT_233	[p16l1461t1089r1513b1133],
33	Myocardial	JJ	O	myocardial	amod	36	SENT_233	[p16l1547t1086r1833b1149],
34	Infarction	NN	O	infarction	nn	36	SENT_233	[p16l1869t1086r2140b1149],
35	)	NN	O	)	nn	36	SENT_233	[p16l1869t1086r2140b1149],
36	study	NN	O	study	prep_in	31	SENT_233	[p16l644t1162r823b1224],
37	,	,	O	,	_	0	SENT_233	[p16l644t1162r823b1224],
38	”	NN	O	”	appos	36	SENT_233	[p16l644t1162r823b1224],
39	which	WDT	O	which	nsubj	40	SENT_233	[p16l857t1162r1016b1210],
40	revealed	VBD	O	reveal	rcmod	38	SENT_233	[p16l1053t1162r1267b1210],
41	that	IN	O	that	complm	49	SENT_233	[p16l1302t1162r1403b1210],
42	the	DT	O	the	det	44	SENT_233	[p16l1437t1162r1518b1210],
43	ischaemic	JJ	O	ischaemic	amod	44	SENT_233	[p16l1555t1162r1816b1210],
44	beneﬁts	NNS	O	beneﬁts	nsubjpass	49	SENT_233	[p16l1851t1162r2056b1210],
45	of	IN	O	of	_	0	SENT_233	[p16l2095t1162r2153b1210],
46	prasugrel	NN	O	prasugrel	prep_of	44	SENT_233	[p16l642t1239r887b1302],
47	are	VBP	O	be	auxpass	49	SENT_233	[p16l905t1256r983b1286],
48	not	RB	O	not	neg	49	SENT_233	[p16l1000t1248r1086b1286],
49	reduced	VBN	O	reduce	ccomp	40	SENT_233	[p16l1102t1239r1310b1286],
50	by	IN	O	by	_	0	SENT_233	[p16l1325t1239r1387b1301],
51	the	DT	O	the	det	52	SENT_233	[p16l1401t1239r1482b1286],
52	CYP2C19	NN	O	cyp2c19	agent	49	SENT_233	[p16l1505t1242r1809b1286],
53	"	''	O	"	punct	52	SENT_233	[p16l1505t1242r1809b1286],
54	"	``	O	"	punct	52	SENT_233	[p16l1505t1242r1809b1286],
55	2	CD	NUMBER	2	num	56	SENT_233	[p16l1505t1242r1809b1286],
56	allele	NN	O	allele	dep	52	SENT_233	[p16l1825t1239r1969b1286],
57	.	.	O	.	_	0	SENT_233	[p16l1825t1239r1969b1286],

1	These	DT	O	these	det	2	SENT_234	[p16l1988t1239r2143b1286],
2	ﬁndings	NNS	O	ﬁndings	nsubj	5	SENT_234	[p16l642t1314r855b1377],
3	are	VBP	O	be	cop	5	SENT_234	[p16l908t1331r985b1362],
4	particularly	RB	O	particularly	advmod	5	SENT_234	[p16l1035t1314r1331b1377],
5	relevant	JJ	O	relevant	_	0	SENT_234	[p16l1379t1314r1586b1362],
6	because	IN	O	because	mark	11	SENT_234	[p16l1634t1314r1839b1362],
7	high-dose	JJ	O	high-dose	amod	8	SENT_234	[p16l1889t1314r2143b1377],
8	clopidogrel	NN	O	clopidogrel	nsubj	11	SENT_234	[p16l643t1390r930b1453],
9	and	CC	O	and	_	0	SENT_234	[p16l944t1390r1040b1438],
10	ticlopidine	NN	O	ticlopidine	conj_and	8	SENT_234	[p16l1051t1390r1326b1452],
11	did	VBD	O	do	ccomp	5	SENT_234	[p16l1340t1390r1422b1438],
12	not	RB	O	not	neg	15	SENT_234	[p16l1433t1400r1519b1438],
13	lower	JJR	O	lower	amod	15	SENT_234	[p16l1530t1390r1674b1438],
14	adverse	JJ	O	adverse	amod	15	SENT_234	[p16l1686t1390r1879b1438],
15	outcomes	NNS	O	outcome	dobj	11	SENT_234	[p16l1893t1400r2142b1438],
16	in	IN	O	in	_	0	SENT_234	[p16l642t1470r694b1514],
17	patients	NNS	O	patient	prep_in	11	SENT_234	[p16l709t1470r913b1529],
18	with	IN	O	with	_	0	SENT_234	[p16l928t1467r1044b1514],
19	high	JJ	O	high	amod	22	SENT_234	[p16l1058t1467r1177b1530],
20	on-treatment	JJ	O	on-treatment	amod	22	SENT_234	[p16l1193t1476r1532b1514],
21	platelet	NN	O	platelet	nn	22	SENT_234	[p16l1546t1467r1735b1529],
22	reactivity	NN	O	reactivity	prep_with	17	SENT_234	[p16l1749t1470r1982b1529],
23	in	IN	O	in	_	0	SENT_234	[p16l1996t1470r2048b1514],
24	the	DT	O	the	det	28	SENT_234	[p16l2062t1467r2143b1514],
25	GRAVITAS	NNP	O	GRAVITAS	nn	28	SENT_234	[p16l644t1545r933b1590],
26	(	CD	NUMBER	(	num	28	SENT_234	[p16l964t1545r1203b1605],
27	Gauging	NNP	O	Gauging	nn	28	SENT_234	[p16l964t1545r1203b1605],
28	Responsiveness	NN	O	responsiveness	prep_in	22	SENT_234	[p16l1229t1545r1634b1604],
29	With	IN	O	with	_	0	SENT_234	[p16l1658t1542r1785b1590],
30	A	DT	O	a	det	34	SENT_234	[p16l1807t1546r1849b1589],
31	VerifyNow	NNP	O	VerifyNow	nn	34	SENT_234	[p16l1870t1542r2145b1605],
32	Assay-Impact	NNP	O	Assay-Impact	nn	34	SENT_234	[p16l641t1621r994b1681],
33	On	IN	O	on	amod	34	SENT_234	[p16l1039t1622r1118b1665],
34	Thrombosis	NNP	O	Thrombosis	prep_with	11	SENT_234	[p16l1161t1618r1475b1665],
35	And	CC	O	and	_	0	SENT_234	[p16l1520t1618r1632b1665],
36	Safety	NNP	O	Safety	conj_and	34	SENT_234	[p16l1679t1618r1879b1681],
37	)	CD	NUMBER	)	num	38	SENT_234	[p16l1679t1618r1879b1681],
38	“	NN	O	“	dep	34	SENT_234	[p16l1679t1618r1879b1681],
39	and	CC	O	and	_	0	SENT_234	[p16l1923t1618r2020b1666],
40	the	DT	O	the	det	44	SENT_234	[p16l2062t1618r2143b1666],
41	RECLOSE	NNP	O	RECLOSE	nn	44	SENT_234	[p16l645t1698r908b1742],
42	2-ACS	NN	O	2-ac	nn	44	SENT_234	[p16l950t1698r1110b1742],
43	(	CD	NUMBER	(	num	44	SENT_234	[p16l1156t1698r1580b1758],
44	Responsiveness	NN	O	responsiveness	conj_and	34	SENT_234	[p16l1156t1698r1580b1758],
45	to	TO	O	to	_	0	SENT_234	[p16l1619t1704r1667b1742],
46	Clopidogrel	NNP	O	Clopidogrel	nn	53	SENT_234	[p16l1708t1695r2010b1758],
47	and	CC	O	and	_	0	SENT_234	[p16l2049t1695r2145b1742],
48	Stent	NNP	O	Stent	nn	53	SENT_234	[p16l646t1774r778b1818],
49	Thrombosis	NNP	O	Thrombosis	nn	53	SENT_234	[p16l793t1770r1108b1818],
50	2-ACS	NN	O	2-ac	nn	53	SENT_234	[p16l1128t1774r1336b1833],
51	)	CD	NUMBER	)	num	53	SENT_234	[p16l1128t1774r1336b1833],
52	“	NN	O	“	nn	53	SENT_234	[p16l1128t1774r1336b1833],
53	studies	NNS	O	study	prep_to	44	SENT_234	[p16l1354t1770r1548b1818],
54	.	.	O	.	_	0	SENT_234	[p16l1354t1770r1548b1818],

1	Panel	NN	O	panel	_	0	SENT_235	[p16l58t1960r193b2004],
2	:	:	O	:	_	0	SENT_235	[p16l58t1960r193b2004],
3	Research	NNP	O	Research	dep	1	SENT_235	[p16l211t1961r415b2004],
4	in	IN	O	in	_	0	SENT_235	[p16l433t1962r473b2003],
5	context	NN	O	context	prep_in	3	SENT_235	[p16l489t1968r675b2004],

1	Systematic	JJ	MISC	systematic	amod	2	SENT_236	[p16l58t2079r322b2134],
2	review	NN	O	review	nsubj	35	SENT_236	[p16l338t2079r497b2121],
3	A	DT	O	a	det	4	SENT_236	[p16l58t2155r90b2194],
4	search	NN	O	search	rcmod	2	SENT_236	[p16l103t2151r239b2195],
5	of	IN	O	of	_	0	SENT_236	[p16l253t2151r301b2195],
6	Medline	NNP	ORGANIZATION	Medline	prep_of	4	SENT_236	[p16l312t2151r488b2195],
7	and	CC	O	and	_	0	SENT_236	[p16l501t2151r583b2195],
8	Embase	NNP	PERSON	Embase	prep_of	4	SENT_236	[p16l598t2151r767b2195],
9	with	IN	O	with	dep	4	SENT_236	[p16l777t2151r876b2194],
10	the	DT	O	the	det	15	SENT_236	[p16l888t2151r961b2195],
11	search	NN	O	search	nn	15	SENT_236	[p16l974t2151r1110b2195],
12	term	NN	O	term	nn	15	SENT_236	[p16l1122t2159r1228b2195],
13	“	CD	NUMBER	“	num	15	SENT_236	[p16l1245t2151r1556b2207],
14	point	NN	O	point	nn	15	SENT_236	[p16l1245t2151r1556b2207],
15	—	NN	O	—	pobj	9	SENT_236	[p16l1245t2151r1556b2207],
16	of	IN	O	of	_	0	SENT_236	[p16l1245t2151r1556b2207],
17	—	CD	NUMBER	—	num	18	SENT_236	[p16l1245t2151r1556b2207],
18	care	NN	O	care	nn	21	SENT_236	[p16l1245t2151r1556b2207],
19	genetic	JJ	O	genetic	amod	21	SENT_236	[p16l1569t2155r1731b2208],
20	test	NN	O	test	nn	21	SENT_236	[p16l1740t2154r1845b2195],
21	”	NN	O	”	prep_of	15	SENT_236	[p16l1740t2154r1845b2195],
22	for	IN	O	for	dep	2	SENT_236	[p16l1857t2151r1921b2195],
23	reports	NNS	O	report	pobj	22	SENT_236	[p16l1935t2159r2089b2207],
24	published	VBN	O	publish	partmod	23	SENT_236	[p16l57t2226r272b2282],
25	in	IN	O	in	_	0	SENT_236	[p16l287t2229r323b2269],
26	English	NNP	MISC	English	prep_in	24	SENT_236	[p16l341t2226r494b2283],
27	before	IN	O	before	_	0	SENT_236	[p16l511t2225r650b2269],
28	Dec	NNP	DATE	Dec	prep_before	24	SENT_236	[p16l666t2230r744b2269],
29	18	CD	DATE	18	num	28	SENT_236	[p16l757t2225r823b2277],
30	,	,	DATE	,	_	0	SENT_236	[p16l757t2225r823b2277],
31	2011	CD	DATE	2011	num	28	SENT_236	[p16l838t2232r957b2277],
32	,	,	O	,	_	0	SENT_236	[p16l838t2232r957b2277],
33	did	VBD	O	do	aux	35	SENT_236	[p16l971t2226r1039b2269],
34	not	RB	O	not	neg	35	SENT_236	[p16l1054t2234r1129b2269],
35	identify	VB	O	identify	_	0	SENT_236	[p16l1143t2225r1311b2282],
36	any	DT	O	any	dobj	35	SENT_236	[p16l1323t2241r1402b2282],
37	that	WDT	O	that	nsubj	38	SENT_236	[p16l1410t2226r1503b2269],
38	documented	VBD	O	document	rcmod	36	SENT_236	[p16l1515t2226r1798b2269],
39	successful	JJ	O	successful	amod	40	SENT_236	[p16l1810t2225r2025b2269],
40	development	NN	O	development	dobj	38	SENT_236	[p16l58t2300r353b2357],
41	or	CC	O	or	_	0	SENT_236	[p16l365t2315r410b2344],
42	clinical	JJ	O	clinical	amod	43	SENT_236	[p16l422t2300r566b2344],
43	use	NN	O	use	conj_or	40	SENT_236	[p16l583t2315r653b2344],
44	of	IN	O	of	_	0	SENT_236	[p16l666t2300r714b2344],
45	point	NN	O	point	nn	46	SENT_236	[p16l723t2300r1015b2357],
46	—	NN	O	—	prep_of	40	SENT_236	[p16l723t2300r1015b2357],
47	of	IN	O	of	_	0	SENT_236	[p16l723t2300r1015b2357],
48	—	CD	NUMBER	—	num	49	SENT_236	[p16l723t2300r1015b2357],
49	care	NN	O	care	prep_of	46	SENT_236	[p16l723t2300r1015b2357],
50	genetic	JJ	O	genetic	amod	51	SENT_236	[p16l1028t2304r1190b2357],
51	testing	NN	O	testing	dep	49	SENT_236	[p16l1199t2304r1365b2357],
52	.	.	O	.	_	0	SENT_236	[p16l1199t2304r1365b2357],

1	A	DT	O	a	det	2	SENT_237	[p16l1378t2304r1410b2343],
2	search	NN	O	search	nsubj	9	SENT_237	[p16l1423t2300r1559b2344],
3	for	IN	O	for	_	0	SENT_237	[p16l1573t2300r1637b2344],
4	randomised	JJ	O	randomised	amod	5	SENT_237	[p16l1652t2300r1912b2344],
5	trials	NNS	O	trial	prep_for	2	SENT_237	[p16l1922t2300r2029b2344],
6	with	IN	O	with	_	0	SENT_237	[p16l56t2374r155b2417],
7	the	DT	O	the	det	8	SENT_237	[p16l167t2374r240b2418],
8	terms	NNS	O	term	prep_with	5	SENT_237	[p16l250t2382r379b2418],
9	“	VBP	O	“	_	0	SENT_237	[p16l393t2374r601b2431],
10	clopidog	NN	O	clopidog	nn	12	SENT_237	[p16l393t2374r601b2431],
11	rel	NN	O	rel	nn	12	SENT_237	[p16l608t2374r679b2418],
12	”	NN	O	”	dobj	9	SENT_237	[p16l608t2374r679b2418],
13	and	CC	O	and	_	0	SENT_237	[p16l692t2374r774b2418],
14	“	NN	O	“	nn	16	SENT_237	[p16l788t2376r1081b2424],
15	CYP2C19	NN	O	cyp2c19	nn	16	SENT_237	[p16l788t2376r1081b2424],
16	*	NN	O	*	dobj	9	SENT_237	[p16l788t2376r1081b2424],
17	2	CD	NUMBER	2	num	18	SENT_237	[p16l788t2376r1081b2424],
18	”	NN	O	”	nsubj	19	SENT_237	[p16l788t2376r1081b2424],
19	identiﬁed	VBD	O	identiﬁed	rcmod	12	SENT_237	[p16l1093t2374r1302b2418],
20	one	CD	NUMBER	one	num	21	SENT_237	[p16l1314t2389r1396b2418],
21	study	NN	O	study	dobj	19	SENT_237	[p16l1409t2374r1539b2431],
22	,	,	O	,	_	0	SENT_237	[p16l1409t2374r1539b2431],
23	ELEVATE	VB	O	elevate	dep	19	SENT_237	[p16l1556t2378r1861b2417],
24	.	.	O	.	_	0	SENT_237	[p16l1556t2378r1861b2417],

1	—	NN	O	—	_	0	SENT_238	[p16l1556t2378r1861b2417],
2	.	.	O	.	_	0	SENT_238	[p16l1556t2378r1861b2417],

1	T	NN	O	t	nsubj	3	SENT_239	[p16l1556t2378r1861b2417],
2	|	CD	NUMBER	|	num	1	SENT_239	[p16l1556t2378r1861b2417],
3	M	NN	O	m	_	0	SENT_239	[p16l1556t2378r1861b2417],
4	|	NN	O	|	nn	5	SENT_239	[p16l1556t2378r1861b2417],
5	56,41	NN	O	56,41	dobj	3	SENT_239	[p16l1877t2374r1975b2425],
6	that	WDT	O	that	nsubj	8	SENT_239	[p16l1985t2374r2078b2418],
7	prospectively	RB	O	prospectively	advmod	8	SENT_239	[p16l57t2449r350b2505],
8	assessed	VBD	O	assess	rcmod	5	SENT_239	[p16l362t2449r548b2492],
9	the	DT	O	the	det	11	SENT_239	[p16l557t2449r630b2492],
10	pharmacodynamic	JJ	O	pharmacodynamic	amod	11	SENT_239	[p16l643t2449r1057b2505],
11	efﬁcacy	NN	O	efﬁcacy	dobj	8	SENT_239	[p16l1070t2448r1233b2505],
12	of	IN	O	of	_	0	SENT_239	[p16l1244t2448r1291b2492],
13	a	DT	O	a	det	15	SENT_239	[p16l1301t2464r1324b2492],
14	pharmacogenetic	JJ	O	pharmacogenetic	amod	15	SENT_239	[p16l1336t2449r1723b2506],
15	approach	NN	O	approach	prep_of	11	SENT_239	[p16l1735t2449r1938b2505],
16	to	TO	O	to	_	0	SENT_239	[p16l1950t2457r1998b2492],
17	antiplatelet	JJ	O	antiplatelet	amod	18	SENT_239	[p16l58t2523r311b2580],
18	treatment	NN	O	treatment	prep_to	8	SENT_239	[p16l320t2531r548b2567],
19	after	IN	O	after	_	0	SENT_239	[p16l561t2523r664b2567],
20	PCI	NNP	O	PCI	prep_after	8	SENT_239	[p16l679t2527r755b2567],
21	.	.	O	.	_	0	SENT_239	[p16l679t2527r755b2567],

1	This	DT	O	this	det	2	SENT_240	[p16l765t2523r857b2567],
2	investigation	NN	O	investigation	nsubj	3	SENT_240	[p16l872t2527r1158b2580],
3	showed	VBD	O	show	_	0	SENT_240	[p16l1173t2523r1345b2567],
4	that	IN	O	that	complm	19	SENT_240	[p16l1355t2523r1448b2567],
5	a	DT	O	a	det	8	SENT_240	[p16l1460t2538r1484b2567],
6	clopidogrel	NN	O	clopidogrel	nn	8	SENT_240	[p16l1497t2523r1739b2580],
7	maintenance	NN	O	maintenance	nn	8	SENT_240	[p16l1757t2527r2044b2567],
8	dose	NN	O	dose	nsubj	19	SENT_240	[p16l58t2597r160b2641],
9	of	IN	O	of	_	0	SENT_240	[p16l172t2597r220b2641],
10	225	CD	NUMBER	225	num	11	SENT_240	[p16l230t2603r310b2647],
11	mg	NN	O	mg	prep_of	8	SENT_240	[p16l327t2612r395b2654],
12	every	DT	SET	every	det	13	SENT_240	[p16l411t2612r528b2654],
13	day	NN	SET	day	tmod	11	SENT_240	[p16l539t2597r617b2654],
14	in	IN	O	in	_	0	SENT_240	[p16l630t2601r667b2640],
15	CYP2C19	NN	O	cyp2c19	nn	16	SENT_240	[p16l682t2599r930b2647],
16	*	NN	O	*	prep_in	11	SENT_240	[p16l682t2599r930b2647],
17	2	CD	NUMBER	2	num	18	SENT_240	[p16l682t2599r930b2647],
18	heterozygotes	NNS	O	heterozygote	dep	11	SENT_240	[p16l947t2597r1259b2654],
19	gave	VBD	O	give	ccomp	3	SENT_240	[p16l1272t2612r1375b2654],
20	similar	JJ	O	similar	amod	22	SENT_240	[p16l1388t2597r1534b2641],
21	platelet	NN	O	platelet	nn	22	SENT_240	[p16l1546t2597r1712b2653],
22	inhibition	NN	O	inhibition	dobj	19	SENT_240	[p16l1726t2597r1938b2641],
23	to	TO	O	to	_	0	SENT_240	[p16l1950t2605r1998b2641],
24	75	CD	NUMBER	75	num	25	SENT_240	[p16l57t2677r109b2721],
25	mg	NN	O	mg	prep_to	19	SENT_240	[p16l126t2686r194b2728],
26	every	DT	SET	every	det	27	SENT_240	[p16l209t2686r327b2727],
27	day	NN	SET	day	dep	25	SENT_240	[p16l338t2671r416b2727],
28	in	IN	O	in	_	0	SENT_240	[p16l429t2674r466b2714],
29	non	JJ	O	non	amod	31	SENT_240	[p16l483t2674r756b2722],
30	—	NN	O	—	nn	31	SENT_240	[p16l483t2674r756b2722],
31	carriers	NNS	O	carrier	prep_in	19	SENT_240	[p16l483t2674r756b2722],
32	,	,	O	,	_	0	SENT_240	[p16l483t2674r756b2722],
33	although	IN	O	although	mark	39	SENT_240	[p16l771t2671r969b2728],
34	this	DT	O	this	det	35	SENT_240	[p16l981t2671r1063b2714],
35	inhibition	NN	O	inhibition	nsubjpass	39	SENT_240	[p16l1078t2671r1290b2714],
36	could	MD	O	could	aux	39	SENT_240	[p16l1305t2671r1424b2714],
37	not	RB	O	not	neg	39	SENT_240	[p16l1439t2679r1513b2714],
38	be	VB	O	be	auxpass	39	SENT_240	[p16l1527t2671r1577b2714],
39	achieved	VBN	O	achieve	advcl	19	SENT_240	[p16l1590t2671r1783b2714],
40	in	IN	O	in	_	0	SENT_240	[p16l1798t2674r1835b2714],
41	CYP2C19	NN	O	cyp2c19	nn	42	SENT_240	[p16l58t2747r305b2795],
42	*	NN	O	*	prep_in	39	SENT_240	[p16l58t2747r305b2795],
43	2	CD	NUMBER	2	num	44	SENT_240	[p16l58t2747r305b2795],
44	homozygotes	NNS	O	homozygote	dep	42	SENT_240	[p16l322t2745r623b2802],
45	despite	IN	O	despite	_	0	SENT_240	[p16l635t2745r794b2802],
46	daily	JJ	SET	daily	amod	47	SENT_240	[p16l806t2745r909b2802],
47	doses	NNS	O	dose	prep_despite	39	SENT_240	[p16l920t2745r1043b2789],
48	of	IN	O	of	_	0	SENT_240	[p16l1055t2745r1102b2789],
49	as	RB	O	as	quantmod	52	SENT_240	[p16l1112t2760r1156b2789],
50	much	JJ	O	much	quantmod	52	SENT_240	[p16l1171t2745r1291b2789],
51	as	IN	O	as	quantmod	52	SENT_240	[p16l1306t2760r1350b2789],
52	300	CD	NUMBER	300	num	53	SENT_240	[p16l1363t2751r1448b2795],
53	mg	NN	O	mg	prep_of	47	SENT_240	[p16l1464t2760r1545b2802],
54	.	.	O	.	_	0	SENT_240	[p16l1464t2760r1545b2802],

1	Interpretation	NN	O	interpretation	_	0	SENT_241	[p16l60t2864r399b2919],
2	As	IN	O	as	dep	1	SENT_241	[p16l58t2941r111b2981],
3	far	RB	O	far	advmod	7	SENT_241	[p16l124t2937r186b2981],
4	as	IN	O	as	dep	7	SENT_241	[p16l199t2952r244b2981],
5	we	PRP	O	we	nsubj	7	SENT_241	[p16l255t2952r320b2981],
6	are	VBP	O	be	cop	7	SENT_241	[p16l335t2952r402b2981],
7	aware	JJ	O	aware	advcl	13	SENT_241	[p16l416t2952r562b2989],
8	,	,	O	,	_	0	SENT_241	[p16l416t2952r562b2989],
9	our	PRP$	O	we	poss	10	SENT_241	[p16l577t2952r653b2981],
10	study	NN	O	study	nsubj	13	SENT_241	[p16l666t2937r791b2994],
11	is	VBZ	O	be	cop	13	SENT_241	[p16l806t2941r836b2981],
12	the	DT	O	the	det	13	SENT_241	[p16l847t2937r922b2981],
13	ﬁrst	NN	O	ﬁrst	dep	28	SENT_241	[p16l935t2937r1024b2981],
14	to	TO	O	to	aux	15	SENT_241	[p16l1035t2945r1083b2981],
15	validate	VB	O	validate	dep	13	SENT_241	[p16l1096t2937r1275b2981],
16	and	CC	O	and	_	0	SENT_241	[p16l1289t2937r1373b2981],
17	to	TO	O	to	aux	18	SENT_241	[p16l1384t2945r1432b2981],
18	show	VB	O	show	dep	13	SENT_241	[p16l1447t2937r1568b2981],
19	clinical	JJ	O	clinical	amod	20	SENT_241	[p16l1581t2937r1730b2981],
20	use	NN	O	use	dobj	18	SENT_241	[p16l1748t2952r1820b2981],
21	of	IN	O	of	_	0	SENT_241	[p16l1834t2937r1882b2981],
22	point	NN	O	point	nn	23	SENT_241	[p16l57t3013r359b3070],
23	—	NN	O	—	prep_of	20	SENT_241	[p16l57t3013r359b3070],
24	of	IN	O	of	_	0	SENT_241	[p16l57t3013r359b3070],
25	—	CD	NUMBER	—	num	26	SENT_241	[p16l57t3013r359b3070],
26	care	NN	O	care	prep_of	23	SENT_241	[p16l57t3013r359b3070],
27	genetic	JJ	O	genetic	amod	28	SENT_241	[p16l373t3017r539b3071],
28	testing	NN	O	testing	pobj	2	SENT_241	[p16l550t3017r721b3071],
29	.	.	O	.	_	0	SENT_241	[p16l550t3017r721b3071],

1	It	PRP	O	it	nsubj	6	SENT_242	[p16l739t3018r768b3057],
2	is	VBZ	O	be	cop	6	SENT_242	[p16l784t3017r814b3057],
3	the	DT	O	the	det	6	SENT_242	[p16l825t3014r900b3057],
4	ﬁrst	JJ	O	ﬁrst	amod	6	SENT_242	[p16l913t3013r1002b3057],
5	randomised	JJ	O	randomised	amod	6	SENT_242	[p16l1018t3014r1285b3057],
6	investigation	NN	O	investigation	_	0	SENT_242	[p16l1302t3017r1597b3071],
7	of	IN	O	of	_	0	SENT_242	[p16l1612t3013r1661b3057],
8	selective	JJ	O	selective	amod	9	SENT_242	[p16l1671t3014r1863b3057],
9	use	NN	O	use	prep_of	6	SENT_242	[p16l1879t3028r1951b3057],
10	of	IN	O	of	_	0	SENT_242	[p16l1965t3013r2013b3057],
11	prasugrel	NN	O	prasugrel	prep_of	9	SENT_242	[p16l58t3087r264b3144],
12	in	IN	O	in	_	0	SENT_242	[p16l283t3091r320b3130],
13	CYP2C19	NN	O	cyp2c19	nn	16	SENT_242	[p16l337t3089r590b3137],
14	*	NN	O	*	nn	16	SENT_242	[p16l337t3089r590b3137],
15	2	CD	NUMBER	2	num	16	SENT_242	[p16l337t3089r590b3137],
16	carriers	NNS	O	carrier	prep_in	11	SENT_242	[p16l606t3091r768b3131],
17	after	IN	O	after	_	0	SENT_242	[p16l782t3087r888b3131],
18	PCI	NN	O	pcus	prep_after	16	SENT_242	[p16l904t3091r983b3131],
19	.	.	O	.	_	0	SENT_242	[p16l904t3091r983b3131],

1	Our	PRP$	O	we	poss	2	SENT_243	[p16l999t3091r1081b3131],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_243	[p16l1093t3087r1277b3144],
3	suggest	VBP	O	suggest	_	0	SENT_243	[p16l1291t3095r1466b3144],
4	that	IN	O	that	complm	10	SENT_243	[p16l1477t3087r1572b3131],
5	personalisation	NN	O	personalisation	nsubj	10	SENT_243	[p16l1586t3087r1932b3144],
6	of	IN	O	of	_	0	SENT_243	[p16l1947t3087r1996b3131],
7	antiplatelet	JJ	O	antiplatelet	amod	8	SENT_243	[p16l58t3161r319b3217],
8	therapy	NN	O	therapy	prep_of	5	SENT_243	[p16l330t3161r505b3217],
9	might	MD	O	might	aux	10	SENT_243	[p16l520t3161r656b3218],
10	reduce	VB	O	reduce	ccomp	3	SENT_243	[p16l672t3161r819b3204],
11	adverse	JJ	O	adverse	amod	13	SENT_243	[p16l834t3161r1004b3204],
12	ischaemic	JJ	O	ischaemic	amod	13	SENT_243	[p16l1021t3161r1240b3204],
13	outcomes	NNS	O	outcome	dobj	10	SENT_243	[p16l1253t3169r1489b3212],
14	;	:	O	;	_	0	SENT_243	[p16l1253t3169r1489b3212],
15	use	NN	O	use	nsubj	26	SENT_243	[p16l1506t3176r1578b3204],
16	of	IN	O	of	_	0	SENT_243	[p16l1592t3161r1640b3204],
17	prasugrel	NN	O	prasugrel	prep_of	15	SENT_243	[p16l1651t3161r1857b3218],
18	only	RB	O	only	advmod	17	SENT_243	[p16l1873t3161r1970b3217],
19	in	IN	O	in	_	0	SENT_243	[p16l1985t3165r2023b3204],
20	high	JJ	O	high	amod	23	SENT_243	[p16l60t3237r258b3294],
21	—	NN	O	—	nn	23	SENT_243	[p16l60t3237r258b3294],
22	risk	NN	O	risk	nn	23	SENT_243	[p16l60t3237r258b3294],
23	individuals	NNS	O	individual	prep_in	17	SENT_243	[p16l274t3237r516b3280],
24	might	MD	O	might	aux	26	SENT_243	[p16l533t3237r668b3294],
25	also	RB	O	also	advmod	26	SENT_243	[p16l682t3237r769b3280],
26	minimise	VB	O	minimise	parataxis	3	SENT_243	[p16l787t3240r994b3280],
27	adverse	JJ	O	adverse	amod	29	SENT_243	[p16l1009t3237r1179b3280],
28	bleeding	NN	O	bleeding	nn	29	SENT_243	[p16l1196t3237r1387b3294],
29	events	NNS	O	event	dobj	26	SENT_243	[p16l1403t3245r1562b3280],
30	.	.	O	.	_	0	SENT_243	[p16l1403t3245r1562b3280],

1	The	DT	O	the	det	2	SENT_244	[p16l1574t3237r1658b3280],
2	development	NN	O	development	nsubj	16	SENT_244	[p16l1672t3237r1974b3293],
3	of	IN	O	of	_	0	SENT_244	[p16l1987t3236r2036b3280],
4	practical	JJ	O	practical	amod	6	SENT_244	[p16l58t3310r244b3367],
5	point	NN	O	point	nn	6	SENT_244	[p16l260t3310r561b3367],
6	—	NN	O	—	prep_of	2	SENT_244	[p16l260t3310r561b3367],
7	of	IN	O	of	_	0	SENT_244	[p16l260t3310r561b3367],
8	—	CD	NUMBER	—	num	9	SENT_244	[p16l260t3310r561b3367],
9	care	NN	O	care	nn	11	SENT_244	[p16l260t3310r561b3367],
10	genetic	JJ	O	genetic	amod	11	SENT_244	[p16l576t3314r742b3367],
11	testing	NN	O	testing	prep_of	6	SENT_244	[p16l753t3314r910b3367],
12	in	IN	O	in	_	0	SENT_244	[p16l929t3314r966b3353],
13	our	PRP$	O	we	poss	14	SENT_244	[p16l981t3325r1057b3354],
14	study	NN	O	study	prep_in	11	SENT_244	[p16l1071t3310r1195b3367],
15	will	MD	O	will	aux	16	SENT_244	[p16l1206t3310r1282b3353],
16	help	VB	O	help	_	0	SENT_244	[p16l1301t3310r1394b3367],
17	to	TO	O	to	aux	18	SENT_244	[p16l1405t3318r1454b3354],
18	integrate	VB	O	integrate	xcomp	16	SENT_244	[p16l1471t3314r1675b3367],
19	genetics	NNS	O	genetics	dobj	18	SENT_244	[p16l1690t3314r1877b3367],
20	into	IN	O	into	_	0	SENT_244	[p16l1893t3314r1982b3354],
21	the	DT	O	the	det	23	SENT_244	[p16l1994t3310r2068b3354],
22	clinical	JJ	O	clinical	amod	23	SENT_244	[p16l58t3384r207b3427],
23	setting	NN	O	setting	prep_into	18	SENT_244	[p16l224t3388r380b3441],
24	and	CC	O	and	_	0	SENT_244	[p16l396t3384r480b3427],
25	will	MD	O	will	aux	26	SENT_244	[p16l492t3384r568b3427],
26	allow	VB	O	allow	conj_and	16	SENT_244	[p16l584t3384r705b3427],
27	large	JJ	O	large	amod	30	SENT_244	[p16l720t3384r956b3441],
28	—	NN	O	—	nn	30	SENT_244	[p16l720t3384r956b3441],
29	scale	NN	O	scale	nn	30	SENT_244	[p16l720t3384r956b3441],
30	investigations	NNS	O	investigation	nsubj	33	SENT_244	[p16l973t3388r1291b3441],
31	to	TO	O	to	aux	33	SENT_244	[p16l1302t3392r1350b3427],
32	deﬁnitively	RB	O	deﬁnitively	advmod	33	SENT_244	[p16l1364t3384r1617b3440],
33	assess	VB	O	assess	xcomp	26	SENT_244	[p16l1630t3399r1765b3427],
34	the	DT	O	the	det	35	SENT_244	[p16l1776t3384r1851b3427],
35	value	NN	O	value	dobj	33	SENT_244	[p16l1864t3384r1984b3427],
36	of	IN	O	of	_	0	SENT_244	[p16l1997t3384r2046b3427],
37	pharmacogenetic	JJ	O	pharmacogenetic	amod	38	SENT_244	[p16l58t3459r454b3516],
38	strategies	NNS	O	strategy	prep_of	35	SENT_244	[p16l468t3462r699b3516],
39	.	.	O	.	_	0	SENT_244	[p16l468t3462r699b3516],

1	The	DT	O	the	det	3	SENT_245	[p17l78t109r219b177],
2	potential	JJ	O	potential	amod	3	SENT_245	[p17l254t109r574b197],
3	value	NN	O	value	nsubjpass	13	SENT_245	[p17l606t109r797b177],
4	of	IN	O	of	_	0	SENT_245	[p17l834t108r916b177],
5	a	DT	O	a	det	7	SENT_245	[p17l938t133r974b177],
6	personalised	JJ	O	personalised	amod	7	SENT_245	[p17l1009t109r1471b197],
7	approach	NN	O	approach	prep_of	3	SENT_245	[p17l1505t109r1841b197],
8	to	TO	O	to	_	0	SENT_245	[p17l1874t122r1942b177],
9	antiplatelet	JJ	O	antiplatelet	amod	10	SENT_245	[p17l1978t113r2138b177, p17l8t217r273b306],
10	treatment	NN	O	treatment	prep_to	7	SENT_245	[p17l291t231r651b285],
11	is	VBZ	O	be	auxpass	13	SENT_245	[p17l670t222r727b285],
12	also	RB	O	also	advmod	13	SENT_245	[p17l751t217r890b285],
13	supported	VBN	O	support	_	0	SENT_245	[p17l914t217r1282b306],
14	by	IN	O	by	_	0	SENT_245	[p17l1300t217r1386b306],
15	the	DT	O	the	det	16	SENT_245	[p17l1404t217r1518b285],
16	ﬁnding	NN	O	ﬁnding	agent	13	SENT_245	[p17l1539t217r1806b307],
17	that	WDT	O	that	dobj	22	SENT_245	[p17l1825t217r1967b285],
18	87	CD	PERCENT	87	num	19	SENT_245	[p17l1987t222r2139b288],
19	%	NN	PERCENT	%	nsubj	22	SENT_245	[p17l1987t222r2139b288],
20	of	IN	O	of	_	0	SENT_245	[p17l9t327r92b394],
21	non-carriers	NNS	O	non-carrier	prep_of	19	SENT_245	[p17l99t331r542b394],
22	had	VBD	O	have	rcmod	16	SENT_245	[p17l563t327r700b394],
23	adequate	JJ	O	adequate	amod	25	SENT_245	[p17l721t327r1046b416],
24	platelet	NN	O	platelet	nn	25	SENT_245	[p17l1067t327r1332b416],
25	inhibition	NN	O	inhibition	dobj	22	SENT_245	[p17l1351t327r1714b394],
26	with	IN	O	with	_	0	SENT_245	[p17l1733t327r1895b394],
27	a	DT	O	a	det	30	SENT_245	[p17l1916t351r1953b394],
28	high	JJ	O	high	amod	30	SENT_245	[p17l1972t327r2140b417],
29	pretreatment	NN	O	pretreatment	nn	30	SENT_245	[p17l8t449r488b524],
30	dose	NN	O	dose	prep_with	25	SENT_245	[p17l535t435r699b504],
31	of	IN	O	of	_	0	SENT_245	[p17l748t435r830b504],
32	clopidogrel	NN	O	clopidogrel	prep_of	30	SENT_245	[p17l865t435r1269b525],
33	on	IN	O	on	_	0	SENT_245	[p17l1317t460r1409b504],
34	the	DT	O	the	det	35	SENT_245	[p17l1455t435r1569b504],
35	basis	NN	O	basis	prep_on	22	SENT_245	[p17l1615t435r1796b504],
36	of	IN	O	of	_	0	SENT_245	[p17l1847t435r1928b504],
37	PRU	NNP	ORGANIZATION	PRU	nn	38	SENT_245	[p17l1967t442r2138b504],
38	values	NNS	O	value	prep_of	35	SENT_245	[p17l7t544r232b612],
39	of	IN	O	of	_	0	SENT_245	[p17l253t544r335b612],
40	more	JJR	O	more	mwe	41	SENT_245	[p17l338t569r531b612],
41	than	IN	O	than	quantmod	42	SENT_245	[p17l548t544r714b612],
42	234	CD	NUMBER	234	prep_of	38	SENT_245	[p17l733t551r872b612],
43	.	.	O	.	_	0	SENT_245	[p17l733t551r872b612],

1	Notably	RB	O	notably	advmod	12	SENT_246	[p17l896t544r1183b634],
2	,	,	O	,	_	0	SENT_246	[p17l896t544r1183b634],
3	rates	NNS	O	rate	nsubj	12	SENT_246	[p17l1203t558r1374b612],
4	of	IN	O	of	_	0	SENT_246	[p17l1394t544r1476b612],
5	high	JJ	O	high	amod	8	SENT_246	[p17l1479t544r1647b634],
6	on-treatment	JJ	O	on-treatment	amod	8	SENT_246	[p17l1664t558r2141b612],
7	platelet	NN	O	platelet	nn	8	SENT_246	[p17l8t655r273b744],
8	reactivity	NN	O	reactivity	prep_of	3	SENT_246	[p17l296t659r624b744],
9	in	IN	O	in	_	0	SENT_246	[p17l647t659r721b721],
10	our	PRP$	O	we	poss	11	SENT_246	[p17l746t679r872b723],
11	study	NN	O	study	prep_in	8	SENT_246	[p17l898t655r1093b744],
12	were	VBD	O	be	_	0	SENT_246	[p17l1114t679r1289b723],
13	lower	JJR	O	lower	dep	14	SENT_246	[p17l1314t655r1517b723],
14	than	IN	O	than	advmod	12	SENT_246	[p17l1539t655r1705b723],
15	in	IN	O	in	_	0	SENT_246	[p17l1730t659r1804b721],
16	previous	JJ	O	previous	amod	17	SENT_246	[p17l1827t659r2138b744],
17	reports	NNS	O	report	prep_in	12	SENT_246	[p17l8t777r263b852],
18	and	CC	O	and	_	0	SENT_246	[p17l282t763r418b832],
19	were	VBD	O	be	cop	21	SENT_246	[p17l429t788r604b832],
20	probably	RB	O	probably	advmod	21	SENT_246	[p17l619t763r937b853],
21	secondary	JJ	O	secondary	conj_and	12	SENT_246	[p17l952t763r1318b853],
22	to	TO	O	to	_	0	SENT_246	[p17l1329t777r1397b832],
23	the	DT	O	the	det	26	SENT_246	[p17l1412t763r1526b832],
24	large	JJ	O	large	amod	26	SENT_246	[p17l1540t763r1719b853],
25	cumulative	JJ	O	cumulative	amod	26	SENT_246	[p17l1735t763r2139b832],
26	doses	NNS	O	dose	prep_to	21	SENT_246	[p17l9t872r208b940],
27	of	IN	O	of	_	0	SENT_246	[p17l280t872r362b940],
28	clopidogrel	NN	O	clopidogrel	prep_of	26	SENT_246	[p17l418t872r822b962],
29	given	VBN	O	give	prep	21	SENT_246	[p17l892t877r1087b962],
30	before	IN	O	before	pcomp	29	SENT_246	[p17l1154t872r1384b940],
31	PCI	NNP	O	PCI	pobj	30	SENT_246	[p17l1457t877r1612b950],
32	,	,	O	,	_	0	SENT_246	[p17l1457t877r1612b950],
33	including	VBG	O	include	conj_and	12	SENT_246	[p17l1684t872r2035b962],
34	a	DT	O	a	det	39	SENT_246	[p17l2104t896r2140b940],
35	mandated	VBN	O	mandate	amod	39	SENT_246	[p17l8t982r376b1049],
36	600	CD	NUMBER	600	num	39	SENT_246	[p17l430t988r557b1049],
37	mg	NN	O	mg	nn	39	SENT_246	[p17l612t1006r732b1072],
38	loading	NN	O	loading	nn	39	SENT_246	[p17l785t982r1058b1072],
39	dose	NN	O	dose	pobj	33	SENT_246	[p17l1112t982r1294b1049],
40	.	.	O	.	_	0	SENT_246	[p17l1112t982r1294b1049],

1	The	DT	O	the	det	4	SENT_247	[p17l1351t982r1492b1049],
2	particularly	RB	O	particularly	advmod	3	SENT_247	[p17l1546t982r1961b1071],
3	low	JJ	O	low	amod	4	SENT_247	[p17l2012t982r2142b1049],
4	frequency	NN	O	frequency	nsubj	14	SENT_247	[p17l8t1090r373b1180],
5	of	IN	O	of	_	0	SENT_247	[p17l397t1090r479b1159],
6	high	JJ	O	high	amod	9	SENT_247	[p17l489t1090r657b1180],
7	on-treatment	JJ	O	on-treatment	amod	9	SENT_247	[p17l683t1104r1160b1159],
8	platelet	NN	O	platelet	nn	9	SENT_247	[p17l1182t1090r1447b1179],
9	reactivity	NN	O	reactivity	prep_of	4	SENT_247	[p17l1471t1095r1798b1180],
10	recorded	VBN	O	record	partmod	9	SENT_247	[p17l1821t1090r2141b1159],
11	in	IN	O	in	_	0	SENT_247	[p17l9t1204r82b1266],
12	non-carriers	NNS	O	non-carrier	prep_in	10	SENT_247	[p17l123t1204r565b1267],
13	further	RB	O	further	advmod	14	SENT_247	[p17l609t1199r868b1267],
14	supports	VBZ	O	support	_	0	SENT_247	[p17l910t1212r1224b1288],
15	the	DT	O	the	det	16	SENT_247	[p17l1266t1199r1380b1267],
16	notion	NN	O	notion	dobj	14	SENT_247	[p17l1423t1204r1661b1267],
17	that	IN	O	that	complm	23	SENT_247	[p17l1701t1199r1843b1267],
18	a	DT	O	a	det	20	SENT_247	[p17l1884t1223r1921b1267],
19	large	JJ	O	large	amod	20	SENT_247	[p17l1960t1199r2139b1289],
20	subgroup	NN	O	subgroup	nsubj	23	SENT_247	[p17l11t1309r357b1398],
21	of	IN	O	of	_	0	SENT_247	[p17l389t1308r470b1377],
22	patients	NNS	O	patient	prep_of	20	SENT_247	[p17l487t1313r773b1397],
23	receives	VBZ	O	receive	ccomp	14	SENT_247	[p17l805t1313r1092b1377],
24	adequate	JJ	O	adequate	amod	25	SENT_247	[p17l1125t1309r1449b1397],
25	protection	NN	O	protection	dobj	23	SENT_247	[p17l1479t1313r1850b1397],
26	against	IN	O	against	_	0	SENT_247	[p17l1881t1313r2141b1398],
27	major	JJ	O	major	amod	30	SENT_247	[p17l8t1422r227b1507],
28	adverse	JJ	O	adverse	amod	30	SENT_247	[p17l252t1417r523b1486],
29	cardiovascular	JJ	O	cardiovascular	amod	30	SENT_247	[p17l551t1417r1074b1486],
30	events	NNS	O	event	prep_against	23	SENT_247	[p17l1100t1431r1326b1486],
31	with	IN	O	with	_	0	SENT_247	[p17l1353t1417r1515b1486],
32	clopidogrel	NN	O	clopidogrel	prep_with	30	SENT_247	[p17l1542t1417r1964b1507],
33	.	.	O	.	_	0	SENT_247	[p17l1542t1417r1964b1507],

1	Our	PRP$	O	we	poss	2	SENT_248	[p17l1996t1423r2141b1486],
2	investigation	NN	O	investigation	nsubj	3	SENT_248	[p17l8t1531r478b1616],
3	conﬁrms	VBZ	O	conﬁrms	_	0	SENT_248	[p17l549t1526r875b1594],
4	the	DT	O	the	det	7	SENT_248	[p17l946t1526r1060b1594],
5	potential	JJ	O	potential	amod	7	SENT_248	[p17l1132t1526r1452b1615],
6	clinical	JJ	O	clinical	amod	7	SENT_248	[p17l1523t1526r1780b1594],
7	beneﬁts	NNS	O	beneﬁts	dobj	3	SENT_248	[p17l1849t1526r2137b1594],
8	associated	VBN	O	associate	partmod	7	SENT_248	[p17l9t1637r379b1704],
9	with	IN	O	with	_	0	SENT_248	[p17l426t1637r588b1704],
10	a	DT	O	a	det	12	SENT_248	[p17l638t1661r675b1704],
11	personalised	JJ	O	personalised	amod	12	SENT_248	[p17l724t1637r1186b1724],
12	approach	NN	O	approach	prep_with	8	SENT_248	[p17l1235t1637r1570b1724],
13	to	TO	O	to	_	0	SENT_248	[p17l1618t1650r1686b1704],
14	antiplatelet	JJ	O	antiplatelet	amod	15	SENT_248	[p17l1737t1637r2141b1724],
15	treatment	NN	O	treatment	prep_to	12	SENT_248	[p17l7t1759r368b1814],
16	with	IN	O	with	_	0	SENT_248	[p17l392t1745r554b1814],
17	selective	JJ	O	selective	amod	18	SENT_248	[p17l585t1745r886b1814],
18	use	NN	O	use	prep_with	8	SENT_248	[p17l914t1769r1039b1814],
19	of	IN	O	of	_	0	SENT_248	[p17l1069t1745r1151b1814],
20	potent	JJ	O	potent	amod	22	SENT_248	[p17l1165t1759r1399b1834],
21	P2Y12	NN	O	p2y12	nn	22	SENT_248	[p17l1430t1751r1651b1813],
22	inhibitors	NNS	O	inhibitor	prep_of	18	SENT_248	[p17l1681t1745r2036b1814],
23	in	IN	O	in	_	0	SENT_248	[p17l2067t1750r2140b1812],
24	patients	NNS	O	patient	prep_in	22	SENT_248	[p17l8t1859r295b1943],
25	at	IN	O	at	_	0	SENT_248	[p17l316t1867r379b1922],
26	increased	VBN	O	increase	amod	27	SENT_248	[p17l395t1854r743b1922],
27	risk	NN	O	risk	prep_at	24	SENT_248	[p17l759t1854r897b1922],
28	of	IN	O	of	_	0	SENT_248	[p17l913t1854r995b1922],
29	adverse	JJ	O	adverse	amod	30	SENT_248	[p17l1000t1854r1271b1922],
30	events	NNS	O	event	prep_of	27	SENT_248	[p17l1290t1867r1517b1922],
31	with	IN	O	with	_	0	SENT_248	[p17l1534t1854r1697b1922],
32	clopidogrel	NN	O	clopidogrel	prep_with	30	SENT_248	[p17l1715t1854r2136b1944],
33	.	.	O	.	_	0	SENT_248	[p17l1715t1854r2136b1944],

1	Moreover	RB	O	moreover	advmod	6	SENT_249	[p17l12t1970r368b2042],
2	,	,	O	,	_	0	SENT_249	[p17l12t1970r368b2042],
3	the	DT	O	the	det	4	SENT_249	[p17l411t1964r525b2032],
4	strategy	NN	O	strategy	nsubj	6	SENT_249	[p17l568t1977r850b2053],
5	will	MD	O	will	aux	6	SENT_249	[p17l886t1964r1019b2032],
6	prevent	VB	O	prevent	_	0	SENT_249	[p17l1059t1977r1334b2052],
7	exposure	NN	O	exposure	dobj	6	SENT_249	[p17l1374t1988r1700b2052],
8	of	IN	O	of	_	0	SENT_249	[p17l1742t1963r1824b2032],
9	lovv-risk	JJ	O	lovv-risk	amod	10	SENT_249	[p17l1850t1964r2142b2032],
10	patients	NNS	O	patient	prep_of	7	SENT_249	[p17l8t2077r295b2161],
11	to	TO	O	to	_	0	SENT_249	[p17l330t2086r397b2140],
12	the	DT	O	the	det	15	SENT_249	[p17l431t2072r545b2140],
13	heightened	VBN	O	heighten	amod	15	SENT_249	[p17l578t2072r991b2162],
14	bleeding	NN	O	bleeding	nn	15	SENT_249	[p17l1022t2072r1338b2162],
15	risks	NNS	O	risk	prep_to	6	SENT_249	[p17l1371t2072r1540b2140],
16	associated	VBN	O	associate	partmod	15	SENT_249	[p17l1578t2072r1947b2140],
17	with	IN	O	with	_	0	SENT_249	[p17l1978t2072r2140b2140],
18	the	DT	O	the	det	22	SENT_249	[p17l7t2182r122b2249],
19	more	RBR	O	more	advmod	20	SENT_249	[p17l156t2206r348b2249],
20	potent	JJ	O	potent	amod	22	SENT_249	[p17l383t2195r618b2271],
21	antiplatelet	JJ	O	antiplatelet	amod	22	SENT_249	[p17l651t2182r1055b2271],
22	agents	NNS	O	agent	prep_with	16	SENT_249	[p17l1089t2195r1341b2272],
23	.	.	O	.	_	0	SENT_249	[p17l1089t2195r1341b2272],

1	Further	JJ	O	further	amod	2	SENT_250	[p17l1383t2182r1655b2249],
2	studies	NNS	O	study	nsubj	13	SENT_250	[p17l1690t2182r1944b2249],
3	with	IN	O	with	_	0	SENT_250	[p17l1978t2182r2140b2249],
4	point-of-care	JJ	O	point-of-care	amod	6	SENT_250	[p17l8t2291r466b2380],
5	genetic	JJ	O	genetic	amod	6	SENT_250	[p17l491t2296r752b2381],
6	testing	NN	O	testing	prep_with	2	SENT_250	[p17l773t2296r1021b2381],
7	in	IN	O	in	_	0	SENT_250	[p17l1043t2296r1117b2358],
8	association	NN	O	association	prep_in	6	SENT_250	[p17l1141t2296r1543b2360],
9	with	IN	O	with	_	0	SENT_250	[p17l1564t2292r1726b2360],
10	pharmacogenetic	JJ	O	pharmacogenetic	amod	11	SENT_250	[p17l1748t2292r2138b2380, p17l10t2405r270b2490],
11	strategies	NNS	O	strategy	prep_with	8	SENT_250	[p17l318t2405r658b2490],
12	could	MD	O	could	aux	13	SENT_250	[p17l707t2400r907b2468],
13	help	VB	O	help	_	0	SENT_250	[p17l950t2400r1108b2489],
14	to	TO	O	to	aux	15	SENT_250	[p17l1155t2414r1222b2468],
15	optimise	VB	O	optimise	xcomp	13	SENT_250	[p17l1270t2405r1587b2489],
16	treatment	NN	O	treatment	dobj	15	SENT_250	[p17l1632t2414r1993b2468],
17	for	IN	O	for	_	0	SENT_250	[p17l2037t2400r2141b2468],
18	patients	NNS	O	patient	nsubj	19	SENT_250	[p17l8t2514r295b2599],
19	undergoing	VBG	O	undergo	prepc_for	15	SENT_250	[p17l320t2510r748b2600],
20	PCI	NNP	O	PCI	nsubj	23	SENT_250	[p17l776t2515r910b2577],
21	(	CD	NUMBER	(	num	23	SENT_250	[p17l943t2510r1207b2600],
22	panel	NN	O	panel	nn	23	SENT_250	[p17l943t2510r1207b2600],
23	)	NN	O	)	xcomp	19	SENT_250	[p17l943t2510r1207b2600],
24	.	.	O	.	_	0	SENT_250	[p17l943t2510r1207b2600],

1	The	DT	O	the	det	3	SENT_251	[p17l78t2618r219b2687],
2	major	JJ	O	major	amod	3	SENT_251	[p17l244t2623r462b2708],
3	limitation	NN	O	limitation	nsubj	8	SENT_251	[p17l483t2618r843b2687],
4	of	IN	O	of	_	0	SENT_251	[p17l868t2618r950b2687],
5	our	PRP$	O	we	poss	6	SENT_251	[p17l962t2643r1088b2687],
6	study	NN	O	study	prep_of	3	SENT_251	[p17l1113t2618r1308b2708],
7	was	VBD	O	be	cop	8	SENT_251	[p17l1328t2643r1464b2687],
8	use	NN	O	use	_	0	SENT_251	[p17l1489t2643r1615b2687],
9	of	IN	O	of	_	0	SENT_251	[p17l1641t2618r1722b2687],
10	a	DT	O	a	det	12	SENT_251	[p17l1734t2643r1771b2687],
11	surrogate	JJ	O	surrogate	amod	12	SENT_251	[p17l1797t2632r2139b2708],
12	endpoint	NN	O	endpoint	prep_of	8	SENT_251	[p17l9t2727r339b2816],
13	to	TO	O	to	aux	14	SENT_251	[p17l386t2741r454b2795],
14	assess	VB	O	assess	infmod	12	SENT_251	[p17l507t2751r728b2795],
15	clinical	JJ	O	clinical	amod	16	SENT_251	[p17l782t2727r1039b2795],
16	efﬁcacy	NN	O	efﬁcacy	dobj	14	SENT_251	[p17l1090t2727r1370b2816],
17	.	.	O	.	_	0	SENT_251	[p17l1090t2727r1370b2816],

1	High	JJ	O	high	amod	4	SENT_252	[p17l1429t2727r1613b2817],
2	on-treatment	JJ	O	on-treatment	amod	4	SENT_252	[p17l1664t2741r2141b2795],
3	platelet	NN	O	platelet	nn	4	SENT_252	[p17l8t2838r273b2927],
4	reactivity	NN	O	reactivity	nsubjpass	16	SENT_252	[p17l312t2842r649b2927],
5	,	,	O	,	_	0	SENT_252	[p17l312t2842r649b2927],
6	as	IN	O	as	mark	7	SENT_252	[p17l694t2862r764b2906],
7	measured	VBN	O	measure	dep	4	SENT_252	[p17l807t2838r1171b2906],
8	by	IN	O	by	_	0	SENT_252	[p17l1209t2838r1295b2927],
9	the	DT	O	the	det	12	SENT_252	[p17l1332t2838r1447b2906],
10	VerifyNovv	NNP	O	VerifyNovv	nn	12	SENT_252	[p17l1487t2838r1874b2927],
11	P2Y12	NN	O	p2y12	nn	12	SENT_252	[p17l1917t2844r2138b2904],
12	assay	NN	O	assay	prep_by	7	SENT_252	[p17l9t2971r209b3036],
13	,	,	O	,	_	0	SENT_252	[p17l9t2971r209b3036],
14	has	VBZ	O	have	aux	16	SENT_252	[p17l233t2946r356b3015],
15	been	VBN	O	be	auxpass	16	SENT_252	[p17l379t2946r556b3015],
16	shown	VBN	O	show	_	0	SENT_252	[p17l580t2946r820b3015],
17	to	TO	O	to	aux	19	SENT_252	[p17l840t2960r908b3015],
18	be	VB	O	be	cop	19	SENT_252	[p17l930t2946r1015b3015],
19	predictive	JJ	O	predictive	xcomp	16	SENT_252	[p17l1036t2946r1392b3035],
20	of	IN	O	of	_	0	SENT_252	[p17l1416t2946r1497b3015],
21	increased	VBN	O	increase	prepc_of	19	SENT_252	[p17l1506t2946r1854b3015],
22	rates	NNS	O	rate	acomp	21	SENT_252	[p17l1875t2960r2046b3015],
23	of	IN	O	of	_	0	SENT_252	[p17l2071t2946r2153b3015],
24	cardiovascular	JJ	O	cardiovascular	amod	25	SENT_252	[p17l9t3055r532b3123],
25	death	NN	O	death	prep_of	22	SENT_252	[p17l594t3055r811b3133],
26	,	,	O	,	_	0	SENT_252	[p17l594t3055r811b3133],
27	stent	JJ	O	stent	amod	28	SENT_252	[p17l879t3068r1056b3123],
28	thrombosis	NN	O	thrombosis	conj_and	25	SENT_252	[p17l1116t3055r1552b3133],
29	,	,	O	,	_	0	SENT_252	[p17l1116t3055r1552b3133],
30	and	CC	O	and	_	0	SENT_252	[p17l1619t3055r1755b3123],
31	non-fatal	JJ	O	non-fatal	amod	34	SENT_252	[p17l1815t3055r2140b3123],
32	myocardial	JJ	O	myocardial	amod	34	SENT_252	[p17l8t3164r412b3253],
33	infarction	NN	O	infarction	nn	34	SENT_252	[p17l495t3164r1033b3231],
34	.1	NN	NUMBER	.1	conj_and	25	SENT_252	[p17l495t3164r1033b3231],
35	°	CD	NUMBER	°	num	36	SENT_252	[p17l495t3164r1033b3231],
36	’	NN	O	’	dep	34	SENT_252	[p17l495t3164r1033b3231],
37	2	CD	NUMBER	2	number	38	SENT_252	[p17l495t3164r1033b3231],
38	““	CD	NUMBER	““	num	22	SENT_252	[p17l495t3164r1033b3231],
39	Although	IN	O	although	mark	41	SENT_252	[p17l1112t3164r1458b3254],
40	our	PRP$	O	we	dep	41	SENT_252	[p17l1541t3189r1667b3232],
41	pharmacodynamic	JJ	O	pharmacodynamic	dep	22	SENT_252	[p17l1748t3164r2138b3253, p18l9t17r323b106],

1	results	NNS	O	result	nsubj	2	SENT_253	[p18l362t17r603b85],
2	conﬁrm	VBP	O	conﬁrm	_	0	SENT_253	[p18l646t17r938b85],
3	the	DT	O	the	det	4	SENT_253	[p18l977t17r1091b85],
4	potential	NN	O	potential	nsubj	20	SENT_253	[p18l1132t17r1452b106],
5	of	IN	O	of	_	0	SENT_253	[p18l1492t17r1574b85],
6	a	DT	O	a	det	8	SENT_253	[p18l1602t41r1639b85],
7	personalised	JJ	O	personalised	amod	8	SENT_253	[p18l1679t17r2141b106],
8	approach	NN	O	approach	prep_of	4	SENT_253	[p18l9t126r346b215],
9	to	TO	O	to	_	0	SENT_253	[p18l373t140r441b195],
10	anti-platelet	JJ	O	anti-platelet	amod	11	SENT_253	[p18l472t126r901b215],
11	treatment	NN	O	treatment	prep_to	8	SENT_253	[p18l927t140r1304b205],
12	,	,	O	,	_	0	SENT_253	[p18l927t140r1304b205],
13	the	DT	O	the	det	16	SENT_253	[p18l1335t126r1449b195],
14	small	JJ	O	small	amod	16	SENT_253	[p18l1483t126r1678b195],
15	sample	NN	O	sample	nn	16	SENT_253	[p18l1710t126r1970b215],
16	size	NN	O	size	prep_to	8	SENT_253	[p18l2002t131r2139b195],
17	and	CC	O	and	_	0	SENT_253	[p18l9t235r145b303],
18	surrogate	JJ	O	surrogate	amod	19	SENT_253	[p18l184t249r526b325],
19	endpoints	NNS	O	endpoint	prep_to	8	SENT_253	[p18l566t235r927b324],
20	mean	VB	O	mean	ccomp	2	SENT_253	[p18l968t260r1175b303],
21	our	PRP$	O	we	poss	22	SENT_253	[p18l1214t260r1339b303],
22	study	NN	O	study	nsubj	25	SENT_253	[p18l1378t235r1573b325],
23	does	VBZ	O	do	aux	25	SENT_253	[p18l1610t235r1772b303],
24	not	RB	O	not	neg	25	SENT_253	[p18l1813t249r1933b303],
25	yield	VB	O	yield	ccomp	20	SENT_253	[p18l1967t235r2141b325],
26	any	DT	O	any	det	29	SENT_253	[p18l9t369r138b434],
27	deﬁnitive	JJ	O	deﬁnitive	amod	29	SENT_253	[p18l194t345r533b413],
28	clinical	JJ	O	clinical	amod	29	SENT_253	[p18l591t345r849b412],
29	conclusions	NNS	O	conclusion	dobj	25	SENT_253	[p18l906t345r1356b412],
30	.	.	O	.	_	0	SENT_253	[p18l906t345r1356b412],

1	Our	PRP$	O	we	poss	3	SENT_254	[p18l1420t351r1565b412],
2	primary	JJ	O	primary	amod	3	SENT_254	[p18l1620t349r1914b434],
3	goal	NN	O	goal	nsubj	7	SENT_254	[p18l1971t345r2136b435],
4	,	,	O	,	_	0	SENT_254	[p18l1971t345r2136b435],
5	however	RB	O	however	advmod	7	SENT_254	[p18l7t453r326b532],
6	,	,	O	,	_	0	SENT_254	[p18l7t453r326b532],
7	was	VBD	O	be	_	0	SENT_254	[p18l368t478r505b522],
8	to	TO	O	to	aux	9	SENT_254	[p18l547t467r615b522],
9	provide	VB	O	provide	xcomp	7	SENT_254	[p18l657t453r928b542],
10	the	DT	O	the	det	15	SENT_254	[p18l969t453r1083b522],
11	ﬁrst	JJ	O	ﬁrst	amod	15	SENT_254	[p18l1125t453r1271b522],
12	proof-of	JJ	O	proof-of	amod	15	SENT_254	[p18l1310t453r1904b542],
13	—	NN	O	—	nn	15	SENT_254	[p18l1310t453r1904b542],
14	concept	NN	O	concept	nn	15	SENT_254	[p18l1310t453r1904b542],
15	study	NN	O	study	dobj	9	SENT_254	[p18l1947t453r2142b543],
16	showing	VBG	O	show	partmod	15	SENT_254	[p18l11t562r320b652],
17	the	DT	O	the	det	18	SENT_254	[p18l354t562r468b630],
18	feasibility	NN	O	feasibility	dobj	16	SENT_254	[p18l505t562r855b651],
19	of	IN	O	of	_	0	SENT_254	[p18l890t562r972b630],
20	point-of-care	JJ	O	point-of-care	amod	22	SENT_254	[p18l994t562r1452b651],
21	genetic	JJ	O	genetic	amod	22	SENT_254	[p18l1490t567r1750b652],
22	testing	NN	O	testing	prep_of	18	SENT_254	[p18l1784t567r2031b652],
23	in	IN	O	in	_	0	SENT_254	[p18l2067t567r2140b629],
24	clinical	JJ	O	clinical	amod	25	SENT_254	[p18l9t672r267b739],
25	practice	NN	O	practice	prep_in	22	SENT_254	[p18l333t676r633b761],
26	.	.	O	.	_	0	SENT_254	[p18l333t676r633b761],

1	Although	IN	O	although	mark	5	SENT_255	[p18l702t672r1049b762],
2	we	PRP	O	we	nsubj	5	SENT_255	[p18l1113t696r1215b739],
3	did	VBD	O	do	aux	5	SENT_255	[p18l1283t672r1398b739],
4	not	RB	O	not	neg	5	SENT_255	[p18l1463t685r1584b739],
5	have	VB	O	have	advcl	15	SENT_255	[p18l1648t672r1815b739],
6	clinical	JJ	O	clinical	amod	7	SENT_255	[p18l1882t672r2140b739],
7	endpoints	NNS	O	endpoint	dobj	5	SENT_255	[p18l9t780r391b869],
8	,	,	O	,	_	0	SENT_255	[p18l9t780r391b869],
9	the	DT	O	the	det	10	SENT_255	[p18l414t780r529b849],
10	development	NN	O	development	nsubj	31	SENT_255	[p18l550t780r1025b869],
11	of	IN	O	of	_	0	SENT_255	[p18l1044t780r1126b849],
12	point-of-care	JJ	O	point-of-care	amod	14	SENT_255	[p18l1133t780r1591b869],
13	genetic	JJ	O	genetic	amod	14	SENT_255	[p18l1613t785r1874b870],
14	testing	NN	O	testing	prep_of	10	SENT_255	[p18l1892t785r2140b870],
15	serves	VBZ	O	serve	_	0	SENT_255	[p18l11t913r229b957],
16	as	IN	O	as	_	0	SENT_255	[p18l259t913r330b957],
17	a	DT	O	a	det	19	SENT_255	[p18l360t913r396b957],
18	crucial	JJ	O	crucial	amod	19	SENT_255	[p18l423t889r666b957],
19	step	NN	O	step	prep_as	15	SENT_255	[p18l694t902r838b978],
20	towards	IN	O	towards	_	0	SENT_255	[p18l864t889r1149b957],
21	the	DT	O	the	det	22	SENT_255	[p18l1176t889r1291b957],
22	integration	NN	O	integration	prep_towards	19	SENT_255	[p18l1317t894r1720b979],
23	of	IN	O	of	_	0	SENT_255	[p18l1747t889r1829b957],
24	genetics	NNS	O	genetics	prep_of	22	SENT_255	[p18l1843t894r2138b979],
25	into	IN	O	into	_	0	SENT_255	[p18l8t1004r151b1068],
26	the	DT	O	the	det	28	SENT_255	[p18l227t1000r341b1068],
27	clinical	JJ	O	clinical	amod	28	SENT_255	[p18l420t1000r676b1068],
28	setting	NN	O	setting	prep_into	15	SENT_255	[p18l756t1004r999b1089],
29	and	CC	O	and	_	0	SENT_255	[p18l1077t1000r1212b1068],
30	will	MD	O	will	aux	31	SENT_255	[p18l1285t1000r1418b1068],
31	allow	VB	O	allow	conj_and	15	SENT_255	[p18l1495t1000r1686b1068],
32	large-scale	JJ	O	large-scale	amod	33	SENT_255	[p18l1759t1000r2139b1089],
33	investigations	NNS	O	investigation	dobj	31	SENT_255	[p18l9t1113r511b1198],
34	to	TO	O	to	aux	36	SENT_255	[p18l548t1122r616b1177],
35	deﬁnitively	RB	O	deﬁnitively	advmod	36	SENT_255	[p18l653t1108r1057b1198],
36	assess	VB	O	assess	xcomp	31	SENT_255	[p18l1091t1133r1313b1177],
37	the	DT	O	the	det	38	SENT_255	[p18l1350t1108r1464b1177],
38	value	NN	O	value	dobj	36	SENT_255	[p18l1498t1108r1689b1177],
39	of	IN	O	of	_	0	SENT_255	[p18l1726t1108r1808b1177],
40	pharmacogenetic	JJ	O	pharmacogenetic	amod	41	SENT_255	[p18l1830t1108r2138b1197, p18l9t1222r352b1307],
41	strategies	NNS	O	strategy	prep_of	38	SENT_255	[p18l378t1222r737b1307],
42	.	.	O	.	_	0	SENT_255	[p18l378t1222r737b1307],

1	Contributors	NNS	O	contributor	nsubj	2	SENT_256	[p18l9t1364r359b1414],
2	]	VBP	O	]	_	0	SENT_256	[p18l9t1434r128b1496],
3	DR	NN	O	dr	nsubj	15	SENT_256	[p18l9t1434r128b1496],
4	and	CC	O	and	_	0	SENT_256	[p18l146t1429r251b1481],
5	DYFS	NN	O	dyf	nsubj	6	SENT_256	[p18l271t1432r433b1481],
6	conceived	VBD	O	conceive	ccomp	2	SENT_256	[p18l457t1429r748b1489],
7	,	,	O	,	_	0	SENT_256	[p18l457t1429r748b1489],
8	designed	VBN	O	design	ccomp	2	SENT_256	[p18l770t1429r1038b1498],
9	,	,	O	,	_	0	SENT_256	[p18l770t1429r1038b1498],
10	and	CC	O	and	_	0	SENT_256	[p18l1060t1429r1166b1481],
11	supervised	VBD	O	supervise	conj_and	6	SENT_256	[p18l1185t1429r1489b1497],
12	the	DT	O	the	det	13	SENT_256	[p18l1505t1429r1594b1481],
13	study	NN	O	study	dobj	11	SENT_256	[p18l1615t1429r1777b1498],
14	;	:	O	;	_	0	SENT_256	[p18l1615t1429r1777b1498],
15	obtained	VBN	O	obtain	conj_and	6	SENT_256	[p18l1800t1429r2045b1481],
16	funding	NN	O	funding	dobj	15	SENT_256	[p18l8t1498r250b1567],
17	;	:	O	;	_	0	SENT_256	[p18l8t1498r250b1567],
18	analysed	VBN	O	analyse	conj_and	6	SENT_256	[p18l272t1498r517b1567],
19	and	CC	O	and	_	0	SENT_256	[p18l535t1498r640b1550],
20	interpreted	VBN	O	interpret	conj_and	6	SENT_256	[p18l658t1498r973b1566],
21	the	DT	O	the	det	22	SENT_256	[p18l990t1498r1079b1550],
22	data	NNS	O	datum	dobj	18	SENT_256	[p18l1098t1498r1228b1558],
23	;	:	O	;	_	0	SENT_256	[p18l1098t1498r1228b1558],
24	and	CC	O	and	_	0	SENT_256	[p18l1250t1498r1356b1550],
25	wrote	VBD	O	write	conj_and	6	SENT_256	[p18l1371t1508r1531b1551],
26	drafts	NNS	O	draft	dobj	25	SENT_256	[p18l1551t1498r1708b1550],
27	of	IN	O	of	_	0	SENT_256	[p18l1729t1498r1793b1550],
28	the	DT	O	the	det	29	SENT_256	[p18l1800t1498r1889b1550],
29	report	NN	O	report	prep_of	26	SENT_256	[p18l1908t1508r2093b1566],
30	.	.	O	.	_	0	SENT_256	[p18l1908t1508r2093b1566],

1	GAW	NNP	O	GAW	nn	3	SENT_257	[p18l10t1572r166b1629],
2	,	,	O	,	_	0	SENT_257	[p18l10t1572r166b1629],
3	SG	NNP	O	SG	nsubj	12	SENT_257	[p18l191t1572r289b1629],
4	,	,	O	,	_	0	SENT_257	[p18l191t1572r289b1629],
5	and	CC	O	and	_	0	SENT_257	[p18l311t1567r416b1620],
6	DYFS	NN	ORGANIZATION	dyf	conj_and	3	SENT_257	[p18l437t1571r598b1620],
7	did	VBD	O	do	_	0	SENT_257	[p18l621t1567r711b1620],
8	the	DT	O	the	det	10	SENT_257	[p18l727t1568r816b1621],
9	statistical	JJ	O	statistical	amod	10	SENT_257	[p18l837t1568r1098b1620],
10	analysis	NN	O	analysis	dobj	7	SENT_257	[p18l1117t1567r1338b1637],
11	and	CC	O	and	_	0	SENT_257	[p18l1359t1568r1465b1620],
12	created	VBD	O	create	conj_and	7	SENT_257	[p18l1483t1567r1686b1621],
13	the	DT	O	the	det	14	SENT_257	[p18l1703t1567r1792b1620],
14	ﬁgures	NNS	O	ﬁgures	dobj	12	SENT_257	[p18l1810t1567r2021b1638],
15	.	.	O	.	_	0	SENT_257	[p18l1810t1567r2021b1638],

1	MRLM	NNP	O	MRLM	nsubj	17	SENT_258	[p18l10t1660r226b1715],
2	,	,	O	,	_	0	SENT_258	[p18l10t1660r226b1715],
3	ML	NNP	O	ML	conj_and	1	SENT_258	[p18l249t1660r357b1715],
4	,	,	O	,	_	0	SENT_258	[p18l249t1660r357b1715],
5	CG	NNP	O	CG	nsubj	17	SENT_258	[p18l380t1659r487b1715],
6	,	,	O	,	_	0	SENT_258	[p18l380t1659r487b1715],
7	MF	NN	O	mf	nn	13	SENT_258	[p18l511t1657r621b1715],
8	,	,	O	,	_	0	SENT_258	[p18l511t1657r621b1715],
9	AD	NN	O	ad	dep	13	SENT_258	[p18l641t1659r752b1715],
10	,	,	O	,	_	0	SENT_258	[p18l641t1659r752b1715],
11	I-FM	NN	O	i-fm	dep	13	SENT_258	[p18l774t1658r929b1722],
12	,	,	O	,	_	0	SENT_258	[p18l774t1658r929b1722],
13	EO	NN	O	eo	nsubj	17	SENT_258	[p18l953t1658r1053b1715],
14	,	,	O	,	_	0	SENT_258	[p18l953t1658r1053b1715],
15	and	CC	O	and	_	0	SENT_258	[p18l1075t1654r1180b1707],
16	ID	NNP	O	ID	nsubj	17	SENT_258	[p18l1201t1660r1270b1706],
17	enrolled	VBD	O	enrol	_	0	SENT_258	[p18l1291t1654r1524b1707],
18	patients	NNS	O	patient	dobj	17	SENT_258	[p18l1541t1658r1780b1723],
19	.	.	O	.	_	0	SENT_258	[p18l1541t1658r1780b1723],

1	GAW	NNP	O	GAW	nn	7	SENT_259	[p18l1802t1658r1959b1715],
2	,	,	O	,	_	0	SENT_259	[p18l1802t1658r1959b1715],
3	MRLM	NNP	O	MRLM	appos	7	SENT_259	[p18l10t1746r226b1801],
4	,	,	O	,	_	0	SENT_259	[p18l10t1746r226b1801],
5	ML	NNP	O	ML	appos	7	SENT_259	[p18l249t1746r357b1801],
6	,	,	O	,	_	0	SENT_259	[p18l249t1746r357b1801],
7	CG	NNP	O	CG	_	0	SENT_259	[p18l380t1744r487b1801],
8	,	,	O	,	_	0	SENT_259	[p18l380t1744r487b1801],
9	MF	NN	O	mf	appos	7	SENT_259	[p18l511t1743r621b1801],
10	,	,	O	,	_	0	SENT_259	[p18l511t1743r621b1801],
11	AD	NN	O	ad	appos	7	SENT_259	[p18l641t1744r752b1801],
12	,	,	O	,	_	0	SENT_259	[p18l641t1744r752b1801],
13	]	NN	O	]	appos	7	SENT_259	[p18l774t1743r929b1808],
14	.	.	O	.	_	0	SENT_259	[p18l774t1743r929b1808],

1	—	NN	O	—	_	0	SENT_260	[p18l774t1743r929b1808],
2	.	.	O	.	_	0	SENT_260	[p18l774t1743r929b1808],

1	FM	NNP	O	FM	nn	9	SENT_261	[p18l774t1743r929b1808],
2	,	,	O	,	_	0	SENT_261	[p18l774t1743r929b1808],
3	EO	NNP	O	EO	appos	9	SENT_261	[p18l953t1743r1053b1801],
4	,	,	O	,	_	0	SENT_261	[p18l953t1743r1053b1801],
5	SG	NNP	O	SG	appos	9	SENT_261	[p18l1078t1744r1176b1801],
6	,	,	O	,	_	0	SENT_261	[p18l1078t1744r1176b1801],
7	ID	NNP	O	ID	appos	9	SENT_261	[p18l1200t1746r1285b1801],
8	,	,	O	,	_	0	SENT_261	[p18l1200t1746r1285b1801],
9	AS	NNP	O	AS	nsubj	14	SENT_261	[p18l1305t1744r1403b1801],
10	,	,	O	,	_	0	SENT_261	[p18l1305t1744r1403b1801],
11	and	CC	O	and	_	0	SENT_261	[p18l1424t1740r1530b1793],
12	MHG	NNP	O	MHG	nsubj	14	SENT_261	[p18l1550t1744r1715b1793],
13	critically	RB	O	critically	advmod	14	SENT_261	[p18l1736t1740r1974b1809],
14	reviewed	VBD	O	review	_	0	SENT_261	[p18l8t1809r261b1862],
15	the	DT	O	the	det	16	SENT_261	[p18l277t1809r366b1862],
16	report	NN	O	report	dobj	14	SENT_261	[p18l385t1820r570b1878],
17	.	.	O	.	_	0	SENT_261	[p18l385t1820r570b1878],

1	AS	JJ	O	as	nsubj	13	SENT_262	[p18l591t1813r670b1862],
2	and	CC	O	and	_	0	SENT_262	[p18l694t1809r799b1862],
3	MHG	NN	O	mhg	conj_and	1	SENT_262	[p18l818t1813r984b1862],
4	supervised	VBD	O	supervise	_	0	SENT_262	[p18l1006t1809r1309b1878],
5	the	DT	O	the	det	7	SENT_262	[p18l1326t1809r1415b1862],
6	core	NN	O	core	nn	7	SENT_262	[p18l1434t1828r1551b1862],
7	laboratory	NN	O	laboratory	dobj	4	SENT_262	[p18l1570t1809r1856b1878],
8	for	IN	O	for	_	0	SENT_262	[p18l1873t1809r1954b1862],
9	direct	JJ	O	direct	amod	11	SENT_262	[p18l1972t1809r2132b1862],
10	DNA	NN	O	dna	nn	11	SENT_262	[p18l12t1882r155b1931],
11	sequencing	NN	O	sequencing	prep_for	4	SENT_262	[p18l174t1882r499b1948],
12	and	CC	O	and	_	0	SENT_262	[p18l518t1878r623b1931],
13	provided	VBN	O	provide	conj_and	4	SENT_262	[p18l640t1878r889b1948],
14	genetic	JJ	O	genetic	amod	15	SENT_262	[p18l908t1882r1110b1948],
15	expertise	NN	O	expertise	dobj	13	SENT_262	[p18l1129t1882r1393b1948],
16	.	.	O	.	_	0	SENT_262	[p18l1129t1882r1393b1948],

1	Conﬂicts	NNS	O	conﬂicts	nsubj	6	SENT_263	[p18l9t1970r247b2020],
2	of	IN	O	of	_	0	SENT_263	[p18l261t1970r320b2020],
3	interest	NN	O	interest	nn	4	SENT_263	[p18l332t1972r543b2020],
4	DYFS	NNS	ORGANIZATION	dyf	prep_of	1	SENT_263	[p18l12t2039r173b2088],
5	has	VBZ	O	have	aux	6	SENT_263	[p18l194t2035r290b2088],
6	received	VBN	O	receive	_	0	SENT_263	[p18l310t2035r543b2089],
7	unrestricted	JJ	O	unrestricted	amod	9	SENT_263	[p18l560t2035r905b2088],
8	research	NN	O	research	nn	9	SENT_263	[p18l922t2035r1162b2088],
9	grants	NNS	O	grant	dobj	6	SENT_263	[p18l1181t2046r1356b2106],
10	for	IN	O	for	_	0	SENT_263	[p18l1376t2035r1458b2088],
11	physician-initiated	JJ	O	physician-initiated	amod	12	SENT_263	[p18l1474t2035r1999b2105],
12	studies	NNS	O	study	prep_for	9	SENT_263	[p18l10t2106r207b2159],
13	from	IN	O	from	_	0	SENT_263	[p18l227t2106r369b2159],
14	Sanoﬁ	NNP	LOCATION	Sanoﬁ	prep_from	6	SENT_263	[p18l391t2106r792b2159],
15	.	.	O	.	_	0	SENT_263	[p18l391t2106r792b2159],

1	—	NN	O	—	_	0	SENT_264	[p18l391t2106r792b2159],
2	.	.	O	.	_	0	SENT_264	[p18l391t2106r792b2159],

1	Aventis	NNP	ORGANIZATION	Aventis	nn	2	SENT_265	[p18l391t2106r792b2159],
2	Canada	NNP	ORGANIZATION	Canada	_	0	SENT_265	[p18l815t2106r1038b2167],
3	,	,	O	,	_	0	SENT_265	[p18l815t2106r1038b2167],
4	Abbott	NNP	ORGANIZATION	Abbott	nn	6	SENT_265	[p18l1058t2106r1247b2159],
5	Vascular	NNP	ORGANIZATION	Vascular	nn	6	SENT_265	[p18l1263t2106r1507b2159],
6	Canada	NNP	ORGANIZATION	Canada	conj_and	2	SENT_265	[p18l1526t2106r1749b2167],
7	,	,	O	,	_	0	SENT_265	[p18l1526t2106r1749b2167],
8	and	CC	O	and	_	0	SENT_265	[p18l1771t2106r1876b2159],
9	Spartan	NNP	ORGANIZATION	Spartan	nn	10	SENT_265	[p18l1898t2110r2115b2175],
10	Biosciences	NNPS	ORGANIZATION	Biosciences	conj_and	2	SENT_265	[p18l12t2178r352b2236],
11	;	:	O	;	_	0	SENT_265	[p18l12t2178r352b2236],
12	and	CC	O	and	_	0	SENT_265	[p18l374t2175r480b2228],
13	honoraria	NN	O	honorarium	conj_and	2	SENT_265	[p18l496t2175r775b2228],
14	from	IN	O	from	_	0	SENT_265	[p18l793t2175r934b2228],
15	Eli	NNP	ORGANIZATION	Eli	nn	17	SENT_265	[p18l955t2175r1027b2227],
16	Lilly	NNP	ORGANIZATION	Lilly	nn	17	SENT_265	[p18l1048t2175r1166b2244],
17	Canada	NNP	ORGANIZATION	Canada	prep_from	13	SENT_265	[p18l1185t2175r1407b2228],
18	.	.	O	.	_	0	SENT_265	[p18l1185t2175r1407b2228],

1	The	DT	O	the	det	3	SENT_266	[p18l1427t2175r1538b2228],
2	other	JJ	O	other	amod	3	SENT_266	[p18l1557t2175r1706b2228],
3	authors	NNS	O	author	nsubj	4	SENT_266	[p18l1724t2175r1937b2228],
4	declare	VBP	O	declare	_	0	SENT_266	[p18l9t2244r208b2297],
5	that	IN	O	that	complm	7	SENT_266	[p18l226t2244r337b2297],
6	they	PRP	O	they	nsubj	7	SENT_266	[p18l353t2244r474b2313],
7	have	VBP	O	have	ccomp	4	SENT_266	[p18l490t2244r620b2297],
8	no	DT	O	no	det	9	SENT_266	[p18l639t2263r711b2297],
9	conﬂicts	NNS	O	conﬂicts	dobj	7	SENT_266	[p18l730t2244r966b2297],
10	of	IN	O	of	_	0	SENT_266	[p18l987t2244r1051b2297],
11	interest	NN	O	interest	prep_of	9	SENT_266	[p18l1059t2248r1286b2297],
12	.	.	O	.	_	0	SENT_266	[p18l1059t2248r1286b2297],

1	Acknowledgments	NNS	O	acknowledgment	nsubjpass	7	SENT_267	[p18l8t2336r525b2403],
2	The	DT	O	the	det	5	SENT_267	[p18l7t2403r117b2456],
3	RAPID	JJ	O	rapid	amod	5	SENT_267	[p18l139t2408r340b2455],
4	GENE	NN	O	gene	nn	5	SENT_267	[p18l362t2406r537b2456],
5	study	NN	O	study	dep	1	SENT_267	[p18l560t2403r712b2472],
6	was	VBD	O	be	auxpass	7	SENT_267	[p18l727t2422r833b2456],
7	funded	VBN	O	fund	_	0	SENT_267	[p18l854t2403r1057b2456],
8	by	IN	O	by	_	0	SENT_267	[p18l1073t2403r1141b2472],
9	Spartan	NNP	O	Spartan	nn	10	SENT_267	[p18l1162t2407r1379b2472],
10	Biosciences	NNP	O	Biosciences	agent	7	SENT_267	[p18l1400t2407r1740b2456],
11	.	.	O	.	_	0	SENT_267	[p18l1400t2407r1740b2456],

1	DYFS	NN	O	dyf	nsubjpass	3	SENT_268	[p18l1765t2407r1926b2456],
2	is	VBZ	O	be	auxpass	3	SENT_268	[p18l1948t2407r1992b2456],
3	supported	VBN	O	support	_	0	SENT_268	[p18l10t2472r296b2541],
4	by	IN	O	by	_	0	SENT_268	[p18l312t2472r379b2541],
5	grants	NNS	O	grant	agent	3	SENT_268	[p18l397t2483r572b2541],
6	from	IN	O	from	_	0	SENT_268	[p18l592t2472r733b2525],
7	the	DT	O	the	det	11	SENT_268	[p18l750t2472r839b2525],
8	Heart	NNP	ORGANIZATION	Heart	nn	11	SENT_268	[p18l861t2478r1021b2525],
9	and	CC	ORGANIZATION	and	_	0	SENT_268	[p18l1040t2472r1145b2525],
10	Stroke	NNP	ORGANIZATION	Stroke	nn	11	SENT_268	[p18l1167t2472r1344b2525],
11	Foundation	NNP	ORGANIZATION	Foundation	prep_from	5	SENT_268	[p18l1366t2472r1691b2525],
12	of	IN	O	of	_	0	SENT_268	[p18l1710t2472r1774b2525],
13	Ontario	NNP	LOCATION	Ontario	prep_of	5	SENT_268	[p18l1784t2475r2000b2525],
14	and	CC	O	and	_	0	SENT_268	[p18l2020t2472r2126b2525],
15	the	DT	O	the	det	17	SENT_268	[p18l7t2541r96b2594],
16	Canadian	JJ	ORGANIZATION	canadian	amod	17	SENT_268	[p18l117t2541r385b2594],
17	Institutes	NNPS	ORGANIZATION	Institutes	conj_and	5	SENT_268	[p18l406t2544r670b2594],
18	of	IN	ORGANIZATION	of	_	0	SENT_268	[p18l692t2541r755b2594],
19	Health	NNP	ORGANIZATION	Health	nn	20	SENT_268	[p18l767t2541r958b2594],
20	Research	NNP	ORGANIZATION	Research	prep_of	17	SENT_268	[p18l979t2541r1246b2594],
21	.	.	O	.	_	0	SENT_268	[p18l979t2541r1246b2594],

1	We	PRP	O	we	nsubj	2	SENT_269	[p18l1266t2547r1357b2594],
2	thank	VBP	O	thank	_	0	SENT_269	[p18l1376t2541r1540b2594],
3	L	NN	O	l	npadvmod	2	SENT_269	[p18l1560t2547r1593b2593],
4	e	SYM	O	e	dep	5	SENT_269	[p18l1661t2560r1690b2594],
5	Stuewe	NNP	PERSON	Stuewe	dep	3	SENT_269	[p18l1713t2545r1929b2602],
6	,	,	O	,	_	0	SENT_269	[p18l1713t2545r1929b2602],
7	Cheryl	NNP	PERSON	Cheryl	nn	8	SENT_269	[p18l10t2610r196b2679],
8	Charlebois	NNP	PERSON	Charlebois	appos	5	SENT_269	[p18l216t2610r534b2671],
9	,	,	O	,	_	0	SENT_269	[p18l216t2610r534b2671],
10	Colleen	NNP	PERSON	Colleen	nn	11	SENT_269	[p18l557t2610r771b2663],
11	Chilton	NNP	PERSON	Chilton	appos	5	SENT_269	[p18l791t2610r1016b2671],
12	,	,	O	,	_	0	SENT_269	[p18l791t2610r1016b2671],
13	Iordan	NNP	PERSON	Iordan	nn	14	SENT_269	[p18l1039t2610r1225b2678],
14	Bernick	NNP	PERSON	Bernick	appos	5	SENT_269	[p18l1246t2610r1478b2671],
15	,	,	O	,	_	0	SENT_269	[p18l1246t2610r1478b2671],
16	an	DT	O	a	det	18	SENT_269	[p18l1499t2629r1568b2663],
17	Luan	NNP	PERSON	Luan	nn	18	SENT_269	[p18l1626t2616r1765b2663],
18	Tran	NNP	PERSON	Tran	appos	5	SENT_269	[p18l1783t2613r1913b2663],
19	for	IN	O	for	_	0	SENT_269	[p18l1930t2610r2012b2663],
20	their	PRP$	O	they	poss	22	SENT_269	[p18l7t2684r142b2737],
21	invaluable	JJ	O	invaluable	amod	22	SENT_269	[p18l159t2684r450b2737],
22	assistance	NN	O	assistance	prep_for	2	SENT_269	[p18l469t2687r767b2737],
23	.	.	O	.	_	0	SENT_269	[p18l469t2687r767b2737],

1	Articles	NNPS	O	Articles	_	0	SENT_270	[p18l6t3220r156b3256],
2	I	PRP	O	I	dep	1	SENT_270	[p18l204t3057r252b3255],

1	wvvw	NN	O	wvvw	_	0	SENT_271	[p18l936t2917r1469b2968],
2	.	.	O	.	_	0	SENT_271	[p18l936t2917r1469b2968],

1	the	DT	O	the	det	2	SENT_272	[p18l936t2917r1469b2968],
2	|	NN	O	|	_	0	SENT_272	[p18l936t2917r1469b2968],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_272	[p18l936t2917r1469b2968],
4	Vol	NNP	O	Vol	dep	2	SENT_272	[p18l1514t2917r1600b2968],
5	379	CD	NUMBER	379	num	6	SENT_272	[p18l1620t2923r1723b2975],
6	May	NNP	DATE	May	dep	2	SENT_272	[p18l1772t2922r1891b2982],
7	5,2012	CD	DATE	5,2012	num	6	SENT_272	[p18l1908t2923r2110b2976],

1	References	NNS	O	reference	_	0	SENT_273	[p18l10t3502r278b3549],
2	21	CD	NUMBER	21	num	1	SENT_273	[p18l2094t3505r2148b3549],
3	1	CD	NUMBER	1	num	5	SENT_273	[p18l9t3579r32b3622],
4	Mega	JJ	ORGANIZATION	mega	amod	5	SENT_273	[p18l140t3579r283b3639],
5	IL	NN	ORGANIZATION	il	dep	1	SENT_273	[p18l301t3579r368b3637],
6	,	,	O	,	_	0	SENT_273	[p18l301t3579r368b3637],
7	Close	NNP	O	Close	nn	8	SENT_273	[p18l389t3574r531b3623],
8	SL	NNP	O	SL	appos	5	SENT_273	[p18l553t3578r629b3630],
9	,	,	O	,	_	0	SENT_273	[p18l553t3578r629b3630],
10	Wiviott	NNP	PERSON	Wiviott	nn	11	SENT_273	[p18l648t3577r838b3623],
11	SD	NN	O	sd	appos	5	SENT_273	[p18l857t3578r948b3630],
12	,	,	O	,	_	0	SENT_273	[p18l857t3578r948b3630],
13	et	FW	O	et	nn	14	SENT_273	[p18l968t3584r1014b3623],
14	al.	FW	O	al.	appos	5	SENT_273	[p18l1031t3574r1086b3623],
15	.	.	O	.	_	0	SENT_273	[p18l1031t3574r1086b3623],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_274	[p18l1108t3574r1427b3638],
2	p-450	NN	O	p-450	_	0	SENT_274	[p18l1445t3577r1586b3638],

1	polymorphisms	NNS	O	polymorphism	_	0	SENT_275	[p18l138t3648r554b3712],
2	and	CC	O	and	_	0	SENT_275	[p18l573t3648r672b3697],
3	response	NN	O	response	conj_and	1	SENT_275	[p18l687t3665r923b3711],
4	to	TO	O	to	_	0	SENT_275	[p18l940t3658r989b3697],
5	clopidogrel	NN	O	clopidogrel	prep_to	1	SENT_275	[p18l1007t3648r1312b3712],
6	.	.	O	.	_	0	SENT_275	[p18l1007t3648r1312b3712],

1	N	NN	O	n	nn	3	SENT_276	[p18l1335t3652r1382b3697],
2	Engl	NNP	O	Engl	nn	3	SENT_276	[p18l1398t3648r1506b3712],
3	]	NNP	O	]	nsubj	4	SENT_276	[p18l1515t3652r1547b3712],
4	Med	VBD	O	med	_	0	SENT_276	[p18l1563t3648r1672b3697],
5	2009	CD	DATE	2009	dobj	4	SENT_276	[p18l1689t3652r1825b3704],
6	;	:	O	;	_	0	SENT_276	[p18l1689t3652r1825b3704],
7	360	CD	NUMBER	360	num	9	SENT_276	[p18l139t3724r245b3770],
8	:	:	O	:	_	0	SENT_276	[p18l139t3724r245b3770],
9	354-62	CD	NUMBER	354-62	dep	5	SENT_276	[p18l267t3723r461b3770],
10	.	.	O	.	_	0	SENT_276	[p18l267t3723r461b3770],

1	Ge	NN	O	ge	nn	2	SENT_277	[p19l140t27r212b73],
2	D	NN	O	d	_	0	SENT_277	[p19l231t28r287b80],
3	,	,	O	,	_	0	SENT_277	[p19l231t28r287b80],
4	Fellay	NNP	PERSON	Fellay	nn	8	SENT_277	[p19l309t24r459b88],
5	I	PRP	O	I	dep	8	SENT_277	[p19l476t28r509b86],
6	,	,	O	,	_	0	SENT_277	[p19l476t28r509b86],
7	Thompson	NNP	PERSON	Thompson	dep	8	SENT_277	[p19l527t24r819b87],
8	A	NNP	O	A	appos	2	SENT_277	[p19l834t27r912b86],
9	]	NN	O	]	dep	8	SENT_277	[p19l834t27r912b86],
10	,	,	O	,	_	0	SENT_277	[p19l834t27r912b86],
11	et	FW	O	et	nn	12	SENT_277	[p19l933t34r979b73],
12	al.	FW	O	al.	appos	2	SENT_277	[p19l995t24r1051b73],
13	.	.	O	.	_	0	SENT_277	[p19l995t24r1051b73],

1	Genetic	JJ	O	genetic	amod	2	SENT_278	[p19l1073t27r1274b73],
2	variation	NN	O	variation	nsubj	5	SENT_278	[p19l1289t27r1520b73],
3	in	IN	O	in	_	0	SENT_278	[p19l1537t27r1590b72],
4	I	PRP	O	I	prep_in	2	SENT_278	[p19l1611t28r1632b72],
5	L28B	VBP	O	l28b	_	0	SENT_278	[p19l1634t28r1767b73],
6	predicts	VBZ	O	predict	ccomp	5	SENT_278	[p19l138t96r345b160],
7	hepatitis	NN	O	hepatitis	dobj	6	SENT_278	[p19l363t96r587b160],
8	C	NN	O	c	prep	7	SENT_278	[p19l608t100r645b145],
9	treatrnent-induced	JJ	O	treatrnent-induced	amod	11	SENT_278	[p19l662t96r1153b145],
10	viral	JJ	O	viral	amod	11	SENT_278	[p19l1168t96r1283b145],
11	clearance	NN	O	clearance	dep	8	SENT_278	[p19l1300t96r1557b145],
12	.	.	O	.	_	0	SENT_278	[p19l1300t96r1557b145],

1	Nature	NNP	O	Nature	_	0	SENT_279	[p19l1580t101r1754b145],
2	2009	CD	DATE	2009	num	1	SENT_279	[p19l1771t101r1907b153],
3	;	:	O	;	_	0	SENT_279	[p19l1771t101r1907b153],
4	461	CD	NUMBER	461	num	6	SENT_279	[p19l138t173r240b218],
5	:	:	O	:	_	0	SENT_279	[p19l138t173r240b218],
6	399-401	CD	NUMBER	399-401	dep	1	SENT_279	[p19l262t173r482b219],
7	.	.	O	.	_	0	SENT_279	[p19l262t173r482b219],

1	Klein	NNP	ORGANIZATION	Klein	nn	2	SENT_280	[p19l141t253r278b303],
2	TE	NNP	ORGANIZATION	TE	_	0	SENT_280	[p19l294t256r381b310],
3	,	,	O	,	_	0	SENT_280	[p19l294t256r381b310],
4	Altman	NNP	PERSON	Altman	nn	5	SENT_280	[p19l400t253r599b303],
5	RB	NN	O	rb	appos	2	SENT_280	[p19l619t258r710b310],
6	,	,	O	,	_	0	SENT_280	[p19l619t258r710b310],
7	Eriksson	NN	PERSON	eriksson	nn	8	SENT_280	[p19l732t253r960b303],
8	N	NN	O	n	appos	2	SENT_280	[p19l978t258r1034b310],
9	,	,	O	,	_	0	SENT_280	[p19l978t258r1034b310],
10	et	FW	O	et	nn	11	SENT_280	[p19l1055t263r1101b303],
11	al.	FW	O	al.	appos	2	SENT_280	[p19l1117t253r1173b303],
12	.	.	O	.	_	0	SENT_280	[p19l1117t253r1173b303],

1	Estimation	NN	O	estimation	_	0	SENT_281	[p19l1196t256r1481b303],
2	of	IN	O	of	_	0	SENT_281	[p19l1499t253r1558b303],
3	the	DT	O	the	det	5	SENT_281	[p19l1564t253r1647b303],
4	Warfarin	NNP	MISC	Warfarin	nn	5	SENT_281	[p19l1663t253r1888b303],
5	dose	NN	O	dose	prep_of	1	SENT_281	[p19l139t328r257b377],
6	with	IN	O	with	_	0	SENT_281	[p19l273t328r390b377],
7	clinical	JJ	O	clinical	amod	10	SENT_281	[p19l408t328r593b377],
8	and	CC	O	and	_	0	SENT_281	[p19l611t328r709b377],
9	pharrnacogenetic	JJ	O	pharrnacogenetic	amod	10	SENT_281	[p19l725t328r1181b392],
10	data	NNS	O	datum	prep_with	1	SENT_281	[p19l1198t328r1318b377],
11	.	.	O	.	_	0	SENT_281	[p19l1198t328r1318b377],

1	N	NN	O	n	nn	3	SENT_282	[p19l1341t333r1388b377],
2	Engl	NNP	O	Engl	nn	3	SENT_282	[p19l1405t328r1513b392],
3	]	NNP	O	]	nsubj	4	SENT_282	[p19l1521t333r1554b392],
4	Med	VBD	O	med	_	0	SENT_282	[p19l1570t328r1679b377],
5	2009	CD	DATE	2009	num	7	SENT_282	[p19l1695t332r1831b384],
6	;	:	O	;	_	0	SENT_282	[p19l1695t332r1831b384],
7	360	CD	NUMBER	360	dobj	4	SENT_282	[p19l139t405r245b450],
8	:	:	O	:	_	0	SENT_282	[p19l139t405r245b450],
9	75	CD	NUMBER	75	num	10	SENT_282	[p19l263t404r318b452],
10	3-64	CD	NUMBER	3-64	dep	7	SENT_282	[p19l325t405r457b450],
11	.	.	O	.	_	0	SENT_282	[p19l325t405r457b450],

1	Mallal	JJ	O	mallal	amod	2	SENT_283	[p19l140t485r300b534],
2	S	NN	O	s	_	0	SENT_283	[p19l321t488r364b541],
3	,	,	O	,	_	0	SENT_283	[p19l321t488r364b541],
4	Phillips	NNP	PERSON	Phillips	nn	5	SENT_283	[p19l386t485r582b549],
5	E	NNP	O	E	appos	2	SENT_283	[p19l604t488r650b541],
6	,	,	O	,	_	0	SENT_283	[p19l604t488r650b541],
7	Carosi	NNP	PERSON	Carosi	nn	8	SENT_283	[p19l671t488r837b534],
8	G	NNP	PERSON	G	appos	2	SENT_283	[p19l855t488r912b541],
9	,	,	O	,	_	0	SENT_283	[p19l855t488r912b541],
10	et	FW	O	et	nn	11	SENT_283	[p19l932t495r979b534],
11	al.	FW	O	al.	appos	2	SENT_283	[p19l995t485r1051b534],
12	.	.	O	.	_	0	SENT_283	[p19l995t485r1051b534],

1	HLA-B	NN	O	hla-b	_	0	SENT_284	[p19l1074t488r1401b536],
2	"	''	O	"	punct	1	SENT_284	[p19l1074t488r1401b536],
3	‘	CD	NUMBER	‘	number	4	SENT_284	[p19l1074t488r1401b536],
4	5701	CD	NUMBER	5701	num	5	SENT_284	[p19l1074t488r1401b536],
5	screening	NN	O	screening	dep	1	SENT_284	[p19l1419t488r1675b549],
6	for	IN	O	for	_	0	SENT_284	[p19l1691t485r1767b534],
7	hypersensitivity	NN	O	hypersensitivity	prep_for	5	SENT_284	[p19l137t558r553b622],
8	to	TO	O	to	_	0	SENT_284	[p19l568t568r617b607],
9	abacavir	NN	O	abacavir	prep_to	7	SENT_284	[p19l635t558r856b607],
10	.	.	O	.	_	0	SENT_284	[p19l635t558r856b607],

1	N	NN	O	n	nn	3	SENT_285	[p19l879t562r926b607],
2	Engl	NNP	O	Engl	nn	3	SENT_285	[p19l942t558r1051b622],
3	]	NNP	O	]	nsubj	4	SENT_285	[p19l1059t562r1092b622],
4	Med	VBD	O	med	_	0	SENT_285	[p19l1107t558r1216b607],
5	2008	CD	DATE	2008	dobj	4	SENT_285	[p19l1234t562r1369b614],
6	;	:	O	;	_	0	SENT_285	[p19l1234t562r1369b614],
7	358	CD	NUMBER	358	num	9	SENT_285	[p19l1390t560r1495b607],
8	:	:	O	:	_	0	SENT_285	[p19l1390t560r1495b607],
9	568-79	CD	NUMBER	568-79	dep	5	SENT_285	[p19l1518t561r1710b608],
10	.	.	O	.	_	0	SENT_285	[p19l1518t561r1710b608],

1	Wang	NNP	PERSON	Wang	nn	2	SENT_286	[p19l137t645r290b705],
2	L	NNP	PERSON	L	_	0	SENT_286	[p19l310t646r352b697],
3	,	,	O	,	_	0	SENT_286	[p19l310t646r352b697],
4	McLeod	NNP	PERSON	McLeod	nn	5	SENT_286	[p19l373t641r584b690],
5	HL	NNS	O	hl	appos	2	SENT_286	[p19l603t646r698b697],
6	,	,	O	,	_	0	SENT_286	[p19l603t646r698b697],
7	Weinshilboum	NNP	O	Weinshilboum	nn	8	SENT_286	[p19l716t641r1111b690],
8	RM	NN	O	rm	appos	5	SENT_286	[p19l1130t646r1237b690],
9	.	.	O	.	_	0	SENT_286	[p19l1130t646r1237b690],

1	Genomics	NNS	O	genomic	_	0	SENT_287	[p19l1259t644r1525b690],
2	and	CC	O	and	_	0	SENT_287	[p19l1544t641r1643b690],
3	drug	NN	O	drug	conj_and	1	SENT_287	[p19l1659t641r1782b705],
4	response	NN	O	response	dep	1	SENT_287	[p19l138t731r387b777],
5	.	.	O	.	_	0	SENT_287	[p19l138t731r387b777],

1	N	NN	O	n	nn	3	SENT_288	[p19l410t718r457b762],
2	Engl	NNP	O	Engl	nn	3	SENT_288	[p19l473t714r622b778],
3	]	NNP	O	]	nsubj	4	SENT_288	[p19l473t714r622b778],
4	Med	VBD	O	med	_	0	SENT_288	[p19l639t714r747b762],
5	2011	CD	DATE	2011	num	7	SENT_288	[p19l764t718r888b770],
6	;	:	O	;	_	0	SENT_288	[p19l764t718r888b770],
7	364	CD	NUMBER	364	dobj	4	SENT_288	[p19l908t718r1014b763],
8	:	:	O	:	_	0	SENT_288	[p19l908t718r1014b763],
9	1144	CD	DATE	1144	number	10	SENT_288	[p19l1035t716r1246b763],
10	—	CD	NUMBER	—	dep	7	SENT_288	[p19l1035t716r1246b763],
11	53	CD	NUMBER	53	dep	10	SENT_288	[p19l1035t716r1246b763],
12	.	.	O	.	_	0	SENT_288	[p19l1035t716r1246b763],

1	Kushner	NNP	PERSON	Kushner	nn	2	SENT_289	[p19l141t797r366b846],
2	FG	NNP	O	FG	nsubj	14	SENT_289	[p19l384t800r477b853],
3	,	,	O	,	_	0	SENT_289	[p19l384t800r477b853],
4	Hand	NNP	O	Hand	nn	5	SENT_289	[p19l499t797r647b846],
5	M	NNP	O	M	appos	2	SENT_289	[p19l665t802r732b853],
6	,	,	O	,	_	0	SENT_289	[p19l665t802r732b853],
7	Smith	NNP	ORGANIZATION	Smith	nn	9	SENT_289	[p19l755t797r914b846],
8	SC	NNP	ORGANIZATION	SC	nn	9	SENT_289	[p19l935t800r1005b846],
9	Ir	NNP	ORGANIZATION	Ir	appos	2	SENT_289	[p19l1026t802r1077b859],
10	,	,	O	,	_	0	SENT_289	[p19l1026t802r1077b859],
11	et	FW	O	et	nn	12	SENT_289	[p19l1097t807r1144b846],
12	al.	FW	O	al.	appos	2	SENT_289	[p19l1160t797r1216b846],
13	2009	CD	DATE	2009	dep	12	SENT_289	[p19l1237t801r1359b846],
14	focused	VBD	O	focus	dep	17	SENT_289	[p19l1377t797r1581b846],
15	updates	NNS	O	update	dobj	14	SENT_289	[p19l1597t797r1815b861],
16	:	:	O	:	_	0	SENT_289	[p19l1597t797r1815b861],
17	ACC	NN	O	acc	_	0	SENT_289	[p19l1834t800r1981b861],
18	/	:	O	/	punct	17	SENT_289	[p19l1834t800r1981b861],
19	AHA	NNP	O	AHA	nn	20	SENT_289	[p19l137t873r277b918],
20	guidelines	NNS	O	guideline	nsubj	38	SENT_289	[p19l293t870r564b934],
21	for	IN	O	for	_	0	SENT_289	[p19l583t869r658b918],
22	the	DT	O	the	det	23	SENT_289	[p19l673t869r756b919],
23	management	NN	O	management	prep_for	20	SENT_289	[p19l773t879r1125b934],
24	of	IN	O	of	_	0	SENT_289	[p19l1142t869r1201b918],
25	patients	NNS	O	patient	prep_of	23	SENT_289	[p19l1208t873r1416b933],
26	with	IN	O	with	_	0	SENT_289	[p19l1432t870r1550b919],
27	ST-elevation	NN	MISC	st-elevation	prep_with	25	SENT_289	[p19l1571t869r1887b919],
28	myocardial	JJ	O	myocardial	amod	30	SENT_289	[p19l138t942r429b1006],
29	infarction	NN	O	infarction	nn	30	SENT_289	[p19l446t942r703b991],
30	(	NN	O	(	nsubj	37	SENT_289	[p19l724t942r976b1007],
31	updating	VBG	O	update	partmod	30	SENT_289	[p19l724t942r976b1007],
32	the	DT	O	the	det	34	SENT_289	[p19l992t942r1074b991],
33	2004	CD	DATE	2004	num	34	SENT_289	[p19l1093t947r1216b991],
34	guideline	NN	O	guideline	dobj	31	SENT_289	[p19l1231t942r1476b1007],
35	and	CC	O	and	_	0	SENT_289	[p19l1494t942r1593b991],
36	2007	CD	DATE	2007	conj_and	34	SENT_289	[p19l1610t945r1730b993],
37	focused	VBD	O	focus	rcmod	20	SENT_289	[p19l1745t942r1949b991],
38	update	VBP	O	update	dep	17	SENT_289	[p19l137t1016r332b1080],
39	)	NN	O	)	dobj	38	SENT_289	[p19l137t1016r332b1080],
40	and	CC	O	and	_	0	SENT_289	[p19l354t1016r452b1065],
41	ACC/AHA	NN	O	acc/aha	conj_and	39	SENT_289	[p19l467t1019r775b1080],
42	/	:	O	/	punct	44	SENT_289	[p19l467t1019r775b1080],
43	SCAI	NN	O	scaus	nn	44	SENT_289	[p19l783t1019r918b1065],
44	guidelines	NNS	O	guideline	dep	39	SENT_289	[p19l939t1016r1210b1080],
45	on	IN	O	on	_	0	SENT_289	[p19l1229t1033r1296b1065],
46	percutaneous	JJ	O	percutaneous	amod	49	SENT_289	[p19l1312t1026r1667b1080],
47	coronary	JJ	O	coronary	amod	49	SENT_289	[p19l1686t1033r1918b1080],
48	intervention	NN	O	intervention	nn	49	SENT_289	[p19l138t1092r461b1138],
49	(	NN	O	(	prep_on	44	SENT_289	[p19l482t1089r733b1153],
50	updating	VBG	O	update	partmod	49	SENT_289	[p19l482t1089r733b1153],
51	the	DT	O	the	det	53	SENT_289	[p19l749t1089r832b1138],
52	2005	CD	DATE	2005	num	53	SENT_289	[p19l851t1092r972b1138],
53	guideline	NN	O	guideline	nsubj	56	SENT_289	[p19l992t1089r1237b1153],
54	and	CC	O	and	_	0	SENT_289	[p19l1256t1089r1354b1138],
55	2007	CD	DATE	2007	nsubj	56	SENT_289	[p19l1371t1092r1491b1139],
56	focused	VBD	O	focus	ccomp	50	SENT_289	[p19l1507t1089r1710b1138],
57	update	VBP	O	update	dep	56	SENT_289	[p19l1725t1089r1920b1153],
58	)	CD	NUMBER	)	dobj	57	SENT_289	[p19l1725t1089r1920b1153],
59	a	DT	O	a	det	60	SENT_289	[p19l139t1179r166b1210],
60	report	NN	O	report	nsubj	57	SENT_289	[p19l182t1171r343b1225],
61	of	IN	O	of	_	0	SENT_289	[p19l360t1161r419b1210],
62	the	DT	O	the	det	64	SENT_289	[p19l425t1161r508b1210],
63	American	NNP	ORGANIZATION	American	nn	64	SENT_289	[p19l524t1164r786b1210],
64	College	NNP	ORGANIZATION	College	prep_of	60	SENT_289	[p19l805t1161r997b1226],
65	of	IN	ORGANIZATION	of	_	0	SENT_289	[p19l1015t1161r1074b1210],
66	Cardiology	NNP	ORGANIZATION	Cardiology	nn	67	SENT_289	[p19l1084t1161r1366b1226],
67	Foundation	NNP	ORGANIZATION	Foundation	prep_of	64	SENT_289	[p19l1384t1161r1686b1210],
68	/	:	ORGANIZATION	/	punct	44	SENT_289	[p19l1689t1165r1974b1225],
69	American	JJ	ORGANIZATION	american	amod	73	SENT_289	[p19l1689t1165r1974b1225],
70	Heart	NNP	ORGANIZATION	Heart	nn	73	SENT_289	[p19l141t1240r290b1284],
71	Association	NNP	ORGANIZATION	Association	nn	73	SENT_289	[p19l305t1238r610b1284],
72	Task	NNP	ORGANIZATION	Task	nn	73	SENT_289	[p19l626t1235r746b1284],
73	Force	NNP	ORGANIZATION	Force	dep	39	SENT_289	[p19l764t1238r905b1284],
74	on	IN	O	on	_	0	SENT_289	[p19l923t1253r990b1284],
75	Practice	NNP	O	Practice	nn	76	SENT_289	[p19l1009t1238r1214b1284],
76	Guidelines	NNS	O	guideline	prep_on	73	SENT_289	[p19l1234t1235r1531b1284],
77	.	.	O	.	_	0	SENT_289	[p19l1234t1235r1531b1284],

1	Circulation	NN	O	circulation	_	0	SENT_290	[p19l1556t1235r1835b1284],
2	2009	CD	DATE	2009	num	1	SENT_290	[p19l140t1313r276b1365],
3	;	:	O	;	_	0	SENT_290	[p19l140t1313r276b1365],
4	120	CD	NUMBER	120	num	6	SENT_290	[p19l297t1313r397b1357],
5	:	:	O	:	_	0	SENT_290	[p19l297t1313r397b1357],
6	2271-306	CD	NUMBER	2271-306	dep	1	SENT_290	[p19l418t1312r669b1359],
7	.	.	O	.	_	0	SENT_290	[p19l418t1312r669b1359],

1	Mehta	NNP	ORGANIZATION	Mehta	nn	2	SENT_291	[p19l140t1392r306b1441],
2	SR	NN	ORGANIZATION	sr	_	0	SENT_291	[p19l326t1395r410b1448],
3	,	,	O	,	_	0	SENT_291	[p19l326t1395r410b1448],
4	Yusuf	NNP	PERSON	Yusuf	nn	5	SENT_291	[p19l429t1392r591b1441],
5	S	NNP	PERSON	S	appos	2	SENT_291	[p19l602t1395r645b1448],
6	,	,	O	,	_	0	SENT_291	[p19l602t1395r645b1448],
7	Peters	NNP	PERSON	Peters	nn	9	SENT_291	[p19l667t1397r824b1441],
8	R	NNP	O	R	nn	9	SENT_291	[p19l846t1397r919b1454],
9	]	NN	O	]	appos	2	SENT_291	[p19l846t1397r919b1454],
10	,	,	O	,	_	0	SENT_291	[p19l846t1397r919b1454],
11	et	FW	O	et	nn	12	SENT_291	[p19l939t1402r985b1441],
12	al.	FW	O	al.	appos	2	SENT_291	[p19l1002t1392r1057b1441],
13	.	.	O	.	_	0	SENT_291	[p19l1002t1392r1057b1441],

1	Effects	NNS	O	effect	nsubj	8	SENT_292	[p19l1080t1392r1252b1441],
2	of	IN	O	of	_	0	SENT_292	[p19l1271t1392r1331b1441],
3	pretreatment	NN	O	pretreatment	prep_of	1	SENT_292	[p19l1338t1402r1685b1456],
4	with	IN	O	with	_	0	SENT_292	[p19l1699t1392r1816b1441],
5	clopidogrel	NN	O	clopidogrel	prep_with	3	SENT_292	[p19l139t1465r431b1529],
6	and	CC	O	and	_	0	SENT_292	[p19l448t1465r546b1514],
7	aspirin	NN	O	aspirin	conj_and	5	SENT_292	[p19l563t1468r746b1528],
8	followed	VBN	O	follow	_	0	SENT_292	[p19l762t1464r987b1514],
9	by	IN	O	by	_	0	SENT_292	[p19l1002t1465r1064b1529],
10	long-term	JJ	O	long-term	amod	11	SENT_292	[p19l1078t1465r1340b1529],
11	therapy	NN	O	therapy	prep_by	8	SENT_292	[p19l1356t1465r1555b1529],
12	in	IN	O	in	_	0	SENT_292	[p19l1570t1468r1623b1513],
13	patients	NNS	O	patient	prep_in	8	SENT_292	[p19l1640t1468r1847b1528],
14	undergoing	VBG	O	undergo	partmod	13	SENT_292	[p19l137t1537r447b1602],
15	percutaneous	JJ	O	percutaneous	amod	17	SENT_292	[p19l463t1547r818b1601],
16	coronary	JJ	O	coronary	amod	17	SENT_292	[p19l837t1555r1069b1601],
17	intervention	NN	O	intervention	dobj	14	SENT_292	[p19l1084t1540r1419b1586],
18	:	:	O	:	_	0	SENT_292	[p19l1084t1540r1419b1586],
19	the	DT	O	the	det	21	SENT_292	[p19l1438t1537r1520b1586],
20	PCI-CURE	NN	O	pci-cure	nn	21	SENT_292	[p19l1541t1540r1826b1586],
21	study	NN	O	study	dep	17	SENT_292	[p19l140t1611r287b1675],
22	.	.	O	.	_	0	SENT_292	[p19l140t1611r287b1675],

1	Lancet	NNP	O	Lancet	_	0	SENT_293	[p19l309t1616r471b1660],
2	2001	CD	DATE	2001	num	1	SENT_293	[p19l489t1615r619b1667],
3	;	:	O	;	_	0	SENT_293	[p19l489t1615r619b1667],
4	358	CD	NUMBER	358	num	6	SENT_293	[p19l639t1613r744b1660],
5	:	:	O	:	_	0	SENT_293	[p19l639t1613r744b1660],
6	527-33	CD	NUMBER	527-33	dep	1	SENT_293	[p19l767t1614r960b1662],
7	.	.	O	.	_	0	SENT_293	[p19l767t1614r960b1662],

1	Steinhubl	NNP	O	Steinhubl	_	0	SENT_294	[p19l142t1693r396b1742],
2	SR	JJ	O	sr	dep	1	SENT_294	[p19l417t1697r501b1749],
3	,	,	O	,	_	0	SENT_294	[p19l417t1697r501b1749],
4	Berger	NNP	PERSON	Berger	nn	5	SENT_294	[p19l524t1698r699b1758],
5	PB	NN	O	pb	appos	2	SENT_294	[p19l717t1698r804b1749],
6	,	,	O	,	_	0	SENT_294	[p19l717t1698r804b1749],
7	Mann	NNP	PERSON	Mann	nn	9	SENT_294	[p19l825t1698r981b1742],
8	IT	NNP	O	IT	nn	9	SENT_294	[p19l999t1696r1058b1756],
9	III	NNP	O	III	appos	2	SENT_294	[p19l1077t1698r1155b1749],
10	,	,	O	,	_	0	SENT_294	[p19l1077t1698r1155b1749],
11	et	FW	O	et	nn	12	SENT_294	[p19l1176t1703r1222b1742],
12	al.	FW	O	al.	appos	2	SENT_294	[p19l1238t1693r1294b1742],
13	.	.	O	.	_	0	SENT_294	[p19l1238t1693r1294b1742],

1	Early	RB	O	early	advmod	3	SENT_295	[p19l1317t1693r1447b1757],
2	and	CC	O	and	nsubj	3	SENT_295	[p19l1464t1693r1562b1742],
3	sustained	VBD	O	sustain	_	0	SENT_295	[p19l1580t1693r1831b1742],
4	dual	JJ	O	dual	amod	7	SENT_295	[p19l1848t1693r1961b1742],
5	oral	JJ	O	oral	amod	7	SENT_295	[p19l139t1767r238b1816],
6	antiplatelet	JJ	O	antiplatelet	amod	7	SENT_295	[p19l255t1767r547b1831],
7	therapy	NN	O	therapy	dobj	3	SENT_295	[p19l562t1767r761b1831],
8	following	VBG	O	follow	_	0	SENT_295	[p19l776t1767r1023b1831],
9	percutaneous	JJ	O	percutaneous	amod	11	SENT_295	[p19l1039t1777r1395b1831],
10	coronary	JJ	O	coronary	amod	11	SENT_295	[p19l1414t1784r1645b1831],
11	intervention	NN	O	intervention	prep_following	7	SENT_295	[p19l138t1843r473b1889],
12	:	:	O	:	_	0	SENT_295	[p19l138t1843r473b1889],
13	a	DT	O	a	det	16	SENT_295	[p19l494t1857r520b1889],
14	randomized	VBN	O	randomize	amod	16	SENT_295	[p19l538t1840r858b1889],
15	controlled	JJ	O	controlled	amod	16	SENT_295	[p19l875t1840r1139b1889],
16	trial	NN	O	trial	dep	7	SENT_295	[p19l1154t1840r1271b1889],
17	.	.	O	.	_	0	SENT_295	[p19l1154t1840r1271b1889],
18	]	SYM	O	]	dep	3	SENT_295	[p19l1284t1843r1458b1904],

1	AMA	NNP	O	AMA	_	0	SENT_296	[p19l1284t1843r1458b1904],
2	2002	CD	DATE	2002	num	1	SENT_296	[p19l1475t1844r1611b1895],
3	;	:	O	;	_	0	SENT_296	[p19l1475t1844r1611b1895],
4	288	CD	NUMBER	288	num	6	SENT_296	[p19l1632t1844r1737b1888],
5	:	:	O	:	_	0	SENT_296	[p19l1632t1844r1737b1888],
6	2411-20	CD	NUMBER	2411-20	dep	1	SENT_296	[p19l1758t1844r1973b1888],
7	.	.	O	.	_	0	SENT_296	[p19l1758t1844r1973b1888],

1	Angiolillo	NN	O	angiolillo	nn	3	SENT_297	[p19l137t1923r396b1987],
2	D	NN	O	d	nn	3	SENT_297	[p19l417t1928r495b1985],
3	]	NN	O	]	_	0	SENT_297	[p19l417t1928r495b1985],
4	,	,	O	,	_	0	SENT_297	[p19l417t1928r495b1985],
5	Fernandez-Ortiz	NN	O	fernandez-ortiz	nn	6	SENT_297	[p19l517t1923r947b1972],
6	A	NN	O	a	appos	3	SENT_297	[p19l964t1926r1019b1979],
7	,	,	O	,	_	0	SENT_297	[p19l964t1926r1019b1979],
8	Bemardo	NNP	O	Bemardo	nn	9	SENT_297	[p19l1041t1923r1284b1972],
9	E	NNP	O	E	appos	3	SENT_297	[p19l1305t1926r1350b1979],
10	,	,	O	,	_	0	SENT_297	[p19l1305t1926r1350b1979],
11	et	FW	O	et	nn	12	SENT_297	[p19l1370t1933r1417b1972],
12	al.	FW	O	al.	appos	3	SENT_297	[p19l1433t1923r1488b1972],
13	.	.	O	.	_	0	SENT_297	[p19l1433t1923r1488b1972],

1	Variability	NN	O	variability	_	0	SENT_298	[p19l1508t1923r1776b1987],
2	in	IN	O	in	dep	1	SENT_298	[p19l1791t1926r1845b1971],
3	individual	JJ	O	individual	amod	4	SENT_298	[p19l138t1996r403b2045],
4	responsiveness	NN	O	responsiveness	pcomp	2	SENT_298	[p19l420t1999r818b2059],
5	to	TO	O	to	_	0	SENT_298	[p19l836t2005r885b2045],
6	clopidogrel	NN	O	clopidogrel	prep_to	4	SENT_298	[p19l903t1996r1207b2060],
7	:	:	O	:	_	0	SENT_298	[p19l903t1996r1207b2060],
8	clinical	JJ	O	clinical	amod	9	SENT_298	[p19l1228t1996r1414b2045],
9	implications	NNS	O	implication	dep	4	SENT_298	[p19l1431t1996r1771b2059],
10	,	,	O	,	_	0	SENT_298	[p19l1431t1996r1771b2059],
11	management	NN	O	management	dobj	4	SENT_298	[p19l138t2078r502b2133],
12	,	,	O	,	_	0	SENT_298	[p19l138t2078r502b2133],
13	and	CC	O	and	_	0	SENT_298	[p19l523t2068r621b2117],
14	future	JJ	DATE	future	amod	15	SENT_298	[p19l636t2068r799b2117],
15	perspectives	NNS	O	perspective	dobj	4	SENT_298	[p19l815t2072r1150b2132],
16	.	.	O	.	_	0	SENT_298	[p19l815t2072r1150b2132],
17	]	SYM	O	]	dep	11	SENT_298	[p19l1163t2073r1195b2132],

1	Am	VBP	O	be	dep	3	SENT_299	[p19l1208t2072r1302b2117],
2	Coll	NNP	O	Coll	nn	3	SENT_299	[p19l1323t2068r1418b2117],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_299	[p19l1439t2068r1619b2117],
4	2007	CD	DATE	2007	num	3	SENT_299	[p19l1637t2071r1768b2124],
5	;	:	O	;	_	0	SENT_299	[p19l1637t2071r1768b2124],
6	49	CD	NUMBER	49	dep	3	SENT_299	[p19l138t2146r213b2191],
7	:	:	O	:	_	0	SENT_299	[p19l138t2146r213b2191],
8	1505-16	CD	NUMBER	1505-16	dep	6	SENT_299	[p19l234t2145r452b2191],
9	.	.	O	.	_	0	SENT_299	[p19l234t2145r452b2191],

1	Price	NN	O	price	nn	3	SENT_300	[p19l141t2228r271b2274],
2	M	NN	O	m	nn	3	SENT_300	[p19l291t2230r381b2288],
3	]	NN	O	]	_	0	SENT_300	[p19l291t2230r381b2288],
4	,	,	O	,	_	0	SENT_300	[p19l291t2230r381b2288],
5	Endemann	NNP	ORGANIZATION	Endemann	nn	6	SENT_300	[p19l403t2225r694b2274],
6	S	NNP	ORGANIZATION	S	appos	3	SENT_300	[p19l715t2229r758b2281],
7	,	,	O	,	_	0	SENT_300	[p19l715t2229r758b2281],
8	Gollapudi	NNP	O	Gollapudi	nn	9	SENT_300	[p19l779t2225r1037b2289],
9	RR	NNP	O	RR	appos	3	SENT_300	[p19l1057t2230r1148b2281],
10	,	,	O	,	_	0	SENT_300	[p19l1057t2230r1148b2281],
11	et	FW	O	et	nn	12	SENT_300	[p19l1168t2235r1215b2274],
12	al.	FW	O	al.	appos	3	SENT_300	[p19l1231t2225r1287b2274],
13	.	.	O	.	_	0	SENT_300	[p19l1231t2225r1287b2274],

1	Prognostic	JJ	O	prognostic	amod	2	SENT_301	[p19l1310t2228r1590b2290],
2	signiﬁcance	NN	O	signiﬁcance	nsubj	7	SENT_301	[p19l1609t2225r1921b2289],
3	of	IN	O	of	_	0	SENT_301	[p19l139t2321r198b2370],
4	post-clopidogrel	JJ	O	post-clopidogrel	amod	6	SENT_301	[p19l205t2321r627b2385],
5	platelet	NN	O	platelet	nn	6	SENT_301	[p19l643t2321r834b2385],
6	reactivity	NN	O	reactivity	prep_of	2	SENT_301	[p19l850t2324r1086b2385],
7	assessed	VBN	O	assess	_	0	SENT_301	[p19l1103t2321r1328b2370],
8	by	IN	O	by	_	0	SENT_301	[p19l1343t2321r1405b2385],
9	a	DT	O	a	det	11	SENT_301	[p19l1421t2338r1448b2370],
10	point-of-care	JJ	O	point-of-care	amod	11	SENT_301	[p19l1464t2321r1795b2385],
11	assay	NN	O	assay	prep_by	7	SENT_301	[p19l1812t2338r1950b2385],
12	on	IN	O	on	_	0	SENT_301	[p19l139t2411r206b2443],
13	thrombotic	JJ	O	thrombotic	amod	14	SENT_301	[p19l221t2394r516b2443],
14	events	NNS	O	event	prep_on	7	SENT_301	[p19l533t2403r697b2443],
15	after	IN	O	after	_	0	SENT_301	[p19l717t2394r835b2443],
16	drug-eluting	JJ	O	drug-eluting	amod	18	SENT_301	[p19l851t2394r1179b2458],
17	stent	NN	O	stent	nn	18	SENT_301	[p19l1197t2403r1325b2443],
18	implantation	NN	O	implantation	prep_after	7	SENT_301	[p19l1340t2394r1694b2457],
19	.	.	O	.	_	0	SENT_301	[p19l1340t2394r1694b2457],

1	Ear	NN	O	ear	nn	2	SENT_302	[p19l142t2469r235b2515],
2	Heart	NNP	O	Heart	_	0	SENT_302	[p19l251t2471r436b2530],
3	]	CD	NUMBER	]	num	4	SENT_302	[p19l251t2471r436b2530],
4	2008	CD	DATE	2008	dep	2	SENT_302	[p19l451t2470r587b2522],
5	;	:	O	;	_	0	SENT_302	[p19l451t2470r587b2522],
6	29	CD	NUMBER	29	num	8	SENT_302	[p19l608t2470r681b2515],
7	:	:	O	:	_	0	SENT_302	[p19l608t2470r681b2515],
8	992-1000	CD	NUMBER	992-1000	dep	2	SENT_302	[p19l702t2470r959b2515],
9	.	.	O	.	_	0	SENT_302	[p19l702t2470r959b2515],

1	Parodi	NNP	PERSON	Parodi	nn	2	SENT_303	[p19l141t2550r308b2599],
2	G	NNP	PERSON	G	_	0	SENT_303	[p19l327t2553r384b2606],
3	,	,	O	,	_	0	SENT_303	[p19l327t2553r384b2606],
4	Marcucci	NNP	PERSON	Marcucci	nn	5	SENT_303	[p19l405t2553r646b2599],
5	R	NNP	PERSON	R	appos	2	SENT_303	[p19l665t2554r715b2606],
6	,	,	O	,	_	0	SENT_303	[p19l665t2554r715b2606],
7	Valenti	NNP	PERSON	Valenti	nn	8	SENT_303	[p19l734t2550r918b2599],
8	R	NNP	O	R	appos	2	SENT_303	[p19l938t2554r988b2605],
9	,	,	O	,	_	0	SENT_303	[p19l938t2554r988b2605],
10	et	FW	O	et	nn	11	SENT_303	[p19l1008t2559r1055b2599],
11	al.	FW	O	al.	appos	2	SENT_303	[p19l1071t2550r1127b2599],
12	.	.	O	.	_	0	SENT_303	[p19l1071t2550r1127b2599],

1	High	JJ	O	high	amod	4	SENT_304	[p19l1149t2550r1283b2614],
2	residual	JJ	O	residual	amod	4	SENT_304	[p19l1299t2550r1510b2599],
3	platelet	NN	O	platelet	nn	4	SENT_304	[p19l1527t2550r1718b2613],
4	reactivity	NN	O	reactivity	_	0	SENT_304	[p19l1733t2553r1970b2614],
5	after	IN	O	after	_	0	SENT_304	[p19l139t2622r257b2671],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_304	[p19l273t2622r566b2687],
7	loading	NN	O	loading	prep_after	4	SENT_304	[p19l581t2622r778b2687],
8	and	CC	O	and	_	0	SENT_304	[p19l795t2622r894b2671],
9	long-term	JJ	O	long-term	amod	11	SENT_304	[p19l909t2622r1170b2686],
10	cardiovascular	JJ	O	cardiovascular	amod	11	SENT_304	[p19l1188t2622r1565b2671],
11	events	NNS	O	event	conj_and	4	SENT_304	[p19l1581t2632r1745b2671],
12	among	IN	O	among	_	0	SENT_304	[p19l1764t2640r1949b2687],
13	patients	NNS	O	patient	prep_among	11	SENT_304	[p19l138t2699r345b2760],
14	with	IN	O	with	_	0	SENT_304	[p19l362t2696r479b2745],
15	acute	JJ	O	acute	amod	17	SENT_304	[p19l497t2706r634b2745],
16	coronary	JJ	O	coronary	amod	17	SENT_304	[p19l652t2713r883b2760],
17	syndromes	NNS	O	syndrome	prep_with	13	SENT_304	[p19l900t2696r1187b2760],
18	undergoing	VBG	O	undergo	partmod	4	SENT_304	[p19l1205t2696r1515b2760],
19	PCI	NN	O	pcus	dobj	18	SENT_304	[p19l1534t2699r1646b2745],
20	.	.	O	.	_	0	SENT_304	[p19l1534t2699r1646b2745],

1	JAMA	NNP	O	JAMA	_	0	SENT_305	[p19l1659t2699r1833b2760],
2	2011	CD	DATE	2011	num	1	SENT_305	[p19l1850t2700r1974b2752],
3	;	:	O	;	_	0	SENT_305	[p19l1850t2700r1974b2752],
4	306	CD	NUMBER	306	num	6	SENT_305	[p19l139t2773r245b2818],
5	:	:	O	:	_	0	SENT_305	[p19l139t2773r245b2818],
6	1215-23	CD	NUMBER	1215-23	dep	1	SENT_305	[p19l266t2771r484b2818],
7	.	.	O	.	_	0	SENT_305	[p19l266t2771r484b2818],

1	Hochholzer	NNP	O	Hochholzer	nn	2	SENT_306	[p19l141t2853r454b2902],
2	W	NNP	O	W	_	0	SENT_306	[p19l469t2858r535b2909],
3	,	,	O	,	_	0	SENT_306	[p19l469t2858r535b2909],
4	Trenk	NNP	ORGANIZATION	Trenk	nn	5	SENT_306	[p19l554t2853r709b2902],
5	D	NNP	ORGANIZATION	D	appos	2	SENT_306	[p19l728t2858r784b2909],
6	,	,	O	,	_	0	SENT_306	[p19l728t2858r784b2909],
7	Fromm	NNP	PERSON	Fromm	nn	8	SENT_306	[p19l807t2856r1004b2902],
8	MF	NN	O	mf	appos	2	SENT_306	[p19l1024t2856r1127b2909],
9	,	,	O	,	_	0	SENT_306	[p19l1024t2856r1127b2909],
10	et	FW	O	et	nn	11	SENT_306	[p19l1148t2863r1195b2902],
11	al.	FW	O	al.	appos	2	SENT_306	[p19l1212t2853r1268b2902],
12	.	.	O	.	_	0	SENT_306	[p19l1212t2853r1268b2902],

1	Impact	NN	O	impact	_	0	SENT_307	[p19l1291t2858r1478b2917],
2	of	IN	O	of	advmod	16	SENT_307	[p19l1495t2853r1554b2902],
3	cytochrome	NN	O	cytochrome	nn	5	SENT_307	[p19l1563t2853r1872b2917],
4	P450	NN	O	p450	nn	5	SENT_307	[p19l141t2929r267b2975],
5	2C19	NN	O	2c19	dobj	16	SENT_307	[p19l286t2929r414b2975],
6	loss-of-function	NN	O	loss-of-function	nn	7	SENT_307	[p19l431t2925r846b2975],
7	polymorphism	NN	O	polymorphism	dep	5	SENT_307	[p19l863t2926r1257b2990],
8	and	CC	O	and	_	0	SENT_307	[p19l1275t2926r1374b2975],
9	of	IN	O	of	conj_and	7	SENT_307	[p19l1391t2926r1450b2975],
10	major	JJ	O	major	amod	12	SENT_307	[p19l1458t2929r1617b2990],
11	demographic	JJ	O	demographic	amod	12	SENT_307	[p19l1634t2926r1985b2990],
12	characteristics	NNS	O	characteristic	pobj	9	SENT_307	[p19l139t2998r515b3047],
13	on	IN	O	on	_	0	SENT_307	[p19l535t3016r602b3047],
14	residual	JJ	O	residual	amod	15	SENT_307	[p19l619t2998r831b3047],
15	platelet	NN	O	platelet	prep_on	12	SENT_307	[p19l848t2998r1042b3062],
16	function	NN	O	function	dep	1	SENT_307	[p19l1057t2998r1283b3047],
17	after	IN	O	after	mark	18	SENT_307	[p19l1301t2998r1420b3047],
18	loading	VBG	O	load	dep	16	SENT_307	[p19l1436t2998r1634b3063],
19	and	CC	O	and	_	0	SENT_307	[p19l1652t2998r1751b3047],
20	maintenance	NN	O	maintenance	nn	21	SENT_307	[p19l138t3075r485b3121],
21	treatment	NN	O	treatment	conj_and	18	SENT_307	[p19l502t3082r764b3121],
22	with	IN	O	with	_	0	SENT_307	[p19l779t3072r897b3121],
23	clopidogrel	NN	O	clopidogrel	prep_with	21	SENT_307	[p19l914t3072r1209b3136],
24	in	IN	O	in	_	0	SENT_307	[p19l1226t3075r1280b3120],
25	patients	NNS	O	patient	prep_in	23	SENT_307	[p19l1297t3075r1506b3136],
26	undergoing	VBG	O	undergo	partmod	25	SENT_307	[p19l1524t3072r1836b3136],
27	elective	JJ	O	elective	amod	30	SENT_307	[p19l139t3145r333b3194],
28	coronary	JJ	O	coronary	amod	30	SENT_307	[p19l351t3162r584b3209],
29	stent	NN	O	stent	nn	30	SENT_307	[p19l602t3154r731b3194],
30	placement	NN	O	placement	dobj	26	SENT_307	[p19l746t3145r1036b3208],
31	.	.	O	.	_	0	SENT_307	[p19l746t3145r1036b3208],
32	]	SYM	O	]	dep	1	SENT_307	[p19l1050t3149r1082b3209],

1	Am	VBP	O	be	dep	3	SENT_308	[p19l1096t3148r1191b3193],
2	Coll	NNP	O	Coll	nn	3	SENT_308	[p19l1211t3145r1307b3194],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_308	[p19l1328t3145r1510b3194],
4	2010	CD	DATE	2010	num	3	SENT_308	[p19l1528t3149r1659b3201],
5	;	:	O	;	_	0	SENT_308	[p19l1528t3149r1659b3201],
6	55	CD	NUMBER	55	dep	3	SENT_308	[p19l141t3219r214b3266],
7	:	:	O	:	_	0	SENT_308	[p19l141t3219r214b3266],
8	2427-34	CD	NUMBER	2427-34	dep	6	SENT_308	[p19l235t3220r456b3268],
9	.	.	O	.	_	0	SENT_308	[p19l235t3220r456b3268],

1	Simon	NNP	PERSON	Simon	nn	2	SENT_309	[p19l142t3305r314b3351],
2	T	NN	PERSON	t	_	0	SENT_309	[p19l329t3305r373b3357],
3	,	,	O	,	_	0	SENT_309	[p19l329t3305r373b3357],
4	Verstuyft	NNP	O	Verstuyft	nn	5	SENT_309	[p19l391t3301r630b3366],
5	C	NNP	O	C	appos	2	SENT_309	[p19l647t3305r699b3358],
6	,	,	O	,	_	0	SENT_309	[p19l647t3305r699b3358],
7	Mary-Krause	NNP	O	Mary-Krause	nn	8	SENT_309	[p19l721t3306r1056b3366],
8	M	NNP	O	M	appos	2	SENT_309	[p19l1075t3306r1142b3358],
9	,	,	O	,	_	0	SENT_309	[p19l1075t3306r1142b3358],
10	et	FW	O	et	nn	11	SENT_309	[p19l1162t3312r1209b3351],
11	al.	FW	O	al.	appos	2	SENT_309	[p19l1225t3302r1281b3351],
12	.	.	O	.	_	0	SENT_309	[p19l1225t3302r1281b3351],

1	Genetic	JJ	O	genetic	amod	2	SENT_310	[p19l1302t3305r1504b3351],
2	determinants	NNS	O	determinant	_	0	SENT_310	[p19l1521t3302r1872b3351],
3	of	IN	O	of	_	0	SENT_310	[p19l1892t3301r1951b3351],
4	response	NN	O	response	prep_of	2	SENT_310	[p19l138t3391r374b3438],
5	to	TO	O	to	_	0	SENT_310	[p19l390t3384r439b3423],
6	clopidogrel	NN	O	clopidogrel	nn	9	SENT_310	[p19l458t3374r750b3439],
7	and	CC	O	and	_	0	SENT_310	[p19l767t3374r865b3423],
8	cardiovascular	JJ	O	cardiovascular	nn	9	SENT_310	[p19l882t3374r1259b3423],
9	events	NNS	O	event	prep_to	2	SENT_310	[p19l1276t3384r1454b3423],
10	.	.	O	.	_	0	SENT_310	[p19l1276t3384r1454b3423],

1	N	NN	O	n	nn	3	SENT_311	[p19l1477t3379r1524b3423],
2	Engl	NNP	O	Engl	nn	3	SENT_311	[p19l1540t3374r1648b3439],
3	]	NNP	O	]	nsubj	4	SENT_311	[p19l1656t3379r1689b3438],
4	Med	VBD	O	med	_	0	SENT_311	[p19l1705t3374r1814b3423],
5	2009	CD	DATE	2009	dobj	4	SENT_311	[p19l1831t3378r1967b3430],
6	;	:	O	;	_	0	SENT_311	[p19l1831t3378r1967b3430],
7	360	CD	NUMBER	360	num	9	SENT_311	[p19l139t3451r245b3496],
8	:	:	O	:	_	0	SENT_311	[p19l139t3451r245b3496],
9	363-75	CD	NUMBER	363-75	dep	5	SENT_311	[p19l267t3450r460b3498],
10	.	.	O	.	_	0	SENT_311	[p19l267t3450r460b3498],

1	Xie	NNP	O	Xie	nn	2	SENT_312	[p20l137t26r225b72],
2	HG	NNP	O	HG	_	0	SENT_312	[p20l245t27r354b72],
3	.	.	O	.	_	0	SENT_312	[p20l245t27r354b72],

1	Genetic	JJ	O	genetic	amod	2	SENT_313	[p20l376t26r577b72],
2	variations	NNS	O	variation	_	0	SENT_313	[p20l592t26r848b72],
3	of	IN	O	of	_	0	SENT_313	[p20l867t23r927b72],
4	S-mephenytoin	NN	O	s-mephenytoin	prep_of	2	SENT_313	[p20l938t23r1340b87],
5	4	CD	NUMBER	4	num	4	SENT_313	[p20l1356t23r1725b87],
6	’	SYM	O	’	dep	2	SENT_313	[p20l1356t23r1725b87],
7	-	:	O	-	_	0	SENT_313	[p20l1356t23r1725b87],
8	hydroxylase	NN	O	hydroxylase	nn	11	SENT_313	[p20l1356t23r1725b87],
9	(	NN	O	(	nn	11	SENT_313	[p20l142t100r201b161],
10	C	NN	O	c	nn	11	SENT_313	[p20l142t100r201b161],
11	YPZC	NN	O	ypzc	dep	2	SENT_313	[p20l205t100r352b146],
12	19	CD	NUMBER	19	num	13	SENT_313	[p20l356t101r421b161],
13	)	NN	O	)	dep	11	SENT_313	[p20l356t101r421b161],
14	in	IN	O	in	_	0	SENT_313	[p20l442t100r495b145],
15	the	DT	O	the	det	17	SENT_313	[p20l511t97r593b146],
16	Chinese	JJ	MISC	chinese	amod	17	SENT_313	[p20l613t97r826b146],
17	population	NN	O	population	prep_in	13	SENT_313	[p20l843t97r1141b160],
18	.	.	O	.	_	0	SENT_313	[p20l843t97r1141b160],

1	Life	NNP	O	Life	nn	2	SENT_314	[p20l1164t97r1251b161],
2	Sci	NNP	O	Sci	_	0	SENT_314	[p20l1271t98r1343b146],
3	2000	CD	DATE	2000	num	5	SENT_314	[p20l1360t101r1497b153],
4	;	:	O	;	_	0	SENT_314	[p20l1360t101r1497b153],
5	66	CD	NUMBER	66	dep	2	SENT_314	[p20l1518t101r1591b146],
6	:	:	O	:	_	0	SENT_314	[p20l1518t101r1591b146],
7	L175	NN	O	l175	dep	2	SENT_314	[p20l1613t100r1828b147],
8	—	CD	NUMBER	—	number	9	SENT_314	[p20l1613t100r1828b147],
9	81	CD	NUMBER	81	dep	7	SENT_314	[p20l1613t100r1828b147],
10	.	.	O	.	_	0	SENT_314	[p20l1613t100r1828b147],

1	Mega	JJ	ORGANIZATION	mega	amod	2	SENT_315	[p20l140t184r283b244],
2	IL	NN	ORGANIZATION	il	_	0	SENT_315	[p20l301t184r368b242],
3	,	,	O	,	_	0	SENT_315	[p20l301t184r368b242],
4	Simon	NNP	PERSON	Simon	nn	5	SENT_315	[p20l391t182r562b228],
5	T	NN	PERSON	t	appos	2	SENT_315	[p20l578t182r621b235],
6	,	,	O	,	_	0	SENT_315	[p20l578t182r621b235],
7	Collet	NNP	PERSON	Collet	nn	9	SENT_315	[p20l643t179r794b228],
8	]	CD	NUMBER	]	num	9	SENT_315	[p20l811t184r882b242],
9	P	NN	O	p	appos	2	SENT_315	[p20l811t184r882b242],
10	,	,	O	,	_	0	SENT_315	[p20l811t184r882b242],
11	et	FW	O	et	nn	12	SENT_315	[p20l902t189r949b228],
12	al.	FW	O	al.	appos	2	SENT_315	[p20l965t179r1021b228],
13	.	.	O	.	_	0	SENT_315	[p20l965t179r1021b228],

1	Reduced-function	NN	O	reduced-function	nn	3	SENT_316	[p20l1044t179r1510b228],
2	C	NN	O	c	nn	3	SENT_316	[p20l1532t183r1571b228],
3	YPZC	NN	O	ypzc	nsubj	14	SENT_316	[p20l1575t183r1722b228],
4	19	CD	NUMBER	19	num	5	SENT_316	[p20l1725t183r1778b228],
5	genotype	NN	O	genotype	dep	3	SENT_316	[p20l139t263r376b317],
6	and	CC	O	and	_	0	SENT_316	[p20l394t253r492b302],
7	risk	NN	O	risk	conj_and	3	SENT_316	[p20l508t253r608b302],
8	of	IN	O	of	_	0	SENT_316	[p20l624t253r683b302],
9	adverse	JJ	O	adverse	amod	11	SENT_316	[p20l691t253r887b302],
10	clinical	JJ	O	clinical	amod	11	SENT_316	[p20l905t253r1091b302],
11	outcomes	NNS	O	outcome	prep_of	7	SENT_316	[p20l1108t263r1362b302],
12	among	IN	O	among	_	0	SENT_316	[p20l1381t270r1566b317],
13	patients	NNS	O	patient	prep_among	11	SENT_316	[p20l1582t256r1789b316],
14	treated	VBN	O	treat	_	0	SENT_316	[p20l137t326r319b375],
15	with	IN	O	with	_	0	SENT_316	[p20l333t326r451b375],
16	clopidogrel	NN	O	clopidogrel	prep_with	14	SENT_316	[p20l468t326r760b390],
17	predominantly	RB	O	predominantly	advmod	14	SENT_316	[p20l776t326r1168b390],
18	for	IN	O	for	_	0	SENT_316	[p20l1184t326r1259b375],
19	PCI	NNP	O	PCI	prep_for	14	SENT_316	[p20l1278t329r1390b375],
20	:	:	O	:	_	0	SENT_316	[p20l1278t329r1390b375],
21	a	DT	O	a	det	22	SENT_316	[p20l1410t343r1437b375],
22	meta-analysis	NN	O	meta-analysis	dep	19	SENT_316	[p20l1454t326r1824b390],
23	.	.	O	.	_	0	SENT_316	[p20l1454t326r1824b390],

1	JAMA	NNP	O	JAMA	_	0	SENT_317	[p20l131t401r305b462],
2	2010	CD	DATE	2010	num	1	SENT_317	[p20l322t402r452b454],
3	;	:	O	;	_	0	SENT_317	[p20l322t402r452b454],
4	304	CD	NUMBER	304	num	6	SENT_317	[p20l473t402r578b447],
5	:	:	O	:	_	0	SENT_317	[p20l473t402r578b447],
6	1821-30	CD	NUMBER	1821-30	dep	1	SENT_317	[p20l599t402r817b447],
7	.	.	O	.	_	0	SENT_317	[p20l599t402r817b447],

1	Hulot	NNP	PERSON	Hulot	nsubj	5	SENT_318	[p20l141t480r293b529],
2	IS	VBZ	O	be	cop	5	SENT_318	[p20l310t484r378b543],
3	,	,	O	,	_	0	SENT_318	[p20l310t484r378b543],
4	Collet	NNP	PERSON	Collet	nn	5	SENT_318	[p20l399t480r550b529],
5	IP	NNP	O	IP	_	0	SENT_318	[p20l568t485r639b543],
6	,	,	O	,	_	0	SENT_318	[p20l568t485r639b543],
7	Silvain	NNP	O	Silvain	appos	5	SENT_318	[p20l662t480r836b529],
8	I	PRP	O	I	dep	7	SENT_318	[p20l854t485r887b543],
9	,	,	O	,	_	0	SENT_318	[p20l854t485r887b543],
10	et	FW	O	et	nn	11	SENT_318	[p20l907t490r953b529],
11	al.	FW	O	al.	appos	5	SENT_318	[p20l970t480r1025b529],
12	.	.	O	.	_	0	SENT_318	[p20l970t480r1025b529],

1	Cardiovascular	NNP	O	Cardiovascular	nn	2	SENT_319	[p20l1047t480r1436b529],
2	risk	NN	O	risk	_	0	SENT_319	[p20l1452t480r1552b529],
3	in	IN	O	in	_	0	SENT_319	[p20l1567t483r1620b529],
4	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	5	SENT_319	[p20l139t554r630b618],
5	patients	NNS	O	patient	prep_in	2	SENT_319	[p20l645t557r853b618],
6	according	VBG	O	accord	_	0	SENT_319	[p20l872t554r1129b619],
7	to	TO	O	to	prepc_according_to	2	SENT_319	[p20l1144t564r1194b603],
8	cytochrome	NN	O	cytochrome	nn	13	SENT_319	[p20l1212t554r1519b618],
9	P450	NN	O	p450	nn	13	SENT_319	[p20l1539t557r1664b603],
10	2C19	NN	O	2c19	nn	13	SENT_319	[p20l1683t557r1872b603],
11	’	CD	NUMBER	’	num	13	SENT_319	[p20l1683t557r1872b603],
12	~	NN	O	~	nn	13	SENT_319	[p20l1683t557r1872b603],
13	‘	NN	O	‘	pobj	2	SENT_319	[p20l1683t557r1872b603],
14	2	CD	NUMBER	2	num	16	SENT_319	[p20l1683t557r1872b603],
15	loss-of-function	JJ	O	loss-of-function	amod	16	SENT_319	[p20l137t628r548b677],
16	allele	NN	O	allele	dep	13	SENT_319	[p20l565t628r699b677],
17	or	CC	O	or	prep	16	SENT_319	[p20l717t645r771b677],
18	proton	NN	O	proton	nn	19	SENT_319	[p20l787t638r963b691],
19	pump	NN	O	pump	dep	17	SENT_319	[p20l979t645r1138b691],
20	inhibitor	NN	O	inhibitor	nn	21	SENT_319	[p20l1156t628r1388b677],
21	coadministration	NN	O	coadministration	dep	19	SENT_319	[p20l1405t628r1867b677],
22	:	:	O	:	_	0	SENT_319	[p20l1405t628r1867b677],
23	a	DT	O	a	det	25	SENT_319	[p20l139t718r166b750],
24	systematic	JJ	O	systematic	amod	25	SENT_319	[p20l184t704r458b765],
25	meta-analysis	NN	O	meta-analysis	dep	21	SENT_319	[p20l474t701r845b765],
26	.	.	O	.	_	0	SENT_319	[p20l474t701r845b765],
27	]	SYM	O	]	dep	16	SENT_319	[p20l858t705r890b765],

1	Am	VBP	O	be	dep	3	SENT_320	[p20l903t704r998b749],
2	Coll	NNP	O	Coll	nn	3	SENT_320	[p20l1018t701r1113b750],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_320	[p20l1134t701r1314b750],
4	2010	CD	DATE	2010	num	3	SENT_320	[p20l1331t705r1461b756],
5	;	:	O	;	_	0	SENT_320	[p20l1331t705r1461b756],
6	56	CD	NUMBER	56	dep	3	SENT_320	[p20l1483t703r1556b749],
7	:	:	O	:	_	0	SENT_320	[p20l1483t703r1556b749],
8	134-43	CD	NUMBER	134-43	dep	6	SENT_320	[p20l1577t705r1762b749],
9	.	.	O	.	_	0	SENT_320	[p20l1577t705r1762b749],

1	US	NNP	ORGANIZATION	US	nn	2	SENT_321	[p20l141t787r218b833],
2	Food	NNP	ORGANIZATION	Food	_	0	SENT_321	[p20l242t784r369b833],
3	and	CC	ORGANIZATION	and	_	0	SENT_321	[p20l386t784r484b833],
4	Drug	NNP	ORGANIZATION	Drug	nn	5	SENT_321	[p20l503t788r638b848],
5	Administration	NNP	ORGANIZATION	Administration	conj_and	2	SENT_321	[p20l654t784r1072b833],
6	.	.	O	.	_	0	SENT_321	[p20l654t784r1072b833],

1	FDA	NNP	ORGANIZATION	FDA	nn	4	SENT_322	[p20l1094t787r1216b832],
2	drug	NN	O	drug	nn	4	SENT_322	[p20l1234t784r1357b848],
3	safety	NN	O	safety	nn	4	SENT_322	[p20l1376t783r1525b848],
4	communication	NN	O	communication	_	0	SENT_322	[p20l1541t787r1974b833],
5	:	:	O	:	_	0	SENT_322	[p20l1541t787r1974b833],
6	reduced	VBN	O	reduce	amod	7	SENT_322	[p20l138t856r350b905],
7	effectiveness	NN	O	effectiveness	dep	4	SENT_322	[p20l367t857r700b905],
8	of	IN	O	of	_	0	SENT_322	[p20l719t856r779b905],
9	plavix	NN	O	plavix	nn	12	SENT_322	[p20l785t856r938b920],
10	(	CD	NUMBER	(	num	12	SENT_322	[p20l958t856r1281b921],
11	clopidogrel	NN	O	clopidogrel	nn	12	SENT_322	[p20l958t856r1281b921],
12	)	NN	O	)	prep_of	7	SENT_322	[p20l958t856r1281b921],
13	in	IN	O	in	_	0	SENT_322	[p20l1301t859r1354b904],
14	patients	NNS	O	patient	prep_in	12	SENT_322	[p20l1371t859r1578b920],
15	who	WP	O	who	nsubj	18	SENT_322	[p20l1595t856r1707b905],
16	are	VBP	O	be	cop	18	SENT_322	[p20l1726t874r1804b905],
17	poor	JJ	O	poor	amod	18	SENT_322	[p20l1821t874r1943b920],
18	metabolizers	NNS	O	metabolizer	rcmod	7	SENT_322	[p20l138t930r476b979],
19	of	IN	O	of	_	0	SENT_322	[p20l495t930r555b979],
20	the	DT	O	the	det	21	SENT_322	[p20l561t930r644b979],
21	drug	NN	O	drug	prep_of	18	SENT_322	[p20l662t930r798b994],
22	.	.	O	.	_	0	SENT_322	[p20l662t930r798b994],

1	March	NNP	DATE	March	_	0	SENT_323	[p20l819t930r988b979],
2	12	CD	DATE	12	num	1	SENT_323	[p20l1006t934r1073b986],
3	,	,	DATE	,	_	0	SENT_323	[p20l1006t934r1073b986],
4	2010	CD	DATE	2010	dep	1	SENT_323	[p20l1094t934r1224b979],
5	.	.	O	.	_	0	SENT_323	[p20l1094t934r1224b979],

1	http://wvvW.fda.gov/drugs/	NN	O	http://wvvw.fda.gov/drugs/	nn	3	SENT_324	[p20l1243t930r1952b994],
2	drugsafety/postmarketdrugsafetyinformationforpatients	NNS	O	drugsafety/postmarketdrugsafetyinformationforpatients	nn	3	SENT_324	[p20l139t1002r1611b1067],
3	andproviders	NNS	O	andprovider	_	0	SENT_324	[p20l1616t1003r1957b1066],
4	/	:	O	/	punct	5	SENT_324	[p20l1962t1007r1982b1066],
5	ucm203888	NN	O	ucm203888	dep	3	SENT_324	[p20l137t1075r572b1124],
6	.	.	O	.	_	0	SENT_324	[p20l137t1075r572b1124],

1	htrn	NN	O	htrn	nn	2	SENT_325	[p20l137t1075r572b1124],
2	(	NN	O	(	nsubj	3	SENT_325	[p20l593t1075r836b1140],
3	accessed	VBD	O	access	_	0	SENT_325	[p20l593t1075r836b1140],
4	Feb	NNP	DATE	Feb	iobj	3	SENT_325	[p20l854t1075r945b1124],
5	18	CD	DATE	18	num	4	SENT_325	[p20l965t1079r1032b1131],
6	,	,	DATE	,	_	0	SENT_325	[p20l965t1079r1032b1131],
7	2012	CD	DATE	2012	num	4	SENT_325	[p20l1053t1079r1202b1140],
8	)	NN	O	)	dobj	3	SENT_325	[p20l1053t1079r1202b1140],
9	.	.	O	.	_	0	SENT_325	[p20l1053t1079r1202b1140],

1	Wiviott	NNP	PERSON	Wiviott	nn	2	SENT_326	[p20l137t1162r327b1208],
2	SD	NN	O	sd	_	0	SENT_326	[p20l347t1162r437b1215],
3	,	,	O	,	_	0	SENT_326	[p20l347t1162r437b1215],
4	Braunwald	NNP	PERSON	Braunwald	nn	5	SENT_326	[p20l459t1159r746b1208],
5	E	NNP	O	E	appos	2	SENT_326	[p20l765t1161r810b1215],
6	,	,	O	,	_	0	SENT_326	[p20l765t1161r810b1215],
7	McCabe	NNP	PERSON	McCabe	nn	8	SENT_326	[p20l832t1159r1044b1208],
8	CH	NN	O	ch	appos	2	SENT_326	[p20l1063t1162r1168b1215],
9	,	,	O	,	_	0	SENT_326	[p20l1063t1162r1168b1215],
10	et	FW	O	et	nn	11	SENT_326	[p20l1188t1168r1235b1208],
11	al.	FW	O	al.	appos	2	SENT_326	[p20l1251t1159r1307b1208],
12	.	.	O	.	_	0	SENT_326	[p20l1251t1159r1307b1208],

1	Prasugrel	NNP	O	Prasugrel	_	0	SENT_327	[p20l1330t1159r1580b1223],
2	versus	CC	O	versus	prep	1	SENT_327	[p20l1595t1176r1763b1208],
3	clopidogrel	NN	O	clopidogrel	dep	2	SENT_327	[p20l139t1231r431b1296],
4	in	IN	O	in	_	0	SENT_327	[p20l448t1234r500b1279],
5	patients	NNS	O	patient	prep_in	1	SENT_327	[p20l517t1234r724b1295],
6	with	IN	O	with	_	0	SENT_327	[p20l741t1231r859b1280],
7	acute	JJ	O	acute	amod	9	SENT_327	[p20l876t1241r1013b1280],
8	coronary	JJ	O	coronary	amod	9	SENT_327	[p20l1031t1249r1262b1295],
9	syndromes	NNS	O	syndrome	prep_with	5	SENT_327	[p20l1279t1231r1581b1295],
10	.	.	O	.	_	0	SENT_327	[p20l1279t1231r1581b1295],

1	N	NN	O	n	nn	3	SENT_328	[p20l1604t1236r1651b1280],
2	Engl	NNP	O	Engl	nn	3	SENT_328	[p20l1667t1231r1775b1296],
3	]	NNP	O	]	nsubj	4	SENT_328	[p20l1783t1236r1816b1295],
4	Med	VBD	O	med	_	0	SENT_328	[p20l1832t1231r1941b1280],
5	2007	CD	DATE	2007	dobj	4	SENT_328	[p20l140t1308r271b1361],
6	;	:	O	;	_	0	SENT_328	[p20l140t1308r271b1361],
7	357	CD	NUMBER	357	num	9	SENT_328	[p20l292t1307r397b1355],
8	:	:	O	:	_	0	SENT_328	[p20l292t1307r397b1355],
9	2001-15	CD	NUMBER	2001-15	dep	5	SENT_328	[p20l418t1308r637b1354],
10	.	.	O	.	_	0	SENT_328	[p20l418t1308r637b1354],

1	Wallentin	NNP	PERSON	Wallentin	nn	2	SENT_329	[p20l137t1387r393b1436],
2	L	NNP	PERSON	L	_	0	SENT_329	[p20l413t1392r455b1443],
3	,	,	O	,	_	0	SENT_329	[p20l413t1392r455b1443],
4	Becker	NNP	PERSON	Becker	nn	5	SENT_329	[p20l478t1387r656b1436],
5	RC	NNP	O	RC	appos	2	SENT_329	[p20l674t1391r767b1443],
6	,	,	O	,	_	0	SENT_329	[p20l674t1391r767b1443],
7	Budaj	NNP	PERSON	Budaj	nn	8	SENT_329	[p20l789t1387r935b1451],
8	A	NNP	O	A	appos	2	SENT_329	[p20l955t1391r1010b1443],
9	,	,	O	,	_	0	SENT_329	[p20l955t1391r1010b1443],
10	et	FW	O	et	nn	11	SENT_329	[p20l1030t1397r1077b1436],
11	al.	FW	O	al.	appos	2	SENT_329	[p20l1093t1387r1149b1436],
12	.	.	O	.	_	0	SENT_329	[p20l1093t1387r1149b1436],

1	Ticagrelor	NNP	O	Ticagrelor	_	0	SENT_330	[p20l1167t1387r1435b1451],
2	versus	CC	O	versus	prep	1	SENT_330	[p20l1449t1404r1617b1436],
3	clopidogrel	NN	O	clopidogrel	dep	2	SENT_330	[p20l1636t1387r1928b1452],
4	in	IN	O	in	_	0	SENT_330	[p20l138t1464r191b1509],
5	patients	NNS	O	patient	prep_in	1	SENT_330	[p20l208t1464r415b1524],
6	with	IN	O	with	_	0	SENT_330	[p20l432t1461r549b1510],
7	acute	JJ	O	acute	amod	9	SENT_330	[p20l566t1471r703b1510],
8	coronary	JJ	O	coronary	amod	9	SENT_330	[p20l722t1478r953b1525],
9	syndromes	NNS	O	syndrome	prep_with	5	SENT_330	[p20l970t1461r1272b1525],
10	.	.	O	.	_	0	SENT_330	[p20l970t1461r1272b1525],

1	N	NN	O	n	nn	3	SENT_331	[p20l1295t1465r1342b1510],
2	Engl	NNP	O	Engl	nn	3	SENT_331	[p20l1358t1461r1466b1525],
3	]	NNP	O	]	nsubj	4	SENT_331	[p20l1474t1465r1507b1525],
4	Med	VBD	O	med	_	0	SENT_331	[p20l1523t1461r1631b1510],
5	2009	CD	DATE	2009	num	7	SENT_331	[p20l1649t1465r1785b1517],
6	;	:	O	;	_	0	SENT_331	[p20l1649t1465r1785b1517],
7	361	CD	NUMBER	361	dobj	4	SENT_331	[p20l139t1538r240b1583],
8	:	:	O	:	_	0	SENT_331	[p20l139t1538r240b1583],
9	1045-57	CD	NUMBER	1045-57	num	11	SENT_331	[p20l261t1536r466b1584],
10	Mega	JJ	O	mega	amod	11	SENT_331	[p20l140t1622r283b1682],
11	IL	NN	O	il	dep	7	SENT_331	[p20l301t1622r368b1680],
12	,	,	O	,	_	0	SENT_331	[p20l301t1622r368b1680],
13	Close	NNP	O	Close	nn	14	SENT_331	[p20l389t1618r531b1667],
14	SL	NNP	O	SL	appos	11	SENT_331	[p20l553t1621r629b1674],
15	,	,	O	,	_	0	SENT_331	[p20l553t1621r629b1674],
16	Wiviott	NNP	PERSON	Wiviott	nn	17	SENT_331	[p20l648t1621r838b1667],
17	SD	NN	O	sd	appos	11	SENT_331	[p20l857t1621r948b1674],
18	,	,	O	,	_	0	SENT_331	[p20l857t1621r948b1674],
19	et	FW	O	et	nn	20	SENT_331	[p20l968t1628r1014b1667],
20	al.	FW	O	al.	appos	11	SENT_331	[p20l1031t1618r1086b1667],
21	.	.	O	.	_	0	SENT_331	[p20l1031t1618r1086b1667],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_332	[p20l1108t1618r1427b1682],
2	P450	NN	O	p450	_	0	SENT_332	[p20l1448t1621r1573b1667],
3	genetic	JJ	O	genetic	amod	4	SENT_332	[p20l1591t1621r1779b1682],
4	polymorphisms	NNS	O	polymorphism	dep	2	SENT_332	[p20l138t1690r554b1754],
5	and	CC	O	and	_	0	SENT_332	[p20l573t1690r672b1739],
6	the	DT	O	the	det	7	SENT_332	[p20l686t1690r769b1739],
7	response	NN	O	response	conj_and	2	SENT_332	[p20l786t1708r1022b1754],
8	to	TO	O	to	_	0	SENT_332	[p20l1039t1700r1088b1739],
9	prasugrel	NN	O	prasugrel	prep_to	7	SENT_332	[p20l1105t1690r1367b1755],
10	:	:	O	:	_	0	SENT_332	[p20l1105t1690r1367b1755],
11	relationship	NN	O	relationship	dep	2	SENT_332	[p20l1387t1690r1702b1754],
12	to	TO	O	to	_	0	SENT_332	[p20l1718t1700r1768b1739],
13	pharmacokinetic	JJ	O	pharmacokinetic	prep_to	11	SENT_332	[p20l138t1763r595b1827],
14	,	,	O	,	_	0	SENT_332	[p20l138t1763r595b1827],
15	pharrnacodynamic	JJ	O	pharrnacodynamic	prep_to	11	SENT_332	[p20l614t1763r1121b1827],
16	,	,	O	,	_	0	SENT_332	[p20l614t1763r1121b1827],
17	and	CC	O	and	_	0	SENT_332	[p20l1141t1763r1239b1812],
18	clinical	JJ	O	clinical	amod	19	SENT_332	[p20l1256t1763r1442b1812],
19	outcomes	NNS	O	outcome	conj_and	13	SENT_332	[p20l1459t1773r1727b1812],
20	.	.	O	.	_	0	SENT_332	[p20l1459t1773r1727b1812],

1	Circulation	NN	O	circulation	_	0	SENT_333	[p20l143t1837r422b1886],
2	2009	CD	DATE	2009	num	1	SENT_333	[p20l440t1841r576b1894],
3	;	:	O	;	_	0	SENT_333	[p20l440t1841r576b1894],
4	119	CD	NUMBER	119	num	6	SENT_333	[p20l597t1841r692b1886],
5	:	:	O	:	_	0	SENT_333	[p20l597t1841r692b1886],
6	2553-60	CD	NUMBER	2553-60	dep	1	SENT_333	[p20l713t1840r944b1886],
7	.	.	O	.	_	0	SENT_333	[p20l713t1840r944b1886],

1	www	NN	O	www	_	0	SENT_334	[p20l6t2061r500b2108],
2	.	.	O	.	_	0	SENT_334	[p20l6t2061r500b2108],

1	the	DT	O	the	det	2	SENT_335	[p20l6t2061r500b2108],
2	|	NN	O	|	_	0	SENT_335	[p20l6t2061r500b2108],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_335	[p20l6t2061r500b2108],
4	Vol	NNP	O	Vol	dep	2	SENT_335	[p20l542t2061r623b2108],
5	379	CD	NUMBER	379	num	4	SENT_335	[p20l641t2067r736b2115],
6	May	NNP	DATE	May	tmod	4	SENT_335	[p20l782t2065r892b2121],
7	5	CD	DATE	5	num	6	SENT_335	[p20l907t2068r951b2116],
8	,	,	DATE	,	_	0	SENT_335	[p20l907t2068r951b2116],
9	2012	CD	DATE	2012	num	6	SENT_335	[p20l969t2067r1095b2108],
10	Wallentin	NNP	O	Wallentin	nn	11	SENT_335	[p20l11t2125r218b2165],
11	L	NNP	O	L	dep	2	SENT_335	[p20l233t2129r267b2171],
12	,	,	O	,	_	0	SENT_335	[p20l233t2129r267b2171],
13	Iames	NNP	O	Iames	nn	14	SENT_335	[p20l284t2129r411b2176],
14	S	NNP	O	S	appos	11	SENT_335	[p20l429t2128r464b2171],
15	,	,	O	,	_	0	SENT_335	[p20l429t2128r464b2171],
16	Storey	NNP	O	Storey	nn	17	SENT_335	[p20l482t2128r614b2177],
17	RF	NNP	O	RF	appos	2	SENT_335	[p20l628t2128r698b2171],
18	,	,	O	,	_	0	SENT_335	[p20l628t2128r698b2171],
19	et	FW	O	et	nn	20	SENT_335	[p20l714t2133r751b2165],
20	al.	FW	O	al.	appos	2	SENT_335	[p20l765t2125r809b2165],
21	.	.	O	.	_	0	SENT_335	[p20l765t2125r809b2165],

1	Effect	NN	O	effect	_	0	SENT_336	[p20l828t2125r947b2165],
2	of	IN	O	of	_	0	SENT_336	[p20l960t2125r1008b2165],
3	CYPZC	NNP	O	CYPZC	prep_of	1	SENT_336	[p20l1018t2128r1171b2165],
4	19	CD	NUMBER	19	num	3	SENT_336	[p20l1174t2129r1216b2165],
5	and	CC	O	and	_	0	SENT_336	[p20l1228t2125r1307b2165],
6	ABCB1	NN	O	abcb1	conj_and	1	SENT_336	[p20l1319t2128r1473b2165],
7	single	JJ	O	single	amod	9	SENT_336	[p20l14t2185r138b2237],
8	nucleotide	NN	O	nucleotide	nn	9	SENT_336	[p20l152t2185r373b2225],
9	polymorphisms	NNS	O	polymorphism	dep	6	SENT_336	[p20l387t2185r722b2237],
10	on	IN	O	on	_	0	SENT_336	[p20l738t2199r791b2225],
11	outcomes	NNS	O	outcome	prep_on	9	SENT_336	[p20l805t2193r1009b2225],
12	of	IN	O	of	_	0	SENT_336	[p20l1025t2185r1073b2225],
13	treatment	NN	O	treatment	prep_of	11	SENT_336	[p20l1078t2193r1287b2225],
14	with	IN	O	with	_	0	SENT_336	[p20l1299t2185r1393b2224],
15	ticagrelor	NN	O	ticagrelor	prep_with	13	SENT_336	[p20l11t2244r212b2296],
16	versus	CC	O	versus	prep	15	SENT_336	[p20l224t2257r359b2283],
17	clopidogrel	NN	O	clopidogrel	dep	16	SENT_336	[p20l375t2244r609b2296],
18	for	IN	O	for	_	0	SENT_336	[p20l623t2243r684b2283],
19	acute	JJ	O	acute	amod	21	SENT_336	[p20l697t2251r807b2283],
20	coronary	JJ	O	coronary	amod	21	SENT_336	[p20l822t2258r1008b2296],
21	syndromes	NNS	O	syndrome	prep_for	17	SENT_336	[p20l1021t2244r1264b2296],
22	:	:	O	:	_	0	SENT_336	[p20l1021t2244r1264b2296],
23	a	DT	O	a	det	25	SENT_336	[p20l1281t2258r1302b2283],
24	genetic	JJ	O	genetic	amod	25	SENT_336	[p20l1317t2246r1468b2296],
25	substudy	NN	O	substudy	dep	1	SENT_336	[p20l14t2302r205b2354],
26	of	IN	O	of	_	0	SENT_336	[p20l218t2302r265b2342],
27	the	DT	O	the	det	29	SENT_336	[p20l270t2302r337b2342],
28	PLATO	NNP	O	PLATO	nn	29	SENT_336	[p20l353t2305r505b2342],
29	trial	NN	O	trial	prep_of	25	SENT_336	[p20l520t2302r614b2342],
30	.	.	O	.	_	0	SENT_336	[p20l520t2302r614b2342],

1	Lancet	NNP	O	Lancet	_	0	SENT_337	[p20l632t2306r763b2342],
2	2010	CD	DATE	2010	num	1	SENT_337	[p20l777t2306r881b2348],
3	;	:	O	;	_	0	SENT_337	[p20l777t2306r881b2348],
4	376	CD	NUMBER	376	num	6	SENT_337	[p20l898t2304r982b2343],
5	:	:	O	:	_	0	SENT_337	[p20l898t2304r982b2343],
6	1320-28	CD	NUMBER	1320-28	dep	1	SENT_337	[p20l999t2306r1180b2342],
7	.	.	O	.	_	0	SENT_337	[p20l999t2306r1180b2342],

1	Marcucci	NNP	PERSON	Marcucci	nn	2	SENT_338	[p20l14t2372r207b2410],
2	R	NNP	PERSON	R	_	0	SENT_338	[p20l223t2373r263b2415],
3	,	,	O	,	_	0	SENT_338	[p20l223t2373r263b2415],
4	Gori	NNP	ORGANIZATION	Gori	nn	5	SENT_338	[p20l280t2372r374b2410],
5	AM	NNP	ORGANIZATION	AM	appos	2	SENT_338	[p20l386t2372r477b2415],
6	,	,	O	,	_	0	SENT_338	[p20l386t2372r477b2415],
7	Paniccia	NNP	PERSON	Paniccia	nn	8	SENT_338	[p20l495t2372r668b2410],
8	R	NNP	PERSON	R	appos	2	SENT_338	[p20l684t2373r725b2415],
9	,	,	O	,	_	0	SENT_338	[p20l684t2373r725b2415],
10	et	FW	O	et	nn	11	SENT_338	[p20l741t2378r778b2410],
11	al.	FW	O	al.	appos	2	SENT_338	[p20l791t2370r836b2410],
12	.	.	O	.	_	0	SENT_338	[p20l791t2370r836b2410],

1	Cardiovascular	NNP	O	Cardiovascular	nn	2	SENT_339	[p20l854t2370r1167b2410],
2	death	NN	O	death	nsubjpass	16	SENT_339	[p20l1180t2370r1296b2410],
3	and	CC	O	and	_	0	SENT_339	[p20l1310t2370r1389b2410],
4	nonfatal	JJ	O	nonfatal	amod	6	SENT_339	[p20l12t2428r187b2468],
5	myocardial	JJ	O	myocardial	amod	6	SENT_339	[p20l201t2428r435b2480],
6	infarction	NN	O	infarction	conj_and	2	SENT_339	[p20l448t2428r656b2468],
7	in	IN	O	in	_	0	SENT_339	[p20l669t2431r711b2467],
8	acute	JJ	O	acute	amod	11	SENT_339	[p20l726t2436r836b2468],
9	coronary	JJ	O	coronary	amod	11	SENT_339	[p20l850t2442r1036b2480],
10	syndrome	NN	O	syndrome	nn	11	SENT_339	[p20l1050t2428r1261b2480],
11	patients	NNS	O	patient	prep_in	2	SENT_339	[p20l1275t2431r1442b2480],
12	receiving	VBG	O	receive	partmod	11	SENT_339	[p20l12t2490r205b2540],
13	coronary	JJ	O	coronary	amod	14	SENT_339	[p20l219t2502r405b2540],
14	stenting	NN	O	stenting	dobj	12	SENT_339	[p20l419t2490r590b2540],
15	are	VBP	O	be	auxpass	16	SENT_339	[p20l604t2502r668b2528],
16	predicted	VBN	O	predict	_	0	SENT_339	[p20l681t2488r879b2539],
17	by	IN	O	by	_	0	SENT_339	[p20l891t2488r942b2540],
18	residual	JJ	O	residual	amod	20	SENT_339	[p20l954t2488r1123b2528],
19	platelet	NN	O	platelet	nn	20	SENT_339	[p20l1137t2488r1290b2539],
20	reactivity	NN	O	reactivity	agent	16	SENT_339	[p20l1303t2490r1493b2540],
21	to	TO	O	to	_	0	SENT_339	[p20l11t2555r51b2586],
22	ADP	NN	ORGANIZATION	adp	prep_to	16	SENT_339	[p20l65t2549r166b2586],
23	detected	VBN	O	detect	partmod	22	SENT_339	[p20l181t2547r356b2586],
24	by	IN	O	by	_	0	SENT_339	[p20l369t2547r419b2599],
25	a	DT	O	a	det	27	SENT_339	[p20l431t2561r453b2586],
26	point-of-care	JJ	O	point-of-care	amod	27	SENT_339	[p20l466t2546r732b2598],
27	assay	NN	O	assay	agent	23	SENT_339	[p20l747t2560r866b2599],
28	:	:	O	:	_	0	SENT_339	[p20l747t2560r866b2599],
29	a	DT	O	a	det	31	SENT_339	[p20l882t2561r904b2586],
30	12-month	JJ	DURATION	12-month	amod	31	SENT_339	[p20l919t2547r1120b2586],
31	follow-up	NN	O	follow-up	dep	27	SENT_339	[p20l1134t2546r1343b2598],
32	.	.	O	.	_	0	SENT_339	[p20l1134t2546r1343b2598],

1	Circulation	NN	O	circulation	_	0	SENT_340	[p20l16t2605r241b2645],
2	2009	CD	DATE	2009	num	1	SENT_340	[p20l255t2609r364b2651],
3	;	:	O	;	_	0	SENT_340	[p20l255t2609r364b2651],
4	119	CD	NUMBER	119	num	6	SENT_340	[p20l381t2609r458b2645],
5	:	:	O	:	_	0	SENT_340	[p20l381t2609r458b2645],
6	237-42	CD	NUMBER	237-42	dep	1	SENT_340	[p20l475t2608r629b2647],
7	.	.	O	.	_	0	SENT_340	[p20l475t2608r629b2647],

1	Breet	NNP	O	Breet	nn	3	SENT_341	[p20l15t2676r125b2712],
2	N	NNP	O	N	nn	3	SENT_341	[p20l140t2676r204b2723],
3	]	NNP	O	]	_	0	SENT_341	[p20l140t2676r204b2723],
4	,	,	O	,	_	0	SENT_341	[p20l140t2676r204b2723],
5	van	NNP	O	van	nn	7	SENT_341	[p20l218t2687r293b2712],
6	Werkum	NNP	ORGANIZATION	Werkum	nn	7	SENT_341	[p20l306t2673r494b2713],
7	IW	NNP	ORGANIZATION	IW	appos	3	SENT_341	[p20l508t2676r577b2723],
8	,	,	O	,	_	0	SENT_341	[p20l508t2676r577b2723],
9	Bouman	NNP	PERSON	Bouman	nn	11	SENT_341	[p20l595t2676r777b2712],
10	H	NNP	O	H	nn	11	SENT_341	[p20l793t2676r861b2723],
11	]	NN	O	]	appos	3	SENT_341	[p20l793t2676r861b2723],
12	,	,	O	,	_	0	SENT_341	[p20l793t2676r861b2723],
13	et	FW	O	et	nn	14	SENT_341	[p20l878t2680r915b2712],
14	al.	FW	O	al.	appos	3	SENT_341	[p20l929t2673r973b2712],
15	.	.	O	.	_	0	SENT_341	[p20l929t2673r973b2712],

1	Comparison	NN	O	comparison	_	0	SENT_342	[p20l991t2675r1252b2724],
2	of	IN	O	of	_	0	SENT_342	[p20l1266t2672r1314b2712],
3	platelet	NN	O	platelet	prep_of	4	SENT_342	[p20l1320t2673r1474b2724],
4	function	NN	O	function	amod	5	SENT_342	[p20l12t2747r192b2787],
5	tests	NNS	O	test	dobj	6	SENT_342	[p20l205t2755r299b2787],
6	in	IN	O	in	dep	1	SENT_342	[p20l314t2750r357b2786],
7	predicting	VBG	O	predict	dep	6	SENT_342	[p20l370t2747r587b2800],
8	clinical	JJ	O	clinical	amod	9	SENT_342	[p20l601t2747r750b2787],
9	outcome	NN	O	outcome	dobj	7	SENT_342	[p20l764t2755r948b2787],
10	in	IN	O	in	dep	9	SENT_342	[p20l962t2750r1005b2786],
11	patients	NNS	O	patient	nsubj	12	SENT_342	[p20l1018t2750r1184b2799],
12	undergoing	VBG	O	undergo	pcomp	10	SENT_342	[p20l1199t2747r1448b2800],
13	coronary	JJ	O	coronary	amod	15	SENT_342	[p20l13t2821r199b2859],
14	stent	NN	O	stent	nn	15	SENT_342	[p20l213t2815r315b2847],
15	implantation	NN	O	implantation	dobj	12	SENT_342	[p20l328t2807r613b2858],
16	.	.	O	.	_	0	SENT_342	[p20l328t2807r613b2858],
17	]	SYM	O	]	dep	1	SENT_342	[p20l623t2810r763b2859],

1	AMA	NNP	O	AMA	_	0	SENT_343	[p20l623t2810r763b2859],
2	2010	CD	DATE	2010	num	1	SENT_343	[p20l777t2810r881b2852],
3	;	:	O	;	_	0	SENT_343	[p20l777t2810r881b2852],
4	303	CD	NUMBER	303	num	6	SENT_343	[p20l898t2810r982b2847],
5	:	:	O	:	_	0	SENT_343	[p20l898t2810r982b2847],
6	754-62	CD	NUMBER	754-62	dep	1	SENT_343	[p20l997t2809r1153b2848],
7	.	.	O	.	_	0	SENT_343	[p20l997t2809r1153b2848],

1	Bonello	NNP	PERSON	Bonello	nn	2	SENT_344	[p20l15t2873r174b2913],
2	L	NNP	PERSON	L	_	0	SENT_344	[p20l191t2877r224b2919],
3	,	,	O	,	_	0	SENT_344	[p20l191t2877r224b2919],
4	Tantry	NNP	ORGANIZATION	Tantry	nn	5	SENT_344	[p20l239t2876r375b2925],
5	US	NNP	ORGANIZATION	US	appos	2	SENT_344	[p20l389t2876r465b2919],
6	,	,	O	,	_	0	SENT_344	[p20l389t2876r465b2919],
7	Marcucci	NNP	PERSON	Marcucci	nn	8	SENT_344	[p20l482t2876r675b2913],
8	R	NNP	PERSON	R	appos	2	SENT_344	[p20l691t2877r732b2919],
9	,	,	O	,	_	0	SENT_344	[p20l691t2877r732b2919],
10	et	FW	O	et	nn	11	SENT_344	[p20l748t2881r785b2913],
11	al.	FW	O	al.	appos	2	SENT_344	[p20l798t2873r843b2913],
12	.	.	O	.	_	0	SENT_344	[p20l798t2873r843b2913],

1	Consensus	NN	O	consensus	nn	4	SENT_345	[p20l861t2876r1091b2913],
2	and	CC	O	and	_	0	SENT_345	[p20l1107t2873r1185b2913],
3	future	JJ	DATE	future	nn	4	SENT_345	[p20l1198t2873r1328b2913],
4	directions	NNS	O	direction	_	0	SENT_345	[p20l13t2933r221b2973],
5	on	IN	O	on	_	0	SENT_345	[p20l236t2947r290b2973],
6	the	DT	O	the	det	7	SENT_345	[p20l303t2933r369b2973],
7	deﬁnition	NN	O	deﬁnition	prep_on	4	SENT_345	[p20l384t2933r591b2973],
8	of	IN	O	of	prep	7	SENT_345	[p20l605t2933r652b2973],
9	high	JJ	O	high	amod	12	SENT_345	[p20l658t2933r755b2985],
10	on-treatrnent	JJ	O	on-treatrnent	amod	12	SENT_345	[p20l769t2941r1046b2973],
11	platelet	NN	O	platelet	nn	12	SENT_345	[p20l1059t2933r1213b2984],
12	reactivity	NN	O	reactivity	dep	8	SENT_345	[p20l1225t2935r1416b2985],
13	to	TO	O	to	_	0	SENT_345	[p20l1427t2941r1467b2973],
14	adenosine	NN	O	adenosine	nn	15	SENT_345	[p20l13t2992r228b3031],
15	diphosphate	NN	O	diphosphate	prep_to	12	SENT_345	[p20l243t2992r514b3043],
16	.	.	O	.	_	0	SENT_345	[p20l243t2992r514b3043],
17	]	SYM	O	]	dep	7	SENT_345	[p20l524t2995r550b3044],

1	Am	VBP	O	be	dep	3	SENT_346	[p20l561t2994r636b3031],
2	Coll	NNP	O	Coll	nn	3	SENT_346	[p20l653t2992r730b3031],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_346	[p20l746t2992r891b3031],
4	2010	CD	DATE	2010	num	3	SENT_346	[p20l905t2995r1010b3037],
5	;	:	O	;	_	0	SENT_346	[p20l905t2995r1010b3037],
6	56	CD	NUMBER	56	dep	3	SENT_346	[p20l1027t2994r1086b3031],
7	:	:	O	:	_	0	SENT_346	[p20l1027t2994r1086b3031],
8	919-33	CD	NUMBER	919-33	dep	6	SENT_346	[p20l1102t2995r1258b3032],
9	.	.	O	.	_	0	SENT_346	[p20l1102t2995r1258b3032],

1	Iakubovvski	NNP	ORGANIZATION	Iakubovvski	nn	2	SENT_347	[p20l14t3059r256b3110],
2	IA	NNP	ORGANIZATION	IA	_	0	SENT_347	[p20l271t3062r332b3110],
3	,	,	O	,	_	0	SENT_347	[p20l271t3062r332b3110],
4	Payne	NNP	PERSON	Payne	nn	5	SENT_347	[p20l350t3063r474b3111],
5	CD	NNP	O	CD	appos	2	SENT_347	[p20l489t3062r569b3104],
6	,	,	O	,	_	0	SENT_347	[p20l489t3062r569b3104],
7	Li	NNP	O	Li	nn	8	SENT_347	[p20l587t3061r625b3098],
8	YG	NNP	O	YG	appos	2	SENT_347	[p20l637t3062r717b3104],
9	,	,	O	,	_	0	SENT_347	[p20l637t3062r717b3104],
10	et	FW	O	et	nn	11	SENT_347	[p20l733t3067r770b3099],
11	al.	FW	O	al.	appos	2	SENT_347	[p20l783t3059r828b3099],
12	.	.	O	.	_	0	SENT_347	[p20l783t3059r828b3099],

1	The	DT	O	the	det	2	SENT_348	[p20l843t3059r926b3099],
2	use	NN	O	use	_	0	SENT_348	[p20l939t3073r1012b3099],
3	of	IN	O	of	_	0	SENT_348	[p20l1026t3059r1074b3099],
4	the	DT	O	the	det	8	SENT_348	[p20l1080t3059r1146b3099],
5	VerifyNovv	NNP	O	VerifyNovv	nn	8	SENT_348	[p20l1159t3059r1384b3111],
6	P2Y12	NN	O	p2y12	nn	8	SENT_348	[p20l15t3121r143b3157],
7	point-of-care	NN	O	point-of-care	nn	8	SENT_348	[p20l158t3117r424b3169],
8	device	NN	O	device	prep_of	2	SENT_348	[p20l438t3117r568b3157],
9	to	TO	O	to	aux	10	SENT_348	[p20l581t3125r621b3157],
10	monitor	VB	O	monitor	infmod	2	SENT_348	[p20l635t3120r809b3157],
11	platelet	NN	O	platelet	nn	12	SENT_348	[p20l822t3117r976b3169],
12	function	NN	O	function	dobj	10	SENT_348	[p20l988t3117r1168b3157],
13	across	IN	O	across	_	0	SENT_348	[p20l1183t3131r1312b3157],
14	a	DT	O	a	det	15	SENT_348	[p20l1327t3131r1349b3157],
15	range	NN	O	range	prep_across	10	SENT_348	[p20l1362t3131r1482b3170],
16	of	IN	O	of	_	0	SENT_348	[p20l13t3176r61b3216],
17	P2Y12	NN	O	p2y12	nn	19	SENT_348	[p20l69t3180r197b3215],
18	inhibition	NN	O	inhibition	nn	19	SENT_348	[p20l212t3176r423b3216],
19	levels	NNS	O	level	prep_of	15	SENT_348	[p20l436t3176r551b3216],
20	following	VBG	O	follow	_	0	SENT_348	[p20l566t3176r765b3229],
21	prasugrel	NN	O	prasugrel	nn	24	SENT_348	[p20l778t3176r979b3229],
22	and	CC	O	and	_	0	SENT_348	[p20l993t3176r1072b3216],
23	clopidogrel	NN	O	clopidogrel	nn	24	SENT_348	[p20l1085t3176r1320b3229],
24	administration	NN	O	administration	prep_following	19	SENT_348	[p20l13t3236r338b3276],
25	.	.	O	.	_	0	SENT_348	[p20l13t3236r338b3276],

1	Thromb	NNP	O	Thromb	nn	2	SENT_349	[p20l358t3236r514b3276],
2	Haemost	NNP	O	Haemost	_	0	SENT_349	[p20l531t3240r709b3276],
3	2008	CD	DATE	2008	num	2	SENT_349	[p20l722t3239r832b3282],
4	;	:	O	;	_	0	SENT_349	[p20l722t3239r832b3282],
5	99	CD	NUMBER	99	num	7	SENT_349	[p20l848t3239r908b3276],
6	:	:	O	:	_	0	SENT_349	[p20l848t3239r908b3276],
7	409-15	CD	NUMBER	409-15	dep	2	SENT_349	[p20l922t3238r1077b3276],
8	.	.	O	.	_	0	SENT_349	[p20l922t3238r1077b3276],

1	Price	NN	O	price	nn	3	SENT_350	[p20l15t3305r120b3342],
2	M	NN	O	m	nn	3	SENT_350	[p20l135t3306r208b3353],
3	]	NN	O	]	_	0	SENT_350	[p20l135t3306r208b3353],
4	,	,	O	,	_	0	SENT_350	[p20l135t3306r208b3353],
5	Angiolillo	NN	O	angiolillo	nn	6	SENT_350	[p20l222t3302r431b3355],
6	D	NN	O	d	appos	3	SENT_350	[p20l447t3306r510b3353],
7	]	CD	NUMBER	]	dep	6	SENT_350	[p20l447t3306r510b3353],
8	,	,	O	,	_	0	SENT_350	[p20l447t3306r510b3353],
9	Teirstein	NNP	PERSON	Teirstein	nn	10	SENT_350	[p20l525t3305r710b3342],
10	PS	NNP	O	PS	appos	3	SENT_350	[p20l726t3305r792b3348],
11	,	,	O	,	_	0	SENT_350	[p20l726t3305r792b3348],
12	et	FW	O	et	nn	13	SENT_350	[p20l808t3310r846b3342],
13	al.	FW	O	al.	appos	3	SENT_350	[p20l859t3302r904b3342],
14	.	.	O	.	_	0	SENT_350	[p20l859t3302r904b3342],

1	Platelet	NN	O	platelet	nn	2	SENT_351	[p20l922t3302r1077b3342],
2	reactivity	NN	O	reactivity	_	0	SENT_351	[p20l1089t3305r1280b3354],
3	and	CC	O	and	_	0	SENT_351	[p20l1293t3302r1372b3342],
4	cardiovascular	JJ	O	cardiovascular	amod	5	SENT_351	[p20l13t3362r316b3402],
5	outcomes	NNS	O	outcome	conj_and	2	SENT_351	[p20l329t3370r534b3402],
6	after	IN	O	after	_	0	SENT_351	[p20l549t3362r644b3402],
7	percutaneous	JJ	O	percutaneous	amod	9	SENT_351	[p20l657t3370r942b3413],
8	coronary	JJ	O	coronary	amod	9	SENT_351	[p20l958t3376r1144b3414],
9	intervention	NN	O	intervention	prep_after	5	SENT_351	[p20l1156t3364r1426b3402],
10	:	:	O	:	_	0	SENT_351	[p20l1156t3364r1426b3402],
11	a	DT	O	a	det	13	SENT_351	[p20l13t3434r35b3460],
12	time-dependent	JJ	O	time-dependent	amod	13	SENT_351	[p20l47t3420r385b3472],
13	analysis	NN	O	analysis	dep	2	SENT_351	[p20l398t3420r564b3473],
14	of	IN	O	of	_	0	SENT_351	[p20l579t3420r627b3460],
15	the	DT	O	the	det	17	SENT_351	[p20l632t3420r699b3460],
16	Gauging	NNP	O	Gauging	nn	17	SENT_351	[p20l714t3423r897b3473],
17	Responsiveness	NN	O	responsiveness	prep_of	13	SENT_351	[p20l912t3423r1244b3472],
18	with	IN	O	with	_	0	SENT_351	[p20l1258t3420r1352b3460],
19	a	DT	O	a	det	22	SENT_351	[p20l1366t3434r1388b3460],
20	VerifyNow	NNP	O	VerifyNow	nn	22	SENT_351	[p20l11t3479r237b3531],
21	P2Y12	NN	O	p2y12	nn	22	SENT_351	[p20l251t3483r380b3518],
22	assay	NN	O	assay	prep_with	17	SENT_351	[p20l395t3493r514b3531],
23	:	:	O	:	_	0	SENT_351	[p20l395t3493r514b3531],
24	Impact	NN	O	impact	dep	2	SENT_351	[p20l533t3483r682b3531],
25	on	IN	O	on	_	0	SENT_351	[p20l695t3493r749b3519],
26	Thrombosis	NN	O	thrombosis	prep_on	24	SENT_351	[p20l761t3479r1018b3519],
27	and	CC	O	and	_	0	SENT_351	[p20l1034t3479r1113b3519],
28	Safety	NN	O	safety	nn	30	SENT_351	[p20l1129t3479r1253b3531],
29	(	CD	NUMBER	(	num	30	SENT_351	[p20l16t3541r281b3591],
30	GRAVITAS	NN	O	gravitas	conj_and	24	SENT_351	[p20l16t3541r281b3591],
31	)	CD	NUMBER	)	num	32	SENT_351	[p20l16t3541r281b3591],
32	trial	NN	O	trial	dep	30	SENT_351	[p20l297t3539r392b3579],
33	.	.	O	.	_	0	SENT_351	[p20l297t3539r392b3579],

1	Circulation	NN	O	circulation	_	0	SENT_352	[p20l412t3539r636b3579],
2	2011	CD	DATE	2011	num	1	SENT_352	[p20l650t3542r750b3584],
3	;	:	O	;	_	0	SENT_352	[p20l650t3542r750b3584],
4	124	CD	NUMBER	124	dep	1	SENT_352	[p20l767t3542r847b3578],
5	:	:	O	:	_	0	SENT_352	[p20l767t3542r847b3578],
6	1132-37	CD	NUMBER	1132-37	num	8	SENT_352	[p20l864t3541r1027b3580],
7	Cutlip	NNP	ORGANIZATION	Cutlip	nn	8	SENT_352	[p20l14t3605r144b3657],
8	DE	NN	ORGANIZATION	de	dep	1	SENT_352	[p20l160t3608r235b3651],
9	,	,	O	,	_	0	SENT_352	[p20l160t3608r235b3651],
10	Windecker	NNP	PERSON	Windecker	nn	11	SENT_352	[p20l249t3605r481b3645],
11	S	NNP	O	S	appos	8	SENT_352	[p20l496t3608r531b3651],
12	,	,	O	,	_	0	SENT_352	[p20l496t3608r531b3651],
13	Mehran	NNP	ORGANIZATION	Mehran	nn	14	SENT_352	[p20l548t3605r715b3645],
14	R	NNP	ORGANIZATION	R	appos	8	SENT_352	[p20l730t3609r771b3651],
15	,	,	O	,	_	0	SENT_352	[p20l730t3609r771b3651],
16	et	FW	O	et	nn	17	SENT_352	[p20l787t3613r825b3645],
17	al.	FW	O	al.	appos	8	SENT_352	[p20l838t3605r883b3645],
18	.	.	O	.	_	0	SENT_352	[p20l838t3605r883b3645],

1	Clinical	JJ	O	clinical	amod	3	SENT_353	[p20l900t3605r1061b3645],
2	end	NN	O	end	nn	3	SENT_353	[p20l1075t3605r1154b3645],
3	points	NNS	O	point	_	0	SENT_353	[p20l1167t3608r1297b3657],
4	in	IN	O	in	_	0	SENT_353	[p20l1312t3608r1355b3644],
5	coronary	JJ	O	coronary	amod	7	SENT_353	[p20l13t3679r199b3717],
6	stent	NN	O	stent	nn	7	SENT_353	[p20l213t3673r315b3705],
7	trials	NNS	O	trial	prep_in	3	SENT_353	[p20l327t3665r443b3705],
8	:	:	O	:	_	0	SENT_353	[p20l327t3665r443b3705],
9	a	DT	O	a	det	10	SENT_353	[p20l459t3679r481b3705],
10	case	NN	O	case	dep	3	SENT_353	[p20l495t3679r582b3705],
11	for	IN	O	for	_	0	SENT_353	[p20l596t3665r657b3705],
12	standardized	JJ	O	standardized	amod	13	SENT_353	[p20l671t3665r943b3705],
13	deﬁnitions	NNS	O	deﬁnitions	prep_for	10	SENT_353	[p20l957t3665r1194b3705],
14	.	.	O	.	_	0	SENT_353	[p20l957t3665r1194b3705],

1	Circulation	NN	O	circulation	_	0	SENT_354	[p20l1214t3665r1439b3705],
2	2007	CD	DATE	2007	num	1	SENT_354	[p20l14t3726r119b3769],
3	;	:	O	;	_	0	SENT_354	[p20l14t3726r119b3769],
4	115	CD	NUMBER	115	num	6	SENT_354	[p20l136t3726r213b3763],
5	:	:	O	:	_	0	SENT_354	[p20l136t3726r213b3763],
6	2344-51	CD	NUMBER	2344-51	dep	1	SENT_354	[p20l230t3726r405b3763],
7	.	.	O	.	_	0	SENT_354	[p20l230t3726r405b3763],

1	Pare	VB	O	pare	_	0	SENT_355	[p21l15t22r106b58],
2	G	NN	O	g	dobj	1	SENT_355	[p21l121t21r167b63],
3	,	,	O	,	_	0	SENT_355	[p21l121t21r167b63],
4	Mehta	NNP	ORGANIZATION	Mehta	nn	5	SENT_355	[p21l184t18r317b58],
5	SR	NN	ORGANIZATION	sr	appos	2	SENT_355	[p21l334t21r402b63],
6	,	,	O	,	_	0	SENT_355	[p21l334t21r402b63],
7	Yusuf	NNP	PERSON	Yusuf	nn	8	SENT_355	[p21l417t18r547b58],
8	S	NNP	PERSON	S	appos	2	SENT_355	[p21l556t21r591b64],
9	,	,	O	,	_	0	SENT_355	[p21l556t21r591b64],
10	et	FW	O	et	nn	11	SENT_355	[p21l607t26r644b58],
11	al.	FW	O	al.	appos	2	SENT_355	[p21l657t18r702b58],
12	.	.	O	.	_	0	SENT_355	[p21l657t18r702b58],

1	Effects	NNS	O	effect	_	0	SENT_356	[p21l720t18r859b58],
2	of	IN	O	of	_	0	SENT_356	[p21l874t18r922b58],
3	C	NN	O	c	nn	4	SENT_356	[p21l932t21r964b58],
4	YPZC	NN	O	ypzc	prep_of	1	SENT_356	[p21l967t21r1085b58],
5	19	CD	NUMBER	19	num	6	SENT_356	[p21l1088t21r1130b58],
6	genotype	NN	O	genotype	dep	1	SENT_356	[p21l1142t26r1333b70],
7	on	IN	O	on	_	0	SENT_356	[p21l1347t32r1401b58],
8	outcomes	NNS	O	outcome	prep_on	6	SENT_356	[p21l13t84r217b116],
9	of	IN	O	of	_	0	SENT_356	[p21l233t76r280b116],
10	clopidogrel	NN	O	clopidogrel	nn	11	SENT_356	[p21l287t76r522b129],
11	treatment	NN	O	treatment	prep_of	8	SENT_356	[p21l535t84r753b116],
12	.	.	O	.	_	0	SENT_356	[p21l535t84r753b116],

1	N	NN	O	n	nn	3	SENT_357	[p21l772t80r809b116],
2	Engl	NNP	O	Engl	nn	3	SENT_357	[p21l822t76r943b129],
3	]	NNP	O	]	nsubj	4	SENT_357	[p21l822t76r943b129],
4	Med	VBD	O	med	_	0	SENT_357	[p21l956t76r1043b116],
5	2010	CD	DATE	2010	dobj	4	SENT_357	[p21l1057t80r1161b122],
6	;	:	O	;	_	0	SENT_357	[p21l1057t80r1161b122],
7	363	CD	NUMBER	363	num	9	SENT_357	[p21l1178t80r1263b116],
8	:	:	O	:	_	0	SENT_357	[p21l1178t80r1263b116],
9	1704-14	CD	NUMBER	1704-14	dep	5	SENT_357	[p21l1280t79r1446b118],
10	.	.	O	.	_	0	SENT_357	[p21l1280t79r1446b118],

1	Holmes	NNP	ORGANIZATION	Holmes	nn	2	SENT_358	[p21l15t144r181b184],
2	MV	NNP	ORGANIZATION	MV	_	0	SENT_358	[p21l197t148r280b189],
3	,	,	O	,	_	0	SENT_358	[p21l197t148r280b189],
4	Perel	NNP	PERSON	Perel	nn	5	SENT_358	[p21l297t144r402b184],
5	P	NN	PERSON	p	appos	2	SENT_358	[p21l418t148r456b189],
6	,	,	O	,	_	0	SENT_358	[p21l418t148r456b189],
7	Shah	NNP	ORGANIZATION	Shah	nn	8	SENT_358	[p21l474t144r580b184],
8	T	NN	ORGANIZATION	t	appos	2	SENT_358	[p21l592t146r627b189],
9	,	,	O	,	_	0	SENT_358	[p21l592t146r627b189],
10	Hingorani	JJ	PERSON	hingorani	amod	11	SENT_358	[p21l645t146r865b196],
11	AD	NN	O	ad	appos	2	SENT_358	[p21l877t147r960b189],
12	,	,	O	,	_	0	SENT_358	[p21l877t147r960b189],
13	Casas	NNP	ORGANIZATION	Casas	nn	14	SENT_358	[p21l977t147r1094b184],
14	IP	NNP	O	IP	appos	2	SENT_358	[p21l1111t148r1167b195],
15	.	.	O	.	_	0	SENT_358	[p21l1111t148r1167b195],

1	CYPZCI9	NN	O	cypzci9	nn	2	SENT_359	[p21l1187t147r1385b184],
2	genotype	NN	O	genotype	_	0	SENT_359	[p21l13t210r214b255],
3	,	,	O	,	_	0	SENT_359	[p21l13t210r214b255],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_359	[p21l230t202r465b255],
5	metabolism	NN	O	metabolism	conj_and	2	SENT_359	[p21l479t202r742b248],
6	,	,	O	,	_	0	SENT_359	[p21l479t202r742b248],
7	platelet	NN	O	platelet	nn	8	SENT_359	[p21l757t202r911b254],
8	function	NN	O	function	conj_and	2	SENT_359	[p21l923t202r1114b248],
9	,	,	O	,	_	0	SENT_359	[p21l923t202r1114b248],
10	and	CC	O	and	_	0	SENT_359	[p21l1130t202r1209b242],
11	cardiovascular	JJ	O	cardiovascular	amod	12	SENT_359	[p21l13t262r316b302],
12	events	NNS	O	event	conj_and	2	SENT_359	[p21l329t270r473b302],
13	:	:	O	:	_	0	SENT_359	[p21l329t270r473b302],
14	a	DT	O	a	det	16	SENT_359	[p21l489t276r511b302],
15	systematic	JJ	O	systematic	amod	16	SENT_359	[p21l526t265r746b314],
16	review	NN	O	review	dep	2	SENT_359	[p21l759t265r898b302],
17	and	CC	O	and	_	0	SENT_359	[p21l911t262r990b302],
18	meta-analysis	NN	O	meta-analysis	conj_and	16	SENT_359	[p21l1003t262r1301b314],
19	.	.	O	.	_	0	SENT_359	[p21l1003t262r1301b314],

1	JAMA	NNP	O	JAMA	_	0	SENT_360	[p21l1311t265r1451b314],
2	2011	CD	DATE	2011	num	1	SENT_360	[p21l14t325r113b367],
3	;	:	O	;	_	0	SENT_360	[p21l14t325r113b367],
4	306	CD	NUMBER	306	num	6	SENT_360	[p21l130t325r215b361],
5	:	:	O	:	_	0	SENT_360	[p21l130t325r215b361],
6	2704-14	CD	NUMBER	2704-14	dep	1	SENT_360	[p21l232t324r403b362],
7	.	.	O	.	_	0	SENT_360	[p21l232t324r403b362],

1	Mega	JJ	O	mega	amod	2	SENT_361	[p21l14t392r129b440],
2	IL	NN	O	il	_	0	SENT_361	[p21l143t392r197b439],
3	,	,	O	,	_	0	SENT_361	[p21l143t392r197b439],
4	Close	NNP	O	Close	nn	5	SENT_361	[p21l214t388r329b428],
5	SL	NNP	O	SL	appos	2	SENT_361	[p21l346t391r407b434],
6	,	,	O	,	_	0	SENT_361	[p21l346t391r407b434],
7	Wiviott	NNP	PERSON	Wiviott	nn	8	SENT_361	[p21l422t391r575b428],
8	SD	NN	O	sd	appos	2	SENT_361	[p21l591t391r664b434],
9	,	,	O	,	_	0	SENT_361	[p21l591t391r664b434],
10	et	FW	O	et	nn	11	SENT_361	[p21l680t396r717b428],
11	al.	FW	O	al.	appos	2	SENT_361	[p21l731t388r775b428],
12	.	.	O	.	_	0	SENT_361	[p21l731t388r775b428],

1	Genetic	JJ	O	genetic	amod	2	SENT_362	[p21l793t391r955b428],
2	variants	NNS	O	variant	_	0	SENT_362	[p21l967t391r1133b428],
3	in	IN	O	in	_	0	SENT_362	[p21l1148t391r1191b427],
4	ABCB1	NN	O	abcb1	nn	7	SENT_362	[p21l1204t391r1357b428],
5	and	CC	O	and	_	0	SENT_362	[p21l13t447r92b486],
6	C	NN	O	c	nn	7	SENT_362	[p21l109t450r140b486],
7	YPZC	NN	O	ypzc	prep_in	2	SENT_362	[p21l143t450r262b486],
8	19	CD	NUMBER	19	dep	7	SENT_362	[p21l264t450r307b486],
9	and	CC	O	and	_	0	SENT_362	[p21l319t447r398b486],
10	cardiovascular	JJ	O	cardiovascular	amod	11	SENT_362	[p21l411t447r714b486],
11	outcomes	NNS	O	outcome	prep_in	2	SENT_362	[p21l728t455r932b486],
12	after	IN	O	after	_	0	SENT_362	[p21l947t447r1042b486],
13	treatment	NN	O	treatment	prep_after	11	SENT_362	[p21l1054t455r1264b486],
14	with	IN	O	with	_	0	SENT_362	[p21l1275t447r1370b486],
15	clopidogrel	NN	O	clopidogrel	prep_with	13	SENT_362	[p21l13t504r248b557],
16	and	CC	O	and	_	0	SENT_362	[p21l262t504r340b544],
17	prasugrel	NN	O	prasugrel	prep_with	13	SENT_362	[p21l353t504r554b557],
18	in	IN	O	in	_	0	SENT_362	[p21l567t507r610b544],
19	the	DT	O	the	det	22	SENT_362	[p21l623t504r689b544],
20	TRITON-TIMI	NN	O	triton-timus	nn	22	SENT_362	[p21l703t507r1018b544],
21	38	CD	NUMBER	38	num	22	SENT_362	[p21l1036t508r1082b544],
22	trial	NN	O	trial	prep_in	11	SENT_362	[p21l1096t504r1190b544],
23	:	:	O	:	_	0	SENT_362	[p21l1096t504r1190b544],
24	a	DT	O	a	det	26	SENT_362	[p21l13t578r34b604],
25	pharrnacogenetic	JJ	O	pharrnacogenetic	amod	26	SENT_362	[p21l48t564r415b616],
26	analysis	NN	O	analysis	dep	2	SENT_362	[p21l429t564r605b616],
27	.	.	O	.	_	0	SENT_362	[p21l429t564r605b616],

1	Lancet	NNP	O	Lancet	_	0	SENT_363	[p21l623t568r754b604],
2	2010	CD	DATE	2010	num	1	SENT_363	[p21l768t567r872b610],
3	;	:	O	;	_	0	SENT_363	[p21l768t567r872b610],
4	376	CD	NUMBER	376	num	6	SENT_363	[p21l889t566r974b604],
5	:	:	O	:	_	0	SENT_363	[p21l889t566r974b604],
6	1312-19	CD	NUMBER	1312-19	dep	1	SENT_363	[p21l991t567r1161b604],
7	.	.	O	.	_	0	SENT_363	[p21l991t567r1161b604],

1	Sibbing	VBG	O	sibb	_	0	SENT_364	[p21l16t631r176b683],
2	D	NN	O	d	dobj	1	SENT_364	[p21l192t635r237b677],
3	,	,	O	,	_	0	SENT_364	[p21l192t635r237b677],
4	Koch	NNP	PERSON	Koch	nn	5	SENT_364	[p21l254t631r360b671],
5	W	NNP	O	W	appos	2	SENT_364	[p21l372t635r425b677],
6	,	,	O	,	_	0	SENT_364	[p21l372t635r425b677],
7	Gebhard	NNP	PERSON	Gebhard	nn	8	SENT_364	[p21l442t631r626b671],
8	D	NNP	O	D	appos	2	SENT_364	[p21l641t635r686b676],
9	,	,	O	,	_	0	SENT_364	[p21l641t635r686b676],
10	et	FW	O	et	nn	11	SENT_364	[p21l702t639r740b671],
11	al.	FW	O	al.	appos	2	SENT_364	[p21l753t631r798b671],
12	.	.	O	.	_	0	SENT_364	[p21l753t631r798b671],

1	Cytochrome	NN	O	cytochrome	_	0	SENT_365	[p21l815t631r1072b683],
2	2C19	NN	O	2c19	dep	1	SENT_365	[p21l1087t633r1259b672],
3	"	''	O	"	punct	2	SENT_365	[p21l1087t633r1259b672],
4	"	``	O	"	punct	2	SENT_365	[p21l1087t633r1259b672],
5	17	CD	NUMBER	17	num	7	SENT_365	[p21l1087t633r1259b672],
6	allelic	JJ	O	allelic	amod	7	SENT_365	[p21l1272t631r1393b671],
7	variant	NN	O	variant	dep	2	SENT_365	[p21l11t692r168b735],
8	,	,	O	,	_	0	SENT_365	[p21l11t692r168b735],
9	platelet	NN	O	platelet	nn	10	SENT_365	[p21l184t690r337b741],
10	aggregation	NN	O	aggregation	appos	1	SENT_365	[p21l351t692r610b742],
11	,	,	O	,	_	0	SENT_365	[p21l351t692r610b742],
12	bleeding	VBG	O	bleed	amod	13	SENT_365	[p21l624t690r808b742],
13	events	NNS	O	event	appos	10	SENT_365	[p21l822t698r966b735],
14	,	,	O	,	_	0	SENT_365	[p21l822t698r966b735],
15	and	CC	O	and	_	0	SENT_365	[p21l982t690r1061b730],
16	stent	NN	O	stent	nn	17	SENT_365	[p21l1075t698r1178b730],
17	thrombosis	NN	O	thrombosis	conj_and	10	SENT_365	[p21l1190t690r1431b730],
18	in	IN	O	in	_	0	SENT_365	[p21l1446t692r1488b729],
19	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	20	SENT_365	[p21l13t748r408b801],
20	patients	NNS	O	patient	prep_in	17	SENT_365	[p21l420t751r587b800],
21	with	IN	O	with	_	0	SENT_365	[p21l601t748r695b788],
22	coronary	JJ	O	coronary	amod	24	SENT_365	[p21l709t762r895b800],
23	stent	NN	O	stent	nn	24	SENT_365	[p21l909t756r1011b788],
24	placement	NN	O	placement	prep_with	20	SENT_365	[p21l1023t748r1255b800],
25	.	.	O	.	_	0	SENT_365	[p21l1023t748r1255b800],

1	Circulation	NN	O	circulation	_	0	SENT_366	[p21l1275t748r1499b788],
2	2010	CD	DATE	2010	num	1	SENT_366	[p21l14t811r118b853],
3	;	:	O	;	_	0	SENT_366	[p21l14t811r118b853],
4	121	CD	NUMBER	121	num	6	SENT_366	[p21l135t811r212b847],
5	:	:	O	:	_	0	SENT_366	[p21l135t811r212b847],
6	512-18	CD	NUMBER	512-18	dep	1	SENT_366	[p21l230t810r379b847],
7	.	.	O	.	_	0	SENT_366	[p21l230t810r379b847],

1	Scott	NNP	ORGANIZATION	Scott	nn	2	SENT_367	[p21l16t877r118b914],
2	SA	NNP	ORGANIZATION	SA	_	0	SENT_367	[p21l134t877r203b920],
3	,	,	O	,	_	0	SENT_367	[p21l134t877r203b920],
4	Sangkuhl	NNP	PERSON	Sangkuhl	nn	5	SENT_367	[p21l222t874r421b927],
5	K	NNP	PERSON	K	appos	2	SENT_367	[p21l437t878r477b920],
6	,	,	O	,	_	0	SENT_367	[p21l437t878r477b920],
7	Gardner	NNP	PERSON	Gardner	nn	8	SENT_367	[p21l494t874r671b914],
8	EE	NNP	O	EE	appos	2	SENT_367	[p21l686t877r752b920],
9	,	,	O	,	_	0	SENT_367	[p21l686t877r752b920],
10	et	FW	O	et	nn	11	SENT_367	[p21l768t882r806b914],
11	al.	FW	O	al.	appos	2	SENT_367	[p21l819t874r864b914],
12	.	.	O	.	_	0	SENT_367	[p21l819t874r864b914],

1	Clinical	JJ	O	clinical	amod	2	SENT_368	[p21l881t874r1042b914],
2	Pharrnacogenetics	NNPS	O	Pharrnacogenetics	_	0	SENT_368	[p21l1058t874r1445b927],
3	Implementation	NNP	O	Implementation	nn	5	SENT_368	[p21l15t934r361b986],
4	Consortium	NNP	O	Consortium	nn	5	SENT_368	[p21l376t937r631b974],
5	guidelines	NNS	O	guideline	dep	2	SENT_368	[p21l645t934r863b986],
6	for	IN	O	for	_	0	SENT_368	[p21l878t934r938b974],
7	cytochrome	NN	O	cytochrome	nn	8	SENT_368	[p21l951t934r1199b986],
8	P450	NN	O	p450	prep_for	5	SENT_368	[p21l1215t936r1434b974],
9	—	CD	NUMBER	—	num	8	SENT_368	[p21l1215t936r1434b974],
10	2C19	NN	O	2c19	nn	16	SENT_368	[p21l1215t936r1434b974],
11	(	NN	O	(	nn	16	SENT_368	[p21l16t996r63b1045],
12	C	NN	O	c	nn	16	SENT_368	[p21l16t996r63b1045],
13	YP2C1	NN	O	yp2c1	nn	16	SENT_368	[p21l66t996r203b1033],
14	9	CD	NUMBER	9	num	16	SENT_368	[p21l209t996r240b1045],
15	)	NN	O	)	nn	16	SENT_368	[p21l209t996r240b1045],
16	genotype	NN	O	genotype	dep	2	SENT_368	[p21l258t1001r448b1045],
17	and	CC	O	and	_	0	SENT_368	[p21l462t993r541b1033],
18	clopidogrel	NN	O	clopidogrel	nn	19	SENT_368	[p21l555t993r790b1045],
19	therapy	NN	O	therapy	dep	2	SENT_368	[p21l803t993r967b1045],
20	.	.	O	.	_	0	SENT_368	[p21l803t993r967b1045],

1	Clin	NNP	O	Clin	nn	3	SENT_369	[p21l987t993r1071b1033],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_369	[p21l1086t993r1304b1033],
3	Ther	NNP	O	Ther	_	0	SENT_369	[p21l1320t993r1413b1032],
4	2011	CD	DATE	2011	num	3	SENT_369	[p21l14t1055r113b1097],
5	;	:	O	;	_	0	SENT_369	[p21l14t1055r113b1097],
6	90	CD	NUMBER	90	num	8	SENT_369	[p21l130t1055r189b1091],
7	:	:	O	:	_	0	SENT_369	[p21l130t1055r189b1091],
8	328-32	CD	NUMBER	328-32	dep	3	SENT_369	[p21l207t1055r366b1091],
9	.	.	O	.	_	0	SENT_369	[p21l207t1055r366b1091],

1	Bouman	NN	PERSON	bouman	nn	2	SENT_370	[p21l15t1123r197b1159],
2	H	NN	O	h	_	0	SENT_370	[p21l212t1123r281b1170],
3	]	CD	NUMBER	]	dep	2	SENT_370	[p21l212t1123r281b1170],
4	,	,	O	,	_	0	SENT_370	[p21l212t1123r281b1170],
5	Schomig	NNP	PERSON	Schomig	nn	6	SENT_370	[p21l300t1119r486b1171],
6	E	NNP	PERSON	E	appos	3	SENT_370	[p21l502t1121r538b1164],
7	,	,	O	,	_	0	SENT_370	[p21l502t1121r538b1164],
8	van	NNP	O	van	nn	10	SENT_370	[p21l553t1133r628b1159],
9	Werkum	NNP	O	Werkum	nn	10	SENT_370	[p21l640t1119r828b1159],
10	IW	NNP	O	IW	appos	3	SENT_370	[p21l843t1123r912b1170],
11	,	,	O	,	_	0	SENT_370	[p21l843t1123r912b1170],
12	et	FW	O	et	nn	13	SENT_370	[p21l928t1127r966b1159],
13	al.	FW	O	al.	appos	3	SENT_370	[p21l979t1119r1024b1159],
14	.	.	O	.	_	0	SENT_370	[p21l979t1119r1024b1159],

1	Paraoxonase-1	NN	O	paraoxonase-1	nsubj	5	SENT_371	[p21l1042t1122r1338b1159],
2	is	VBZ	O	be	cop	5	SENT_371	[p21l1352t1121r1385b1159],
3	a	DT	O	a	det	5	SENT_371	[p21l13t1191r35b1217],
4	major	JJ	O	major	amod	5	SENT_371	[p21l48t1180r175b1229],
5	determinant	NN	O	determinant	_	0	SENT_371	[p21l188t1177r452b1217],
6	of	IN	O	of	_	0	SENT_371	[p21l465t1177r513b1217],
7	clopidogrel	NN	O	clopidogrel	nn	8	SENT_371	[p21l519t1177r754b1230],
8	efficacy	NN	O	efficacy	prep_of	5	SENT_371	[p21l768t1177r931b1229],
9	.	.	O	.	_	0	SENT_371	[p21l768t1177r931b1229],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_372	[p21l949t1181r1025b1217],
2	Med	NNP	O	Med	_	0	SENT_372	[p21l1039t1177r1126b1217],
3	2011	CD	DATE	2011	num	2	SENT_372	[p21l1140t1181r1239b1223],
4	;	:	O	;	_	0	SENT_372	[p21l1140t1181r1239b1223],
5	17	CD	NUMBER	17	num	7	SENT_372	[p21l1256t1180r1312b1218],
6	:	:	O	:	_	0	SENT_372	[p21l1256t1180r1312b1218],
7	110-16	CD	NUMBER	110-16	dep	2	SENT_372	[p21l1329t1181r1474b1217],
8	.	.	O	.	_	0	SENT_372	[p21l1329t1181r1474b1217],

1	Sibbing	VBG	O	sibb	_	0	SENT_373	[p21l16t1245r175b1297],
2	D	NN	O	d	dobj	1	SENT_373	[p21l190t1248r235b1290],
3	,	,	O	,	_	0	SENT_373	[p21l190t1248r235b1290],
4	Koch	NNP	PERSON	Koch	nn	5	SENT_373	[p21l252t1245r357b1284],
5	W	NNP	O	W	appos	2	SENT_373	[p21l369t1248r422b1290],
6	,	,	O	,	_	0	SENT_373	[p21l369t1248r422b1290],
7	Massberg	NNP	LOCATION	Massberg	nn	8	SENT_373	[p21l438t1245r640b1297],
8	S	NNP	O	S	appos	2	SENT_373	[p21l656t1247r691b1290],
9	,	,	O	,	_	0	SENT_373	[p21l656t1247r691b1290],
10	et	FW	O	et	nn	11	SENT_373	[p21l707t1253r744b1284],
11	al.	FW	O	al.	appos	2	SENT_373	[p21l757t1245r801b1284],
12	.	.	O	.	_	0	SENT_373	[p21l757t1245r801b1284],

1	No	DT	O	no	det	2	SENT_374	[p21l818t1248r877b1284],
2	association	NN	O	association	_	0	SENT_374	[p21l891t1247r1123b1284],
3	of	IN	O	of	_	0	SENT_374	[p21l1136t1244r1184b1284],
4	paraoxonase-1	NN	O	paraoxonase-1	nn	6	SENT_374	[p21l1189t1248r1484b1296],
5	Q192R	NN	O	q192r	nn	6	SENT_374	[p21l14t1307r155b1354],
6	genotypes	NNS	O	genotype	prep_of	2	SENT_374	[p21l168t1311r377b1356],
7	with	IN	O	with	_	0	SENT_374	[p21l390t1303r484b1343],
8	platelet	NN	O	platelet	nn	9	SENT_374	[p21l497t1303r650b1355],
9	response	NN	O	response	prep_with	2	SENT_374	[p21l662t1317r850b1355],
10	to	TO	O	to	_	0	SENT_374	[p21l863t1311r902b1343],
11	clopidogrel	NN	O	clopidogrel	prep_to	9	SENT_374	[p21l916t1303r1149b1356],
12	and	CC	O	and	_	0	SENT_374	[p21l1163t1303r1241b1343],
13	risk	NN	O	risk	conj_and	11	SENT_374	[p21l1254t1303r1333b1343],
14	of	IN	O	of	_	0	SENT_374	[p21l1346t1303r1394b1343],
15	stent	JJ	O	stent	amod	16	SENT_374	[p21l14t1371r116b1403],
16	thrombosis	NN	O	thrombosis	prep_of	2	SENT_374	[p21l127t1363r367b1403],
17	after	IN	O	after	_	0	SENT_374	[p21l382t1363r476b1403],
18	coronary	JJ	O	coronary	amod	19	SENT_374	[p21l489t1377r674b1415],
19	stenting	NN	O	stenting	prep_after	16	SENT_374	[p21l687t1366r867b1415],
20	.	.	O	.	_	0	SENT_374	[p21l687t1366r867b1415],

1	Eur	NNP	O	Eur	nn	2	SENT_375	[p21l885t1365r959b1403],
2	Heart	NNP	O	Heart	_	0	SENT_375	[p21l972t1367r1119b1415],
3	]	CD	NUMBER	]	num	4	SENT_375	[p21l972t1367r1119b1415],
4	2011	CD	DATE	2011	dep	2	SENT_375	[p21l1131t1366r1230b1409],
5	;	:	O	;	_	0	SENT_375	[p21l1131t1366r1230b1409],
6	32	CD	NUMBER	32	num	8	SENT_375	[p21l1246t1367r1305b1403],
7	:	:	O	:	_	0	SENT_375	[p21l1246t1367r1305b1403],
8	1605-13	CD	NUMBER	1605-13	dep	2	SENT_375	[p21l1322t1365r1496b1403],
9	.	.	O	.	_	0	SENT_375	[p21l1322t1365r1496b1403],

1	Cayla	NNP	PERSON	Cayla	nn	4	SENT_376	[p21l14t1429r126b1482],
2	G	NNP	PERSON	G	nn	4	SENT_376	[p21l141t1432r187b1475],
3	,	,	O	,	_	0	SENT_376	[p21l141t1432r187b1475],
4	Hulot	NNP	PERSON	Hulot	nsubj	8	SENT_376	[p21l205t1429r327b1469],
5	IS	VBZ	O	be	cop	8	SENT_376	[p21l341t1432r396b1480],
6	,	,	O	,	_	0	SENT_376	[p21l341t1432r396b1480],
7	O'Connor	NNP	PERSON	O'Connor	nn	8	SENT_376	[p21l413t1432r624b1469],
8	SA	NNP	O	SA	_	0	SENT_376	[p21l640t1432r709b1475],
9	,	,	O	,	_	0	SENT_376	[p21l640t1432r709b1475],
10	et	FW	O	et	nn	11	SENT_376	[p21l725t1437r763b1469],
11	al.	FW	O	al.	appos	8	SENT_376	[p21l776t1429r821b1469],
12	.	.	O	.	_	0	SENT_376	[p21l776t1429r821b1469],

1	Clinical	JJ	O	clinical	nsubj	8	SENT_377	[p21l838t1429r1009b1475],
2	,	,	O	,	_	0	SENT_377	[p21l838t1429r1009b1475],
3	angiographic	JJ	O	angiographic	appos	1	SENT_377	[p21l1025t1429r1313b1482],
4	,	,	O	,	_	0	SENT_377	[p21l1025t1429r1313b1482],
5	and	CC	O	and	_	0	SENT_377	[p21l13t1489r92b1529],
6	genetic	JJ	O	genetic	amod	7	SENT_377	[p21l105t1492r257b1541],
7	factors	NNS	O	factor	appos	1	SENT_377	[p21l270t1489r410b1529],
8	associated	VBN	O	associate	_	0	SENT_377	[p21l425t1489r641b1529],
9	with	IN	O	with	_	0	SENT_377	[p21l652t1489r747b1529],
10	early	JJ	O	early	amod	13	SENT_377	[p21l760t1489r861b1541],
11	coronary	JJ	O	coronary	amod	13	SENT_377	[p21l874t1503r1060b1541],
12	stent	NN	O	stent	nn	13	SENT_377	[p21l1074t1497r1177b1529],
13	thrombosis	NN	O	thrombosis	prep_with	8	SENT_377	[p21l1188t1489r1441b1529],
14	.	.	O	.	_	0	SENT_377	[p21l1188t1489r1441b1529],

1	JAMA	NNP	O	JAMA	_	0	SENT_378	[p21l7t1551r147b1600],
2	2011	CD	DATE	2011	num	1	SENT_378	[p21l160t1551r260b1593],
3	;	:	O	;	_	0	SENT_378	[p21l160t1551r260b1593],
4	306	CD	NUMBER	306	num	6	SENT_378	[p21l277t1551r362b1587],
5	:	:	O	:	_	0	SENT_378	[p21l277t1551r362b1587],
6	1765-74	CD	NUMBER	1765-74	dep	1	SENT_378	[p21l379t1550r549b1589],
7	.	.	O	.	_	0	SENT_378	[p21l379t1550r549b1589],

1	Brandt	NNP	PERSON	Brandt	nn	2	SENT_379	[p21l15t1615r159b1655],
2	IT	NNP	O	IT	_	0	SENT_379	[p21l172t1617r224b1666],
3	,	,	O	,	_	0	SENT_379	[p21l172t1617r224b1666],
4	Close	NNP	O	Close	nn	5	SENT_379	[p21l241t1615r356b1655],
5	SL	NNP	O	SL	appos	2	SENT_379	[p21l373t1618r434b1661],
6	,	,	O	,	_	0	SENT_379	[p21l373t1618r434b1661],
7	Iturria	NNP	ORGANIZATION	Iturria	nn	8	SENT_379	[p21l452t1618r587b1655],
8	SI	NNP	ORGANIZATION	SI	appos	2	SENT_379	[p21l604t1618r657b1666],
9	,	,	O	,	_	0	SENT_379	[p21l604t1618r657b1666],
10	et	FW	O	et	nn	11	SENT_379	[p21l673t1623r710b1655],
11	al.	FW	O	al.	appos	2	SENT_379	[p21l724t1615r768b1655],
12	.	.	O	.	_	0	SENT_379	[p21l724t1615r768b1655],

1	Common	JJ	O	common	amod	2	SENT_380	[p21l786t1618r988b1655],
2	polymorphisms	NNS	O	polymorphism	nsubj	11	SENT_380	[p21l1001t1615r1336b1667],
3	of	IN	O	of	_	0	SENT_380	[p21l13t1673r61b1713],
4	C	NN	O	c	nn	5	SENT_380	[p21l71t1676r102b1713],
5	YPZC	NN	O	ypzc	prep_of	2	SENT_380	[p21l105t1676r223b1713],
6	19	CD	NUMBER	19	num	5	SENT_380	[p21l226t1677r269b1713],
7	and	CC	O	and	_	0	SENT_380	[p21l281t1674r360b1713],
8	C	NN	O	c	nn	9	SENT_380	[p21l377t1676r408b1713],
9	YP2C	NN	O	yp2c	conj_and	2	SENT_380	[p21l411t1676r530b1713],
10	9	CD	NUMBER	9	dep	9	SENT_380	[p21l533t1677r555b1713],
11	affect	VBP	O	affect	_	0	SENT_380	[p21l567t1674r681b1713],
12	the	DT	O	the	det	16	SENT_380	[p21l693t1674r760b1713],
13	pharrnacokinetic	JJ	O	pharrnacokinetic	amod	16	SENT_380	[p21l773t1674r1131b1725],
14	and	CC	O	and	_	0	SENT_380	[p21l1145t1674r1224b1713],
15	pharrnacodynamic	JJ	O	pharrnacodynamic	conj_and	13	SENT_380	[p21l12t1732r410b1785],
16	response	NN	O	response	dobj	11	SENT_380	[p21l423t1746r613b1784],
17	to	TO	O	to	dep	16	SENT_380	[p21l626t1740r666b1772],
18	clopidogrel	NN	O	clopidogrel	dep	16	SENT_380	[p21l680t1732r915b1785],
19	but	CC	O	but	_	0	SENT_380	[p21l928t1732r999b1772],
20	not	RB	O	not	neg	21	SENT_380	[p21l1012t1740r1082b1772],
21	prasugrel	NN	O	prasugrel	dep	16	SENT_380	[p21l1094t1732r1305b1785],
22	.	.	O	.	_	0	SENT_380	[p21l1094t1732r1305b1785],
23	]	SYM	O	]	dep	16	SENT_380	[p21l7t1796r33b1844],

1	Thromb	NNP	O	Thromb	nn	2	SENT_381	[p21l48t1792r205b1832],
2	Haemost	NNP	O	Haemost	_	0	SENT_381	[p21l222t1796r399b1832],
3	2007	CD	DATE	2007	num	2	SENT_381	[p21l413t1794r519b1837],
4	;	:	O	;	_	0	SENT_381	[p21l413t1794r519b1837],
5	5	CD	NUMBER	5	num	7	SENT_381	[p21l537t1794r569b1832],
6	:	:	O	:	_	0	SENT_381	[p21l537t1794r569b1832],
7	2429-36	CD	NUMBER	2429-36	dep	2	SENT_381	[p21l586t1795r769b1832],
8	.	.	O	.	_	0	SENT_381	[p21l586t1795r769b1832],

1	Varenhorst	NNP	O	Varenhorst	nn	2	SENT_382	[p21l11t1858r248b1898],
2	C	NNP	O	C	_	0	SENT_382	[p21l262t1861r304b1904],
3	,	,	O	,	_	0	SENT_382	[p21l262t1861r304b1904],
4	Iames	NNP	O	Iames	nn	5	SENT_382	[p21l320t1862r447b1909],
5	S	NNP	O	S	appos	2	SENT_382	[p21l465t1861r500b1904],
6	,	,	O	,	_	0	SENT_382	[p21l465t1861r500b1904],
7	Erlinge	NNP	O	Erlinge	nn	8	SENT_382	[p21l518t1858r669b1911],
8	D	NNP	O	D	appos	2	SENT_382	[p21l685t1862r730b1904],
9	,	,	O	,	_	0	SENT_382	[p21l685t1862r730b1904],
10	et	FW	O	et	nn	11	SENT_382	[p21l746t1866r784b1898],
11	al.	FW	O	al.	appos	2	SENT_382	[p21l797t1858r842b1898],
12	.	.	O	.	_	0	SENT_382	[p21l797t1858r842b1898],

1	Genetic	JJ	O	genetic	amod	2	SENT_383	[p21l859t1861r1021b1898],
2	variation	NN	O	variation	nsubj	7	SENT_383	[p21l1033t1861r1219b1898],
3	of	IN	O	of	_	0	SENT_383	[p21l1233t1858r1281b1898],
4	C	NN	O	c	nn	5	SENT_383	[p21l1291t1861r1322b1898],
5	YPZC	NN	O	ypzc	prep_of	2	SENT_383	[p21l1326t1861r1444b1898],
6	19	CD	NUMBER	19	num	7	SENT_383	[p21l1447t1862r1489b1898],
7	aﬁects	NNS	O	aﬁects	_	0	SENT_383	[p21l13t1918r147b1958],
8	both	CC	O	both	preconj	9	SENT_383	[p21l161t1918r257b1958],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	12	SENT_383	[p21l270t1918r628b1970],
10	and	CC	O	and	_	0	SENT_383	[p21l642t1918r721b1958],
11	pharrnacodynamic	JJ	O	pharrnacodynamic	amod	12	SENT_383	[p21l733t1918r1131b1970],
12	responses	NNS	O	response	dobj	7	SENT_383	[p21l1144t1932r1354b1970],
13	to	TO	O	to	_	0	SENT_383	[p21l1368t1926r1408b1958],
14	clopidogrel	NN	O	clopidogrel	prep_to	12	SENT_383	[p21l13t1977r248b2029],
15	but	CC	O	but	_	0	SENT_383	[p21l260t1977r332b2016],
16	not	RB	O	not	_	0	SENT_383	[p21l344t1985r415b2016],
17	prasugrel	NN	O	prasugrel	conj_negcc	12	SENT_383	[p21l427t1977r628b2029],
18	in	IN	O	in	_	0	SENT_383	[p21l641t1979r684b2016],
19	aspirin-treated	JJ	O	aspirin-treated	amod	20	SENT_383	[p21l698t1977r1005b2028],
20	patients	NNS	O	patient	prep_in	17	SENT_383	[p21l1018t1979r1185b2028],
21	with	IN	O	with	_	0	SENT_383	[p21l1198t1977r1293b2016],
22	coronary	JJ	O	coronary	amod	24	SENT_383	[p21l1307t1991r1493b2029],
23	artery	NN	O	artery	nn	24	SENT_383	[p21l13t2043r135b2088],
24	disease	NN	O	disease	prep_with	7	SENT_383	[p21l147t2035r309b2075],
25	.	.	O	.	_	0	SENT_383	[p21l147t2035r309b2075],

1	Eur	NNP	O	Eur	nn	2	SENT_384	[p21l328t2038r403b2075],
2	Heart	NNP	O	Heart	_	0	SENT_384	[p21l416t2039r565b2088],
3	]	CD	NUMBER	]	num	4	SENT_384	[p21l416t2039r565b2088],
4	2009	CD	DATE	2009	dep	2	SENT_384	[p21l577t2039r687b2081],
5	;	:	O	;	_	0	SENT_384	[p21l577t2039r687b2081],
6	30	CD	NUMBER	30	num	8	SENT_384	[p21l703t2039r762b2075],
7	:	:	O	:	_	0	SENT_384	[p21l703t2039r762b2075],
8	1744-52	CD	NUMBER	1744-52	dep	2	SENT_384	[p21l780t2038r951b2077],
9	.	.	O	.	_	0	SENT_384	[p21l780t2038r951b2077],

1	Alexopoulos	NNP	PERSON	Alexopoulos	nn	2	SENT_385	[p21l11t2103r271b2154],
2	D	NNP	O	D	_	0	SENT_385	[p21l288t2106r333b2148],
3	,	,	O	,	_	0	SENT_385	[p21l288t2106r333b2148],
4	Dimitropoulos	NNP	PERSON	Dimitropoulos	nn	5	SENT_385	[p21l351t2103r660b2154],
5	G	NNP	PERSON	G	appos	2	SENT_385	[p21l676t2105r722b2148],
6	,	,	O	,	_	0	SENT_385	[p21l676t2105r722b2148],
7	Davlouros	NNP	PERSON	Davlouros	nn	8	SENT_385	[p21l740t2103r953b2142],
8	P	NN	PERSON	p	appos	2	SENT_385	[p21l970t2106r1008b2148],
9	,	,	O	,	_	0	SENT_385	[p21l970t2106r1008b2148],
10	et	FW	O	et	nn	11	SENT_385	[p21l1024t2111r1062b2142],
11	al.	FW	O	al.	appos	2	SENT_385	[p21l1075t2103r1120b2142],
12	.	.	O	.	_	0	SENT_385	[p21l1075t2103r1120b2142],

1	Prasugrel	NNP	O	Prasugrel	nsubj	2	SENT_386	[p21l1138t2103r1339b2155],
2	overcomes	VBZ	O	overcome	_	0	SENT_386	[p21l13t2175r238b2201],
3	high	JJ	O	high	amod	6	SENT_386	[p21l252t2161r350b2214],
4	on-clopidogrel	JJ	O	on-clopidogrel	amod	6	SENT_386	[p21l364t2161r668b2214],
5	platelet	NN	O	platelet	nn	6	SENT_386	[p21l681t2161r835b2213],
6	reactivity	NN	O	reactivity	dobj	2	SENT_386	[p21l847t2164r1038b2213],
7	post-stenting	VBG	O	post-stent	partmod	6	SENT_386	[p21l1050t2164r1326b2214],
8	more	RBR	O	more	dobj	7	SENT_386	[p21l1339t2175r1451b2201],
9	effectively	RB	O	effectively	advmod	8	SENT_386	[p21l13t2221r224b2273],
10	than	IN	O	than	prep	9	SENT_386	[p21l235t2221r332b2261],
11	high-dose	JJ	O	high-dose	amod	12	SENT_386	[p21l345t2221r553b2273],
12	(	NN	O	(	dep	10	SENT_386	[p21l570t2223r750b2273],
13	150-mg	JJ	O	150-mg	amod	15	SENT_386	[p21l570t2223r750b2273],
14	)	NN	O	)	nn	15	SENT_386	[p21l570t2223r750b2273],
15	clopidogrel	NN	O	clopidogrel	dep	12	SENT_386	[p21l767t2221r1012b2273],
16	:	:	O	:	_	0	SENT_386	[p21l767t2221r1012b2273],
17	the	DT	O	the	det	18	SENT_386	[p21l1027t2221r1094b2261],
18	importance	NN	O	importance	dep	12	SENT_386	[p21l1107t2224r1351b2273],
19	of	IN	O	of	_	0	SENT_386	[p21l1365t2221r1413b2261],
20	C	NN	O	c	nn	21	SENT_386	[p21l16t2282r48b2319],
21	YP2C19	NN	O	yp2c19	prep_of	18	SENT_386	[p21l51t2282r265b2320],
22	"	''	O	"	punct	18	SENT_386	[p21l51t2282r265b2320],
23	‘	NN	O	‘	nn	25	SENT_386	[p21l51t2282r265b2320],
24	2	CD	NUMBER	2	num	25	SENT_386	[p21l51t2282r265b2320],
25	genotyping	NN	O	genotyping	dep	18	SENT_386	[p21l277t2282r524b2332],
26	.	.	O	.	_	0	SENT_386	[p21l277t2282r524b2332],
27	]	SYM	O	]	dep	8	SENT_386	[p21l535t2282r664b2332],

1	ACC	NNP	O	ACC	nn	3	SENT_387	[p21l535t2282r664b2332],
2	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_387	[p21l679t2280r895b2319],
3	Interv	NNP	O	Interv	_	0	SENT_387	[p21l909t2283r1027b2319],
4	2011	CD	DATE	2011	num	3	SENT_387	[p21l1040t2283r1140b2325],
5	;	:	O	;	_	0	SENT_387	[p21l1040t2283r1140b2325],
6	4	CD	NUMBER	4	num	8	SENT_387	[p21l1156t2283r1190b2319],
7	:	:	O	:	_	0	SENT_387	[p21l1156t2283r1190b2319],
8	403-10	CD	NUMBER	403-10	dep	3	SENT_387	[p21l1205t2283r1360b2319],
9	.	.	O	.	_	0	SENT_387	[p21l1205t2283r1360b2319],

1	Pena	NNP	PERSON	Pena	nn	2	SENT_388	[p21l15t2351r117b2387],
2	A	NNP	O	A	nsubj	11	SENT_388	[p21l129t2350r174b2393],
3	,	,	O	,	_	0	SENT_388	[p21l129t2350r174b2393],
4	Collet	NNP	PERSON	Collet	nn	5	SENT_388	[p21l191t2347r313b2387],
5	IP	NNP	O	IP	appos	2	SENT_388	[p21l326t2351r383b2398],
6	,	,	O	,	_	0	SENT_388	[p21l326t2351r383b2398],
7	Hulot	NNP	PERSON	Hulot	appos	5	SENT_388	[p21l401t2347r523b2387],
8	IS	VBZ	O	be	cop	11	SENT_388	[p21l537t2350r592b2398],
9	,	,	O	,	_	0	SENT_388	[p21l537t2350r592b2398],
10	et	FW	O	et	nn	11	SENT_388	[p21l608t2355r646b2387],
11	al.	FW	O	al.	_	0	SENT_388	[p21l659t2347r704b2387],
12	.	.	O	.	_	0	SENT_388	[p21l659t2347r704b2387],

1	Can	MD	O	can	aux	3	SENT_389	[p21l721t2350r804b2387],
2	we	PRP	O	we	nsubj	3	SENT_389	[p21l816t2361r875b2387],
3	override	VB	O	override	_	0	SENT_389	[p21l890t2347r1062b2387],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_389	[p21l1076t2347r1312b2399],
5	resistance	NN	O	resistance	dobj	3	SENT_389	[p21l12t2406r242b2446],
6	?	.	O	?	_	0	SENT_389	[p21l12t2406r242b2446],

1	Circulation	NN	O	circulation	_	0	SENT_390	[p21l261t2406r486b2446],
2	2009	CD	DATE	2009	num	1	SENT_390	[p21l500t2409r609b2451],
3	;	:	O	;	_	0	SENT_390	[p21l500t2409r609b2451],
4	119	CD	NUMBER	119	dep	1	SENT_390	[p21l627t2409r703b2446],
5	:	:	O	:	_	0	SENT_390	[p21l627t2409r703b2446],
6	2854	CD	DATE	2854	number	7	SENT_390	[p21l721t2408r891b2447],
7	—	CD	NUMBER	—	dep	4	SENT_390	[p21l721t2408r891b2447],
8	57	CD	NUMBER	57	dep	7	SENT_390	[p21l721t2408r891b2447],
9	.	.	O	.	_	0	SENT_390	[p21l721t2408r891b2447],

1	Price	NNP	O	Price	nn	2	SENT_391	[p21l15t2475r120b2513],
2	MI	NNP	O	MI	_	0	SENT_391	[p21l135t2477r207b2524],
3	,	,	O	,	_	0	SENT_391	[p21l135t2477r207b2524],
4	Berger	NNP	PERSON	Berger	nn	5	SENT_391	[p21l226t2477r366b2525],
5	PB	NN	O	pb	appos	2	SENT_391	[p21l381t2477r451b2518],
6	,	,	O	,	_	0	SENT_391	[p21l381t2477r451b2518],
7	Teirstein	NNP	PERSON	Teirstein	nn	8	SENT_391	[p21l466t2475r651b2513],
8	PS	NNP	O	PS	appos	2	SENT_391	[p21l667t2476r733b2518],
9	,	,	O	,	_	0	SENT_391	[p21l667t2476r733b2518],
10	et	FW	O	et	nn	11	SENT_391	[p21l749t2481r787b2513],
11	al.	FW	O	al.	appos	2	SENT_391	[p21l800t2473r845b2513],
12	.	.	O	.	_	0	SENT_391	[p21l800t2473r845b2513],

1	Standard	NNP	O	Standard	_	0	SENT_392	[p21l864t2473r1065b2513],
2	-	:	O	-	_	0	SENT_392	[p21l864t2473r1065b2513],
3	vs	CC	O	vs	cc	4	SENT_392	[p21l1078t2487r1121b2513],
4	high-dose	JJ	O	high-dose	nsubj	1	SENT_392	[p21l1135t2473r1343b2525],
5	clopidogrel	NN	O	clopidogrel	dep	4	SENT_392	[p21l13t2532r248b2584],
6	based	VBN	O	base	_	0	SENT_392	[p21l260t2532r382b2571],
7	on	IN	O	on	_	0	SENT_392	[p21l396t2546r450b2571],
8	platelet	NN	O	platelet	nn	10	SENT_392	[p21l463t2532r617b2583],
9	function	NN	O	function	nn	10	SENT_392	[p21l629t2531r810b2571],
10	testing	NN	O	testing	prep_based_on	1	SENT_392	[p21l822t2534r966b2584],
11	after	IN	O	after	_	0	SENT_392	[p21l980t2531r1075b2571],
12	percutaneous	JJ	O	percutaneous	amod	14	SENT_392	[p21l1088t2540r1373b2583],
13	coronary	JJ	O	coronary	amod	14	SENT_392	[p21l13t2604r199b2642],
14	intervention	NN	O	intervention	prep_after	1	SENT_392	[p21l211t2593r481b2630],
15	:	:	O	:	_	0	SENT_392	[p21l211t2593r481b2630],
16	the	DT	O	the	det	17	SENT_392	[p21l496t2590r563b2630],
17	GRAVITAS	NNP	O	GRAVITAS	nsubj	18	SENT_392	[p21l578t2593r815b2630],
18	randomized	VBD	O	randomize	parataxis	1	SENT_392	[p21l831t2590r1090b2630],
19	trial	NN	O	trial	dobj	18	SENT_392	[p21l1102t2590r1196b2630],
20	.	.	O	.	_	0	SENT_392	[p21l1102t2590r1196b2630],

1	JAMA	NNP	O	JAMA	_	0	SENT_393	[p21l1206t2593r1346b2642],
2	2011	CD	DATE	2011	num	1	SENT_393	[p21l1360t2594r1459b2636],
3	;	:	O	;	_	0	SENT_393	[p21l1360t2594r1459b2636],
4	305	CD	NUMBER	305	num	6	SENT_393	[p21l13t2652r98b2689],
5	:	:	O	:	_	0	SENT_393	[p21l13t2652r98b2689],
6	1097	CD	DATE	1097	dep	1	SENT_393	[p21l115t2653r312b2691],
7	—	CD	NUMBER	—	number	8	SENT_393	[p21l115t2653r312b2691],
8	105	CD	NUMBER	105	dep	6	SENT_393	[p21l115t2653r312b2691],
9	.	.	O	.	_	0	SENT_393	[p21l115t2653r312b2691],

1	Mega	JJ	O	mega	amod	2	SENT_394	[p21l14t2719r129b2768],
2	IL	NN	O	il	_	0	SENT_394	[p21l143t2719r197b2766],
3	,	,	O	,	_	0	SENT_394	[p21l143t2719r197b2766],
4	Hochholzer	NNP	PERSON	Hochholzer	nn	5	SENT_394	[p21l215t2715r465b2755],
5	W	NNP	PERSON	W	appos	2	SENT_394	[p21l477t2719r529b2761],
6	,	,	O	,	_	0	SENT_394	[p21l477t2719r529b2761],
7	Frelinger	NNP	PERSON	Frelinger	nn	9	SENT_394	[p21l547t2715r739b2768],
8	AL	NNP	PERSON	AL	nn	9	SENT_394	[p21l750t2718r812b2754],
9	III	NNP	PERSON	III	appos	2	SENT_394	[p21l827t2719r891b2761],
10	,	,	O	,	_	0	SENT_394	[p21l827t2719r891b2761],
11	et	FW	O	et	nn	12	SENT_394	[p21l907t2723r944b2755],
12	al.	FW	O	al.	appos	2	SENT_394	[p21l957t2715r1002b2755],
13	.	.	O	.	_	0	SENT_394	[p21l957t2715r1002b2755],

1	Dosing	NN	O	dosing	nn	2	SENT_395	[p21l1020t2718r1171b2768],
2	clopidogrel	NN	O	clopidogrel	nsubj	3	SENT_395	[p21l1185t2715r1420b2768],
3	based	VBN	O	base	_	0	SENT_395	[p21l11t2775r134b2815],
4	on	IN	O	on	_	0	SENT_395	[p21l147t2789r201b2815],
5	C	NN	O	c	nn	6	SENT_395	[p21l218t2778r250b2815],
6	YPZC	NN	O	ypzc	prep_on	3	SENT_395	[p21l253t2778r371b2815],
7	19	CD	NUMBER	19	num	8	SENT_395	[p21l374t2778r416b2815],
8	genotype	NN	O	genotype	dep	6	SENT_395	[p21l429t2783r619b2827],
9	and	CC	O	and	_	0	SENT_395	[p21l633t2775r712b2815],
10	the	DT	O	the	det	11	SENT_395	[p21l725t2775r791b2815],
11	effect	NN	O	effect	prep_on	3	SENT_395	[p21l806t2775r920b2815],
12	on	IN	O	on	_	0	SENT_395	[p21l934t2789r987b2815],
13	platelet	NN	O	platelet	nn	14	SENT_395	[p21l1001t2775r1154b2826],
14	reactivity	NN	O	reactivity	prep_on	11	SENT_395	[p21l1167t2777r1358b2827],
15	in	IN	O	in	_	0	SENT_395	[p21l1370t2777r1413b2814],
16	patients	NNS	O	patient	prep_in	3	SENT_395	[p21l12t2836r179b2885],
17	with	IN	O	with	_	0	SENT_395	[p21l193t2834r287b2873],
18	stable	JJ	O	stable	amod	20	SENT_395	[p21l302t2834r422b2873],
19	cardiovascular	JJ	O	cardiovascular	amod	20	SENT_395	[p21l436t2834r740b2873],
20	disease	NN	O	disease	prep_with	3	SENT_395	[p21l753t2834r915b2873],
21	.	.	O	.	_	0	SENT_395	[p21l753t2834r915b2873],

1	JAMA	NNP	O	JAMA	_	0	SENT_396	[p21l925t2837r1065b2886],
2	2011	CD	DATE	2011	num	1	SENT_396	[p21l1079t2837r1178b2879],
3	;	:	O	;	_	0	SENT_396	[p21l1079t2837r1178b2879],
4	306	CD	NUMBER	306	num	6	SENT_396	[p21l1195t2837r1280b2873],
5	:	:	O	:	_	0	SENT_396	[p21l1195t2837r1280b2873],
6	2221-28	CD	NUMBER	2221-28	dep	1	SENT_396	[p21l1297t2837r1477b2873],
7	.	.	O	.	_	0	SENT_396	[p21l1297t2837r1477b2873],

